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FOREWORD 
These guidelines are intended to provide guidance as to the fonnat and presentation of  the documentation to be 
submitted, to applicants wishing to have active substances included in Annex I to Directive 911414/EEC, as 
well  as  to  other interested  parties  wishing  to  have  other infonnation  taken  into account  by  the  relevant 
regulatory authorities.  The summaries of  data and information included in the appendices to these guidelines 
are intended to be illustrative of the approach to be taken in the preparation of the comprehensive summaries 
required.  The appendices concerned have not been critically examined for their technical content. 
The current draft of  the guidelines was prepared by the Commission with the benefit of  the comments made on 
earlier drafts,  by  experts  from  the  competent  authorities  of the  Member  States  during  the  course  of the 
European Commission Pilot Project meetings (ECPPM) and the first two rounds of the European Commission 
Co-ordination (ECCO) meetings organized by the Biologische Bundesanstalt fiir Land- und Forstwirtschaft 
(BBA) and the Pesticides Safety Directorate (PSD).  In preparing this current draft, the Commission also had 
the benefit of the comments provided in the context of the  Joint EU-OECD Meeting on guidance documents 
for industry data submissions (dossiers) and country data review  reports (monographs), which was held in 
Dublin on 25 and 26 September 1997.  Finally, the Commission had available to it comments provided by 
ECPA and by GCPF. 
In preparing this draft of  the guidelines, the current texts of  the revised versions of  the various chapters of  both 
Annex nand Annex III of  the Directive, whether existing in adopted or in draft fonn, were relied upon
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• 
Commission  Directive 93n1/EEC of 27 July  1993  amending  Council  Directive  911414/EEC  concerning the placing of plant 
protection products on the market  OJ No L 221,31. 8. 1993, p 27 
Corrigendum to Commission Directive 93n1/EEC of27 July 1993 amending Coubcil Directive 91/414/EEC concerning the placing 
of  plant protection products on the market.  OJ No L 4, 6. 1. 1996, p 16 
Commission  Directive  94/37/EC  of 22  July  1994  amending  Council  Directive  911414/EEC  concerning the  placing  of plant 
protection products on the market  OJ No L 194,29. 7. 1994, p 65 
Commission Directive 94n91EC of 21  December 1994 amending Council Directive 911414/EEC concerning the placing of plant 
protection products on the market OJ No L 354, 31. 12. 1994, p 16 
Corrigendum to Commission Directive 94n91EC of 21  December 1994 amending Council Directive 911414/EEC concerning the 
placing of  plant protection products on the market  OJ No L 280,23. 11. 1995, p 58 
Commission  Directive  95/35/EC of 14  July  1995  amending  Council  Directive  911414/EEC  concerning the  placing of plant 
protection products on the market  OJ No L 172,22. 7. 1995, p 6 
Commission  Directive  95/36/EC  of 14  July  1995  amending ·council  Directive  911414/EEC  concerning the.  placing of plant 
protection  products on the market.  OJ No L 172, 22. 7. 1995, p 8 
Commission  Directive  96/12/EC of 8  March  1996 amending  Council  Directive  911414/EEC  concerning the  placing  of plant 
protection products on the market.  OJ No L 65, 15 March 1996, p 20 
Commission  Directive  96/46/EC  of 16  July  1996  amending  Council  Directive  911414/EEC  concerning the  placing  of plant 
protection products on the market  OJ No L 214,23 August 1996, p 18 
Commission Directive 96/68/EC of 21  October 1996 amending Council  Directive 91/414/EEC concerning the placing of plant 
protection products on the market.  OJ No L 277,21 October 1996, p 25 
Commission Document 7109Nl/94- rev 6, 14 July 1995-Guideline developed within the Standing Committee on Plant Health with 
regard to the applicability of Good Laboratory Practice to data requirements  according to Annexes  II,  Part A, and III,  Part A, of Council 
Directive 91/414/EEC 
Commission Document 7017Nl/95- rev 4,  10 June 1996- Guideline developed within the Standing Committee on Plant Health 
with regard to the acceptability of  data, whether or not performed in accordance with the principles of  Good Laboratory Practice (GLP) 
Commission Document 1607  NII97 - rev 1 of22 July 1997 - Guidelines for the generation of  data concerning residues as provided in 
Annex II part A, section 6 and Annex III, part A, section 8 of Directive 91/414/EEC concerning the placing of  plant protection products on the 
market 
Commission Document 7028Nl/95-rev 2  of6 January 1997-Appendix A, Metabolism and distribution in plants 
Commission Document 7029Nl/95-rev 4  of21 January 1997- Appendix B, General Recommendations for the design, preparation 
and realization of  residue trials 
Commission Document 7524Nl/95-rev 1 of7 January 1997-Appendix C. Testing of  plant protection products in rotational crops 
Commission Document 7525Nl/95- rev I  of 16 January 1997- Appendix D, Comparability, extrapolation, group tolerances and 
data requirements 
Commission Document 7035Nl/95-rev 4  of7 January 1997-Appendix E, Processing studies 
Commission Document 7030Nl/95-rev 2  of6 January 1997-Appendix F, Metabolism and distribution in domestic animals 
Comn:Ussion Document 7031 Nl/9  5 - rev 3  of  4 March 1996 - Appendix G, Livestock feeding studies 
Commission Document 7032Nl/95-rev 4  of7 January 1997- Appendix H. Storage stability of  residue samples 
Commission Document 7039/Vl/95- of22 July 1997-Appendix I, Calculation of  maximum residue levels and safety intervals 
('()If~ V  1/  S-2.,  ..............  _.  ____________________ _ Where on  particular points of detail, additional or more detailed guidance is required,  applicants and other 
interested  parties  are  advised  to  contact  the  designated  authority  of the  Member  State  to  which  the 
docuni'entation is to  be  submitted.  The names and addresses of the designated authorities of the Member 
States. the contact points in each Member State for the application of  Directive 91/414/EEC. the contact points 
in each designated authority and in the Commission to which dossiers for new active substances should be sent 
and the contact points in each designated authority and the Commission to which dossiers for active substances 
included in the re-evaluation programme should be sent, are listed in Commission document ·l6061VI/95 
2
,  a 
document which is updated on a regular basis.  The requirements of the various designated authorities with 
respect  to  the number of complete and summary dossiers to  be submitted for both new and existing active 
substances are also listed in that document. 
These guidelines have been conceived as an opinion of  the 'Commission Services and were elaborated in co-
operation with the Member States.  Being guidelines, they are not intended to·have legally binding effects.· 
Given  its  nature,  this  document  does  not prejudice  any  measures  taken  by a  Member  State  or  by the 
Commission in the implementation of  the measures concerned,  nor any case law produced by the European 
Court of  Justice. 
Commission Document 1606!VII95, rev 15 of  10 December 1997, Working document· contact points for the application of 
Directive 91 /414/EEC. for the re-evaluation programme for existing active substances, for the evaluation of  new active substances, and for the 
exchange of  information according to Article 12 
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1.1 
1.2 
1.3 
1.4 
1.5 
1.6 
GENERAL INTRODUCTION 
The guidance provided and criteria specified, apply to the preparation of complete dossiers 
and summary dossiers, whether submitted in support of applications for inclusion of·active 
substances in Annex I, or in the context of the review or renewal of  any such inclusion.  . 
While requiring standardization in general lay out, subject matter, terminology and units of 
measurement. applicants nevertheless are required to use expert judgement in preparing the 
documentation  concerned.  Within  the  constraints  imposed  by  the  provisions  of the 
Directive,  which  require  the  submission  of separate  Annex  II  and  Annex  III  dossiers, 
applicants nevertheless should treat these guidelines as providing a degree of  flexibility. 
These guidelines and criteria apply to documentation submitted for consideration, whether 
submitted  by  applicants,  or  by  other  interested  parties  wishing  to  submit  technical  or 
scientific information, with regard to the potentially dangerous effects of active substances, 
plant protection products, or their residues, on human or animal health or the environment. 
The objective is to achieve standardization, to the extent that is practicable and feasible, of 
the format and presentation of  documentation submitted, with a view to: 
•  ensuring the quality and consistency of  the documentation submitted~ 
•  facilitating  efficiency  and  economy  in  the  use  of resources  necessary  for  the 
preparation of  that documentation; 
•  facilitating  applicants  in  checking  the  completeness  and  quality  of  the 
documentation prior to its submission; 
•  facilitating the use of  electronic media for the submission, archiving and retrieval of 
the documentation submitted; and 
•  facilitating  efficiency  and  economy  in  the  use  of resources  necessary  for  its 
evaluation. 
Notwithstanding the clear need for evaluators, whether toxicologists, chemists or biologists, 
to assess original study reports and supporting data and information, summaries of the data 
base submitted are also required (dossier summaries), to facilitate: 
•  .checking for completeness by applicants and by the designated authorities of the 
Member States; 
•  evaluation  and  assessment  of the  documentation  concerned  by  the  Rapporteur 
Member State concerned; 
•  evaluation  and  assessment  of the  documentation  concerned  by  the  committees 
established or convened by the Commission for that purpose; and 
•  decision making by the Commission. 
Accordingly, those wishing to submit data and information  .. in support of proposals for the 
inclusion  of active  substances  in  Annex  I  of the  Directive,  are  themselves  required  to 
summarize, evaluate and assess the data concerned in the light of the relevant evaluative and 
decision making criteria.  They are also required to make proposals for the decision to be 
· made in the light of  their assessment of the data and information concerned, proposals which 
should be supported with statements as to the rationale used. 1.7 
1.8 
1.9. 
1.10 
-2-
General Introduction 
The tiered approach specified for the preparation of dossier summaries in these guidelines is 
designed to facilitate efficiency  in the use of evaluative resources and to facilitate decision 
making.  The approach specified further serves to facilitate efficiency in the use of resources 
necessary for the preparation of summary dossiers since summaries relating to preparations, 
when supplemented with relevant efficacy  data and information,  will  also be  suitable for 
submission to the Competent Authorities of the Member States in support of applications for 
the authorization of the. plant protection products concerned. 
Forms,  developed  to  facilitate  checks  to  be carried  out  to  ensure  that  all  the  necessary 
infonnation, data and summaries have been included in dossiers submitted and which are to 
be completed and submitted by applicants, are also intended to be of  benefit to applicants for 
the purposes of checking that all the necessary information, data and summaries have been 
included in dossiers being prepared for submission. 
Standard Units, Terms and Abbreviations: 
e  Standard Units 
•  Standard Terms and 
Standard Abbreviations 
the  English  language  version  of  Standard 
International  Units  must  be  used  in  reporting 
and  summarizing  tests  and  studies,  although 
other  units,  if desired  or considered  relevant, 
may be used in parentheses 
3
, 
in the interest of  avoiding confusion~ standard 
technical terms and abbreviations ~  specified in 
Appendices  1  and  2,  must  be  used  - these 
Appendices  will  be  further  developed  as 
required.  Where terms and abbreviations not 
listed  are used,  a  con~ise explanation  of each 
such term or abbreviation should be provided in 
the text when it is used for the first time.  In 
addition,  a  listing of all  such additional  terms 
and  abbreviations  should  be  provided  as  an 
Annex to each relevant summary document. . 
Hard copies of  complete and summary dossiers, should be Submitted.  In addition, applicants 
should provide information in a suitable electronic form in accordance with the requirements 
of the  relevant designated authority - applicants are advised to discuss the approach they 
propose  using with the designated authority of the Member  State  to  which  they  propose 
making applicatiqn.  A  number of options are available for the electronic submission of 
information.  Of  the two options described here under, the first is the minimum considered 
acceptable, the second option being the preferred approach: 
Option 1  the summary dossier, which contains the summary and assessment information 
and supporting documentation.  but  not  the  test  and study  reports,  should  be 
provided  in  a  suitable  word  processor,  and  where  appropriate,  spreadsheet 
fonnat, saved on disc~ 
Option 2  the  entire  dossier,  including  test  and  study  reports,  individual  animal  data, 
historical  control  data,  other  relevant  data  and  information,  as  well  as  the 
summary and assessment infonnation and supporting documentation, should be 
provided using the CADDY electronic dossier interchange and archiving format, 
3  Particular attention is drawn to the requirement to use metric units- e.g.  in the case of application rates, kg active substancelha~ content of 
acti\'e substance in formulations, glkg or gil; content of  residues, mglkg; doses in feeding studies, mglkg body weight 
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which utilizes CD-ROM technology.  The CADDY system allows submission of 
study  repons as  image files  and has provision for  the  summary  dossier to  be 
included on  the CD-ROM  in  the form  of word  processor/spreadsheet files,  as. 
appropriate.  Further information on CADDY can be obtained from -
Dr Jurgen Wenzelburger 
Geschaftsbereich Pflanzenschut Entwicklung Registrierstrategie 
Landwirtschaftszentrurn Monheim 
Alfred-Nobel  Stra~e 50 
D-51368 Leverkusen 
Germany 
Telefax number:  +.49.2173.38 33 23 
email:  hans.juergen.  wenzelburger@bayer-ag.de 
and by means of  the GCPF server at the following internet address - . 
http:/  /www.gcpf.org/ 
Through the use of CADDY, savings in the costs of assembling,  transporting, 
handling and storing complete dossiers will accrue to both applicants and the 
designated authorities of  the Member States. 
Regardless  of the  option  chosen,  applicants  are  encouraged,  where  possible,  to  present 
information  in  tabular  form  (e.g.  GAP  Tables  (Documents  D1  and  02),  MRL  lists 
(Documents E1 and E2), reference lists).  Separate items of information such as the names 
of authors should be allocated to separate cell columns.  A row should be allocated to each 
entry.  Alternatively a  spreadsheet format can be used.  The recommended approach is 
intended  to  facilitate  the  subsequent  manipulation  of the  information  provided  by  the 
designated authority of  the Member State to which application is made. 
The  requirements  of the  various  designated  authorities  with  respect  to  the  number  of 
complete and summary dossiers to be submitted for both new and existing active substances 
are listed in Commission document 1606/VI/95
2
•  Since that document is subject to regular 
updating, applicants are advised to ensure that they consult the currently valid version. -4-
2  DOCUMENTATION REQUIRED 
2.1 
2.1.1 
2.1.2 
2.2 
Document A 
Introduction 
The summary documentation to  be  prepared and submitted, should allow a comprehensive 
understanding of the application and facilitate evaluation and decision making with respect 
to: 
•  the  criteria  specified  in  Articles  4  and  5  of  the  Directive  911414/EEC,  as 
appropriate~ 
•  the criteria and guidelines for evaluation and decision making with respect to the 
inclusion of  active substances in Annex I, where they exist; and 
•  to  the extent that they  are relevant,  the  evaluative  and decision  making criteria 
specified in Annex VI; 
notwithstanding the clear need for reference to the individual study reports and the detailed 
data (e.g.  data on relevant variables for individual animals), during the course of evaluating 
the data base concerned. 
Whether the application involves a proposal for the inclusion of  an active substance in Annex 
I,  or to  vary the conditions of any  such  inclusion,  or relates  to  the renewal  of any  such 
inclusion, the applicant's objective should be to produce summaries and assessments which, 
accurately  reflect  the  conclusions  that  can  be  derived  from  the  data  and  information 
submitted and includes a proposal, prepared by the applicant, for the decision to be taken by 
the Commission on the advice of the Standing Committee on Plant Health,  in accordance 
with Article 6 of  the Directive of 1991. 
Individual Documents Required 
The documentation required comprises a number of separate elements and should include, in 
the following order: 
a statement of  the context in which the dossier is submitted -
•  first inclusion of  a new active substance in Annex I, 
•  first inclusion of  an existing active substance in Annex I, 
•  modification or removal of conditions or restrictions associated with the inclusion of 
an active substance included in Annex  I~ 
•  special review of the inclusion of an active substance in Annex I,  where indications 
exist suggesting that the conditions of inclusion are no longer satisfied, or 
•  routine review anticipating expiry of the period for which the active substance was 
included in Annex I (i.e. following expiry of the period of  inclusion in Annex I)~ 
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2.2  Documentation Required - Individual Documents Required 
Dowment B  where in the context of ArticleS (2) of Directive 91/414/EEC and Commission Regulations 
made pursuant to that Article, there is an obligation on notifiers of particular existing active 
substances to  take all reasonable steps to present collectively the _dossiers  concerned and, 
where it is not possible to so present the dossiers -
•  a claim that all reasonable steps were taken to present the dossiers collectively, and 
•  documentation to justify the claim made~· 
Document C  where  requested,  copies  of existing or proposed  label(s)  and  where  relevant  leaflets  (see 
Article 16 (2) of the Directive) for each of the preparations for which an Annex III dossier is 
submitted and in addition, labels and leaflets relevant to the uses on the basis of  which import 
tolerances are supported or proposed.  Where relevant, a translation of  the texts of labels and 
leaflets submitted; 
Dowment D-1  details of the intended uses (uses that are being supported by the applicant, for which data 
have been provided or for which data are to be provided by a specified date) and conditionS of 
use (GAPs), on both food and feed crops and on non food and feed crops in the territory of 
the EU, supported in relation to  the proposed inclusion of the active substance in Annex I 
(Document D-1) - the information concerned should be provided using fonns as set out in 
Part 1 of Appendix 3.  Uses which are not yet authorized should be identified by means of 
an asterisk or footnote; 
Document D-2  for existing active substances, a list of current authorized uses in EU Member States and an 
indication of whether,  or not,  actually  used  (Document D-2)  - the information concerned 
should be provided using fonns as set out in Part 2 of Appendix 3.  The listing provided 
should include those uses which are currently authorized but which are not being supported 
by the applicant.  The information provided with respect to actual use, should identify those 
authorizations that are not currently availed of (some  uses  or all uses),  and further should 
describe those instances where the rate and manner of use in practice is more restrictive than 
is prpvided for in the existing authorization (e.g.  authorized uses of a plant protection product 
for  which  the  product  is  not  currently  commercialized;  uses  for  which  the  maximum 
authorized application rate is seldom if  ever availed of): 
Dowment D-3  details of the intended uses (uses that are being supported by  the applicant, for which data 
have been provided or for which data are to be pro,·idcd by a specified date) and conditions of 
use (GAPs), on both food and feed crops which arc unported in significant quantities into the 
territory  of the EU and  for  which  import  tolerances  arc  required  (Document  D-3)  - the 
information concerned should be provided using forms as set out  in Part 1 of Appendix 3; 
Document E-1  where they exist, a listing ofEU 'MRLs established for the &Jcti\·c substance, where relevant a 
listing ofMRLs established by Member States and a listing of MRLs established by the CAC 
or proposed by the CCPR, together with the associated residue definitions, should be provided 
(Document E-1) using forms as set out in Part 3 of Appendix 3: 
Document E·2  where  an import  tolerance  is  required,  a  listing  of the  MRLs  established  for  the  active 
substance in countries that export the plants and plant products concerned and in addition, 
where .  relevant,  a  listing  of MRLs  and  import  tolerances  established  in  non-EU  OECD 
countries, together with the associated residue definitions, should be provided (Document E-
2) using forms as set out in Part 3 of Appendix 3; -6-
2.2  Documentation Required - Individual Documents Required 
Dowment F 
Dowments 
G ·I 
Dowment G 
Doaament H 
Dowment I 
Dowment J 
where relevant. in the case of  existing active substances, a copy of  each notification submitted 
to the Commission in the context of the programme of work undertaken for the examination 
of existing active substances pursuant to Article 8 (2) of ihe Directive; 
unless a dossier in accordance with Annex II is submitted for every formulant included in the 
preparation (ingredient other than active substance}, the following -
•  a statement as to whether the substance is permitted in food,  animal feeding stuffs, 
medicines or cosmetics in accordance with Community legislation, 
•  a copy of the safety data sheet prepared in accordance with Directive 67  /548/EEC, 
and 
•  where requested, other available toxicological and environmental data; 
where  relevant  and desired,  a  statement  to  indicate  the  data and information  involving 
industrial and commercial secrets for which confidentiality is requested, in accordance with 
Article 14 of  Directive 91/414/EEC.  To facilitate the secure handling of such information, it 
should  be  included  in  a  separate  file,  where  it  is  feasible  to  do  so  (e.g.  details  of 
manufacturing processes,  detailed specifications of active  substance  and preparations and 
individual  medical  records).  The file  should be identified as containing industrial  and 
commercial  secrets.  Where  applicants  wish  to  have  data  and  information  involving 
industrial and commercial secrets treated as confidential, applicants should -
•  taking account of the  provisions  of Article  14  of Directive  91/414/EEC  and of 
Council  Directive  90/313/EEC  of 7  June  1990  on  the  freedom  of access  to 
information on the environment, provide a  listing of the data and information for 
which confidentiality is  requested,  clearly cross-referenced,  for each item,  to the 
relevant test and study reports, as well as to the dossier summaries and supporting 
documentation  submitted  - the  listing should  be  included  in the file  referred  to 
above, 
•  for each item listed, provide a justification for the claim that it is, or constitutes, an 
industrial and commercial secret - the justifications should be included in the file 
r~ferred to above, and 
•  highlight  other  items  of information  for  which  confidentiality  is  requested,  in 
relevant  study  reports,  dossier  summaries  and  supporting  documentation  (e.g. 
identity of  test laboratories); 
Dowment K-11  individual test and study reports in accordance with the requirements specified in Annex II 
Dowment K-Ill  and in Annex III (Figure 1) -
•  although Article 6.2 of the Directive provides that an Annex III dossier for at least 
one  preparation be  submitted,  in order to  ensure that the Annex  I  inclusion,  in 
principle,  embraces  all  uses  that  are  being  supported,  thereby  facilitating 
authorization of preparations containing the active substance by Member States for 
all such uses, the number of  preparations for which an Annex III dossier is submitted 
should be sufficient to reflect the types of formulations and applications envisaged, 
as well as worst case scenarios for operator, worker and environmental exposure, 
I  .. 
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I 
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2.2  Documentation Required - Individual Documents Required 
Documents 
L-N 
Document L-11 
Document L-111 
•  since in accordance with Article 5.1 of.Directive 91/414/EEC, it is necessary that the 
impact of residues. consequent on application consistent with good plant protection 
practice. on human and animal health be assessed, and since, it is not required that 
Annex  III  dossiers  for  all  relevant  preparations  be  submitted,  all  residue  studies 
necessary to assess the exposure of humans and animals to  residues resulting from 
uses which are being supported should be provided as part of the Annex II  dossier, 
thereby facilitating the establishment or review of maximum pesticide residue levels 
(MRLs), as appropriate, and 
•  since in accordance with Article 5.1 ofDirective 91/414/EEC, for the purposes of the 
inclusion  of an active  substance  in  Annex  I,  the  consideration  of efficacy  or of 
unacceptable effects on plants or plant products, does not arise, Annex III dossiers 
submitted need ·not include efficacy study reports - see also subparagraph 3.1.2 (ii). 
However,  in the case of applications for the inclusion of new active substances in 
Annex I,  it is envisaged that an application will  simultaneously be made for the 
authorization of  a plant protection product containing the active substance.  In such 
caSes a complete overview of  efficacy - to be used in the context of the consideration 
of the possible authorization of the plant protection product concerned, but not for 
the consideration of the possible inclusion -of the active substance in Annex I - is 
required as part of  the relevant Annex III dossier summary.  Such overviews should 
be prepared in accordance with the appropriate guidelines 
4
• 
a summary, evaluation and assessment of  the Annex II and each Annex III dossier, prepared 
in accordance with the tiered structure described here under, and presented graphically in 
Figure 1, to include-
(Tier 1) 
Document L (reference lists) 
•  for the individual tests and studies submitted, reports as to their 
quality, prepared by or on behalf of  the applicant, together with a 
list of the test,  study reports and documents submitted - see also 
paragraphs 3.1.1 and 3.2.1, 
Document M-Il 
Document M-Ill 
(Tier II)  •  a summary and assessment of  the individual tests and studies and 
groups of tests and studies, as appropriate, in the light of relevant 
evaluative and decision making criteria - see also paragraphs 3  .1.2 
and 3.2.2, 
•  where relevant,  to  include an evaluation,  cross  referenced  to  the 
supporting documentary  evidence,  of the  relevance  of particular 
studies conducted regionally (e.g.  residue data), to the agricultural, 
plant health and environmental (including .climatic) conditions of 
other  regions,  together  with  the  rationale  for  extrapolations 
proposed, 
4  Commission Document 7600!VI/9S, rev 6 of 14 July 1997, Guidelines and criteria for the preparation and presentation of  data concerning 
efficacy as provided in Annex III. parts A and B. section 6 of Directive 91/414/EEC concerning the placing of  plant protection products on the 
market (biological assessment dossier) 2.2 
-8-
Documentation Required - Individual Documents Required 
Figure 1 
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1.2  Documentation Required - Individual Documents Required 
2.3  - Samples and Analytical Standards 
Dowment N  (Tier Ill)  •  an overall summary and assessment of the application in the light 
of relevant evaluative and decision making criteria. the conclusions 
reached by  the applicant on the basis of the data and information · 
submitted~ together with a statement of  the proposed conditions and 
restrictions  to  be  associated  with  any  inclusion  of the  active 
substance  in  Annex  I.  supported  with  the  rationale  for  the 
proposals made- see also paragraphs 3.3.1 to 3.3.5, and 
Dowment 0  a completed set of the forms for the checking of dossiers for completeness (evaluation forms 
1, 2, 3, and 4- see paragraphs 4.1 to 4.2.4). 
2.3  Samoles and Analytical Standards 
Where requested, a  sample of each active substance as manufactured and which complies 
with the speci:fication(s)  submitted, together with analytical standards for each component 
included in the proposed residue definition and of analYtical standards for inactive isomers 
and impurities of  toxicolo~cal or environmental concern present in significant quantities in 
the active substance as manufactured, shoUld be provided. 3 
3.1 
3.1.1 
(i) 
(ii) 
(iii) 
(iv) 
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DOSSIER  SUMMARIES  . AND  OVERALL  ASSESSMENTS 
REQUIREMENTS 
DETAILED 
Annex D dossier 
Tier I - Document L-11 - Checks  as  to  the  acceptability  of the  quality  of individual 
Annex n test and study reports 
The dossier summary should,  in  principle,  include a  report  as to  the acceptability of the 
quality of  each individual test and study submitted to address each point of Annex II.  Those 
reports should be assembled in six Sections as specified in subparagraph (xv).  Within those 
Sections, or Sub-Sections, the sequence set out in the relevant part of Annex II, should be 
followed, ensuring that each point of Annex II is addressed. 
The Tier I checks as to the acceptability of the quality of individual test and study reports to 
be submitted are intended to facilitate efficiency in the use of the resources available to the 
competent  authorities  of the  Member  States  for  the  evaluation  of dossiers  (scientific 
secretariats  and specialist  evaluators).  In  particular they  are  intended  to  facilitate  the 
checking of dossiers .as to completeness and fonna~ checks to ensure compliance with the 
principles of GLP/GEP, as appropriate and, checks relating to the suitability of test methods 
used.  Except as  specified hereunder for supervised residue trials and for soil  dissipation 
studies· (subparagraphs  viii  and  ix),  a  summary  of the  findings  or experimental  results 
obtained, should not be included in Tier I. 
In the case of testing as to the physical and chemical properties of active substances and by 
way  of exception,  it is  not necessary  that reports  as to  the quality  of individual  tests  be 
provided.  Details of the methodologies used should be provided in the Tier II summary (see 
paragraph 3.1.2) and instances of non compliance with or, of divergence or omissions from 
the  requirements  relating  to  the  principles  of GLP  or GEP,  as  appropriate,  should  be 
indicated and be justified for each individual test or study. 
Where the test methods used were those currently specified, and where the tests or studies 
concerned were conducted in accordance with the, principles of GLP/GEP,  as appropriate, 
Tier 1 checks as to the acceptability of the quality of individual test and study reports should 
take the following form (examples are provided in Part 1 of Appendix 4): 
1.1 
1.2 
2 
3.1 
3.2 
3.3 
3.4 
3.5 
3.6 
4.1 
4.2 
5 
6.1 
the Annex II point addressed, 
a description of the type of test or study; 
reference point (location) of the repon in  the dossier (e.g.  section 3, Annex 
IIA point 5.2.1/01)~ 
the names of  the authors, 
the title of the test or study report. 
the owner of the report, 
an indication as to whether it is a published or unpublashcd report, 
the report number, 
the date of  the report; 
the name and address of the testing facility. 
the laboratory report/project number: 
the dates of commencement and completion of experimental work~ 
the identity of the  test  substance or material  (ISO  common  name,  batch 
number and degree of  purity), 
I 
"' 
I 
I 
I 
.I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I I 
.... 
I 
3.1.1 
~ 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
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6.2  an explicit reference to the relevant specification of-composition of  the test 
substance or material~ 
7.1  the identity of the test guideline used, 
7.2  where test guidelines provide choice as to the method to be used, a reasoned 
justification for the method used, 
7.3  where  deviations  from  the,  test  guidelines  specified  are  employed,  a 
description of  and reasoned justification for the deviations; 
8  confirmation  that  the  principles  of GLP  or  GEP,  as  appropriate,  were 
complied with - in the event of non-compliance a description of the degree 
of  non-compliance and a justification for non-compliance. 
(v)  For tests and studies for which the test methods used were not those currently specified (i.e. 
studies conducted in accordance with test guidelines which have been replaced or were never 
accepted),  a  more  detailed  ~pproach is  necessary  in  which  each  of the  following  points 
should be addressed in the Tier 1 checks as to the acceptability of the quality of individual 
test and study reports - where a particular heading is not relevant,  the reason that it is not 
relevant should be stated: 
1.1  the Annex II point addressed, 
1.2  · a description of the type of test or study; 
2  reference point (location) of the report in the dossier (e.g.  section 3, Annex 
IIA point 5.2.2 /01)~ 
3  .1  the names of  the authors, 
3. 2  the title of the test or study report, 
3. 3  the owner of the report, 
3.4  an indication as to whether it is a published or unpublished report, 
3. 5  the report number, 
3. 6  the date of  the report; 
4.1  the name and address of  the testing facility, 
4.2  the laboratory report/project number; 
5.1  the dates of  commencement and completion of  experimental work, 
5.2  a statement of  the objectives of  the test or study; 
6.1  the identity of the test  substance  or material  (ISO  common  name.  batch 
number and degree of  purity), 
6.2  an explicit reference to the relevant specification of composition of the test · 
substance or material, 
6.3.  where available, data relevant to the storage stability of the test substance 
or material,, 
6.4  where relevant and available, data as to the stability of  the test -substance or 
material. in the dosing vehicle, 
6.5  where  relevant  and  available,  data  as  to  the  homogeneity  of the  test 
substance or material in the dosing or testing vehicle, 
6.6  where data relating to the stability or homogeneity of the test substance is 
not  available  (e.g.  certain  older studies),  a justification of the  scientific 
validity of  the study, 
6.7  where relevant, information as to the physical form of  the test substance or material, 
6.8  full details of  the composition of  any dosing vehicles or solvents used; 3.1.1 
-12-
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(vi) 
(vii) 
7.1 
7.2 
7.3 
7.4 
7.5 
8.1 
8.2 
8.3 
8.4 
9.1 
9.2 
9.3 
the identity of  the test method used, 
where not a method specified in Annex II, a reasoned justification for the 
choice of method used in terms of its scientific validity and comparability 
with the method specified in Annex II, 
on request, a copy of the method - full details of methods used which are 
unlikely to  be accessible to  competent authority of the Member State to 
which  the dossier  is  submitted,  should  be  attached  to  the  study  or test 
report, 
where test guidelines provide choice as to the method to be used, a reasoned 
justification for the method used, 
where deviations from the test guidelines specified, or from other methods 
used,  are  employed,  a  description  of and  reasoned justification  for  the 
deviations; 
where relevant, an indication as to whether, or not,  the test or study has 
been conducted by a laboratory certified as to its competence to conduct the 
test or study in compliance with the principles of GLP, 
where relevant, the certifying authority, 
where applicable, an indication as to whether, or not, the principles of GLP 
have been complied with, 
where relevant,  a justification for non compliance with the principles of 
GLP~ 
where relevant, a clear statement that the requirements of points 2.2 and 
2.3  of the  introduction  to  Annex II to  Directive  93171/EEC  have been 
complied with - Good Experimental Practice (GEP), 
where the requirements of points 2.2 and 2.3 of the introduction to Annex 
II to Directive 93171/EEC apply, whether conducted by an official or an 
officially recognized testing facility or organization, 
where relevant, a justification for non compliance with the requirements of 
points 2.2 and 2.3 of  the introduction to Annex II to Directive 93171/EEC~ 
10  a description of  the test system; 
11  the identity of  any statistical and other techniques applied to the data to aid 
interpretation,  together  with  adequate  documentation  thereof  and  a 
justification  for  the  use  of the  technique  selected  where  non  standard 
techniques are used; 
12.1  where reference to published papers is  made in  Ti£7  I quality checks, the 
bibliographic referpnces concerned. 
12.2  copies of  the papers concerned: and 
13  where reference to unpublished data is made m Tier I quality checks (e.g.  historical 
control data on strains of  test animals) a summal)· of  such data. 
A number of  specimens of Tier I checks as to the acceptability of the quality of individual test 
and study reports for Annex II studies. conducted in accordance with test guidelines other 
than those specified, are contained in Part 2 of Appendix 4. 
It is not necessary that Tier I checks as to acceptability of the quality of reports be provided 
for  reports  relating  to  analytical  methods,  regardless of whether  the  methods  concerned 
relate  to  residues  analysis,  analysis  of active  substance  as  manufactured  or analysis  of 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
·I 
I 
I 
I 
I 
I 
I I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
3.1.1 
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(viii) 
(ix) 
(x) 
(xi) 
(xii) 
formulations.  Details of the methods of analysis concerned should be provided in the Tier 
II summary and evaluation (see paragraph 3.1.2 viii and Appendix 7, Part 2). 
By way of further exception to the general rule, summaries of individual supervised residue 
trials submitted in accordance with Annex II, point 6.3 (Residue trials), rather than checks as 
to the acceptability of the quality of individual study reports, should be provided.  For the 
purposes of compiling such Tier I summaries, the forms as contained in Part 1 of Appendix 
5, should be used.  Trials data relevant to all  GAPs for which Community MRLs exist or 
are proposed, should be included.  Where an import tolerance is required, trials data relevant 
to all GAPs for which the import tolerance is required must also be included.  The forms 
concerned should be grouped by crops and within crops by the country in which trials were 
conducted.  · 
A similar approach should be taken with respect to soil dissipation studies (Annex II, point 
7  .1.1.2.2.  In preparing Tier I summaries of soil dissipation studies, the forms as contained 
in Part 2 of  Appendix 5, should be used. 
The final part of Tier I of  the SUIIllllai)' dossier should comprise a listing of  all test and study 
reports, test guidelines, and published'papers, submitted as part of the dossier and a separate 
listing of all test and study reports, test guidelines, and published papers, not submitted as 
part of the dossier, of  which the applicant is aware and which are relevant to the regulatory 
decision  proposed  (i.e.  those  that address  relevant  end-points).  It is  to  be  noted  that 
applicants are obliged to submit all relevant information of  which they are aware concerning 
potentially dangerous effects, not just a reference to such reports and papers. 
In preparing the listing,  applicants  should  conduct  a  detailed  literature  search  - expert 
judgement is required to determine the nature and extent of  the search to be conducted.  The 
date on which the reference list was  compiled, the identity of the data bases searched, the 
date range established for the purposes of the search (e.g.  abstracts dated earlier than 1980 
not requested),  the language constraints, if  any,  imposed and the key words used for the 
purposes of  the literature search, should be indicated. 
The listing of test and study reports, test guidelines, and published papers submitted as part 
of the complete dossier,  should cover each section of the dossier separately.  References 
which relate to  more than one section should be listed in each relevant section.  Within 
sections,  for  each  Annex  II  point,  and where  appropriate,  sub-point,  the  list  should  be 
arranged alphabetically by author.  Where for a particular author there is more than "tme 
report or paper, they should be listed in chronological order, with the most recent report or 
paper listed last.  In cases where for a particular author, more than one reference is listed for 
any one year, the references should be distinguished by inserting letters after the year i.e. a, b, 
c, etc., as appropriate.  For each test and study report, an indication .should be provided as to 
whether or not it is published and as to whether or not it was conducted in compliance with 
the principles of GLP or the requirements of points 2.2 and 2.3 of the introduction to Annex 
II to Directive 93/71/EEC, as appropriate.  The listing of individual test and study reports 
should be annotated to indicate their owner and to indicate whether or not data protection is 
claimed in accordance with the requirements of Article 13  (3) (d) of the Directive.  Before 
decisions to  include particular active  substances in Annex I are made,  applicants may be 
. required,  where appropriate,  to  certify  that the studies for  which they  have claimed. data 
protection,  were  not submitted to  the designated authorities of any of the Member States 
(including those of Austria, Finland and Sweden) in support of an authorization decision.  A 
suggested format for the presentation of the listings of test and study reports, test guidelines, 
and published papers submitted is contained in Part 1 of Appendix 6.  In order to facilitate 
the subsequent manipulation of the reference list by  the designated authority to which it is 
submitted.  the listing should be compiled using a word processing table function,  using a 
separate row for each reference. 3.1.1 
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(xiii) 
(xiv) 
(XV) 
A  second  version  of the  listing  of test  and study  reports,  test  guidelines,  and  published 
papers, submitted as part of the complete dossier, which should again cover each section of 
the dossier separately, but in which the tests and studies are listed alphabetically by author 
and for individual authors, in chronological order, should be provided.  A suggested format 
for  the  presentation  of the  second  listing  of test  and  study  reports,  test  guidelines,  and 
published papers submitted is contained in Part 2 of Appendix 6.  In order to facilitate the 
subsequent  manipulation  of the  reference  list  by  the  designated  authority  to  which  it  is 
submitted,  the listing should be  compiled using a word processing table function,  using a 
separate row for each reference. 
In the case of test and study reports and published papers not submitted, a separate listing of 
such documents, arranged alphabetically by author, should be  provided at the end of each 
section.  A suggested format for the presentation of the listings of test and study reports and 
published papers not submitted is contained in Part 3 of Appendix 6.  In order to facilitate 
the subsequent manipulation of the reference list by  the designated authority to which it is 
submitted, the listing should be compiled using a word  processing table function,  using a 
separate row for each reference. 
The  separate  sections  for  which  a  listing  of test  and study- reports,  test  guidelines,  and 
published papers is required are as follows: 
Section 1  •  Identity of  the active substance (Annex II, Point 1), 
Section 2 
Section 3 
Section 4 
Section 5 
Section 6 
•  Physical and chemical properties of the active substance (Annex II,  Point 
2), 
•  Further information on the active substance (Annex II, Point 3), and 
•  Proposals including justification for the proposals for the classification and 
labelling of  the active substance (Annex II, Point 10);  · 
Analytical methods, (Annex II, Points 4.1 and 4.2); 
Toxicological and metabolism studies on the active  substance  (Annex II, 
Point 5); 
Residues in or on treated products, food or feed (Annex II, Point 6); 
Fate and behaviour in the environment (Annex II, Point 7); and 
Ecotoxicological studies on the active substance (Annex II, Point 8). 
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Tier II - Document M-Il - Annex n dossier su~mary  and assessment 
(i)  The Tier  II  summary should  contain  six  sections  such  that  it  contains a  discussion  and 
interpretation of the results of all  Annex II  tests and studies and within each section,  the 
conclusions reached.  The six sections, which broadly correspond to the main headings of 
Annex II, are those specified in paragraph 3.1.1 (xv). 
(ii) 
(iii) 
(iv) 
(v) 
(vi) 
(vii) 
In accordance with Article 5.1 (b) of  Directive 91/414/EEC, for the purposes of  the inclusion 
of an active substance in Annex I, the consideration ot efficacy or of unacceptable effects on 
plants or plant products, does not arise.  It therefore is neither necessary nor appropriate that 
the Tier II summary include such information~ 
The Tier  II  summary should be confined to  and  rely  only  on that data and information 
contained in the Annex II dossier provided.  If  desired, a reference to corresponding Annex 
III SUmmaries can be included. 
In the· case of non submission of  particular studies, full justifications should be provided. 
Where the principles of GLP or the requirements of points 2.2 and 2.3 of the introduction to 
Annex II to Directive 93171/EEC have not been followed, or where the methodologies used 
were not those prescribed in Annex II or,  where there were deviations from the methods 
prescribed or other methods used, a justification of the overall quality and scientific validity 
of  the test or study reported should be provided. 
As a  general rule, a concise but comprehensive summary of each individual test and study 
should be included.  Each summary should include the following elements, as appropriate: 
•  the reference number of  the test or study; 
•  the appropriate test or study reference (e.g.  Casida et al1919); 
•  the test guideline and method used; 
•  relevant GLP/GEP information; 
•  a brief description of the methodology used; 
• 
• 
a  concise tabular presentation of the  findings  with  supporting  text,  in which  the 
significance of results obtained, effects and ohservations reported, are highlighted; 
and 
conclusions reached (to be highlighted); 
By way of exception to the general rule.  in the  case of 'c:rtain parts of the dossier such as 
that relating to the physical and chemical propenies of  the active substance, and that relating 
to residue trials (supervised residue trials) a tabular approach to  the presentation of the data 
may be appropriate, while in the case of metabolism studies (animals, plants and soil) and 
soil dissipation studies, it may be more convenient to provide summaries of groups of tests 
and  studies.  In the  case of supervised  residues  trials  data,  it is  necessary  that,  where 
relevant, a clear statement be included to indicate the differences,  if any,  in the data base 
included in comparison to that presented by the applicant to the  JMP~  for the purposes of 
the elaboration of CAC MRLs. -16-
3.1.2 ·  D~ssler  Summaries and Overall Assessments - Detailed Requirements - Anne1 II Dossier - Tier II - Doe~~•••  M-Il 
(viii) 
(ix) 
(x) 
(xi) 
Examples of parts of an Annex  II  Tier  II  summary are provided in Appendix  7  - Part  I 
contains the suggested format for that part of  a Tier II summary which relates to the physical 
and chemical properties of the active substance,  Part 2 contains the suggested format  for 
part of a Tier II summary relating to analytical methods,  while Part 3 contains an example 
of part of a Tier II  summary  relating to toxicological and metabolism studies.  Part 4 of 
Appendix 7 contains suggestions for the format to be used for the presentation of residue data 
in summary form  - the suggested approach  is based on that recommended in the JMPR 
Manual for FAO Panel Members 
5
.  An example of  part of  a Tier II summary relating to fate 
and behaviour in the environment (fate  and behaviour in soil),  is provided in Part 5 of 
Appendix 7. 
For each of the six sections of the Tier  II  summary,  it is particularly important that the 
concluding element for each point and the concluding element of sub-sections and sections, 
highlight the parameters of relevance to decision making, and include the rationale relied on 
for the conclusions  n~ached in the light of the weight of evidence provided by  the data 
reported. 
Where relevant, an evaluation, cross referenced to the supporting documentary evidence, of 
the relevance of  particular studies conducted regionally (e.g. residue data), to the agricultural, 
plant health and environmental (including climatic)  conditions of other regions,  together 
with the rationale for extrapolations proposed, should be included. 
Within each section and sub-section. having regard to the data provided, it is necessary that 
each decision making point be highlighted, having regard to: 
•  the weight of  the evidence available - extent, quality and consistency of  the data; 
•  the criteria specified in Article 5 of  Directive 91/414/EEC; 
•  the criteria and guidelines for evaluation and decision making with respect to the 
inclusion of  active substances in Annex I, wher~  they exist; and 
•  to the extent that they are relevant,  the evaluative and decision  making criteria 
specified in Annex VI. 
~  Pesticide residues in food- 1994.  Report of the Joint Meeting of the FAO  Panel  of Experts  on  Pesticide  Residues  in  Food and the 
Environment and the WHO Expert Group on Pesticide Residues.  FAO Plant Production and Protection Paper 127. 
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Annex m dossier 
Tier I - Document L-111 - Checks as to the acceptability of the quality  of individual 
Annex m test and study reports 
(i)  The dossier summary should.  in  principle,  include  a  report  as  to  the  acceptability of the 
quality of each  individual  test  and study  submitted to  address  each point of Annex  III. 
Thos~ reports should be  compiled in seven  Sections as  specified  in subparagraph  (xvi). 
Within those Sections, or Sub-Sections, the sequence set out in the relevant part of Annex III, 
should be followed, ensuring that each point of Annex III is addressed. 
(ii)  Although Article 6.2 of the Directive provides that an Annex m dossier for at least one 
preparation be submitted, in order to ensure that the Annex I  inclusion embraces all 
uses  that .  are  being  supported,  thereby  facilitating  authorization  of  preparations 
containing the active  substance  by  Member States for all  such  uses,  the number of 
preparations for which an Annex m dossier is submitted should be sufficient to reflect 
the types of formulations and applications envisaged, as well as worst case scenarios for 
operator, worker and environmental exposure. 
(iii)  The Tier I checks as to the acceptability of the quality of individual test and study reports to 
be submitted are intended to facilitate efficiency in the use of the resources available to the· 
competent  authorities  of the  Member  States  for  the  evaluation  of dossiers  (scientific 
secretariats  and  specialist  evaluators).  In particular they  are  intended  to  facilitate  the 
checking of dossiers as to completeness and fonnat, checks to  ensure compliance with the 
principles of GLP/GEP, as appropriate and, checks relating to the suitability of test methods 
used.  Except as specified hereunder for supervised residue trials and for soil .dissipation 
studies (subparagraphs ix and x), a summary of  the findings or experimental results obtained, 
should not be included in Tier I. 
(iv)  In the case of testing as to the physical, chemical and technical properties of plant protection 
products  and  by  way  of exception,  it  is  not  necessary  that  reports  as  to  the  quality  of 
individual tests be provided.  Details of the methodologies used should be provided in the 
Tier  II  summary  (see  paragraph  3.2.2)  and  instances  of non  compliance  with  or,  of 
divergence or omissions from the requirements relating to the principles of GLP .or GEP, as 
appropriate, should be indicated and be justified for each individual test or study. 
(v)  Where the test methods used were those currently specified, and where the tests or studies 
concerned were conducted in accordance with the principles of GLP/GEP,  as appropriate, 
Tier 1 checks as to the acceptability of the quality of individual test and study reports should 
take the following form (examples are provided in Part 1 of Appendix 4): 
1.1  the Annex III point addressed, 
1.2  a description of the type of test or study; 
2  reference point (location) of the report in the dossier (e.g.  section 3, Annex 
IliA point 7.1.4/01); 
3.1  the names of  the authors, 
3.2  the title of the test or study report, 
3. 3  the owner of the report, 
3.4  an indication as to whether it is a published or unpublished report, 
3.5  the report number, 
3. 6  the date of  the report; 
4.1  the name and address of the testing facility, 
4.2  the laboratory report/project number; 3.2.1 
,· 
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(vi) 
5 
6.1 
6.2 
7.1 
7.2 
7.3 
the dates of  commencement and completion of experimental work; 
the identity of the test  substance or material  (brand name,  batch  number 
and degree of purity), 
an explicit reference to the relevant specification of composition of the test 
substance or material~ 
the identity of  the test guideline used, 
where test guidelines provide choice as to the method to be used, a reasoned 
justification for the method used; 
where  deviations  from  the  test  guidelines  specified  are  employed,  a 
description of  and reasoned justification for the deviations; 
8  confirmation  that  the  principles  of GLP  or  GEP,  as  appropriate,  were 
complied with - in the event of non-compliance a description of the degree 
of non-compliance and a justification for non-compliance. 
For tests and studies for which the test methods used were not those currently specified (i.e. 
studies conducted in accordance with test guidelines which have been replaced or were never 
accepted),  a  more  detailed approach  is  necessary  in which each of the  following  points 
should be addressed in the Tier 1 checks as to the acceptability of tqe quality of individual 
test and study reports - where a particular heading is not relevant,  the reason that it is not 
relevant should be stated: 
1.1  the Annex III point addressed, 
1.2  a description of  the type of test or study; 
2  reference point (location) of the report in the dossier (e.g.  section 3, Annex 
IliA, point 7.1.4 /01); 
3  .1  the names of  the authors, 
3. 2  the title of the test or study report, 
3. 3  the owner of the report, 
3. 4  an indication as to whether it is a published or unpublished report, 
3. 5  the report number, 
3.6  the date of  the report; 
4.1  the name and address of  the testing facility, 
4.2  the laboratory report/project number; 
5.1 
5.2 
6.1 
6.2 
6.3 
6.4 
6.5 
the dates of  commencement and completion of  experimental work, 
a statement of the objectives of  the test or study; 
the identity of the test  substance or material (brand name,  batch number 
and degree of purity), 
an explicit reference to the relevant specification of composition of the test 
substance or material, 
where available, data relevant to the storage stability of the test substance 
or material, 
where relevant and available, data as to the stability of the test substance or 
material in the dosing vehicle, 
where  relevant  and  available,  data  as  to  the  homogeneity  of the  test 
substance or material in the dosing or testing vehicle, 
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6.6  where data relating to the stability or homogeneity of the test substance is 
not  available  (e.g.  certain  older studies),  a justification of the  scientific 
validity of  the study, 
6.7  where relevant, infonnation as to the physical fonn of the test.substance or material, 
6.8  full details of the composition of  any dosing vehicles or solvents used~ 
7.1  the identity of  the test method used. 
7.2  where not a method specified in Annex III, a reasoned justificatiQn for the 
choice of method used in tenns of its scientific validity and comparability 
with the method specified in Annex III, 
7. 3  on request, a copy of the method - full  details of methods used which are 
unlikely to be  accessible  to  competent authority  of the Member State to 
which  the dossier  is  submitted,  should  be  attached  to  the  study  or test 
report, 
7.4  where test guidelines provide choice as to the method to be used, a reasoned 
justification for the method used, 
7.5  where deviations from the test guidelines specified, or from other methods 
used,  are  employed,  a  description  of and  reasoned justification for  the 
deviations; 
8.1  where relevant, an indication as to whether,  or not,  the test or study has 
been conducted by a laboratory certified as to its competence to conduct the 
test or study in compliance with the principles of  GLP, 
8.2  where relevant, the certifying authority, 
8.3  where applicable, an indication as to whether, or not, the principles of GLP 
have been complied with, 
8.4  where relevant, a justification for non compliance with the principles of 
GLP;. 
9.1  where relevant, a clear statement that the requirements of points 2.2 and ' 
2.3  of the  introduction  to  Annex  II  to  Directive  93171/EEC  have  been 
complied with - Good Experimental Practice (GEP), 
9.2  where the requirements of points 2.2 and 2.3  of the introduction to Annex 
II  to Directive 93171/EEC apply,  whether conducted by  an official or an 
officially recognized testing facility or organization. 
9.3  where relevant, a justification for non compliance with the requirements of 
points 2.2 and 2.3 of  the introduction to Annex II to Directive 93171/EEC; 
10  a description of the test system: 
11  the identity of  any statistical and other techmques applied to the data to aid 
interpretation,  together  with  adequate  documentation  thereof  an!l  a 
justification  for  the  use  of the  techmque  selected  ''here  non  standard 
techniques are used~ 
12.1  where reference to published papers is  made  in  Tier  I quality checks,  the 
bibliographic references concerned. 
12.2  copies of  the papers concerned: and 
13  where reference to unpublished data is made in Tier I quality checks (e.g.  historical 
control data on strains of  test animals) a summary of  such data. 3.2.1 
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(vii) 
(viii) 
(ix) 
(x) 
(xii) 
(xiii) 
The suggested format  for  the  presentation of Tier  I checks as to  the  acceptability of the 
quality of individual test and study reports for Annex III tests and studies is the same as that 
for Annex II tests and studies. as presented in Part 2  of Appendix 4. 
It is not necessary that Tier I checks as to acceptability of the quality of repons be provided 
for  repons  relating  to  analytical  methods,  regardless  of whether  the  methods  concerned 
relate to residues analysis, or analysis of formulations. 
By way of further exception to the general rule, summaries of individual supervised residue 
trials submitted in accordance with Annex III, point 8.1  (Residue trials),  rather than checks 
as to the acceptability of  the quality of individual study reports, should be provided.  For the 
purposes of compiling such Tier I summaries, the forms as contained in Part 1 of Appendix 
5, should be used.  Trials data relevant to all GAPs for which Community MRLs exist or 
are proposed, should be included, except where the information concerned has already been 
provided as part of the relevant Annex II dossier 
6
.  Similarly, where an import tolerance is 
required, trials data relevant to all GAJ>s for which the import tolerance is required must be 
included, except where the information concerned has  already been provided as part of the 
relevant Annex II  dossier.  The forms concerned should be grouped by  crops and within 
crops by the country in which trials were conducted. 
A similar approach should be taken with respect to soil dissipation studies (Annex III, point 
9  .1.1.2).  In preparing Tier I summaries of soil dissipation studies, the forms as contained in 
Part 2 of  Appendix 5, should be used. 
The final part of Tier I of  the summary dossier should comprise a listing of  all test and study 
reports, test guidelines, and published papers, submitted as part of the dossier and a separate 
listing of all test and study reports,  test guidelines, and published papers, not submitted as 
part of the dossier, of which the applicant is aware and which are relevant to the regulatory 
decision  proposed  (i.e.  those  that address  relevant  end-points).  It  is  to  be  noted  that 
applicants are obliged to submit all relevant information of which they are aware concerning 
potentially dangerous effects, not just a reference to such reports and papers. 
In preparing  the  listing,  applicants  should  conduct  a  detailed  literature  search  - expert 
judgement is required to determine the nature and extent of  the search to be conducted.  The 
date on which the reference list was compiled,  the identity of the data bases searched,  the 
date range established for the purposes of the search (e.g.  abstracts dated earlier than 1980 
not requested),  the language constraints, if  any,  imposed and the key  words  used for the 
purposes of  the literature search, should be indicated. 
The listing of test and study reports, test guidelines, and published papers submitted as part 
of the complete dossier,  should cover each section of the dossier separately.  References 
which relate to  more than one section should be listed in each relevant section.  Within 
sections,  for  each  Annex  III  point,  and where  appropriate,  sub-point,  the  list  should  be 
arranged alphabetically by  author.  Where for a particular author there is more than one 
report or paper, they should be listed in chronological order, with the most recent report or 
paper listed last.  In cases where for a particular author, more than one reference is listed for 
any one year. the references should be distinguished by inserting letters after the year i.e. a, b, 
c, etc., as appropriate.  For each test and study report, an indication should be provided as to 
whether or not it is published and as to whether or not it was conducted in compliance with 
6  In the case of  applications for the inclusion of  existing active substances in Annex I. it is envisaged that residue studies relevant to all existing 
and proposed critical GAPs which are being supported will be provided as part of  the Annex II dossier.  For new active substances. the Annex II 
dossier will  contain residue studies relevant to the critical  GAPs then identified.  Annex  III  dossiers submitted after inclusion of the active 
substance in Annex I. in the context of  the authorization of particular preparations. should contain residue studies relevant to all additional uses 
proposed. 
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(xiv) 
(xv) 
(xvi) 
the principles of GLP or the requirements of points 2.2 and 2.3 of the introduction to Annex 
II to Directive 93171/EEC.  as appropriate.  The listing of individual test and study reports 
should be annotated to  indicate their owner.  Before decisions to  include particular active 
substances in Annex I are made,  applicants may  be  required,  where appropriate, to  certify 
that  the  studies  for  which  they  have  claimed  data  protection,  were  not  submitted  to  the 
designated authorities of any of the Member States (including those of Austria, Finland and 
Sweden) in support of an authorization decision.  A suggested format for the presentation of 
th~ listings  of test  and study  reports,  test  guidelines,  and  published  papers  submitted  is 
contained in Part 1 of Appendix 6.  In order to facilitate the subsequent manipulation of the 
reference  list by  the  designated  authority  to  which  it  is  submitted,  the  listing  should  be 
compiled using a_ word processing table function, using a separate row for each reference. 
A  second  version  of the  listing of test  and study  reports,  test  guidelines,  and  published 
papers, submitted as part of the complete dossier, which should again cover each section of 
the dossier separately, but in which the tests and studies are listed alphabetically by author 
and for individual authors, in chronological order, should be provided.  A suggested fonnat 
for  the  presentation  of the  second  listing  of test  and  study  reports,  test guidelines,  and 
published papers submitted is contained in Part 2 of Appendix 6.  In order to facilitate the 
subsequent  manipulation  of the  reference  list by  the  designated  authority  to  which  it is 
submitted,  the listing should be compiled using a word processing table function,  using a 
separate row for each reference. 
In the case of test and stu4Y reports and published papers not submitted, a separate listing of 
such documents, arranged' alphabetically by author,  should be provided at the end of each 
section.  A suggested format for the presentation of the listings of  test and study reports and 
published papers not submitted is contained in Part 3 of Appendix 6.  In order to facilitate 
the, subsequent manipulation of the reference list by the designated authority to which it is 
submitted,  the listing should be compiled using a word processing table function,  using a 
separate row for each reference. 
The  separate  sections  for  which  a  listing of test  and  study  reports,  test  guidelines.  and 
published papers is required are as follows: 
Section 1  •  Identity of  the plant protection product (Annex III, Point 1), 
•  Physical, chemical and technical properties of the plant protection product 
(Annex III, Point 2), 
•  Data on application (Annex III, Point 3), 
•  Further information on the plant protection product (Annex III, Point 4), 
•  Proposals  including  justification  for  the  classification , and  labelling 
proposed (Annex III, Point 12.3), and 
•  Proposals for risk and safety phrases in accordance with Article  16( 1)  (g) 
and (h) and proposed label (Annex III, Point 12.4); 
Section 2  Anal)tical methods (Annex III, Points 5.1 and 5.2)~ 
Section 3  Toxicological studies (Annex III, Point 7); 3.2.1 
3.2.2 
3.2.2 
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(i) 
(ii) 
(iii) 
(iv) 
(v) 
Section 4 
Section 5 
Section 6 
Section 7 
- Tier II - Doe~~•e•l  11-111 
Residues in or on treated products, food or feed  (Annex III, Points 8 and 
12.2)~ 
Fate and behaviour in the environment (Annex III, Point 9); and 
Ecotoxicological studies (Annex III, Point 10). 
Efficacy data (Annex III, Point 6). 
Tier II - Document M-Ill - Annex m dossier summary and assessment 
Tier  II summaries  should contain  seven  sections  such that  it  contains  a  discussion  and 
interpretation of the re~ts of all Annex III tests and studies and within each section, the 
conclusions reached.  The seven sections, which broadly correspond to the main headings of 
Annex III, are those listed in paragraph 3.2.1 (xvi). 
Since in accordance with Article 5.1  (b) of Directive 91/414/EEC, for the purposes of the 
inclusion of an active substance in Annex I, the consideration of efficacy or of unacceptable 
effects on plants or plant products, does not arise, summaries of such data are not required 
(see also subparagraph 3.1.2 (ii)).  It therefore is neither necessary or appropriate Tier II 
summaries  include  such  information.  However,  where  application  is  .made  for  the . 
authorization of a  plant protection product,  the Annex lll dossier submitted must contain 
relevant efficacy test and study reports, summaries and overviews.  In such cases,  the Tier II 
summary and assessment of efficacy which should be presented as Section 7 of the Tier II 
summary and assessment, will be used by the relevant designated authority for the purposes 
of  its examination of  the application for the authorization of  the plant protection product, but 
will not be used for the purposes of  the consideration of  any proposed Annex I inclusion of  an 
active substance contained in it.  Tier II summaries and assessments of  efficacy data should 
be prepared in accordance with the appropriate guidelines 
7
• 
Tier II summaries, which should consist of a discussion and interpretation of the results of 
the tests ·and studies contained in the Annex III dossier, for the purposes of that discussion 
and interpretation, should draw on data and information contained in the relevant Annex II 
dossier(s). 
In the case of non submission of  particular studies, full justifications should be provided. 
Where the principles of GLP or the requirements of points 2.2 and 2.3 of the introduction to 
Annex II to Directive 93/71/EEC have not been followed,  or where the methodologies used 
were not those prescribed in Annex III or,  where there were deviations from the methods 
prescribed or other methods used, a justification of the overall quality and scientific validity 
of  the test or study reported should be provided. 
7  See footnote 4 on page 7 
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(vi) 
(vii) 
As a general rule, a concise but comprehensive summary of each individual test and study 
should be included.  Each summary should include the following elements, as appropriate: 
•  the reference number of  the test or study: 
•  the appropriate test or study reference (e.g.  Casida et a/1979); 
•  the test guideline and method used; 
•  relevant GLP/GEP infonnation; 
• 
• 
a brief  description of  the methodology used; 
a  concise tabular presentation of the findings  with supporting text in which the 
significance of results obtained, effects and observations reported, are highlighted; 
and 
•  conclusions reached (to be highlighted); 
By way of exception to the general rule,  in the case of certain parts of the dossier such as 
Section 1 and that relating to residue trials (supervised residue trials), a tabular approach to 
the presentation of the data may be appropriate,  while in the case of metabolism studies 
(animals, plants and soil) and soil dissipation studies, it may be more convenient to provide 
summaries of groups of  tests and studies.  In the case of supervised residues trials data, it is 
necessary that,  where relevant, a clear statement be  included to indicate the differences, if 
any, in the data base included in comparison to that presented by the applicant to the JMPR 
for the purposes of the elaboration of  CAC MRLs. 
(viii)  Examples ofparts of  an Annex III Tier II summary are provided in Appendix 8: 
(ix) 
(x) 
•  Part I  contains an example of that part of a  Tier II summary which relates to the 
identity of  the plant protection product; physical, chemical and technical properties 
ofthe plant protection product; data on application; and further information on the 
·plant protection product; 
•  Part 2 contains an example of a Tier II summary  relating to toxicological studies; 
and 
•  Part  3  contains  an  example  of a  Tier  II summary  relating  to  ecotoxicological 
studies. 
The fonnat described in Part 4 of Appendix 7 is that proposed for the presentation of residue 
data in summary fonn - the suggested approach is based on that recommended in the JMPR 
Manual for F AO Panel Members 
8
. 
\' 
For each of the seven Sections of the Tier II summary, it is particularly important that the 
concluding element for each point and the concluding element of sub-sections and sections, 
highlight the parameters of relevance to decision making, and include the rationale relied on 
for  the conclusions  reached  in  the  light of the weight of evidence  provided by  the data 
reported. 
8  See footnote 5, page 16 3.2.1 
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(xi) 
(xii) 
Where relevant. an evaluation. cross referenced to the supporting documental)' evidence. of 
the relevance of particular studies conducted regionally (e.g.  rate of degradation in soil),  to 
the  agricultural,  plant  health  and  environmental  (including  climatic)  conditions  of other 
regions. together with the rationale for extrapolations proposed, should be included. 
Within each section and sub-section, having regard to the data provided, it is necessary that 
each decision making point be highlighted, having regard to: 
•  the weight of  the evidence available - extent, quality and consistency of  the data; 
• 
• 
•· 
the criteria specified in Article 5 of  Directive 91/414/EEC; 
the criteria and guidelines for evaluation and decision making with respect to the 
inclusion of  active substances in Annex I, where they exist; and 
to  the  extent  relevant,  the  evaluative  arid  decision  making  criteria  specified  in 
Annex VI. 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I' 
I 
I 
I 
I 
I 
I 
I 
I I 
I 
I 
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I 
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I 
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I 
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I 
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3.3  Overall Summary and Assessment (Annex D and lll Dossiers) - Tier Ill - Dowment N 
3.3.1  This,  the  final  evaluation  level,  should  involve  an  integration of the  results  obtained  and 
conclusions drawn on the basis of the Annex II and Annex III tests. studies and information 
provided.  The order in which the various elements should be presented is indicated in Table 
I. 
3.3.2  The Tier III overall summary and assessment should contain a concise summary of the data 
base presented in the Annex II and Annex III dossiers.  That summary should be supported 
with  a detailed  statement of, the  applicant's overall  assessment of the  dossier,  and  should 
contain  a  reasoned  statement  of the  conclusions  which  the  applicant  believes  should  be 
reached on the basis of the data and information provided, having regard to: 
3.3.3 
3.3.4 
3.3.5 
•  the weight of the evidence available - the extent, quality and consistency of the data; 
•  the criteria specified in Article 5 ofDirective 91/414/EEC; 
• 
• 
the criteria and guidelines for evalUation and decision making with respect  to  the 
inclusion of  active substances in Annex I, where they exist; and 
to  the  extent  that they  are  relevant,  the  evaluative  and  decision  making  criteria 
specified in Annex VI. 
The  Tier III overall  summary and assessment prepared,  should  where  relevant,  include a 
diagrammatic repre~ntation of the metabolic pathway(s) for· the active subspmce in animals, 
plants, soil and water.  The molecular structure of the active substance and its metabolites, 
degradation  and  reaction  products  should  be  shown.  Major  pathways  should  be 
distinguishable from minor pathways, which in turn should be distinguishable from possible 
or suspected pathways. 
The assessment of the data base provided,  should  establish the  rationale for the envisaged 
Annex  I entry.  It is  especially  important  that  the  overall  assessment  of the  data  base 
prepared include proposals relating to the conditions and  restrictions to be associated with 
any inclusion ·of the active substance in Annex I. together with a detailed justification for the 
proposals made.  A listing of  all end points which are used in or are relevant to the p~oposed 
decision should be appended to the Tier Ill overall summaf)·  and assessment.  In order. to 
ensure a consistent approach in preparing the  hstang  of end  points,  the format provided in 
Appendix 9 should be used.  · 
An example of a Tier III summary and overall assessment for an active substance is provided 
in Appendix 10. • 26. 
3.3  Dossier Summaries and Overall Assessments- Overall Summary  and  Assessment  -Annex II + Ill- Tier Ill 
-Do~•e•t  N 
Table 1. 
Chapter 
1.1 
1.2 
1.3 
1.4 
Chapter  2 
2.1 
2.2 
2.3 
Chapter  3 
3.1 
3.2 
3.3 
3.4 
3.5 
3.6 
Chapter  4 
4.1 
4.2 
4.3 
4.4 
4.5 
4.6 
Chapter  5 
5.1 
5.2 
5.3 
5.4 
Order in which the reasoned statement of the conclusions reached by the applicant are 
to be presented 
The active substance,  ~ts properties, uses. proposed classification and labelling 
Identity 
Physical and chemical properties 
Details of  uses and further infonnation 
Classification and labelling 
Methods of  analysis 
for analysis of  the active substance as manufactured 
for fonnulation analysis 
for residue analysis 
Impact on human and animal health 
Effects having relevance to human and animal health arising from exposure to the 
active substance or to impurities contained in the active substance or to their 
transfonnation products 
ADI 
AR:fD (acute reference dose) 
AOEL 
Drinking water limit 
Residues 
Impact on human or animal health arising from exposure to the active substance 
or to impurities contained in it 
Definition of the residue relevant to MRLs 
Residues relevant to consumer safet)· 
Residues relevant to worker safet)· 
proposed EU :MRLs and compliance with cx1stmg EU MRLs 
proposed EU import tolerances and compliance wuh existing EU :MRLs 
basis for differences, if  any, in conclusions reached having regard to established or 
proposed CAC MRLs 
Fate and behaviour in the environment 
Definition of  the residue relevant to the environment 
Fate and behaviour in soil 
Fate and behaviour in water 
Fate and behaviour in air 
I 
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I 
I 
I 
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Table 1.  (Continued) 
Chapter  6 
6.1 
6.2 
6.3 
6.4 
6.5 
6.6 
6.7 
Final Chapter 
Effects on non-target species 
Effects on terrestrial vertebrates 
Effects on aquatic species 
Effects on bees and other arthropod species 
Effects on eanhwonns and other soil macro-organisms 
Effects on soil micro-organisms 
Effects on other non-target organisms (flora and fauna) 
Effects on biological methods of sewage treatment 
Overall conclusions 
Proposed decision 
Further information to be submitted 
-Doca•eal N 0 4 
4 
4.1 
4.2 
4.2.I 
4.2.2 
4.2.3 
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CHECKING OF DOSSIERS FOR COMPLETENESS 
Introduction 
The  guidance  and  forms  provided  herewith,  are  for  use  in  checking  dossiers  for 
completeness,  whether  such  dossiers  are  to  be  submitted  in  support  of applications  for 
inclusion of existing or new active  substances in Annex  I,  and regardless of whether the 
dossiers have been submitted in the context of the review or renewal of any such inclusion. 
It is  intended that the forms  be  completed by  applicants and be  submitted as part of the 
application for inclusion of  an active substance in Annex I (Document 0). 
SuggeSted Aoproacb 
The nature and extent of  the check for completeness should be such that it is confirmed that: 
(i)  all the required supporting documentation has been included (DocUments A to J); 
(ii)  the Annex nand Annex III Tier I checks as to the acceptability of individual test 
and study reports, the Tier II dossier summaries and assessments and the Tier III 
overall summary and assessment, have been included;  · 
(iii)  all test and study reports required in accordance with the requirements of Annex n 
(Documents  K-11)  or,  in the  case  of particular test  and  study  reports,  either  a 
justification  for  non  provision,  or  an  undertaking  to  provide  them  at  a  future 
specified date, have been provided; and 
(iv)  all test and study reports required in accordance with the requirements of Annex III 
(Documents  K-Ill)  or,  in the  case  of particular test  and  study  reports,  either a 
justification  for  non  provision,  or an  undertaking  to  provide  them  at a  future 
specified date, have been provided. 
Specimen forms for use in checking dossiers for completeness are provided in Appendix 11: 
Part I  Evaluation Form I  -
Part 2  Evaluation Form 2  -
Part 3  Evaluation Form 3  -
Part 4  Evaluation Form 4  -
for use in  checking that the required supporting 
documentation has been provided; 
for  usc  an  chcckmg that  the  required  Annex II 
and Anne' I  I  I dossier summaries and an overall 
assessment. ha\·e been provided;  · 
for usc  an chcd  .. mg thai all test and study reports 
reqUired  an accordance \\ith Annex II have been 
provided. and 
for use in checking that all test and study reports 
required in accordance with Annex III have been 
provided. 
A completed set of evaluation forms  1,  2,  3 and 4 (Document 0  -hard copy and diskette) 
must  accompany  each  dossier  submitted.  The  completed  forms  will  be  used  by  the 
competent authority of  the Member State concerned in conducting its initial evaluation of the 
dossier to check it for completeness. 
I 
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Although  it  is  not  necessary  that  completed  forms  be  submitted,  forms  and  supporting 
documentation for use in checking the acceptability of the quality of individual test and study 
reports, are also provided in Appendix II -
Part 5  Evaluation Form 5  - for use in checking that the Tier I quality checks 
for individual. test and study reports conducted in 
accordance with  test  methods  other than those 
currently specified, are themselves of acceptable 
quality.  . 
Part 6  Listing of the test guidelines specified and the requirements relating to compliance 
with GLP and GEP for individual Annex IIA tests and studies, and 
Part 7  Listing of the test guidelines specified and the requirements relating to compliance 
with GLP and GEP for individual Annex IliA tests and studies. I 
-30- ~ 
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Appendix 1 
A 
ACh 
AChE 
ADI 
ADP 
AE 
.AFID 
AJG 
ai 
ALDso 
ALT 
AOEL 
AMD 
ANOVA 
AP 
approx 
ARC 
ARID 
as 
AST 
ASV 
ATP 
BCF 
bfa 
BOD 
bp 
BSAF 
BSE 
BSP 
Bt 
Bti 
Btk 
Btt 
BUN. 
bw 
c 
oc 
CA 
CAD 
CADDY 
cd 
CDA 
eDNA 
CEC 
cf 
CFU 
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APPENDIX 1 
STANDARD TERMS AND ABBREVIATIONS 
ampere 
acetylcholine 
acetylcholinesterase 
acceptable daily intake 
adenosine diphosphate 
acid equivalent 
Part 1  Technical Terms 
alkali flame-ionization detector or detection 
albumin/globulin ratio 
active ingredient 
approximate median lethal dose, 50% 
alanine aminotransferase (SGPT) 
acceptable operator exposure level 
automatic multiple development 
analysis of  variance 
alkaline phosphatase 
approximate 
anticipated residue contribution 
acute reference dose 
active substance 
aspartate aminotransferase (SOOT) 
air saturation value 
adenosine triphosphate 
bioconcentration factor 
body fluid assay 
biological oxygen demand 
boiling point 
biota-sediment accumulation factor 
bovine spongiform encephalopathie 
bromosulfophthalein 
bacillus thuringiensis 
bacillus thuringiensis israelensis 
bacillus thuringiensis kurstaki 
bacillus thuringiensis tenebrionis 
blood urea nitrogen 
body weight 
centi- (x 10-
2
) 
degree Celsius (centigrade) 
controlled atmosphere 
computer aided design 
computer  aided  dossier  and  data supply  (an  electronic dossier  interchange  and  archiving 
format)  · 
candela 
controlled drop(let) application 
complementary DNA 
cation exchange capacity 
confer. compare to 
colony forming units ! I 
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ChE  cholinesterase  I  CI  confidence interval 
CL  confidence limits 
em  centimetre 
I 
CNS  central nervous system 
COD  chemical oxygen demand 
CPK  creatinine phosphatase 
cv  coeffrcient of  variation  I  Cv  ceiling value 
CXL  Codex Maximum Residue Limit (Codex MRL) 
d  day  I 
DES  diethylstilboestrol 
DFR  dislodgeable foliar residue 
I 
DMSO  dimethylsulfoxide 
DNA  deoxyribonucleic Acid 
dna  designated national authority 
DO  dissolved oxygen  I  DOC  dissolved organic carbon 
dpi  days pot inoculation 
DRES  dietary risk evaluation system 
I 
DTso  period required for 50 percent dissipation (define method of estimation) 
DT9o  period required for 90 percent dissipation (define method of  estimation) 
dw  dry weight 
DWQG  drinking water quality guidelines  I 
E.  decadic molar extinction coefficient 
ECso  median effective concentration  I  ECD  electron capture detector 
ECU  European currency unit 
ED so  median effective dose 
I 
EDI  estimated daily intake 
ELISA  enzyme linked immunosorbent assay 
e-mail  electronic mail 
EMDI  estimated maximum daily intake  I  EPMA  electron probe micro analysis 
ERC  environmentally relevant concentration 
ERL  extraneous residue limit 
I  F  field 
Fo  parental generation 
I 
F1  filial generation, first 
F~  filial generation, second 
FIA  fluorescence immuno assay 
FID  flame ionization detector  I  FOB  functional observation battery 
fp  freezing point 
FPD  flame photometric detector 
I 
FPLC  fast protein liquid chromatography 
g  gram 
I. 
G  glasshouse 
GAP  good agricultural practice 
GC  gas chromatography 
GC-EC  gas chromatography with electron capture detector  I I 
:  ... 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
Append.i.I l 
GC-FID 
GC-MS 
GC-MSD 
'GEP 
GFP 
GGT 
GI 
GIT 
GL· 
GLC 
GLP 
9M 
GMO 
GMM 
GPC 
GPPP 
GPS 
GSH 
GV 
h 
H 
ha 
Hb 
HCG 
Hct 
HDT 
hL 
HEED 
HID 
HPAEC 
HPLC 
HPLC-MS 
HPPLC 
HPTLC 
HRGC 
Hs 
Ht 
I  so 
ICso  . 
ICM 
ID 
IEDI 
IGR 
im 
inh 
ip 
IPM 
IR 
ISBN 
ISSN 
iv 
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gas chromatography with flame ionization detector 
gas chromatography-mass spectrometry 
gas chromatography with mass-selective detection 
good experimental practice 
good field practice 
gamma glutamyl transferase 
gastro-intestinal 
gastro-intestinal tract 
guideline level 
gas liquid chromatography 
good laboratory practice 
geometric mean 
genetically modified organism 
genetically modified micro-organism 
gel-permeation chromatography 
good plant protection practice_ 
global positioning system 
glutathion 
granulosevirus 
hour(s) 
Henry's Law constant (calculated as a unitless value) (see also K) 
hectare 
haemoglobin 
human chorionic gonadotropin 
haematocrit 
highest dose tested 
hectolitre 
high energy electron diffraction 
helium ionization detector 
high performance anion exchange chromatography 
high pressure liquid chromatography or high performance liquid chromatography 
high pressure liquid chromatography - mass spectrometry 
high pressure planar liquid chromatography 
high performance thin layer chromatography 
high resolution gas chromatography 
Shannon-VVeaverindex 
haematocrit 
indoor 
inhibitory dose, 50% 
median immobilization concentration or median inhibitor) concentration 9 
integrated crop management 
ionization detector 
international estimated daily intake 
insect growth regulator 
intramuscular 
inhalation 
intraperitoneal 
integrated pest management 
infrared 
international standard book number 
international standard serial number 
intravenous 
I  '  The forst time the abbreyjation is used in a doc:umenl it  should be defined (using a f-te  to do so) Appendix 1 
IVF 
k 
K 
Kads 
~es 
Koc 
Kom 
kg 
L 
LAN 
LASER 
LBC 
LC 
LC-MS 
LCso 
LCA 
LCLo 
LC-MS-MS 
LDso 
LDLo 
LDH 
LOAEC 
LOAEL 
LOD 
LOEC 
LOEL 
LOQ 
LPLC 
LSC 
LSD 
LSS 
LT 
m 
M 
l.lffi 
MC 
MCH 
MCHC 
MCV 
MDL 
MFO 
llg 
mg 
MHC 
min 
mL 
MLT 
MLD 
mm 
mo 
mol 
MOS 
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in vitro fertilization 
kilo 
Kelvin or Henry's Law constant (in atmospheres per cubic meter per mole) (see also H) 
9 
adsorption constant 
apparent desorption coefficient 
organic carbon adsorption coefficient 
organic matter adsorption coefficient 
kilogram 
litre 
local area network 
light amplification by stimulated emission of radiation 
loosely bound capacity 
liquid chromatography 
liquid chromatography- mass spectrometry 
lethal concentration, median 
life cycle analysis 
lethal concentration low 
liquid chromatography with tandem mass spectrometry 
lethal dose, median; dosis letalis media 
lethal dose low 
lactate dehydrogenase 
lowest observable adverse effect concentration 
lowest observable adverse effect level 
limit of  detection 
lo'Yest observable effect concentration 
lowest observable effect level 
limit of  quantification (determination) 
low pressure liquid chromatography 
liquid scintillation counting or counter 
least squared denominator multiple range test 
liquid scintillation spectrometry 
lethal threshold 
metre 
molar 
micrometer (micron) 
moisture content 
mean corpuscular haemoglobin 
mean corpuscular haemoglobin concentration 
mean corpuscular volume 
method detection limit 
mixed function oxidase 
. microgram 
milligram 
moisture holding capacity 
minute(s) 
millilitre 
median lethal time 
minimum lethal dose 
millimetre 
month(s) 
Mole(s) 
margin of safety 
I 
...... 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I I 
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mp  melting point 
MRE  maximum residue expected 
:tv1RL  maximum residue level or limit 
I 
mRNA  messenger ribonucleic acid 
MS  mass spectrometry 
MSDS  material safety data sheet 
MID  maximum tolerated dose 
I  n  nonnai (defining isomeric configuration) or number of observations 
9 
NAEL  no adverse effect level 
I 
nd  not detected 
NEDI  national estimated daily intake 
NEL  no effect level 
NERL  no effect residue level 
I 
ng  nanogram 
nm  nanometer 
NMR  nuclear magnetic resonance 
I 
no  number 
NOAEC  no observed adverse effect concentration 
NOAEL  no observed adverse effect level 
I 
NOEC  no observed effect concentration 
NOED  no observed effect dose 
NOEL  no observed effect level 
NOIS  notice of  intent to suspend 
I 
NPD  nitrogen-phosphorus detector or detection 
NPV  nuclear polyhedrosis virus 
NR  not reported 
I 
NTE  neurotoxic target esterase 
oc  organic carbon content 
I 
OCR  optical character recognition 
ODP  ozone-depleting potential 
ODS  ozone-depleting substances 
OM  organic matter content 
I 
op  organophosphorous pesticide 
Pa  pascal 
I 
PAD  pulsed amperometric detection 
2-PAM  2-pralidoxime 
pc  paper chromatography 
PC  personal computer 
I 
PCV  haematocrit (packed corpuscular volume) 
PEC  predicted environmental concentration 
PECA  predicted environmental concentration in air 
I 
PECs  predicted environmental concentration in soil 
PECsw  predicted environmental concentration in surface water 
PECaw  predicted environmental concentration in ground water 
I 
PED  plasma-emissions-detector 
pH  pH-value 
PHED  pesticide handler's ex1>osure data 
Pill  pre-harvest interval 
I 
PIC'  prior infonned consent 
pic  phage inhibitory capacity 
PIXE  proton induced X-ray emission 
I 
pKa  negative logarithm (to the base 1  0) of the dissociation constant) I 
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PNEC  predicted no effect concentration  I  po  by mouth 
Pow  partition coefficiet:tt between n-octanol and water 
POP  persistent organic pollutants 
I 
ppb  parts per billion (  10 "
9
) 
PPE  personal protective equipment 
ppm  parts per million (  10 "
6
) 
I 
ppp  plant protection product 
ppq  parts per quadrillion (  10 "
24
) 
ppt  parts per trillion (  10 "
12
) 
PSP  phenolsulfophthalein  I  PrT  prothrombin time 
PRL  practical residue limit 
PT  prothrombin time 
I 
PIDI  provisional tolerable daily intake 
PTT  partial thromboplastin time 
QSAR  quantitative structure-activity relationship  I 
r  correlation coefficient  .., 
coefficient of determination  r- I 
RBC  red blood cell 
REI  restricted entry interval 
Rf  retardation factor 
I 
RID  reference dose 
RH  relative humidity 
RLso  median residual lifetime 
RNA  ribonucleic acid  I  RP  reversed phase 
rpm  rotations per minute 
rRNA  ribosomal ribonucleic acid 
I 
RRT  relative retention time 
RSD  relative standard deviation 
s  second  I  SAC  strong adsorption capacity 
SAP  serum alkaline phosphatase 
SAR  structure/activity relationship  I  SBLC  s~low  bed liquid chromatography 
sc  subcutaneous 
see  sister chromatid exchange 
I 
SD  standard deviation 
se  standard error 
SEM  standard error of  the mean 
SEP  standard evaluation procedure  I  SF  safety factor 
SFC  supercritical fluid chromatography 
SFE  supercritical fluid extraction  I  SIMS  secondary ion mass spectroscopy 
SOP  standard operating procedures 
sp  species (only after a generic name) 
I 
SPE  solid phase extraction 
SPF  specific pathogen free 
spp  subspecies 
sq  square  I I 
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I 
SSD  sulphur specific detector 
SSMS  spark source mass spectrometry 
STEL  short term exposure limit 
I 
STIMR  supervised trials median residue 
tonne (metric ton) 
tv.  half-life (define method of estimation) 
I 
T3  tri -iodothyroxine 
T4  thyroxine 
TADI  temporary acceptable daily intake 
I 
TBC  tightly bound capacity 
TCD  thermal conductivity detector 
TC1o  toxic concentration, low 
I 
TID  thermionic detector, alkali flame detector 
TD1o  toxic dose low 
TOR  time domain reflectrometry 
TER  toxicity exposure ration 
I 
TERI  toxicity exposure ration  for initial exposure 
TER.sr  toxicity exposure ration following repeated exposure 
TERu  toxicity exposure ration following chronic exposure 
I 
tert  tertiary (in a chemical name) 
TEP  typical end-use product 
TGGE  temperature gradient gel electrophoresis 
TIFF  tag image file format 
I 
TLC  thin layer chromatography 
Tim  median tolerance limit 
TLV  threshold limit value 
I 
TMDI  theoretical maximum daily intake 
TIMRC  theoretical maximum residue contribution 
T1MRL  temporary maximum residue limit 
I 
TOC  total organic carbon 
Tremcard  Transport emergency card 
tRNA  transfer ribonucleic acid 
TSH  thyroid stimulating hormone (thyrotropin) 
I 
TWA  time weighted average 
UDS  unscheduled DNA synthesis 
I 
UF  uncertainty factor (safety factor) 
ULV  ultra low volume 
uv  ultraviolet 
I 
v/v  volume ratio (volume per volume) 
WBC  white blood cell 
I 
wk  week 
wt  weight 
w/v  weight per volume 
I 
ww  wet weight 
w/w  weight per weight 
I 
XRFA  X-ray fluorescence analysis 
I  yr  year 
I Appendb 1  .  Standard Tenns and Abbreviations 
less than 
less than or equal to 
greater than 
greater than or equal to 
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Appendix 1 
ACPA 
ASTM 
BA 
BART 
CA 
CAB 
CAC 
CAS 
CCFAC 
CCGP 
CCPR 
CCRVDF 
CE 
CIPAC 
COREPER 
EC 
ECB 
ECCA 
ECDIN 
ECDIS 
ECE 
ECETOC 
ECLO 
ECMWF 
ECPA 
EDEXIM 
EHC (number) 
EINECS 
ELINCS 
EMIC 
EPA 
EPO 
EPPO 
ESCORT 
EU 
EUPHIDS 
EUROPOEM 
FAO 
FOCUS 
FRAC 
GATT 
GAW 
GIFAP 
GCOS 
GCPF 
GEDD 
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Part 2  Organisations and Publications 
American Crop Protection Association 
American Society for Testing and Materials 
Biological Abstracts (Philadelphia) 
Beneficial Arthropod Registration Testing Group 
Chemical Abstracts 
Centre for Agriculture and Biosciences International 
Codex Alimentarius Commission 
Chemical Abstracts Service 
Codex Committee on Food Additives and Contaminants 
Codex Committee on General Principles 
Codex Committee on Pesticide Residues 
Codex Committee on Residues of Veterinary Drugs in Food 
Council of  Europe 
Collaborative International Pesticides Analytical Council Ltd 
Comite des Representants Permanents 
European Commission 
European Chemical Bureau 
European Crop Care Association 
Environmental Chemicals Data and Infonnation Network of  the European Communities 
European Environmental Chemicals Data and Infonnation System 
Economic Commission for Europe 
European Chemical Industry Ecology and Toxicology Centre 
Emergency Centre for Locust Operations 
European Centre for Medium Range Weather Forecasting 
European Crop Protection Association 
European Database on Export and Import of  Dangerous Chemicals 
Environmental Health Criteria (number) 
European Inventory of  Existing Commercial Chemical Substances 
European List of  New Chemical Substances 
Environmental Mutagens Information Centre 
Environmental Protection Agency 
European Patent Office 
European and Mediterranean Plant Protection·Organization 
European Standard Characteristics ofBeneficials Regulatory Testing 
European Union 
European Pesticide Hazard Information and Decision Support System 
European Predictive Operator Exposure Model 
Food and Agriculture Organization of the UN 
Forum for the Co-ordination of  Pesticide Fate Models and their Use 
Fungicide Resistance Action Committee 
General Agreement on Tariffs and Trade 
Global Atmosphere Watch 
Groupement  International  des  Associations  Nationales  de  Fabricants  de  Produits 
Agrochimiques (now known as GCPF) 
Global Climate Observing System 
Global Crop Protection Federation (formerly known as GIF AP) 
Global Environmental Data Directory Appendix l 
.. 
GEMS  · 
GIEWS 
GRIN 
HRAC 
IARC 
IATS 
mT 
ICBB 
ICBP 
ICES 
ICPBR 
ILO 
IMO 
IOBC 
IPCS 
IRAC 
IRC 
ISCO 
ISO 
IUPAC 
JECFA 
JFCMP 
JMP 
JMPR 
NATO 
NAFTA 
NCI 
NCTR 
NGO 
NTP 
OECD 
OLIS 
PAN 
RNN 
RTECS 
SCPH 
SETAC 
SI 
SITC 
TOXLINE 
UN 
UNEP 
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Standard Tenns and Abbreviations 
Global Environmental Monitoring System 
Global Infonnation and Early Warning System for Food and Agriculture 
Gennplasm Resources Infonnation Network 
Herbicide Resistance Action Committee 
International Agency for Research on Cancer 
International Academy of  Toxicological Science 
Industrial Bio-Test Laboratories 
International Commission of  Bee Botany 
International Council for Bird Preservation 
International Council for the Exploration of the Seas 
International Commission for Plant-Bee Relationships 
International Labour Organization 
International Maritime Organisation 
International Organization for Biological Control of  Noxious Animals and Plants 
International Programme on Chemical Safety 
Insecticide Resistance Action Committee 
International Rice Commission 
International Soil Conservation Organization 
International Organization for Standardization 
International Union of  Pure and Applied Chemistry 
F  AOIWHO Joint Expert Committee on Food Additives 
Joint F  AOIWHO Food and Animal Feed Contamination Monitoring Programme 
Joint Meeting on Pesticides (WHO/F  AO) 
. Joint  Meeting  of the  FAO  Panel  of Experts  on  Pesticide  Residues  in  Food  and  the 
Environment and the WHO Expert Group on Pesticide Residues (Joint Meeting on Pesticide 
Residues) 
North Atlantic Treaty Organisation 
North American Free Trade Agreement 
National Cancer Institute (USA) 
National Centre for Toxicological Research (USA) 
non-governmental organization 
National Toxicology Programme (USA) 
Organization for Economic Co-operation and Dc,·clopmcnt 
On-line Infonnation Service of  OECD 
Pesticide Action Network 
Re-registration Notification Network 
Registry ofToxic Effects of Chemical Substances <USA) 
Standing Committee on Plant Health 
Society of  Environmental Toxicology and Chemistl)· 
Systeme International d'Unites 
Standard International Trade Classification 
Toxicology Infonnation On-line 
United Nations 
United Nations Environment Programme 
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WCDP 
WCP 
WCRP 
WFP 
WHO 
WTO 
WWF 
Standard Tenns and Abbreviations 
World Climate Data Programme 
World Climate Programme 
-41-
World Climate Research Programme 
World Food Programme 
World Health Organization · 
World Trade Organization 
World Wildlife Fund I 
-42- "' 
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APPENDIX2 
PREPARATION (FORMULATION) TYPES AND CODES* 
Code Description  Definition 
AB 
AE 
AL 
BB 
BR 
CB 
CG 
cs 
DC 
DP 
DS 
EC 
ED 
EO 
ES 
EW 
FD 
Grain bait 
Aerosol dispenser 
Other liquids to be applied 
undiluted 
Block baits 
Briquette 
Bait concentrate 
Encapsulated granule 
Capsule suspension 
Dispersible concentrate 
Dustable powder 
Powder for dty seed 
treatment 
Emulsifiable concentrate 
Electrochargeable liquid 
Emulsion, water in oil 
Special forms ofbait. 
A container-held  preparation  which  is  dispersed  generally  by  a 
propellant as fine droplets/particles upon actuation of  a valve. 
Self defining. 
Special forms of  bait. 
Solid block  designed for  controlled  release  of active  ingredient 
into water. 
A solid or liquid intended for dilution before use as a bait. 
A granule with a protective or release controlling coating. 
A stable suspension of capsules in a fluid nonnally intended for 
dilution with water before use. 
A  liquid  homogeneous  preparation  to  be  applied  as  a  solid 
dispersion after dilution in water. 
A free-flowing powder suitable for dusting. 
A powder for application in the dty state directly to seed. 
A liquid,  homogenous  preparation  to  be applied as  an emulsion 
after dilution in water. 
Special  liquid  preparation  for  electrostatic  (electrodynamic) 
spraying. 
A fluid,  heterogeneous  preparation consisting of a  dispersion of 
fine globules of pesticide m "atcr an  a continuous organic liquid 
phase. 
Emulsion for seed treatment  A stable emulsion for application to the seed either directly or after 
dilution. 
Emulsion, oil in water  _  A fluid,  heterogeneous  preparation consisting of a  dispersion of 
fine  globules  of pesticide  in  an  organic  liquid  in  a  continuous 
water phase. 
Smoke tin  Special form of  smoke generator. -44-
Appendbl  Preparation (Formulation) Types and Codes* 
Code Description 
FG  Fine granule 
FK  Smoke candle 
FP  Smoke cartridge 
FR  Smoke rodlet 
FS  Flowable concentrate for 
seed treatment 
Ff  Smoke tablet 
FU  Smoke generator 
FW  Smoke pellet 
GA  Gas 
GB  Granular bait 
GE  Gas generating product 
GG  . Macrogranule 
GP  Flo-dust 
GR  Granule 
GS  Grease 
HN  Hot fogging concentrate 
KN  Cold fogging concentrate 
LA  Lacquer 
LS  Solution for seed treatment 
MG  Microgranule 
OF  Oil miscible flowable 
(=oil active substances 
in a miscible suspension) 
Definition 
A granule in the particle size range from 300 to 2500  J.l. 
A smoke generator in the fonn of a candle. 
Special form of smoke generator. 
Special form of smoke generator. 
A stable suspension for application to the seed either directly 
or after dilution. 
Special form of smoke generator. 
A combustible  preparation generally  solid,  which  upon  ignition 
releases the active substances in the fonn of a smoke. 
Special form of smoke generator. 
A gas packed in pressure bottle or pressure tank. 
Special fonns of  bait. 
A preparation which generates a gas by chemical reaction. 
A granule in the particle size range from 2000 to 6000  J.l . 
Very  fine  dustable  powder  for  pneumatic  application  in glass-
houses. 
A free-flowing  solid preparation of a defined granule size  range 
. ready for use. 
Very viscous preparation based on oil or fat. 
A preparation suitable for application by fogging equipment either 
directly or after dilution. 
A preparation suitable for application by cold fogging equipment, 
either directly or after dilution. 
A solvent based film-forming preparation. 
A  solution  for  application  to  the. seed  either  directly  or  after 
dilution. 
A granule in the particle size range from  100 to 600  J.l. 
A stable suspension of concentrate fluid intended for dilution  · 
in an organic liquid before use. 
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Code Description 
OL  Oil miscible liquid 
OP  ·  Oil dispersible powder 
PA 
PB 
PC 
PR 
PS 
RB 
SB 
sc 
SE 
SG 
SL 
so 
SP 
ss 
su 
Paste 
Plate bait 
Gel or paste concentrate 
Plant rodlet 
Seed coated with a pesticide 
Bait (ready for use)  · 
Scrap bait 
Suspension concentrate 
(= flowable concentrate) 
Suspo-emulsion 
Water soluble granul~s 
Soluble concentrate · 
Spreading oil 
Water soluble powder 
Water soluble powder for 
seed treatment 
Ultra low volume (UL  V) 
suspension 
Definition 
A liquid, homogenous preparation to be applied as a homogenous 
liquid after dilution in an organic liquid. 
A  powder  preparation  to  be  applied  as  a  suspension  after 
dispersion in an organic liquid. 
A water based film forming preparation. 
Special forms of  bait. 
A solid preparation to be applied as a gel or a paste after dilution 
with water. 
A  small rodlet,  usually  a  few  centimetres in length and a  few 
millim~tres in diameter containing active substance. 
Self defining. 
A  preparation  designed  to  attract  and  be  eaten  by  the  target 
species. 
Special forms of  bait: 
A stable suspension of  active substance(s) in a fluid intended for 
dilution with water before use. 
A  fluid,  heterogeneous  preparation  cons1stmg  of  a  stable 
dispersion of active substance(s) in  ,the form of solid particles and 
of  fine globules iri a continuous water phase. 
A  preparation  consisting  of granules  to  be  applied  as  a  true 
solution  of active  substance  after  dissolution  in.  water but  may 
contain insoluble inert ingredients. 
A liquid homogenous preparation to be applied as a true solution 
of  the active substance after dilution with water  .. 
A preparation designed to form a surface layer on application to 
water. 
A powder preparation to be applied as a true solution of  the active 
substance after solution in water but which may contain insoluble 
inert ingredients. 
A powder to be dissolved in water before application to the seed. 
A suspension ready for use through UL V equipment. -46-
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Code Description 
TB 
TP 
UL 
VP 
WG 
WP 
ws 
XX 
Tablet 
Tracking powder 
Ultra low volume (UL  V) 
liquid 
Vapour releasing product 
Water dispersible 
Wettable powder 
Water dispersible powder for 
slurry seed treatment 
Others 
Definition 
Solid preparation in the form of  small, flat plates for dissolution in 
water. 
A rodenticidal contact preparation in powder form. 
A homogenous liquid ready for use through UL V equipment. 
A  preparation  containing  one or more volatile  ingredients,  the 
vapours of which  are  released  into  the air.  Evaporation  rate 
normally  is  controlled  by  using  suitable  preparations  and/or 
dispensers. 
A preparation granule consisting of granules to be applied after 
disintegration and dispersion in water. 
A  powder  preparation  to  be  applied  as  a  suspension  after 
dispersion in water. 
A powder to be dispersed at high concentration in water before 
application as a slurry to the seed. 
* based upon the catalogue of Pesticide Formulation types and In~ational Coding Systems, developed by GIF  AP in co-operation with the 
Gennan working group on documentation questions.  (Arbeitsgruppe EDV Pflanzenschutz Versuchswesen).  GIFAP Teclmical Monograph No 
2.  1989. 
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APPENDIX 3- PART 2 
FORM FOR USE IN REPORTING AUTHORIZED USES AND ACTUAL USES 
Authorized uses  Actual uses, if current practice is known to 
(crops, harmful organisms, rates of application,  deviate from the authorized uses 
number of applications,  timings of applications - (crops, harmful organisms, rates of application, 
growth stages and where appropriate, season)  number of applications,  timings of applications -
S!I"Owth staees and where appropriate, season) 
Austria 
Belgium 
Denmark 
Fmland 
France 
Germany 
Greece 
Ireland 
. 
. 
. 
. 
. 
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APPENDIX 3- PART 3 
FORM FOR USE IN REPORTING MAXIMUM RESIDUE LIMITS (MRLs) 
International Organization of 
Commodity  MRL  Residue Definition 
Country  mg/kg 
EU 
EU Member State 
Other OECD Country 
I 
, Exporting Country 
CACMRL 
Codex Proposal (indicate step) I 
. so.  .. 
I 
... 
I 
I 
I 
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I 
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I 
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1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
1. 
.2. 
3. 
4. 
5. 
6. 
7 •. 
8. 
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APPENDIX4 
FORMAT FOR COMPILATION OF Tier I QUALITY CHECKS 
PART! 
SUMMARY REPORT- APPROPRIATE FOR STUDIES CONDUCTED IN ACCORDANCE 
WITH THE TEST GUIDELINES CURRENTLY SPECIFIED 
EXAMPLE I 
Annex point(s)  llA,  5.2.2  Acute toxicity - dermal 
Reference point  Volume 7, Section 3, Annex IIA, point 5.2.2 I 01 
(location) in 
dossier 
Authors (year)  F. Keller (199lc) 
Title  XXXX - Study of  acute dermal toxicity in the rat. 
Owner, Date  Organics Inc, unpublished report No. 20417,  July 05,  1991 (c) 
Testing facility  Organics Inc, Institute of Toxicology, Castlebar, Ireland, Report 10564 
Dates of work  October 28, ·1990- December 4,  1990 
Test substance  ISO common name: XXXX, Batch number:  17002190,  Purity: 93.6 %' 
Specification number 4 (Document J) 
Test method  OECD 402: FIFRA § 81-2: EEC B.3 
Deviations - analytical confirmation of the composition of the formulation was not 
available at the start of the study. 
GLP  Yes  (laboratory certified by the Irish Laboratory Accreditation Board, 
Glasnevin, Dublin 7, Ireland) 
EXAMPLE2 
Annex point(s)  llA,  5.2.3  Acute toxicity - inhalation 
Reference point  Volume 7, Section 3, Annex IIA, point 5.2.3 I 04 
(location) in 
dossier 
Authors (year)  J.  Parker (1990) 
Title  XXXX - Study of acute inhalation toxicity in the rat. 
Owner, Date  Organics Inc, unpublished report No.  19806,  December 12,  1990 
Testing facility  Organics Inc, Institute of  Toxicology, Castlebar, Ireland, Report 9, 703 
Dates of work  May 29,  1990 to June 19, 1990 
Test substance  ISO common name: XXXX, Batch number:  17002190,  Purity: 94.6  %, 
Specification number 4 (Document J) 
Test method  OECD 403: EEC B.2 
Deviations - Statistics:  A.P. Rosiello, J.M. Essigmann and G.N. Wogan-(1977), 
modified by Pauluhn (1983), based on the  ~.I. Bliss 
Maximum Likelihood method (1938) 
GLP  Yes  (laboratory certified -by the Irish Laboratory Accreditation Board, 
Glasnevin, Dublin 7, Ireland)Glasnevin, Dublin 7, Ireland) -52-
Appeadix4  Format for Compilation of 
Tier 1 Quality Cbecks 
Part 1  Summary Report - appropriate for studies conducted in 
accordance witb tbe test guidelines currendy specified 
EXAMPLEJ 
1.  Annex point(s)  llA,  5.3.2  Subchronic toxicity in rats 
2.  Reference point  Volume 8, Section 3, Annex IIA, point 5.3.2 I 02 
(location) in 
dossier 
3.  Authors (year)  R.  Eiben, E. Hartmann ( 1992) 
Title  XXXX - Subchronic toxicity study in wistar rats (thirteen-week administration in 
the diet with a four-week recovery period). 
Owner, Date  Organics Inc, unpublished reoort No. 21627, August 18, 1992 
4.  Testing facility  Organics Inc, Institute ofToxicolo~v, Castlebar, Ireland, Report No 11,204 
5.  Dates of work  October 10. 1990- February 04, 1991 
6.  Test substance  ISO common name: XXXX, Batch number:  17002/90,  Purity: 93.6 %' 
Specification number 4 (Document J) 
7.  Test method  OECD 408 :: FIFRA § 83-1 :: EEC Directive 88/302/EEC, OJ No L 133 of 30 
May 1988 
Deviations- none 
8.  GLP  Yes  (laboratory certified by the Irish Laboratory Accreditation Board, 
Glasnevin, Dublin 7, Ireland) 
EXAMPLE4 
1.  Annex point(s)  DA,  5.3.2  Subchronic toxicity - dog 
2.  Reference point  Volume 9, Section 3, Annex IIA, point 5.3.2 I 04 
(l_ocation) in 
dossier 
3.  Authors (year)  -R.  D. Jones, L. E. Elcock (1994) 
Title  XXXX:  13-Week subchronic feeding study in beagle dogs. 
Owner, Date  Organics Inc, unpublished report No. MR7442, December 07, 1994 
4.  Testing facility  Organics Inc, Institute of Toxicology, Castlebar, Ireland, Report No 13,256 
5.  Dates of work  November 05, 1991  -February 06, 1992 
6.  Test substance  ISO common name: XXXX, Batch number:  17002/90,  Purity: 93.5 % - 94.9 %, 
Specification number 4 (Document J) 
7.  Test method  FIFRA § 82-1:: OECD 409:: EEC Directive 88/302/EEC, Part B, OJ No L 133 
of 30 May 1988 
Deviations- none 
8.  GLP  Yes  (laboratory certified by the Irish Laboratory Accreditation Board, 
Glasnevin, Dublin 7. Ireland) 
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Appendix 4  Format for Compilation of 
Tier 1 Quality Checks 
Part 1  Summary Report - appropriate for studies conducted in 
accordance with tbe test guidelines currently specified 
EXAMPLE5 
1.  Annex point(s)  DA,  8.1.2  Short term toxicity to birds 
2.  Reference point  Volume 24, Section 6, Annex IIA, point 8.1.2 I 03 
(location) in 
dossier 
3.  Authors (year)  R.  Grandy (1995) 
Title  XXXX techn. - 5-day dietary LC50 to mallard duck. 
Owner, Date  Organics Inc, unpublished report No. GMU/VE-006,  April 5, 1995 
4.  Testing facility  Organics Inc, Institute for Environmental Research, Goresbridge, County 
Kilkenny, Ireland, Report 24,123 
5.  Dates of work  May 12 - 20, 1994 
6.  Test substance  ISO common name: XXXX, Batch No. 898114002,  Purity: 96.6 %, 
Specification number 3 (Document J) 
7.  Test method  OECD 205:: EPA 71-2 
Deviations - none 
8.  GLP  Yes  (laboratory certified by the Irish Laboratory Accreditation Board, 
Glasnevin, Dublin 7, Ireland) 
EXAMPLE6 
1.  Annex point(s)  DA,  8.5  Effects on soil non-target micro-organisms 
2.  Reference point  Volume 27, Seetion 6, Annex IIA, point 8.5 I 03 
(location) in 
dossier 
3.  Authors (year)  J.  Nielson (1993) 
Title  Influence of XXXX SC 400 on microbial nitrogen mineralization in soil.· 
Owner, Date  Organics Inc, unpublished report No.  AJO'J 13193.  December 13, 1993 
4.  Testing facility  Organics Inc, Institute for Environmental Research. Goresbridge, County 
Kilkenny, Ireland, Re_port 23,123 
5.  Dates of work  September 13, 1993 to November 9.  199) 
6.  Test substance  XXXX SC 400, Batch 089A from 04023 10021. contents 424.0 g as/1, 
Specification-number 3 (Document J) 
7.  Test method  1.  Guidelines for the Official Testing of Plant Proteetams. Part VI, 1-1 
"Influence on the Activity of the Soil Microflora·. BBA Braunschweig, 
Germany, March 1990 (2nd ed.). 
2.  ISO/DIS 1036-6: 1992, Soil Quality - Sampling - Part 6:  Guidance on the 
Collection, Handling and Storage of Soil for the Assessment of Aerobic 
Microbial Processes in the Laboratory 
Deviations - none 
8.  GLP  Yes  (laboratory certified by the Irish Laboratory Accreditation Board, 
Glasnevin, Publin 7. Ireland) -54- I 
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Appendix 4  Format for Compilation of 
Tkr 1 Quality Checks 
Part 2  Detailed Report - appropriate for studies not conducted 
in accordance with the test guidelines currently spedfied 
PART2 
DETAD..ED REPORT- APPROPRIATE FOR STUDIES NOT CONDUCTED IN ACCORDANCE 
Wim THE TEST GUIDELINES CURRENTLY SPECIFIED 
EXAMPLE I 
AnnexllA  Point addressed 5.2.2  Acute toxicity - percutaneous 
Note:  The report contains data on acute toxicity using di:fferent routes of application.  In 
the dossier it is filed in each relevant section - 5.2.1  (oral toxicity);  5.2.1  (dennal toxicity)~ 5.2.3 (inhalation 
toxicity);  5.2.4  (skin  irritation);  5.2.5  (eye  irritation);  5.2.7  (subcutaneous  toxicity);  5.2.8  (intraperitoneal 
toxicity). 
2  Reference point: 
3.1  Authors: 
3.2  Title: 
3.3  Owner: 
3.4  Published: 
3.5  Report No: 
3.6  Date of report: 
4.1  Testing facility: 
4.2  Lab. report No: 
5.1  Dates of 
Volume 7,  Section 3, Annex IIA, 5.2.2 I 03 
Report: 
Summary: 
X. Xxxxxxx, X. Xxxxxxxxxxxx 
X. Xxxxxxxxxxx 
XXX 1111 - Acute Toxicity Studies 
xxxxxxxx 
no 
xxxxx file No.: 0000 
January 7, 1980 
Xxxxxxxxx, Xxxxxxxxxxxxx, Xxxxxxxxxxxxxxx, Xxxxxxxxx 
xxxxxxxx 
experimentaJ work:  February i  979 - August 1979 
5.2  Objectives:  Investigation of  acute dennal toxicity. in rats 
6.1  Test substance:  XXX 1111, active substance as manufactured, 97.5 % pure, batch number: xxx 
6.2  Specification:  as given in document J - specification number 5 -56-
Appendix 4  · Format for Compilation of 
Tier 1 Quanty Checks 
Partl  Detailed Report - appropriate for studies not conducted 
in accordance witb tbe test guidelines currently specified 
Example 1  Acute toxicity - percutaneous 
·Company name  Month and year  Aetlve Substance (Name}  Annex IIA, Point 5.2.2  page 2 of  3 
6.3  Storage stability: 
6.4  Stability 
in vehicle: 
6.5  Homogeneity 
in vehicle: 
6.6  Validity: 
6.7  Physical form: 
6.8  Vehicle/solvent: 
7.1  Test method: 
7.2  Justification: 
7.3  Copy of metbod: 
not applicable (single treatment only) 
not applicable 
not applicable 
not applicable 
oily, viscous mass with crystalline parts 
none (undiluted application) 
In house method according to the method of  Noakes and Sanderson, 1969.  At the 
time the study was performed, no particular method was compulsory.  For details 
on the method used see description below. 
The experiment was performed and complied to a great extent to then in force EPA 
Guidelines  (Proposed  Guidelines  for  Registering Pesticides  in the  US,  Federal 
Register, Vol 43, No.  163, August 22,  1978).  The method used differs from the 
prescribed  method  (EEC  B.3)  in  the  following  respects  ................................  , 
differences which do not compromise the scientific validity of the results obtained. 
a description of method is included in study report 
7.4  Choice of method:  not applicable 
7.5  Deviations:  see details below 
8.1  Certified laboratory: not applicable 
8.2  Certifying authority: not applicable 
8.3  GLP: 
8.4  Justification: 
9.1  GEP: 
9.2  Type of Facility 
(official or officially 
no 
When the study was performed. GLP was not compulsory. 
not applicable 
recognized):  not applicable 
9.3  Justification:  not applicable 
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Tier 1 Quality Cbecks 
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Part 2  Detailed Report - appropriate for studies not conducted 
in accordance witb tbe test guidelines currently specified 
Example 1  Acute toxicity - percutaneous 
Company name  Month and year  Active Substance (Name)  Annex IIA, Point S.l.l  page l  of  3 
10  Test system - Animal species: 
Source: 
Number of animals: 
Dosage: 
Administration: 
General observations: 
Recording periods: 
11  Statistics:  not applicable 
12.1 References:  Noakes and Sanderson, 1969 
Wistar rat (TNO/W 74) 
Winkelmann, Borchen, Germany 
10 male, 15 female (  5 I 10 per group) 
2500 and 5000 mglkg bw 
dermal over 24 hours - removal of the compound 
from the skin with lukewarm tap water and soap. 
After administration, all animals were kept .  under 
observation for 14 days. 
0- 14 days, body weight: day 0, 7, 14 
13  Unpublis~ed data:  no unpublished data cited in this summary - S8-
Appendix 4  ·. Format for Compilation of 
Tier 1 Quality Checks 
Part 2  Detailed Report - appropriate for studies not conducted 
in accordance witb tbe test guidelines currently specified 
AnnexDA 
2  Reference point: 
3.1  Authors: 
3.2  Title: 
3.3  Owner 
3.4  Published: 
3.5  Report No: 
3.6  Date of report: 
4.1  Testing .facility: 
4.2  Lab. report No: 
5.1  Dates of 
EXAMPLE2 
Point addressed 5.3.2  Short term oral toxicity - 90 day 
Volume 7, Section 3, Annex IIA, 5.3.2 I 01 
Report: 
Addendum: 
Summary: 
X. Xxxxxxxxx, X. Xxxxxxxxxxx 
X.Xxxxxx 
X. Xxxxxxxxxxxxx 
XXX 1111  sub-chronic toxicity study on rats (three-month feeding experiment), 
and histopathological addendum 
xxxxxxxxx 
no 
xxxxxxx file No.: 0000 (report), 0000 (addendum) 
June 4, 1980 (report), Janwny 29, 1981 (addendum) 
Xxxxxxxxxxxx, Xxxxxxxxxxxxx, Xxxxxxxxxxxxxxx, Xxxxxxxxxx 
xxxxx 
experimental work:  November 1979-February 1980 
5.2  Objectives: 
6.1  Test substance: 
6.2  Specification: 
6.3  Storage stability: 
as title 
XXX 1111, active substance as manufactured, 97.5 % pure, batch number: xxx 
as given in document J - specification number 4 
analysis performed at the beginning and at the end of the experimental  phase, 
demonstrated that the active substance was stable. 
6.4  Stability in vehicle:  analysis  of diet  conducted  at the  beginning of the  study  and twice  during the 
ex")lerimental phase confirmed the stability of  the active substance in the diet. 
6.5  Homogeneity 
in vehicle: 
6.6  validity: 
Confirmed by concentration check: several sub-samples were measured and 
compared. 
not applicable 
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Partl  Detailed Report - appropriate for studies not conducted 
in accordance with the test guidelines curready specified 
Example 2  Short term oral toxidty - 90 day 
Company name  Month and year  Active Substance (Name)  Annes IIA, Point 5.3.2  page 2 of  4 
6. 7  Physical form:  pulverised chow 
6.8  Vehicle I solvent:  50%  premix  in  Wessalon  S  (=  silica,  CAS  7631-86-9)  followed  by  dietary 
admixture to the food Altromin® 
7.1  Test method:  The method used was an in-house method.  For details on' the method used, see the 
description under 12 below. 
7.2  Justification:  When  the  study  was  performed,  no  particular method  was compulsory.  The 
method uSed complied to a great extent to then in force E~A  Guidelines (Proposed 
Guidelines for Registering Pesticides in the US Federal Register, Vol. 43, No.  163, 
August 22, 1978).  The method used differs from the prescribed method (Directive 
87  /302/EEC, Part B, sub-chronic oral toxicity test) in the following respects - brain 
weight was not recorded, skin and parathyroid were not investigated histologically. 
These deviations do not limit or impair the scientific validity of the study.  The 
study design permits an accurate setting of a  NOAEL and an elucidation of all 
relevant toxic effects. 
7.3  Copy of method:  Description of  method used is included in the report.  ,  For details see also descrip-
tion below at point 12. 
7.4  Choice of method:  not applicable 
7.5  Deviations:  not applicabl~ 
8.1  Certified laboratory: not applicable 
8.2  Certifying authority: not applicable 
8.3  GLP:  no 
8.4  Justification:  When the study was performed, GLP was not compulsory. 
9.1  GEP:  not applicable 
9.2  Type of Facility 
(official or officially · 
recognized):  not applicable 
9.3  Justification:  not applicable Appendix 4  .Format for Compilation of 
Tier I Quality Checks 
-60-
Part 2  Detailed Report - appropriate for studies not conducted 
in accordance witb tbe test guidelines currently specified 
Example 2  Short term oral toxicity - 90 day 
Company name  Month and year  Active Substance (Name)  Annes IIA, Point 5.3.2  page 2 of  4 
10  Test system- Animal species: 
Source: 
Number of animals: 
Dosage (as): 
Administration: 
Duration: 
Wistar rats (TNO W.  74) 
Winkelmann, Borchen, Germany 
120 male, 120 female 
(30 per dosage group including two  satellite groups of 5 
animals each for  testing  possible  enzyme  induction at 7 
and 28 days) 
0, 50, 100 and 500 ppm corresponding to: 
3.24, 8.39 and 28.52 mg/kg bw/day in males, and 
3.70, 9.83 and 32.97 mg/kg bw/day in females 
oral by feeding 
3 months 
General observations: daily check for-mortality and moribundity, daily cage-side 
observations for toxic signs (all animals) 
Food consumption:  measured weekly 
Body weight:  measured weekly 
Haematology:  erythrocyte  count,  leucocyte  count,  haemoglobin,  MCV, 
MCH,  MCHC,  thrombocyte count,  haematocrit,  differen-
tial blood  count,  thromboplastin time  (1,  3 months after 
initiation of  treatment; 5 male and 5 female per group) 
Clinical chemistry:  alkaline  phosphatase,  aspartate aminotransferase,  (blood) 
alanine  aminotransferase,  creatinine,  urea,  blood  sugar, 
cholesterol,  bilirubin,  total  protein  (  1,  3  months  after 
initiation of treatment), glutamate dehydrogenase (only at 
termination of  study~ 5 male and 5 female per group) 
·Enzyme induction  N-demethylase activity. 0-demethylase activity, 
assays:  cytocluome P 450 content (7  days,  28 days,  3  months~ 5 
male and 5 female per group) 
Urinalysis:  glucose,  blood,  protein,  pH,  ketone  bodies,  bilirubin, 
deposits ( 1,  3 months after initiating of the study;  5 male 
and 5 female per group) 
Gross pathology:  all animals which died during the study and all surviving 
rats;  sacrifice  via  exsanguination  in  deep  diethyl  ether 
anaesthesia 
Organ weights:  thyroid,  thymus,  heart,  lungs,  liver,  spleen,  kidneys, 
adrenals, testes, ovaries (end of treatment; all animals) 
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Part l  Detailed Report - appropriate for studies not conducted 
in accordance witb tbe test guidelines curreody specified 
Example l  Short term oral toxicity - 90 day 
Company name  Month and year  Active Substance (Name)  Annex IIA, Point 5.3.2  page 2 of  4 
11  Statistics: 
12.1 References: 
Histopathology:  heart,  lungs,  liver,  spleen,  kidneys,  pancreas,  pituitary, 
thyroid,  adrenals,  testes,  epididymides,  prostate,  seminal 
vesicles,  ovaries,  uterus,  salivary  glands,  oesophagus, 
stomach,  intestines  (4  sections),  lymph  nodes,  thymus, 
urinary  bladder,  'brain,  eyes,  aorta,  trachea,  skeletal 
muscle, femur, bone marrow. 
Histopathology was performed on 19 males and 20 females 
of  the control group as well as on 20 males and 20 females 
of  the highest dose group.  The livers of 15 males and 15 
females in the 30 ppm group and 15 males and 14 females 
in the mid group (100 ppm) were also examined. 
The values of the treated groups were compared with the control values by the 
Wilcoxon-Mann-Whitney U-test at the levels of  significance a. = 5% and a. = 1%. 
no publications cited in this summary 
13  Unpublished data:  no unpublished data cited in this summary -62-
Appendix 4  · Format for Compilation of 
T~er 1 Quality Checks 
Part l  Detailed Report - appropriate for studies not conducted 
in accordance with the test guidelines currently specified 
AnnexDA 
2  Reference point: 
3.1  Authors: 
3.2  Title: 
3.3  Owner: 
3.4  Published: 
3.5  Report No: 
3.6  Date of report: 
4.1  Testing facility: 
4.2  Lab. report No: 
5.1  Dates of 
EXAMPLE3 
Point Addressed 6.1  Metabolism,  distribution  and  expression  of 
residue in plants 
Volume 9, Section 4. Annex IIA,  6.1 I 03 
Report:  X.X. Xxxxxxx, X.X. Xxxxx  Summary:  X. xxxxxxxxxx 
Metabolism of XXX 1111 in potatoes 
xxxxxxx 
no 
xxxxxxxx File No.:  123456 
November 22, 1983, revised December 1, 1986 
Xxxxxxxxx Xxxxxxxxxxx Xxxxx, Xxxxxxxxx, Xxxxxx 
not applicable 
experimental work:  September, 1982 to April, '1983 
5.2  Objectives: 
6.1  Test substance: 
6.2  Specification: 
To detennine the overall fate of  XXX 1111 in mature potato plants; 
only the fluorophenoxy-benzyl portion of the compound was investigated 
since this portion is unique to XXX 1111 
ISO common name: 
Label: 
XXX 1111, 99.8 % pure, batch number xxxx 
phenyl-UL-
14C 
*  indicates label position 
Radiochemical purity: 99%, 23.65 mCi/mmole 
The compound used was a mixture of 4 diastereoisomeric enantiomers and had a 
cis I trans ratio of approximately 00/00, similar to that of the commercial material, 
which is approximately 00/00. 
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Appendix 4  · Format for Compilation of 
Tier 1 Quality Checks 
Part 2  Detailed Report .. appropriate for studies oot cooducted 
io accordaoce with .the test guidelioes curreotly specified 
Example 3  Metabolism, distribution aod expression of residues io plaots 
Company name  Month and year  Active Substance (Name)  Anne  I  IIA, Point 5.3.1  pa'ge l of  3 
6.3  Storage stability:  not applicable 
6.4  Stability in vehicle:  not applicable 
6.5  Homogeneity 
in vehicle:  not applicable 
6.6  Validity:.  not applicable 
6.7  Physical form:  emulsifiable concentrate 
6.8  Vehicle/solvent:  200 EC xylene formulation carrier 
7.1  Test method:  In  house  method. 
performed. 
Guidelines  were  not  available  at  the  time  the  test  was 
7.2  Justification:  The  method was  developed  following  discussions  with  regulatory  officials from 
several European authorities and from EPA.  The method used is consistent in all 
important respects to the methodology currently employed. 
7.3  Copy of method:  description of methods included in report 
7.4 · Choice of method:  not applicable 
7.5  Deviations:  not applicable 
8.1  Certified laboratory: not applicable 
8.2  Certifying authority: not applicable 
8.3  ·GLP:  no 
8.4  Justification:  when the study was performed, GLP was not required 
9.1  GEP:  not applicable 
9.2  Type of Facility 
(official or officially 
recognized):  not applicable 
9.3  Justification:  not applicable Appendix 4 
Company name 
· Format for Compilation of 
Tier 1 Quality Checks 
-64-
Part l  Detailed Report - appropriate for studies not conducted 
in accordance with the test guidelines currently spedfied 
Example 3  Metabolism, distribution and expression of residues in plants 
Month and year  Active Substance (Name)  Annex I lA, Point 5.3.2  pa~:e 2 of  3 
10  Test system - Test plants:  seed potatoes (Solanum tuberosum) 
Test conditions: 
Time of treatment: 
Method of application: 
Applied rate: 
corresponding to: 
Sampling: 
Analytical methods: 
greenhouse 
60 days after planting (initiation of  blooming) 
spray (soil surface covered during treatment) 
40 g as/40 1/ha 
(20.1 mg of [I
4C]  XXX 1111 in 0.1 mi of 200 EC 
xylene carrier dissolved in 19 ml of  water) 
approx. 100 g as/1 00 1/ha 
0, 42, 52, 80 and 98 days post treatment 
extraction  with  xxxx,  filtered,  liquid  liquid 
extraction  into  xxxx,  florisil  colwnn 
chromatography,  followed  by  thin-layer 
chromatography  and  co-chromatography  of 
standards, one-dimension on silica gel plates 
Radioactive areas on plates:  autoradiography 
Non-radioactive standards: 
Radioassay: 
11  Statistics:  not applicable 
fluorescence  quenching  under  short  wavelength 
ultraviolet light. 
Triton  X-100  scintillation  fluid,  liquid 
scintillation spectrometer. 
12.1 References:  no publications cited in this summary 
13  Unpublished data:  no unpublished data cited in this summary 
I 
I  .. 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I I 
• 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
-65-
Appendix 4  Format for Compilation of 
Tier 1 Quality Cbecks 
Part 2  Detailed Report - appropriate for studies not conducted 
in accordance witb tbe test guidelines currently specified 
.AnnexDA 
2  Reference point: 
3.1  Authors: 
3.2  Title: 
3.3  Owner: 
3.4  Published: 
3.5 ·Report No: 
3.6  Date of report: 
4.1  Testing facility: 
4.2  Lab. report No: 
5.1  Dates of 
EXAMPLE4 
Point Addressed 7.1.3.2  Aged residue column leaching ·study 
Volume 18, Section 5, Annex IIA, 7.1.3.2 I 01 
Report: 
Summary: 
X. Xxxxxxxx, X. Xxxxxxxxxxx 
X. Xxxxxxx 
Leaching characteristics of substance aged in soil 
xxxxxxxx 
no 
Company file No.: 00000 
September 27, 1985 
~.  Xxxxxxxxxxxxxxx, Xxxxxxxx, Xxxxxxxxxxxxxxx 
not applicable 
experimental work:  August 1984 to January 1985 
5.2  Objectives: 
6.1  Test substance: 
a) radiolabelled: 
b) non-labelled: 
as title 
ISO common name:  XXX 1111, 
fluorobenzene-U-
14C, 99.8% pure, batch number xxx. 
Radiochemical purity: >00 %, 00 J.LCilmg 
*  indicates label position 
XXX Ill  L as manufactured - used to increase the volume of the radiolabelled test 
material, 97.5 % pure. batch number xxxxxx -66-
Appendix 4  · Format for Compilation of 
Tier 1 Quality Ch~ 
Part l  Detailed Report - appropriate for studies not conducted 
in accordance with .the test guidelines currently spedfied 
Example 4 Aged residue column leaching study 
Company name  Month and year  Active Substance (Name)  Annes: I  lA, Point 5.3.2  page 2 of  3 
6.2  Specification: 
a) radiolabelled:  The compound used was a mixture of 4 diastereoisomeric enantiomers and had a 
cis I  trans  ratio  of 00/00,  similar to  that of the  commercial  material,  which  is 
approximately 00/00. 
b) non-labelled: 
6.3  Storage stability: 
6.4  Stability in vehicle: 
6.5  Homogeneity 
in vehicle: 
6.6  Validity: 
6.7  Physical form: 
6.8  Vehicle/solvent: 
7.1.  Test method: 
7.2  Justification: 
7.3  Copy of method: 
7.4  Choice of method: 
7.5  Deviations: 
as given in document J - specification No. 7 
not applicable 
not applicable 
not applicable (solution) 
not applicable 
solution 
acetone  · 
Merkblatt (Bulletin) No.  37 of BBA - corresponds with the recommended SET AC 
method 
not applicable 
not relevant 
not applicable 
none 
8.1  Certified laboratory: no 
8.2  Certifying authority: not applicable 
8.3  GLP:  no 
8.4  Justification:  When the study was performed. GLP was not required. 
9.1  GEP:  no 
9.2  Type of Facility 
(official or officially 
recognized):  not applicable 
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Part 2  Detalled Report - appropriate for studies not conducted 
in accordance with the test guidelines currendy specified 
Example 4 Aged residue colunm leaching study 
Company name  Month and year  ·  Active Substance (Name)  Anne  I  I lA, Point 5.3.2  page l  of  3 
9.3  Justification: 
10  Test system-
.11  Statistics: 
12.1 ·  References: 
not applicable 
BBA standard soil2.1: 
Concentration: 
Sampling: 
Thin-layer-chromatography 
and co-chromatography 
(pH 7.0;  0.69% org. C; 
10.7% fine particles< 20J.L) 
22 °C, 40 % ~mum  water holding capacity 
0.5 mg as/ kg soil 
0, 30 and 90 days 
of standards:  one-dimension on silica gel plates 
Radioactivity measurement:  liquid scintillation counting (fluids), 
linear analyzer (plates) 
or combustion (soil) 
none 
no publications data cited in this summary 
13  Unpublished data:  no unpublished data cited in this summary -68- I 
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APPENDIX6 
•' 
FORMAT FOR THE LISTING OF TEST AND STUDY REPORTS AND OTHER DOCUMENTATION 
1 
2 
3 
4 
5 
PART I 
LISTING BY ANNEX D AND ANNEX m POINT 
As indicated in subparagraphs 3.1.1 (x) and (xii) and subparagraphs 3.2.1 (xi), (xii) and (xiii), 
the listing should cover each section of  the dossier separately and should include: 
•  for each test and study report included in the complete dossier submitted, its title, source, 
company and report number; 
•  for each test and study report, an indication as to whether it is published or unpublished; 
•  for  each  test  and  study  report,  an  indication  as  to  whether  it  has  been  conducted  in 
compliance with the principles ofGLP or the requirements of points 2.2 and 2.3 ofthe 
introduction to Annex II to Directive 93/71/EEC, as appropriate; 
•  in the case of  unpublished reports, an indication of  the identity of  the owner of  the test or 
study concerned, where the owner is not the person or organization that submitted it; and 
•  in the  case  of unpublished  reports  an indication  as  to  whether  or not  data  protection  is 
claimed  in  accordance  with  Article  13  of DireCtive  91/414/EEC,  for  the  purposes  of the 
authorization of  preparations containing the active substance. 
As  specified  in  subparagrapn  3.1.1  (xi)  and  subparagraph  3.2.1  (xii),  in  preparing  the  listing; 
applicants should conduct a detailed literature search - expert judgement is required to determine the 
nature and extent of the search to be conducted..  The date on which the reference list was compiled, 
the identity of the data bases searched, the date range established for the purposes of the search (e.g. 
abstracts dated earlier than 1980 not requested), the language constraints, if  any, imposed and the key 
words used for the purposes of  the literature search, should be indicated. 
For each Annex point or sub-point, the documents should be listed alphabetically by author and where 
for a particular author there is more than one report, they should be listed in chronological order - the 
most recent study being listed last.  In cases where for a particular author. more than one reference is 
listed for any one year, the references should be distinguished by inserting letters after the year i.e.  a, 
b, c, etc., as appropriate. 
Where data protection,  in accordance  with  the  provisions  of An1clc  13  (3)  (d)  of the Directive  is 
claimed, footnotes should be included to indicate that fact. 
In the case of reports that are relevant to more than one pomt.  sub-pomt or section, the entry should 
. be repeated for each point for which it is relevant - the list that follows is intended to be illustrative of 
the required approach. ' 
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Appendix6- Fonnat for the Ustin1 of  test and study reports 
and other documentation 
Part 1  Listing by Annes Point of  test and study 
reports and pubUshed papers submitted 
Reference List, 
by Annex Point  , 
Active Substance-XXX 1111  Company Name  Month & Year 
List Compiled 
Section 3, Toxicological and Metabolism Studies on the Active Substance (Annex IIA, Point 5) 
Title  Data 
Annex  Author(s)  Year  Source (where different from company)  Protection  Owner 
point I  Company, Report No  Claimed 
reference  GLP or GEP status (where relevant), 
number  Published or not  YIN 
Annex ll Data and Information 
IIA, 5.1101  Casida, J.E.,  1979  Comparative metabolism of pyrethroids derived  N  -
Gaughan, L.C,  from 3-phenoxybenzyl and a.-cyano-3- -
Ruzo, L.O.  phenoxybenzyl alcohols. 
Advances in pesticide science, Fo.urth 
International Congress of  Pesticide Chemistry, 
ZUrich, Switzerland, July 24-38, 1978, part 2, 
182-189 
Not GLP, Published 
IIA, 5.1/02  Chopade,  1983  The distribution and metabolism of  XXX 1111  N  ORG 
H.M.,  in laying hens. 
McCann, S.A.,  Organics Inc Report No: MR86044 
Gentile, C. C.  Not GLP, Unpublished 
IIA, 5.1/03  Eben, A.,  1981  Thiocyanate excretion in rats• urine after  N  ORG 
Thyssen, J.  intraperitoneal administration of  XXX 1111 and 
decamethrin in comparable doses and after  .  exposure to defined XXX 1111 concentrations 
in the inhalation air. 
Organics Inc Report No:  10130 
Not GLP, Unpublished 
IIA, 5.1/04  Eben, A.,  1982a  Comparative study of rats on absorption of  N  ORG 
Heimann, K.G,  XXX 1111 after single oral administration in 
Machemer,L.  polyethylene glycol 400 or cremophor Ellwater 
as formulation vehicle. 
Organics Inc Report No: -10715 
Not GLP, Unpublished 
IIA, 5.1/05  Eben, A.,  1982b  Comparative study of inhibition of the Na  +, K+  N  ORG 
Machemer, L.,  and Mg ++-dependent A  TPase from rats and 
Thyssen, J.  chickens• brains in vitro by XXX 1722, some of 
its metabolites and further substances DDT, 
ouabain, some pyrethroids and phosphoric acid 
esters. 
Organics Inc Report No:  11116 
Not GLP, Unpublished 
--
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Appendix 6  Format for the Ustlng of  test and study reports 
and other documentation 
Part 1  Listing by Annex Point of  test and study 
reports and pubUshed papers submitted 
Reference List, 
by Annex Point 
Active Substance - XXX 1111  Company Name  Month & Year 
List Compiled 
Section 3, Toxicological and Metabolism Studies on the Active Substance (Annex DA, Point 5) 
Title  Data 
Annex  Author(s)  Year  Source (where different from company)  Protection  Owner 
point I  Company, Report No  Claimed 
reference  GLP or GEP status (where relevant), 
number  Published or not  YIN 
IIA, 5.1106  Eben, A.,  1987  Biotransfonnation of  XXX 1111 in the chicken  N  ORG 
Fuchs, R.,  after oral administration of  a high dose. 
Kurz, J.,  Organics Inc Report No:  15849 
Wunsche, C.,  GLP, Unpublished 
Fincke, W. 
IIA, 5.1/07  Ecker, W.  1982  Biotransfonnation of [Fluorbenzene ring- U- N  ORG 
14C]-XXX 1111; characterisation and 
provisional identification of metabolites. 
Organics Inc ~eport  No:  10575 
Not GLP, Unpublished 
IIA, 5.1108  Ecker, W.  1993  [Fluorobenzene-UL-
14C]XXX 1111;  N  ORG 
[fluorobenzene-UL-
14C]XXX 1111: metabolism 
part of  the general metabolism study in the rat. 
Organics Inc Report No: 2059 
GLP, Unpublished 
IIA. 5.1109  Klein, 0.,  1983  [U~
14C]-C  ([U-
14C]XXX 1111), fluorobenzene  N  ORG 
Weber, H.,  label): biokinetic part of the general metabolism 
Suwelak, 0.1  study in the rat. 
Organics Inc Report No:  11872 
Not GLP, Unpublished 
IIA, 5.1/10  Miyamoto, L.,  1981  The chemistry, metabolism and residue analysis  N  -
Beynon, K.I.,  of synthetic pyrethroids. 
Roberts, T.R.,  Pure & Appl. Chern., Vol. 53, pp.  1976-2022, 
Hemingway,  1981 
R.J., Swaine,  Not GLP, Published 
H. 
IIA, 5.1/11  Shaw,H.R,  1983  Metabolism of XXX 1111 in a dairy cow.  N  ORG 
Ayers, J. E.,  Organics Inc Report No: .MR.86043 
McCann, S.A.  Not GLP, Unpublished 
IIA. 5.1112  Weber, H.,  1983  Fluorophenyl-U-
14C XXX 1111) biokinetic study  N  ORG 
Suwelack, D.  on rats. 
Organics Inc Report No: PH11575(F) 
Not GLP, Unpublished -74-
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Active Substance - XXX 1111  Company Name  Month & Year 
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Section 3, Toxicological and Metabolism Studies on the Active Substance (Annex IIA, Point 5) 
Title  Data 
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reference  GLP or GEP status (where relevant), 
number  Published or not  YIN 
IIA, 5.2/01  Bomann, W.  1991  XXX 1111 I study for acute oral toxicity in  y  10  ORG 
rats. 
Organics Inc Report No:  19852 
GLP, Unpublished 
IIA, 5.2102  Flucke, W.,  1980a  XXX 1111 I acute toxicity studie~.  N  ORG 
Thyssen, J.  Organics Inc Report No: 8800 
Not GLP, Unpublished 
IIA, 5.2103  Flucke, W.,  1981  XXX 1111 (cis:trans isomer ratio= 11:11) I  N  ORG 
Thyssen, J.  acute toxicity studies. 
Organics Inc Report No: 9673 
Not GLP, Unpublished 
IIA, 5.2104  Heimann, K.G.  1982a  XXX 1111 I comparative tests for acute toxicity  N  ORG 
with various formulation aids. 
Organics Inc Report No:  10931 
Not GLP, Unpublished 
IIA, 5.2105  Heimann, K.G  1982b  Determination of  acute toxicity (LDso).  N  ORG 
Organics Inc 
Not GLP, Unpublished 
IIA, 5.2/06  Heimann, K.G.  1984  Determination of acute toxicity (LDso).  N  ORG 
Organics Inc 
Not GLP, Unpublished 
IIA, 5.2107  Heimann, K. G.  1987  XXX 1111 I study for acute oral toxicity to rats  N  ORG 
(formulation acetone and peanut oil). 
Organics Inc Report No:  15847 
GLP, Unpublished 
IIA, 5.2/08  Hoffmann, K.  1981a  XXX 1111 I acute toxicity for sheep after oral  N  ORG 
administration. 
Organics Inc Report No: 9750 
Not GLP,-Unpublished 
I 
, 
I 
I 
I 
-I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
10 protection for 5 years claimed from date of  decision concerning listing in Annex I -the study report has not previously been submitted to any of  I 
the Member States in support of  an application for authorization I  .. 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
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number  Published or not  YIN 
IIA, 5.2/09  Hoffmann, K.  1981b  XXX 1111/ Akute Toxizi~t  am Hund nach  N  ORG 
oraler Verabreichung, 
Organics Inc Report No: Letter 
Not GLP, Unpublished 
IIA, 5.2110  Iyatomi, A.,  1982a  XXX 1111/ eye and skin irritation study on  N  NTN 
Watanabe, M.,  rabbits. 
Ohta, K.  . Nihon Tokushu Noyaku Seizo Report No: 54165 
Organics Inc Report No:  1~365 
Not GLP, Unpublished 
IIA, 5.2111  lyatomi, A.  1982b  Report of  acute toxicity - A.  N  NTN 
Nihon Tokushu Noyaku Seizo Report No:  5378 
Organics Inc Report No:  10373 
Not GLP, Unpublished 
IIA, 5.2112  Iyatomi, A.  1983  Report of  acute toxicity - B.  N  NTN 
Nihon Tokushu Noyaku Seizo Report No: 59261 
Organics Inc Report No:  11343 
Not GLP, Unpublished 
IIA, 5.2113  Mihail, F.  1981a  XXX 1111 I intracutaneous sensitisation test on  N  ORG 
guinea pigs (Draize-test). 
Organics Inc Report No:  I 0222 
Not GLP, Unpublished 
IIA. 5.2114  Mihail, F.  1981b  XXX 1111 I test for sensitismg effect on guinea  N  ORG 
pigs (Maximization test according to 
Magnusson and Klingman). 
Organics Inc Report No:  I 026 7 
Not GLP, Unpuhlished 
IIA, 5.2115  Pauluhn, J.,  1982  XXX 1111 I Study for acute inhalation  N  ORG 
Thyssen, J.  toxicology (effect of  formulation agent on 
inhalation). 
Organics Inc Report No:  10965 
Not GLP, Unpublished 
IIA, 5.2116  Pauluhn, J.,  1983  XXX 1111 I study for acute and subacute  N  ORG 
Kaliner. G.  inhalation toxicity on chickens. 
Organics Inc Report No:  11558 
Not GLP. Unpublished -76-
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IIA. 5.2117  Pauluhn, J.  1987  XXX 1111 I study of  the acute inhalation  N  ORG 
toxicity to rats using OECD guideline No. 403. 
Organics Inc Report No:  15612 
GLP, Unpublished 
IIA, 5.2118  Pauluhn, J.  1988a  XXX 11111 study for sensory irritant potential  N  ORG 
in the rat (RDso detennination). 
Organics Inc Report No:  16693 
GLP, Unpublished 
IIA, 5.2119  Pauluhn, J.  1988b  XXX 11111 study for sensory irritant potential  N  ORG 
in the mouse (RDso detennination). 
Organics Inc Report No:  16713 
GLP, Unpublished 
IIA, 5.2/20  Pauluhn, J.  1988c  XXX 1111 I study of  the blood gases in rats.  N  ORG 
Organics Inc Report No:  16763 
GLP, Unpublished 
IIA, 5.2121  Pauluhn, J.  1989  XXX 1111 I studies of  acute inhalation toxicity  yiO  ORG 
in the mouse, in accordance with OECD 
guideline No. 403. 
Organics Inc Report No:  17765 
GLP, Unpublished 
IIA, 5.2/22  Sachsse, K.  1985a  Acute oral toxicity (LDso) study with XXX 1111  N  ORG 
(  c.n. XXX 1111) vehicle: cremophor EL 2% in 
distilled water in the hen. 
Organics Inc Report No: R3621 
GLP, Unpublished 
IIA, 5.2/23  Sachsse, K.  1985b  Acute oral toxicity (LDso) study with XXX 1111  N  ORG 
vehicle: PEG 400 in the hen. 
Organi~s Inc Report No: R3622 
GLP, Unpublished 
IIA, 5.2/24  Thyssen, J.,  1981  XXX 1111 I neurotoxicity studies on hens.  N  ORG 
Kaliner, G.,  Organics Inc Report No: 9753 
Groning, P.  Not GLP, Unpublished 
I 
• 
I 
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I 
I 
I 
I 
I 
I 
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I 
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Section 3, Toxicological and Metabolism Studies on tbe Active Substance (Annex DA, Point 5) 
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number  Published or not  YIN 
IIA, 5.2125  Thyssen, J.  1982  XXX 1111, fonnulation in water and influence  N  ORG 
on acute oral toxicity. 
·organics Inc 
Not GLP, Unpublished 
IIA, 5.2126  Watanabe, M.,  1984  Acute inhalation study of  XXX 1111 on rats.  N  NTN 
Iyatomi, A.  Nihon Toktishu Noyaku Seizo Report No: 73126 
Not GLP, Unpublished 
IIA, 5.3/01  Flucke, W.,  1980b  XXX 1111 I subacute oral toxicity study on rats.  N  ORG 
Schilde, B.  .  Organics Inc Report No: 9039 
Not GLP, Unpublished 
IIA, 5.3102  Loser, E.,  1980  XXX 1111 I subchronic toxicity study on rats  N  ORG 
Schilde, B.  (three-month feeding experiment). 
Organics Inc Report No: 9386 
Not GLP, Unpublished I 
-78- -
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Appendix 6  Fonnat for the Usting of  test and study rep~rts and other documentation 
PART2 
LISTING BY AUTHOR 
1  As  in  the  case  of the  listing by  Annex  point  of test  and  study  reports  and  other documentation 
submitted (see Part 1 of  Appendix 6), the listing should cover each section of  the dossier separately 
and should include: 
2, 
3 
4 
5 
•  for each test and study report included in the complete dossier submitted, its title, source, 
company and report number; 
•  for each test and study report, an indication as to whether it is published or  unpublished~ 
•  for  each  test  and  study  report,  an  indication  .as  to  whether  it  has  been  conducted  in 
compliance with the principles of  GLP or the requirements of  points 2.2 and 2. 3 of  the 
introduction to Annex II to Directive 93171/EEC, as appropriate; 
•  in the case of  unpublished reports, an indication of  the id~ntity of  the owner of  the test or 
study concerned, where the owner is not the person or organization that submitted it; and 
•  in the case  of unpublished  reports  an indication  as  to  whether or not data  protection  is 
claimed in accordance  with Article  13  of Directive 911414/EEC,  for the purposes  of the 
authorization of  preparations containing the active substance. 
As  specified  in subparagraph  3.1.1  (xi)  and,  subparagraph  3.2.1  (xii),  in preparing  the  listing, 
applicants should conduct a detailed literature search - eXpert judgement is required to determine the 
nature and extent of  the search to be conducted.  The ctate on which the reference list was compiled, 
the identity of the data bases searched, the date range established for the purposes of the search (e.g. 
abstracts dated earlier than 1980 not requested), the language constraints, if  any, imposed and the key 
words used for the purposes of  the literature search, should be indicated. 
Within  sections,  the  listing  should  be  arranged  alphabetically  by  author.  Where for  particular 
authors,  there is more than one reference,  they should be  listed in chronological order.  In cases 
where for a particular author, more than one reference is listed for any one year, the references should 
be distinguished by inserting letters after the year i.e. a, b, c, etc., as appropriate. 
Where data protection,  in accordance with the  provisions of Article  13  (3)  (d)  of the Directive is 
claimed, footnotes should be included to indicate that fact. 
The reference lists that follow are intended to be illustrative of the required approach and relate to a 
fictitious compound, active substance .XXX 1111. -80-
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Reference List, 
by Author 
Active Substance - XXX 1111  Company Name  Month & Year 
List Compiled 
Section 3, Toxicological and Metabolism Studies on the Active Substance (Annex DA, Point 5) 
Title  Data 
Author(s)  Annex point  Year  Source (where different from company)  Protection  Owner 
I reference  Company, Report No  Claimed 
number  GLP or GEP status (where relevant), 
Published or not  YIN 
Annex ll Data and Information 
Bomann, W.  IIA, 5.2/01  1991  XXX 1111 I study for acute oral toxicity in  yll  ORG 
rats. 
Organics Inc Report No: 19852 
GLP, Unpublished 
Casida, J.E.,  IIA, 5.1101  1979  Comparative metabolism of  pyrethroids derived  N  -
Gaughan,  from 3-phenoxybenzyl and a.-cyano-3-
L.C, Ruzo,  phenoxybenzyl alcohols. 
L.O.  Advances in pesticide science, Fourth 
International Congress of  Pesticide Chemistiy, 
ZUrich, SWitzerland, July 24-38, 1978, part 2, 
182-189 
Not GLP, Published 
Chopade,  IIA, 5.1/02  1983  The distribution and metabolism of  XXX 1111  N  ORG 
H.M.,  in laying hens. 
McCann. S.A.,  Organics Inc R~port  No: MR86044 
Gentile, C. C.  Not GLP, Unpubli~hed 
Eben, A.,  IIA, 5.1/06  1987  Biotransfonnation of  XXX 1111 in the chicken  N  ORG 
Fuchs, R.,  after oral administration of  a high dose. 
Kurz, J.,  Organics Inc Report No:  15849 
Wunsche, C.,  GLP, Unpublished 
Flucke, W. 
Eben, A.,  IIA, 5.1104  1982a  Comparative study of rats on absorption of  N  ORG 
Heimann,  XXX 1111 after single oral administration in 
K.G,  polyethylene glycol 400 or cremophor El/water 
Machemer, L.  as formulation vehicle. 
Organics Inc Report No:  10715 
Not GLP, Unpublished 
11  protection for S years claimed from date of  decision concerning listing in Annex I - the study report has not previously been submitted to 
any of  the Member States in support of  an application for authorization 
I 
I 
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Reference List, 
by Author 
Active Substance - XXX 1111  Company Name  Month & Year 
List Compiled . 
Section 3, Toxicological and Metabolism Studies on the Active Substance (Annex DA, Point 5) 
Title  Data 
Author(s)  Annex point  Year  Source (where different from company)  Protection  Owner 
I reference  Company, Report No  Claimed 
number  GLP or GEP status (where relevant), 
Published or not  YIN 
Eben, A.,  IIA, 5.1/05  1982b  Comparative study of inhibition of the Na+, K+  N  ORG 
Machemer, L.,  and Mg  ++--dependent A  TPase from rats and 
Thyssen, J.  chickens' brains in vitro by XXX 1722, some of 
its metabolites and further substances DDT, 
ouabain, some pyrethroids and phosphoric acid 
esters. 
Organics Inc Report No:  11116 
Not GLP, Unpublished 
Eben, A.,  ITA, 5.1./03  1981  Thiocyanate excretion in rats' urine after  N  ORG 
Thyssen, J.  intraperitoneal administration of  XXX 1111 and 
decamethrin in comparable doses and after 
exposure to defined XXX 1111 concentrations 
·  in the inhalation air. 
Organics Inc Report No:  10130 
Not GLP, Unpublished 
Ecker, W.  IIA, 5.1/07  1982  Biotransformation of  [Fl~orbenzene ring- U- N  ORG 
'
4C]-XXX 1111; characterisation and 
provisional identification of metabolites. 
Organics Inc Report No:  10575 
Not GLP, Unpublished 
Ecker, W.  IIA, 5.1/08  1993  [Fluorobenzene-UL-
14C]:XXX  I III:  N  ORG 
[fluorobenzene-UL-
14C})DCX  II II : metabolism 
part of the general metabolism  ~tud~ in the rat. 
Organics Inc Report No:  20~9 
GLP, Unpublished 
Flucke, W.,  IIA, 5.3/01  1980b  XXX 1111 I subacute oral  toxJclt~  stud~ on rats.  N  ORG 
Schilde, B.  Organics Inc Report No: 90  3  9 
f  Not GLP, Unpublished 
Flucke, W.,  IIA, 5.2/02  1980a  XXX 1111 I acute toxicity studies.  N  ORG 
Thyssen, J.  Organics Inc Report No:  8800 
Not GLP, Unpublished 
Flucke, W.,  IIA, 5.2/03  1981  XXX  1111 (cis:trans isomer ratio= 11:11) I  N  ORG 
Thyssen, J.  acute toxicity studies. 
Organics Inc Report No:  9673 
Not GLP, Unpublished 
I -82-
Appendh 6  Fonnat for the Usting oftest and study reports 
and other  documentation 
Part 2  Listing by Author of  test and -.tudy 
reports and published papers submitted 
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by Author 
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Section 3, Toxicological and Metabolism Studies on the Active Substance (Annex DA, Point 5)  , 
Title  Data 
Author(s)  Annex point  Year  Source (where different from company)  Protection  Owner 
I reference  Company, Report No  Claimed 
number  GLP or GEP status (where relevant), 
Published or not  YIN 
Heimann, K.G  IIA, 5  .  .2/05  1982b  Determination of acute toxicity (LDso).  N  ORG 
Organics Inc 
Not GLP, Unpublished 
Heimann, K.G  IIA, 5.2/04  1982a  XXX 1111 I comparative tests for acute toxicity  N  ORG 
with various formulation aids. 
Organics Inc Report No:  10931 
Not GLP, Unpublished 
Heimann, K.G  IIA, 5.2106  1984  Determination of acute toxicity (LDso).  N  ORG 
Organics Inc 
Not GLP, Unpublished 
Heimann, K.G  IIA, 5.2107  1987  XXX 1111 I study for acute oral toxicity to rats  N  ORG 
(formulation acetone and peanut oil). 
Organics Inc Report No:  15847 
i 
GLP, Unpublished 
Hoffmann, K.  IIA, 5.2/08  1981a  XXX 1111 I acute toxicity for sheep after oral  N  ORG 
administration. 
Organics Inc Report No: 9750 
Not GLP, Unpublished 
Hoffmann, K.  IIA, 5.2/09  1981b  XXX 1111 I Akute Toxizitat am Hund nach  N  ORG 
oraler Verabreichung. 
Organics Inc Report No: Letter 
Not GLP, Unpublished 
Iyatomi, A.  IIA, 5.2111  1982b  Report of acute toxicity- A.  N  NTN 
Nihon Tokushu Noyaku Seizo Report  No:  5378 
Organics Inc Report No:  10373 
Not GLP, Unpublished 
Iyatomi, A.  IIA, 5.2/12  1983  Report of acute toxicity- B.  N  NTN 
Nihon Tokushu Noyaku Seizo Report No: 59261 
Organics Inc Report No:  11343 
Not GLP, Unpublished 
I 
I  .. 
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Reference List, 
by Author 
Active Substance - XXX 1111  Company Name  Month & Year 
List Compiled 
Section 3, Toxicological and Metabolism Studies on the Active Substance (Annex DA, Point 5) 
Title  Data 
Author(s)  Annex point  Year  Source (where different from compan~)  Protection  Owner 
I reference  Company, Report No  Claimed 
number  GLP or GEP status (where relevant), 
Published or not  YIN 
Iyatomi, A.,  IIA, 5.2110  1982a  XXX 1111 I eye and skin irritation study on  N  NTN. 
Watanabe, M.,  rabbits. 
Ohta, K.  Nihon Tokushu Noyaku Seizo Report No: 54165 
Organics Inc Report No:  10365 
Not GLP, Unpublished 
Klein, 0.,  ITA, 5.1109  1983  [U-
14C]-C ((U-
14C])CXX 1111), fluorobenzene  N  ORG 
Weber, H.,  label): biokinetic part of the general metabolism 
Suwelak, D  .1  study in the rat. 
Organics Inc Report No:  11872 
Not GLP, Unpublished 
I 
Loser, E.,  IIA, 5.3102  1980  XXX 1111/ subchronic toxicity study on rats  N  ORG 
Schilde, B.  (three-m.onth feeding experiment). 
Organics Inc Report No: 9386 
Not GLP, Unpublished 
Mihail, F.  IIA, 5.2113  1981a  XXX 1111 I intracutaneous sensitisation test on  N  ORG 
guinea pigs (Draize-test). 
Organics Inc Report No:  10222 
Not GLP, Unpublished 
Mihail, F.  IIA, 5.2/14  1981b  XXX 1111 I test for sensitising effect on guinea  N  ORG 
pigs (Maximization test according to 
Magnusson and Klingman). 
Organics Inc Report No:  10267 
Not GLP, Unpublished 
Miyamoto, L.,  IIA, 5.1110  1981  The chemistry, metabolism and residue analysis  N  -
Beynon, K.I.,  of synthetic pyrethroids. 
Roberts, T.R.,  Pure & Appl. Chern., Vol. 53, pp.  1976-2022,  I 
Hemingway,  1981 
RJ., Swaine,  Not GLP, Published 
H. 
Pauluhn, J.  IIA, 5.2/17  1987  XXX 1111 I study of the acute inhalation  N  ORG 
toxicity to rats using OECD guideline No. 403. 
Organics Inc Report No:  15612 
GLP, Unpublished -84-
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Reference List, 
by Author 
Active Substance - XXX 1111  Company Name  Month & Year 
List Compiled 
Section 3, Toxicological and Metabolism Studies on the Active Substance (Annex DA, Point 5) 
Title  Data 
Author(s)  Annex point  Year  Source (where different from company)  Protection Owner 
I reference  Company, Report No  Claimed 
number  GLP or GEP status (where relevant), 
Published or not  YIN 
Pauluhn, J.  IIA, 5.2118  1988a  XXX 1111 I study for sensory irritant potential  N  ORG 
in the rat (RDso determination). 
Organics Inc Report No: 16693 
GLP, Unpublished 
Pauluhn, J.  IIA, 5.2119  1988b  XXX 1111 I study for sensory irritant potential  N  ORG 
in the mouse (RDso determination). 
Organics Inc Report No:  16713 
GLP, Unpublished 
Pauluhn, J.  IIA, 5.2120  1988c  XXX 1111 I study of  the blood gases in rats.  N  ORG 
Organics Inc Report No: 16763 
'  GLP, Unpublished 
Pauluhn, J.  IIA, 5.2121  1989  XXX 1111 I studies of  acute inhalation toxicity  yll  ORG 
in the mouse, in accordance with OECD 
guideline No. 403. 
Organics Inc Report No:  17765 
GLP, Unpublished 
Pauluhn, J.,  IIA, 5.2116  1983  XXX 1111 I study for acute and subacute  N  ORG 
Kaliner. G.  inhalation toxicitY on chickens. 
Organics Inc Report No:  11558 
Not GLP, Unpublished 
Pauluhn, J.,  IIA, 5.2115  1982  XXX 1111 I Study for acute mhalat1on  N  ORG 
Thyssen, J.  toxicology (effect offonnulauon a~cnt on 
inhalation). 
Organics Inc Report No:  10965 
Not GLP, Unpublished 
Sachsse, K.  IIA, 5.2/22  1985a  Acute oral toxicity (LD~o)  stud~ \\lth XXX  1111  N  ORG 
(c.n. XXX 1111) vehicle: cremophor EL 2o/o in 
distilled water in the hen. 
Organics Inc Report No: R3621 
GLP, Unpublished 
Sachsse, K.  IIA, 5.2/23  1985b  Acute oral toxicity (LDso) study with XXX 1111  N  ORG· 
vehicle: PEG 400 in the hen. 
Organics Inc Report No: R3622 
GLP, Unpublished 
I 
' 
I 
~ 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I I 
I 
• 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
-85-
Appendh6  Fonnat for the listing oftest and study reports 
and other documentation 
Part 2  Listing by Author of  test and study 
reports and published papers submitted 
Reference List, 
by Author 
Active Substance - XXX 1111  Company Name  Month & Year 
List Compiled 
Section 3, Toxicological and Metabolism Studies on the Active Substance (Annex IIA, Point 5) 
Title  Data 
Author(s)  Annex point  Year  Source (where different from company)  Protection  Owner 
I reference  Company, Report No  Claimed 
number  GLP or GEP status (where relevant), 
Published or not  YIN 
Shaw,H.R,  IIA, 5.1/11  1983  Metabolism of XXX 1111 in a dairy cow.  N  ORG 
Ayers, J. E.,  Organics Inc Report No: MR86043 
McCann, S.A.  Not GLP, Unpublished 
Thyssen, J.  IIA, 5.2/25  1982  XXX 1111, formulation in water and influence  N  ORG 
on acute oral toxicity. 
Organics Inc 
Not GLP, Unpublished 
Thyssen, J.,  IIA, 5.2/24  1981  XXX 1111/ neurotoxicity studies on hens.  N  ORG 
Kaliner, G.,  Organics Inc Report No: 9753 
Groning, P  Not GLP, Unpublished 
Watanabe, M.,  IIA, 5.2/26  1984  Acute inhalation study of XXX 1111 on rats.  N  NTN 
Iyatomi, A.  Nihon Tokushu Noyaku Seizo Report No: 73126 
Not GLP, Unpublished 
Weber, H.,  IIA, 5.1/18  1983  Fluorophenyl-U-
1"C XXX 1111) biokinetic study  N  ORG 
Suwelack, D.  on rats. 
Organics Inc Report No: PH11575(F) 
Not GLP, Unpublished I 
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Appendu6  ·  Fonnat for the Osting of  test and study reports and other documentation 
1 
2 
3 
PART3 
LISTING OF TEST AND STUDY REPORTS AND PUBLISHED PAPERS NOT SUBMITTED 
As in the case of the listing of test and study reports and other documentation submitted (see Parts 1 
and 2 of Appendix 6), the listing of  test and study reports and published papers not submitted as part 
'  of  the complete. dossier, should cover each section of  the dossier separately and should include: 
•  for each test and study report, its title, source, company and report number; 
•  for each test and study report, an indication as to whether it is published or unpublished; and 
•  for each test and study  report,  an indication as to  the· reason  the test  or study  report  or 
published paper was not submitted; 
Within sections,  the listing $hould  be  arranged alphabetically  by  author.  Where  for  particular 
authors, there is more than one reference,  they should be listed in chronological order.  In cases 
where for a particular author, more than one reference is listed for any one year, the references should 
be distinguished by inserting letters after the year i.e. a, b, c, etc., as appropriate. 
The reference lists that follow are intended to be illustrative of the required approach and relate to a 
fictitious compound, active substance XXX 1111. -88-
Appendil6  · Fonnat for the Usting of  test and study reports  Part 3  Listing of  test and study reports and 
and other documentation  , published papers not submitted 
Reference List,  Active Substance - XXX 1111 
by Author 
Company Name  Month & Year 
List Compiled 
Section 3, Toxicological and Metabolism Studies on the Active Substance (Annex DA, Point 5) 
Title  Data 
Author(s)  Annex point  Year  Source (where different from company)  Protection  Owner 
Company, Report No  Claimed 
Indication of the reason not submitted 
Published or not  YIN 
Becker, H.  IIA, 5.6.2  1983  Dose-finding embryotoxicity (including  N  ORG 
teratogenicity) study with XXX 1111 in the rat 
(preliminary study) 
Organics Inc Report No. R8128 
Provides no useful information.  Unpublished 
Becker, H.  IIA, 5.6.2  1992a  Second dose range-finding embryotoxicity study  N  ORG 
(including teratogenicity) with XXX 1111 in the 
rabbit 
Organics Inc Report No. R5513 
Provides no useful information.  Unpublished 
Becker, H.  IIA, 5.6.2  1993  Dose-finding embryotoxicity (including  N  ORG 
teratogenicity) study with XXX 1111 in the rat 
(preliminary study) 
Organics Inc Report No. R5980 
Provides no useful information.  Unpublished 
Becker, H.,  IIA, 5.6.2  1992b  Dose range-finding embryotoxicity study  N  ORG 
Biedermann,  (including teratogenicity) with XXX 1111 in the 
K.  rabbit 
Organics Inc Report No. R5512 
Provides no useful information.  Unpublished 
Flucke, W.  IIA, 5.2.1  1980  XXX 1111, diastereomers - determination of the  N  ORG 
acute toxicity (LD,o) 
Organics Inc Report No. Rl398 
Method used no longer accepted.  Unpublished 
Heimann,  IIA, 5.2.6  1982  Comparative study of  Ethyl-4-:Aminobenzoate,  N  ORG 
K.G.  Formaldehyde, Potassium Penicillin G. and 
XXX 1111 to test for sensitisation effect using 
various test methods (Sensitization tests of 
Draize, Magnusson and Klingman, and Maurer) 
Organics Inc Report· No.  10812 
Method used no longer accepted.  Unpublished 
Heimann,  IIA, 5.2.2  1984  XXX 1111 - determination of acute toxicity  N  ORG 
K.G.  (LD50) (Lutrol) 
Organics Inc Report No R2542, September 25, 
1984 
Method used no longer accepted.  Unpublished 
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·Fonnat for the listing of  test and study reports 
and other documentation 
Active Substance- XXX 1111 
Part 3  Listing of  test and study reports and 
. published papers not submitted 
Company Name  Month & Year 
List Compiled 
Section 3, Toxicological and Metabolism Studies on the Active Substance (Annex DA, Point 5) 
Title  Data 
Author(s)  Annex point  Year  Source (where different from company)  Protection  Owner 
Company, Report No  Claimed 
Indication of the reason not submitted 
Published or not  - YIN 
KaZda, S.  IIA. 5.8.2  1979  XXX 1111 - Effect on arterial blood pressure  N  ORG 
and heart rate 
Organics Inc Report No. R7359 
I  Test material not identified.  Unpublished 
Marshall, J.A  ..  ITA, 5.8.2  1985  Effects of  pyrethroids on reactions of  rats.  N  -
Fund. Appl. Toxicol. 8, 742 - 748 
Study design statistically faulty.  Published 
Mihail, F.L.  ITA, 5.2.1  1978  XXX 1111-TOX I  N  ORG 
Organics Inc Report No. R84  72 
Test material not identified.  Unpublished 
Roberts. M.J.  ITA, 5.7  1981  Impact of  pyrethroid insecticides on vertebrates.  N'  -
Neuropathol. Appl. Neurobiol. 6, 285 - 289 
Test material not identified.  Published 
Sanders, W.H.  IIA, 5.7  1986  Toxicological properties of  pyrethroids.  N  -
Critical Reviews in Toxicology 18, 286-291, 
Test material not identified.  Published 
) I 
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APPENDIX7 
FORMAT FOR THE COMPILATION OF TIER II SUMMARIES- ANNEX D 
Section 't 
PART I 
Identity  of the  Active  Substance;  Physical  and  Chemical  Properties  of the Active 
Substance;  Further  Information  on  the  Active  Substance;  Proposals  including 
Justification  of  the  Proposals  for  the  Classification  and  Labelling  of  the  Active 
Substance  (Annex D, points 1 to 3 and 10) 
The example of a summary and assessment of data which follows is intended to illustrate the approach_ 
recommended for the preparation of Tier 11 sununaries and assessments.  The material included has not been 
critically assessed for its technical content.  Although based on a real submission, the data included in the 
following summary and evaluation has been amended to protect the commercial interests of  the owner of  the 
data. 
Applicant should be aware that these guidelines are intended to provide a degree of  flexibility.  Where in 
particular cases, it is more appropriate to present the data and information in another format, applicants may 
do so.  In such cases it is recommended that the applicant discuss the format proposed with the Competent 
Authority of the Member State to which application is to be made. 
2  Physical and chemical properties of the active substance 
Test or Study  Guideline  Test material  Findings  Comments  GLP  Reference 
&  and  purity and 
Annex point  method  specification  \  YIN 
Melting point,  OECD 102  XXX:X,  melting point = 117 - OECD 102  is  y  Johnson, 
freezing point  98.5% pure,  119 oc  equivalent to EEC  1995 
or solidification  specification 4,  A.1 
point 
/ 
DocmnentJ 
_(IIA 2.1.1) 
Boiling point  , 
(IIA 2.1.2) 
Temperature of 
decomposition 
of  sublimation 
(IIA 2.1.3) 
Relative 
density 
(IIA 2.2) 
Vapour 
pressure 
(IIA 2.3.1) 
Henry's law 
constant 
[IIA 2.3.2) Appe~db7  Fonnat for the Compilation of  Tier II 
Summaries - Annes II 
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Company name  Month and year  Active Substance (Name) 
Test or Study  Guideline  Test material  Findings 
&  and  purity and 
Annex point  method  specification 
Colour and 
physical state 
(llA 2.4.1) 
Odour 
(llA 2.4.2) 
lNIVIS, IR, 
NMR,MS 
spectra (as) 
(llA 2.5.1) 
lNMS,IR., 
NMR,MS 
spectra 
(impurities) 
(llA 2.5.2) 
Solubility in 
water 
(llA 2.6) 
Solubility in 
organic 
solvents 
(llA 2.7) 
n-octanollwater 
partition co-
efficient 
(llA 2.8) 
Hydrolysis rate 
at pH 4,7 and 9 
under sterile 
conditions in 
the absence of 
light 
(llA 2.9.1) 
Direct photo-
transformation 
(llA 2.9.2) 
\ 
Quantum yield 
of  direct photo-
transformation 
(llA 2.9.3) 
Dissociation 
constant 
(llA 2.9.4) 
Estimated 
photochemical 
oxidative 
degradation 
(llA 2.10) 
Flammability 
(llA 2.11.1) 
I 
Part 1  Section 1  I 
pa:e  of  I 
Comments  GLP  Reference  I 
YIN  I 
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Company name  Month and year  Active Substance (Name) 
Test or Study  Guideline  Test material  Findings 
&  and  purity and 
Annex point  method  specification 
Auto-
flammability 
(llA 2.11.2) 
Flash point 
(llA 2.12) 
Explosive 
properties 
(llA 2.13) 
Surface 
Tension 
(llA 2.14) 
Oxidizing 
properties 
(llA 2.15) 
Summary and Conclusions 
Part 1  Section 1 
page  of 
Comments  GLP  .Reference 
YIN 
-
XXXX is a herbicide with xxxxxxxxxxx structure consisting of two diastereois<:>mers.  Its vapour pressure and 
volatility are low.  Due to its basic properties the water solubility of XXXX varies in the range between pH 3 
and 9 from very soluble to  soluble.  At < 3 its  log  Pow  is  not critical  in respect to ecological  impact and 
environmental behaviour.  Hydrolysis and photolysis are only of minor importance in its degradation in the 
environment.  Its flammability, explosive and oxidizing propenies are not critical. I 
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Appendix 7  Fonnat for the Compilation of Tier 11 Summaries - Annex II 
PART2 
Section 2  Analytical methods (Annex n, Point 4.1 and 4.2) 
The example of  a summary and assessment of data which follows is intended to illustrate the approach 
recommended for the preparation of Tier II summaries and assessments.  The material included has not been 
critically assessed for its technical content.  Although based on a real submission, the data included in the 
following summary and evaluation has been amended to protect the commercial interests of the owner of the 
data. 
Applicant should be aware that these guidelines are intended to provide a degree of  flexibility.  Where in 
particular cases, it is more appropriate to present the data and information in another format, applicants may 
do so.  In such cases it is recommended that the applicant discuss the format proposed with the Competent 
Authority of the Member State to which application is to be made. 
4.2  Methods for the determination of residues 
Matrix  Method  Limit of quantification  Reference 
crops  GC-ECD  Peter and Paul, 1992 
wheat  0.01 mglkg 
grape  0.05 mglkg 
crops  GC-ECD  Hinz and Kunz, 1993 
wheat  0.01 mglkg 
grape  0.05 mglkg 
milk  GC-PND  0.01 mglkg  Paul and Mary, 1992 
meat, egg  GC-PND  0.05 mglkg  Paul and Mary, 1992 
soil  HPLC-UV  0.05 mglkg  Mary and Peter, 1992 
water  GC-MS  0.05 J.lg/1  Herbert, 1993 
air  HPLC-UV  0.3  J.lg/m3  Louise et al., 1994 
, blood 
I  GC-MS  0.1  Jlg/1  Laura and Sean, 1995 Appendix 7  · Format for the Compilation of Tier II 
Summaries - Annex II 
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Company name  Month and year  Active Substance (Name) 
Par1 2  Section 2  AnaJytical methods 
page  of 
4.2.1  Residues  in  and/or  on  plants,  plant  products,  foodstuffs  (of  plant  and  animal  origin), 
feedingstuffs 
4.2.1.1  Description of methods 
Peter and Paul, 1992 
Residues ofxxx in plant material (wheat, grape) were determined according to standard-multi-method DFG S 
19 (Specht and Thier, 1987) and supplements t~ the method (Peter and Paul, 1992).  xxx was extracted from 
the sample material with acetone/water.  Water was added in an amount such that, taking into account the 
water content of the sample, the acetone/water ratio was 2/1.  Sodium chloride and dichloromethane were 
added to the extract leading to a separation of the organic and the aqueous phase.  In accordance with the on-
line version,  cyclohexanelethyl  acetate  can be substituted for dichloromethane. ·  The organic phase  was 
evaporated and a cleanup of the residue achieved using gel chromatography with Bio-Beads S-X3.  Elution 
was done with a cyclohexanelethyl acetate mixture.  The fraction containing the residues of xxx was further 
cleaned on a  silica gel column eluted with toluene/acetone.  The active substance was determined by gas 
chromatography with an electron capture detector. 
Hinz and Kunz, 1993 
The method of Peter and Paul (1992) was validated by Hinz and Kunz (1993).  During the inter laboratory 
validation exercise, two minor modifications to the original method were introduced.  In addition, the detector 
linearity study curve was determined at a standard concentration of 0.025 mglkg.  The second modification 
was in the ratio of  acetone/water used - it was increased from 2: 1 to 2.5: 1. 
Paul_ and Mary, 1992 
Residues of  xxx in animal tissues, eggs and milk were determined by gas-chromatography.  xxx was extracted 
from tissue samples and eggs with acetonitrile.  An aliquot of  the extract was cleaned up using gel permeation 
chromatography (GPC) followed by elution through alumina and Florisil  solid phase extraction cartridges. 
The eluate was  evaporated to dryness  and taken up  in a  known  volume  of acetone  for  analysis  by  gas-
chromatography with phosphorus-nitrogen-detection (GC-PND).  xxx residues in milk samples were extracted 
using acetonitrile and partitioned into dichloromethane.  The extract  was  cleaned as described for animal 
tissue and eggs. 
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Appendix 7  Format for the Compilation of Tier 11  Partl  Section 2  Analytical methods 
Summaries - Annex II 
Company name  Month and year  Active Substance (Name)  page  of 
4.2.1.2  Validation data for analytical methods for the determination of residues of xxx in food of plant 
and animal origin 
Reference  Matrix  Fortification  Recovery rate[%]  RSD  n 
level [mg!kg]  mean  ran~e  [%] 
Peter and Paul,  wheat  0.01*  95  85-109  8.2  8 
1992  0.1  87  80-97  6.1  8 
grape  0.05*  102  99-110  4.2  10 
0.1  99  98-100  1.0  6 
Hinz and Kunz,  wheat  0.01*  90  85-100  7.2  4 
1993  0.1  89  83-99  9.3  4 
grape  0.05*  102  100-107  3.5  4. 
0.1  92  88-94  3.0  4 
Paul and Mary,  milk  0.01*  88  85-100  9.8  6 
1992  0.2'  93  86-107  14.2  6 
eggs  0.05*  86  78-93  12.3  6 
1.0  91  90-93  2.0  3 
muscle  0.05*  78  75-80  3.4  6 
1.0  84  80-90  5.0  3 
liver  0.05*  80  73-86  7.3  13 
* Limit of quantification, defmed by the lowest validated fortification level. 
4.2.2  Residues in soil 
4.2.2.1  Description of method 
Mary and Peter, 1992 
xxx and its major soil metabolite (xyz123) can be determined using high performance liquid chromatography 
(HPLC).  The analytes in soil samples were extracted with methanol/water.  An aliquot of the extract was 
, then subjected to liquid':'liquid partitioning using an acidified sodium chloride solution and dichloromethane. 
The dichloromethane ex1ract  was  evaporated  to  dryness and taken  up  in a known volume of HPLC  mobile 
phase (acetonitrile/water, gradient) and was analysed by high perfonnance liquid chromatography using UV 
detection.  Quantitative  confirmation  of residues  present  may  be  carried  out  using  HPLC  with  triple 
quadrupole mass spectrometry.  The method can be run either manually or automated as a robotic system. -98-
Appeadix 7  · Format for the Compilation of Tier II 
Summaries - Annex II 
Part 2  Section 2  Analytical methods 
Company .name  Month and year  Active Substance (Name) 
4.2.2.2  validation data for analytical methods for the determination of residues of xu in soil 
Reference 
(analyte) 
Mary and Peter 
1992 
(XXX) 
(xyz123) 
Matrix 
soil 
soil 
Fortification 
level [  mg!kg] 
0.05 
0.1 
0.5 
0.05 
0.1 
0.5 
Recovery rate [%]-
mean 
102 
99 
88 
86 
91 
80 
range 
99-110 
98-100 
85-100 
78-93 
90-93 
73-86 
RSD 
{%] 
4.2 
1.0 
9.8 
12.3 
2.0 
7.3 
pa:e  of 
10 
6 
6 
6 
3 
3 
n 
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Appendix 7  . Format for the Compilation of Tier II  Summaries - Annex II 
PARTJ 
Section 3  Toxicological and Metabolism Studies on the Active Substance (Annex II, Point 5) 
The example of  a summary and assessment of  data which follows is intended to illustrate the approach 
recommended for the preparation of Tier II summaries and assessments.  The material included has not been 
critically assessed for its technical content.  Although based on a real submission, the data included in the 
following summary has been amended to protect the commercial interests of the owner of  the data. 
Applicant should be aware that these guidelines are intended to provide a degree of  flexibility.  Where in 
particulm: cases, it is more appropriate to present the data and information in another fonnat, applicants may 
do so.  In such cases it is recommended that the applicant discuss the format proposed with the Competent 
Authority of  the Member State to which application is to be made. 
5.2  Acute toxicity 
5.2.1  Oral 
Report:  Glaza,  S.M.  (1993c)~  Acute  oral  toxicity of technical  XXX-YYYYYY in  rats~ 
Hazleton Wisconsin, Madison, WI, USA;  unpublished report no.  HWI21201693, 
19.04.1993;  dates of  experimental work: 04.01.1993 to 19.04.1993. 
Guidelines:  EPA FIFRA,  subdivision  F,  §81-1  (equivalent  to  EEC  method  B.2  - Directive 
92/69/EEC);  deviations: none except that the limit dose was 5000 mglkg instead of 
2000 mglkg 
GLP:  Yes (self certification by the laboratory) 
1
: 
Material ~d  methods:  Test material:  XXX-YYYYYY:  Batch  FL-921658:  Purity:  95.0  % 
13
•  The test 
material was suspended in distilled water and admamstered to groups of 5 male and 
5 female  fasted  Crl:CD®aR  rats  by  oral  gavage  at  a  dose  level  of 5000  mglkg 
(application volume 10 mllkg). 
Findings:  No mortalities were observed (Table 5.2  I -I)  Except for one male which had a soft 
stool at one hour after dosing, no clinical signs were observed throughout the observation period.  No effects 
on body weight development were noted.  At gross necropsy no visible lesions were observed. 
12 In the US,  l~ratories  are responsible for certifYing that they have complied with FIFRA GLP requirements.  COmpliance is verified by the 
EPA (Envirorunental Protection Agency, Office of  Compliance Monitoring) by means of  periodic inspections. 
13 Details with respect to the purity and content of  impurities of  the test material are provided in Document J -100-
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Table 5.2.1-1:  Acute oral toxicity ofXXX-YYYYYY 
Dose  Time of  death  Dose  Time of  death 
5000m 
Conclusion:  The oral LD50 of the test compound in rats was determined to be greater than 5000 
mglkg.  In according with the provisions of  Council Directive 67  /5.48/EEC, classification is not required. 
5.2.2  Percutaneous 
Report:  Glaza, S.M. (1993d), Acute dermal toxicity of  technical XXX-:YYYYYY in rabbits, 
Hazleton Wisconsin,  Madison,  WI,  USA,  unpublished  report  No.  HWI21201694, 
19.04.1993;  dates of  experimental work: 12.01.1993 to 19.04.1993. 
Guidelines:  EPA FIFRA,  Subdivision F,  §81-2  (equivalent  to  EEC  method  B.3  - Directive 
92/69/EEC);  deviations: none 
GLP:  Yes (self certification by the laboratory) 
12 
Material and methods:  Test  material:  XXX-YYYYYY;  Batch  FL-921658;  Purity:  95.0  % 
13
.  The 
moistened (0.9% saline) test material was applied to the shaved skin ofHra:(NZW) 
SPF  rabbits at a  dose  level  of 2000  mglkg and held  in place with an occlusive 
wrapping. 
Finding~:  No mortalities or clinical symptoms of systemic toxicity were observed during the 
study period.  Body weights were unaffected by  treatment.  No  visible  lesions were  observed at gross 
necropsy.  One female rabbit was inadvertently sacrificed and necropsied on day 7 instead of  day 14. 
Table 5.2.2-1:  Acute dermal toxicity of XXX-YYYYYY 
Males 
Dose  Time of death  Dose  Time of  death 
2000m  2000m 
Conclusion:  The dermal LDso of  the test compound in rabbits was·determined to be greater than 
2000 mglkg.  In according with the provisions of  Council Directive 67  /548/EEC, classification is not required. 
5.2.3  Inhalation 
Report:  Hartmann,  H.R.  (1993),  XXX-YYYYYY  - acute  inhalation  toxicity  in the  rat, 
Short-term Toxicology,  Ciba-Geigy Ltd.,  4332  Stein,  Switzerland;  unpublished 
report  No.  921200,  11.11.1993;  dates  of experimental  work:  08.09.1993  to 
22.09.1993 
Guidelines:  OECD 403, EEC method B.2-Directive 92/69/EEC;  deviations: none 
Yes (certified laboratory) 
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I 
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Material and methods:  Test material: XXX-YYYYYY;  Batch P.208009;  Purity 95.6 % 
13
;  Groups of 5 
male and 5 female Tif:RAif (SPF) rats were exposed to the test material.  The main 
exposure parameters were as follows -
Parameter  1  Value 
Findings:  No mortalities were recorded during the study (Table 5.2.3-1).  Clinical signs in 
both sexes included piloerection, hunched posture, and dyspnea, which 'Cleared by day 3.  Body weight gain 
was in the expected range and comparable to that of control rats.  There were no observable abnormalities at · 
gross necropsy. 
Table 5.2.3-1:  Acute inhalation toxicity of:XXX-YYYYYY 
Dose  Time of  death  Dose  Time of  death 
5082m  5082m 
Conclusion:  The acute inhalation LC50 of the test material in albino rats was determined to be 
greater than 5082 mg/m
3
.  In according with the provisions of Council Directive 67/548/EEC, classification i~ 
not required. 
5.2.4  Skin irritation 
Report:  Glaza, S.M. (1993a); Primary dermal irritation of CGA-277476 technical in rabbits; 
Hazleton Wisconsin,  Madison,  WI,  USA;  unpublished report No.  HWI21201695, 
11.03 .1993; dates of  experimental work: 11.0 1.1993 to 14.01.1993. 
Guidelines:  EPA  FIFRA,  Subdivision  F  §81-5  (equivalent  to  EEC  method  B.4  - Directive 
92/69/EEC);); deviations: 6 instead of  3 rabbits were used - a regulatory requirement 
in the USA. 
GLP:  Yes (self certification by the laboratory) 
12 
Materials and methods:  Test material:  XXX-YYYYYY;  Batch  FL-921658;  Purity:  95.0  % 
13
;  The 
moistened test material (0.9% saline) was applied to the shaved skin of  4 male and 2 
female Hra: (NZW) SPF rabbits.  The application area was covered with a 2.5 x 2.5 
em gauze pad secured with paper tape and overwrapped to provide a semiocclusive 
dressing. -102-
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Findings: 
application. 
Very slight (barely perceptible) erythema was observed in 2/6 rabbits, 4 hours after 
No signs of  skin irritation were present at 24, 48 and 72 hours (Table 5.2.4-1). 
Table 5.2.4-1:  Individual and mean skin irritation scores according to the Draize scheme 
Erythema  Oedema 
Animal no  44529  44530  44531  44418  44448  44286  44529  44530  44531  44478  44448  44286 
after4hr  0  1  0  1  0  0  0  0  0  0  0  0 
after24 hr  0  0  0  0  0  0  0  0  0  0  0  0 
after48 hr  0  0  0  0  0  0  0  0  0  0  0  0 
after 72 hr  0  0  0  0  0  0  0  0  0  0  0  0 
mean score 24-72 h  0.0  0.0 
Additional criteria specified in Directive 93/21/EEC Point 3.2.6.1 fulfilled:  Yes/No 
I 
I 
I 
I 
I 
I 
I 
Conclusion:  .On the basis of the degree of skin reaction observed (mean skin irritation scores 24  I 
to 72  hours after removal of the test article), and the criteria specified in Council Directive 67/548/EEC, the 
test compound does not classify as a skin irritant 
5.2.5.  Eye irritation 
Report:  Glaza, S.M. (1993b);  Primary eye irritation of  technical XXX-YYYYYY in rabbits; 
Hazleton Wisconsin, Madison,  WI,  USA;  unpublished report No.  HWI21201696, 
11.03.1993;  dates of  experimental work: 11.01.1993 to 16.01.1993 
Guidelines: 
GLP: 
EPA  FIFR.A,  Subdivision  F  §81-4  (equivalent  to  EEC  method  B.5  - Directive 
92/69/EEC);  deviations:  9 instead of 3 rabbits were used,  the eyes  of six  rabbits 
remained unwashed (regulatory requirement in the USA); the eyes of the remaining 
3 animals were washed 30 seconds after instillation of  the test article. 
Yes (self certification by the laboratory) 
12 
Materials and methods:  Test  material:  XXX-YYYYYY;  Batch  FL-921658;  Purity:  95.0  % 
13
.  Each 
I 
I 
·I 
I 
I 
Hra:(NZW)  SPF  rabbit  received  0.03  g  (weight  equivalent  of 100  J.d)  of XXX- I 
YYYYYY, placed into the elevated lower lid of  the right eye. 
Findings:  Slight conjunctival redness was observed in the unwashed eyes of 2/6 rabbits 1 hour 
1 
after application.  No signs of  irritation were present at 24, 48 and 72 hours in unwashed eyes (Table 5.2.5-1). 
In washed eyes no signs of ocular irritation were noted 1, 24, 48 and 72 hours after instillation. 
Table 5.2.5-1:  Eye irritation scores according to tbe Draize scbeme-unwasbed eyes  I 
Co  mea  Iris  Conjunctiva-redness  Conjunctiva-chemosis 
Time/ Rabbit  1  2  3  4  5  6  l  2  3  4  5  6  1  2  3  4  5  6  1  2  3  4  5.  6 
1 hour  0  0  0  0  0  0  0  0  0  0  0  0  0  l  0  0  1  0  0  0  0  0  0  0 
24 hours  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0 
48 hours  0  0  0  0  0  0  0  0  0  .o  0  0  0  0  0  0  0  0  0  0  0  0  0  0  I 
72 hours  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0  0 
mean scores 24-72 h  0.0  0.0  0.0  0.0 
Additional criteria in Directive 93/21/EEC Point 3.2.6.2 fulfilled: Yes/No  I 
I I  . 
I 
I 
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Conclusion:  On the basis of reactions observed (mean eye irritation scores 24 to 72 hours after 
instillation of the test article), and the criteria specified in Council Directive 67/548/EEC, the test compound 
does not classify as an eye irritant. 
5.2.6  Skin sensitization 
Two sensitization studies were carried out:  a non-adjuvant 'Closed Patch test' (according to Buehler) and an 
adjuvant 'Maximization test' according to Magnusson and Klingman. 
5.2.6.1 · Closed Patch test 
Report:  Glaza, S.M.  (1993e);  Dermal sensitization study of XXX-YYYYYY technical in 
Guinea pigs - Closed Patch technique;  Hazleton Wisconsin, Madison,  WI,  USA; 
unpublished report No.  HWI21204587,  30.04.1993~  dates of experimental work: 
12.01.1993 to 15.02.1993.  , 
Guidelines:  EPA FIFRA, Subdivision F,  §81-6 (equivalent to EEC method B.6- Buehler test-
Directive 92/69/EEC);  deviations: the test group consisted of only 10 animals.  The 
positive control group consisted of  only 4 animals.  A group of I 0 naive (previously 
untreated)  control  animals  were  used  as  a  negative  control  group.  It  is  not 
considered that these deviations effect the validity of  the study. 
GLP:  Yes (self certification by the laboratory) 
12 
Material and methods:  Test  material:  XXX-YYYYYY;  Batch  FL-921658~  Purity:  95.0  % 
13
•  In a 
preliminary  irritation  screen,  no  signs  of dermal  irritation with  25,  50,  75% or 
undiluted material were revealed.  Accordingly the undiluted test article (i.e.  the 
maximum subirritant concentration) was used for induction and challenge:  After 
the induction and challenge applications, the test sites were observed for erythema 
reactions  at 24  and 48  hours  following  patch  removal  according to  the Buehler 
scoring scale.  DNCB  (2,4-dinitrochlorobenzene) served as  positive control.  For 
induction 0.4 ml of 0.3  % w/v DNCB  in  80  °/o v/v ethanol in deionized water was 
used.  The challenge was done using 0.4 ml of  0.1 % w/v DNCB in acetone. 
Findings:  During the induction phase with test -compound. no signs of dermal irritation were 
noted.  The positive control animals displayed moderate  to  se,·ere  s1gns  of skin  irritation.  Allergic skin 
reactions did not occur 24  or 48  hours after challenge applicataon  m test-compound  treated or in negative 
control animals (Table 5.2.6-1).  In all four positive control  group  moderate signs of allergic skin reactions 
(erythema) were noted, indicating that the animals were sensitized against DNCB. 
Table 5.2.6-1:  Closed patch test:  Number of animals with signs of allergic skin reactions 
Conclusion: 
sensitizing properties. 
Scored after ...  24 h  '48 h 
Negative control  0/10  OliO 
Test group  0110  0/10 
Positive control  4/4  4/4 
In  a  modified  Buehler test,  there  was  no  evidence  that  the  test  compound  has -104-
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5.2.6.2  Maximization test 
Report:  M.  Drew. J.  Kerr (1992);  XXX-YYYYYY- Skin sensitising effect in guinea pigs 
(Maximization  Test  according  to  Magnusson  and  Klingman);  Organics  Inc, 
unpublished  report  No.:  21687  (August 21,  1994;  report)  and 21644A  (July  07, 
1996; addendum); Organics Inc, Institute of  Toxicology, Castlebar, Ireland;  dates of 
experimental work: April 1991 - May 1991. 
Guidelines:  OECD 406 (equivalent to EEC method B.6-Directive 92/69/EEC); deviations: none 
GLP:  Yes (certified laboratory) 
Material and methods:  Test material: XXX-YYYYYY;  Batch FL 921658; purity: 95.6% 
13
,  in 0.9% NaCl 
solution I  Cremophor EL (2  %  w/v);  applied at 0.1  ml/injection  intradermally to 
guinea pigs (BOR:DHPW): 5 % (intradermal application) 6 % (topical application, 1 
week  after intradermal  induction);  0.5  %,  1.0  %  (first  challenge,  3  weeks  after 
intradermal induction); 0.05 %, 0.1 % (second challenge, 4 weeks after intradermal 
induction) 
Findings:  Range  finding  for  intracutaneous  induction:  One  guinea  pig  was  injected 
intradermally with 0.1  mi of the test article· as the following concentrations: 0 %,  1 %, 2.5 %, 5  %.  The 
injection sites were assessed after 24 and 48 hours with the following results:  0 % no reaction; 1 % - 5 % grey 
region with red margin 
Range finding for topical  induction:  4  concentrations  were  tested  twice  on 4 
guinea pigs.  The results of  the treatment for 24 hours under occlusive conditions with 4 dressings soaked in 
0.5 ml of  the test material are shown in Table 5.2.6.2-1. 
Hours 
1st test 
Hours 
2nd test 
Table 5.2.6.2-1:  Number of animals exhibiting skin reddening in the range-finding test for 
topical induction (48 and 72 hours after application)  . 
6%  12%  25%  50% 
48  . I  72  48  I  72  48  I  72  48  I 
4  I  4  4  l  4  4  l  4  4  I 
0.5%  1%  3%  6% 
48  I  72  48  I  72  48  I  72  48  I 
0  I  0  0  T  0  0  I  0  4  I  . 
72 
4 
72 
4 
1st and 2nd challenge:  Clinical  Signs:  The  treatment  was  tolerated  by  all 
animals - there were no visible effects.  The body weight gain of  ~e  treatment group of  animals corresponded 
to that of  the control groups. 
Local findings:  After the first  challenge,  14  out of 20 
test-group animals responded to the 1 % test material while none of 9 control animals showed skin reactions; 5 
animals showed a positive response to the 0.5% concentration.  No skin reactions were observed following the 
second challenge. 
I 
... 
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Table 5.2.6.2-2:  Number of animals exhibiting skin reactions in the maximisation test 
(48 and 72 hours after initiation of challenge) 
Test substance group  1st and lnd control troup 
page  of 
Test J~&tm  Control  patch  Test patch  Control patch 
Hours  48  7l  48  7l  48  7l  48  7l 
lst-1%  11  10  0  0  0  0  2  2 
1st-o.s 0/o  4  2  1  0  0  0  1  1 
lnd -0.1%  0  0  0  0  0  0  0  0 
lnd - O.OS  0/8  1  0  0  0  0  0  0  0 
Following the first challenge x %and x  % of  the test animals exhibited skin redness to the 1 % and 0.5 % test 
material concentrations respectively, while none of  the control animals reacted.  After the 1st challenge xx out 
of xx test-group animals responded to the 1 %concentration while none of xx control animals showed skin 
reactions; xx animals exhibited a positive reaction to the 0.5% concentration. 
Conclusion:  XXX-YYYYYY  has  skin  sensitizing  potential  under·  the  conditions  of  the 
Maxiinization Test.  Skin sensitization was not provoked following the second challenge. 
5.2.  7  Summary of acute toxicity:· 
Table 5.2.  7-1:  Overview of acute toxicity studies with XXX-YYYYYY 
Parameter  Species  Result  Reference 
Acute oral LDso  Rat  > 5000 mg/kg  Glaza, 1993c 
Acute dermal LDso  Rabbit'  > 2000 mglkg  Glaza, 1993d 
Acute inhalation LC50 ( 4 h)  Rat  > 5082 mg/m
3  Hartmann 1993 
Acute skin irritation  Rabbit  non irritant  Glaza, 1993a 
Acute eye irritation  Rabbit  non irritant  Glaza, 1993b 
Skin sensitization  - Buehler test  Guinea pig  non-sensitizing  Glaza; 1993e 
- Maximization test  Guinea pig  sensitizing  ·Drew and Kerr, 1992 
XXX-YYYYYY is of  low toxicity.  Slight signs of  dermal and ocular irritation were noted after application to 
the skin and eye of rabbits.  In a  Buehler type sensitization test,  XXX-YYYYYY was  found  to  have no 
sensitizing potential.  In a  maximization ·test according to  Magnusson and Klingman one out of twenty 
animals (5 %) displayed signs of  allergic skin reactions. -106-
Appe11dix 7  · Fonnat for the Compilation of  Tier II  Pan 3 
Summaries - Anne~  II 
Company name  Month and year  Active Substance (Name) 
5.3  Short-term  toxicity 
5.3.1  Oral28-day studies 
5.3.1.1  &t 
Section 3  To:dcological and MetaboUsm Studies 
on the Active Substance 
pa~:e  of 
Report:  F.  Keller,  P.  Gears (1992):  XXXX - Subacute oral toxicity  study  in rats (feeding 
study).  Organics Inc, unpublished report No.  21644 (August 21,  1994; report) and 
21644A (July 07, 1996; addendum); Organics Inc, Institute of  Toxicology, Castlebar, 
Ireland, (Dates of  experimental work: April 1991 - May 1991 ). 
Guidelines:  OECD 407 » EEC B.7. 
·GLP:  yes (certified laboratory). 
Deviations:  The report was  not  audited  by  Quality  Assurance.  There  is  no  mention  of the 
analysis of  the diet to confirm dose levels. 
Material and methods:  Groups  of 10  male  and  10  female  Wistar  rats  received  XXXX  (purity  94.6  %; 
specification 00 - Document J) in the feed at concentrations of  0, 11, Ill or Ill ppm 
for 4 weeks.  Five male and 5 female animals from each dose group were selected 
for  haematology,  clinical  chemistty,  urinalyses and histopathology.  In order of 
increasing doses the treated rats ingested the equivalent of:  males:  1.1,  11.1,  and 
11.1 mglkg bw/day; females: 1.1, 11.1 and 11.1 mglkg bw/day of  XXXX. 
Findings: 
General observations:  Survival rates were unaffected at levels up. to and including 1111 ppm.  Female rats 
exhibited slight transient apathy at 1111 ppm.  Food and water intake did not differ significantly from those in 
controls throughout the entire study.  A transient retardation of  body weight development occurred in males of 
the Ill  I ppm group (Tab.: 5.3.1.1-1). 
Table 5.3.1.1-1: 4-week f~ding  study in rats: Body weights (glanimalld) 
Oppm  11 ppm  111 ppm  llll ppm 
Males 
Day  0  92  93  92  92 
Day  6  126  128  124  118 ++ 
Day 14  171  172  168  157++ 
Day21  202  204  200  190 + 
Day28/29  232  236  232  221 
Females 
Dav  0  84  82  84  84 
Day 28/29  155  153  159  153 
+  U-test, I%  significance level~++ U-test, 5% significance level 
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Table 5.3.1.1-2: 4-week feeding study in rats: Haematology and clinical chemistry 
Oppm  11  ppm  111 ppm  1111 ppm 
Males 
LEUCO 110
9/ll  5.9  7.6  7.6  6.8 + 
SEGMr%1  5.2  5.8  6.2  3.5 + 
PROT [gl]l  59.0  57.8  58.2  54.8 ++ 
CHOL [mmoVIl  2.32  2.14  2.22  1.87 ++ 
Na rmmol/l]  144  144  144  143 + 
·Females 
CREA fmcmoVIl  50  61  44  39+ 
Glucose rmmoVI)  4.75  4.60  4.55  4.18 ++ 
Na fmmolll1  144  145  143  142 + 
+ U-test, 1%  significance level~++ U-test, 5% significance level 
Haematology, clinical chemistry. urinalysis:  Haematology tests afforded no evidence  of a  treaunent-
related effect on the red or white blood cell population, or on the haematopoetic organs at levels up to  and 
including 1111  ppm.  Leucocyte counts (LEUCO) were elevated, and the qumbers of polymorphs (SEGM) 
were lower in male rats at 1111  ppm.  The clinical chemistry of liver tissue showed elevated levels of the 
cytochrome P-450 mono-oxygenase system (P 450) in male 1111 ppm group rats.  In the 1111 ppm group, the 
males  exhibited  lower  protein  (PROT)  and  cholesterol  (CHOL)  levels,  and the  females  lower  creatinine 
(CREA) and glucose concentrations. The sodium (Na) levels in both sexes were lower than in the controls 
(Tab.: 5.3.1.1-2). 
Gross pathology, organ weights, histopathology:  In the 1111  ppm group, the absolute brain weights were 
reduced  in males,  and the relative  spleen weights were  increased in females.  Relative  liver weight was 
elevated in males at 111 ppm and above (Tab.: 5.3.1.1-3).  Slight to moderate fatty deposits in the hepatocytes 
were observed in the livers of male and female rats in the groups treated with doses of Ill  ppm and above. 
The incidence/severity of this finding in the  11  ppm group was not significantly different from that in the 
controls.  Hyperkeratosis of the oesophageal mucosa was observed at Ill  ppm and above.  In addition one 
female  1111  ppm group  ani~  exhibited moderate hyperplasia of the urinary bladder epithelium.  These 
findings  are  regarded  as  treaunent-related effects  probably  arising fro  m  the  strong  irritant properties  of 
XXXX.  Ophthalmic examinations afforded no evidence for treaunent related changes of  the eyes. 
Table 5.3.1.1-3: Results of a 4-week feeding study in rats: Organ weights 
Oppm  11 ppm  111 oom  1111 ppm 
Males 
absolute brain weight [mgl  1734  1711  1753  1674 + 
relative liverweicllt fmJV100£1  4276  4415  4507++  4429+ 
Females 
I 
relative spleen weight fmJVl00£1  211  229  230  243 + 
+  U-test, 1% significance level;++  U-test, 5% significance level 
Conclusion:  No-obsenred-effect level: 11 ppm;  equal to 1.1 mglkg bw/day (males); 1.1 mglkg 
bw/day  (females)  - based  on  the  histopathology  findings  (hyperkeratosis  of 
oesophagus mucosa) at 111 ppm -108-
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5.3.1.2  Rat 
Report:  F.  Keller, E.  Hagen (1992): XXXX - Subacute ·oral toxicity in rats.  Organics Inc, 
unpublished report No. 21841(August 21, 1994; report) and 21644A (July 07,  1996; 
addendum);  Organics  Inc,  InstitUte  of Toxicology,  Castlebar,  Ireland,  (Dates  of 
experimental work: April1991-May 1991). 
Guidelines:  OECD 407 » EEC B. 7.  Deviations: none 
GLP:  yes (certified laboratory) 
Deviations:  Histopathology was carried out on 2 male and 2 female rats per dose level only. 
Material and methods:  In an oral gavage study groups of 10 male and I 0 female Wistar rats received XXXX 
Findings: 
. (purity 93.6 %; specification 00 - Document J)  at daily doses of 0,  11,  II or Ill 
mglkg bw over a period of  4 weeks.  Five male and 5 female animals from each dose 
group  were  selected  for  haematology,  clinical  . chemistry,  urinalyses  and 
histopathology. 
General observations:  In all  dose-groups  clinical  symptoms  such  as  salivation,  tremor,  digging  and 
preening activities were observed after application.  These findings and the elevated water intake are regarded 
to be the result of  the local irritant action of  XXXX.  At Ill mglkg bw, body weight development was reduced 
(Table 5.3.1.2-1).  Survival rates were unaffected in all dose groups. 
Haematology, clinical chemistry, urinalysis:  The  results  of clinieochemical  tests  with  liver  tissue 
indicated an induction of hepatic enzymes.  This was manifested by elevated N-demethylase activities (N-
DEM) at 111  mglkg bw/d in males and elevated cytochrome P-450 figures (P 450) at 11 mglkg bw/d and above 
in males and at 111 mglkg bw/d in females.  The ASAT and ALAT (males) and SAP (females) activities were 
higher than in controls at 111 mglkg bw/d.  The ASAT activity in males was also increased at 11 mglkg bw/d. 
The albumin levels were depressed in both sexes at 111  mglkg bw/d.  In addition, the males in this group 
exhibited depressed creatinin levels (CREA).  In the females triglyceride (TRIGL) at 11  mglkg bw/d and 
above and protein levels (PROT) were reduced (Table 5.3.1.2-2). 
Table 5.3.1.2-1: Results of a 4-week gavage study in rats: Body weights (g/animaVd) 
Omefk2bw  11 mefk2 bw  ll  melk2 bw  111 m~:fklbw 
Males 
Dav  0  102  101  99  102 
D~14  179  178  176  155 + 
Day28/29  241  240  243  222+ 
Females 
Day  0  93  91  93  93 
Day 14  140  141  137  132++ 
Da)'28/29  166  177  165  144 + 
+  U-test, I%  significance levet ++  U-test, 5% significance level 
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Table 5.3.1.2-2: Results of a 4-week gavage study in rats: Clinical chemistry 
Om~:lk2bw  11 melk2 bw  11 m2lk2 bw  111 m21k2 bw 
Males 
N-DEM (mU/21  125.1  151.4  159.9  189.9 ++ 
P450  nmol!g]  41.8  43.8  49.4 ++  '57.7++ 
ASAT [UilJ  33.6  39.S  44.4 ++  42.8+ 
ALAT [UilJ  33.6  33.8  38.7  48.9 ++ 
ALBUMIN [gil]  32.2  31.7  31.2  30.3 + 
CREA [mcmol!l]  S2  S2  49  43+ 
Females 
N-DEM [mU/gl  61.8  Sl.4  '57.0  72.1 
P 450  nmot/g]  36.8  3'5.7  38.8  48.4 ++ 
SAP [U/lJ  238  242  26S  297+ 
TRIGL rmmol/11  1.19  0.80 ++  0.8S  0.5S + 
ALBUMIN (gill  35.2  35.1  35.7  32.3 ++ 
PROT [gil]  65.9  6S.O  66.2  60.8 ++ 
+  = U-test, 1 % significance level; ++ = U-test, 5 % significance level 
Gross pathology. organ weights. histopathology:  The elevated relative liver weights dete~ned  in animals 
of  the Ill mglkg bw/d group (Table 5.3.1.2-3) correlated with the results of the clinicochemical tests.  In the 
histopathological examination very slight degenerative effects were seen in hepatocytes of high dose group 
animals  (minimal  hepatocellular  steatosis  in the  periportal  lobular  zones).  The other  histopathological 
findings obtained in animals receiving Ill mglkg bw/d are regarded to be causally 
related to the strong irritarlt effect of  XXXX on mucosal tissue: 
•  simple hyperplasia of  the urinary bladder epithelium in females; 
•  hyperkeratosis of the cornifying, multilayer squamous epithelium of the forestomach mucosa in both 
sexes. 
The ophthalmic examinations afforded no evidence for damage to the eyes in the groups treated at doses up to 
and including 11 mglkg bw/d.  However, the finding that lens fibres were visible in animals receiving Ill 
mglkg bw/d is regarded to be treatment-related. 
Table 5.3.1.2-3: R~lts  of a 4-week gavage study in rats: Relatil·e organ weights (mg/100 g) 
Ome/k2bw  11 melkl bw  JJ m2/Q bw  111 mrlk2 bw 
Males 
Liver  3900  4086  3972  4322 ++ 
Spleen  210  233  219  2S3++ 
Kidneys  658  684  t•'~t•  ~  1- 743++ 
Testes  1217  1248  1ur:  1357 ++ 
Females 
Pituitary  7  5  h  5+ 
Adrenals  29  27  l()  32+ 
Liver  4170  4256  430:!  4435 + 
+  U-test, 1 % significance level~ ++  U-test, 5 % significance level 
Conclusion:  XXX was tolerated without systemic adverse effects at a  dose of 11  mglkg bw 
With regard to systemic effects, tbe NOEL was 11  mgfkg bw/day based on liver 
enzyme induction at 11 mglkg bw/day. -110-
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5.3.2  Oral 90-day studies 
5.3.3.2  Rat 
Report:  R.  Elbers, E.  Hagen (1992a): XXXX- Subchronic toxicity in wistar rats (13-week 
administration  in  the  diet  with  a  four-week  recovery  period).  Organics  Inc, 
unpublished  report  No.:  21627  No.  (July  07,  ·1996);  Organics  Inc,  Institute  of 
Toxicology,  Castlebar,  Ireland,  (Dates  of experimental  work:  April  1991  - May 
1991). 
Guidelines:  OECD 408 » FIFRA § 83-1 » 67  /548/EEC. 
GLP:  yes (certified laboratory) 
D~viations:  T3,  T4  and  thyroxine  in  the  blood  were  measured  in  excess  of  Guideline 
requirements.  In addition P450 levels in the blood were measured. 
Material and methods:  Groups of 10 male and 10 female Wistar rats were administered XXXX (purity 93.6 
%; specification 00 -Document J) at levels of 0,  11, Ill  or 611  ppm in their diet 
over a period of 13  weeks.  Additional recovery groups made up of ten rats of each 
sex were treated at levels of 0 or Ill ppm over a period  of- 13  weeks,  and then 
obseiVed for four  w~eks.  In order of increasing doses the treated rats ingested the 
equivalent of:  males: 1.1, 11.1, and 11.1  mglkg bw/day; females:  1.1, 11.1 and 11.1 
mglkg bw/day of  XXXX. 
Findings: 
General obseiVations:  At  611  ppm,  several  animals  exhibited  a  depressed  general  condition  and  an 
ungroomed coat.  These findings were reversible. 
Figure 5.3.3.2 -1: Results of  a 13-week feeding study in rats: Mean Body weights [g)- males 
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Figure 5.3.3.2 -2: Results of  a 13-week feeding study in rats: Mean Body weights [g)-females 
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The  retarded  body  weight  gains  observed  at the  high-dose  level  were  not  fully.  reversible  within  a  post 
observation period of four weeks  (Fig.: 5.3.3.2).  Food intake was  not affected at levels up to 611  ppm. 
Animals drank slightly less water at () 11 ppm. 
Haematoloev. clinical chemistrv. urinalysis:  No adverse effects on red and white blood cell numbers 
were detected at levels up to 611 ppm.  Evidence of  impaired blood coagulation (transiently lower thrombocyte 
counts (THRO) and elevated Hepato-Quick readings (HQUICK) could be seen in the high-dose group, but no 
longer existed following the recovery period.  Cytochrome P-450 levels (P 450) in the liver samples from rats · 
treated over a period of 13  weeks showed a statistical significant increase at 111  ppm and above in males. 
Effects on the liver were observed in high-dose group animals: liver enzyme ~ctivities in the serum (aspartate-
and alanine-aminotransferase, alkaline phosphatase) were ~levated in both sexes.  Blood cholesterol (CHOL). 
levels were depressed to a statistically significant extent in both sexes of  the high-dose group.  No evidence of 
disturbances in the kidney function or damage to the kidneys were found at levels up to 611 ppm. 
Table 5.3.3.2-1: Results of a 13-week feeding study in rats: Baematology, clinical cbemistry 
Oppm  ll_nm  111 ppm  611__mtm 
Week  5  13  17  5  13  17  5  13  17  5  13  17 
Males 
THRO [I  0
9/l} 
HQUICK [sec}  · 
P 450 [nmollgJ 
ASAT rtlll 
ALAT {Ufll 
SAP [l/l 
CHOL [mmol/1]  2.28  2.46  2.42  2.29  2.53  2.32  2.50  1.68  2.00+  1.95 
re  ++  re+ 
Females 
THRO flO~fll 
HQUICK [sec] 
ASAT [U/l] 
ALAT [UilJ 
SAP fU/1 
CHOL(mmol/1]  2.44  2.14  2.19  2.35  2.13  2.20  2.04  1.60  1.51  1.87 
re  ++  ++  re++ 
re recovery groups; +  U-test,  I %; ++  U-test, 5 % -112-
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Table 5.3.3.2-2:  Results of a 13-week feeding study in rats: Incidence of treatment related 
histopathological findings 
Oppm  11 ppm  Ill ppm  611 ppm 
m/f  m/f  m/f  m/f 
BLADDER UROTHEL (no. examined)  10/10  10/10  10 I 10  10 I 10 
-hyperplasia (multifocal)  010  0/0  010  314 
TONGUE (no. examined)  10 I 10  10 I 10  10 I 10  10/10 
- hyperkeratosis  0/0  0/0  0/0  7/10 
OESOPHAGUS (no. examined)  10/10  10 I 10  10/10  10/10 
- hyperkeratosis  110  0/0  9/ s  10/10 
- hwerplasial hVPertroohv  1/0  0/0  91 s  10/10 
FORESTOMACH (no. examined)  10/10  10/10  10/10  10110 
- hyperkeratosis  0/0  0/0  1/0  3/8 
LIVER (no. examined)  10/10  10/10  10/10  10/10 
- hvaline droplets  0/0  0/0  0/0  3/0 
Gross pathology, organ weights. histopathology:  Slight degenerative liver changes (hyaline droplets) were 
observed in three of  ten males in the high dose group.  These effects were no longer manifest or were observed 
to a lesser degree after 4 weeks recovery.  The urinary bladder epithelia of  several 611 ppm animals exhibited 
hyperplastic change. This change turned out to be reversible.  Hyperkeratosis in the superficial epithelium was 
determined in both sexes at Ill ppm and above (in oesophagus and forestomach) and at 611  ppm (in the 
tongue), and was also accompanied by hyperplastic changes and hypertrophy in the oesophagus of  the affected 
animals. Hyperkeratosis, which also occurred in a few control rats, could no longer be observed, or was only 
seen at a considerably lower incidence, at the end of the recovery period (Table 5.3.3.2-2).  The ophthalmic 
examinations and histopathology afforded no evidence for oculotoxic effects at 611 ppm. 
Conclusion: 
5.3.2.2  Mouse 
Report: 
Guidelines: 
GLP: 
Deviations: 
NOEL: 11  ppm, equivalent to:  1.1  mglkg bw/day (males), 1.1  mglkg bw/day 
(females), based on histopathological findings in the liver at 111 ppm. 
R.  Elbers, E. Hagen (1992b): XXXX- Subchronic range-finding test for a two-year 
study in B6C3Fl mice (administration in the diet over a period of  about 13 weeks). 
Organics Inc, unpublished report No.: 21022 (July 07.  1996)~ Organics Inc, Institute 
of Toxicology, Castlebar, Ireland. (Dates of expcnmcntal work:  April  1991  - May 
1991). 
OECD 408 » FIFRA § 83-1 » 67  /548/EEC 
yes (certified laboratory) 
none. 
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I 
I 
I 
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Material and methods:  Groups of 10  male and 10 female B6C3Fl Mice were administered XXXX (purity  I 
94.6  %~ specification 00 - Document J)  at levels of 0,  1,  11,  Ill or 1111  ppm in 
their diet over a  period of 13  weeks.  In order of increasing doses the treated rats 
ingested the equivalent of:  males:  1.1,  11.1, and 11.1  mg/kg bw/day; females:  1.1,  I 
11.1 and 11.1 mglkg bw/day of  XXXX. 
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Findings: 
General observations: At 1111  ppm depressed general condition and emaciation, hair loss and ungroomed fur 
were Qbserved in isolated male mice.  In this dose group mice exhibited desiccated or crusted areas of skin at 
the  auricles  and/or  tail,  which  on  histological  examination  was  shown  to  represent  marked  epidermal 
hyperplasia. Minimal epidermal hyperplasia was also observed in the histology of the auricles in several Ill 
ppm males.  Two males and one female died. with causal relationship to the treatment at 1111 ppm. A slightly 
elevated rate of mortality was noted in both sexes at the high dose.  Food and water intakes underwent no 
significant effect at levels up to 111  ppm.  At the high dose, females consumed less food,  and males drank 
more water than the control animals (Table 5.3.2.2-1).  The body weight development was not altered to a 
toxicologically relevant extent at 1 ppm in males, or at levels up to 111 ppm in females.  Marginal effects on 
the weight development were noted in males at !Land Ill ppm.  At the high dose, males and females initially 
lost weight.  As the study progressed, growth in the males was retarded, but was unaffected in females at 1111 
·ppm. 
Table 5.3.2.2-1: Results of a 13-week feeding study in mice: Food intake and water intake 
Oppm  lppm  11ppm  111 ppm  1111 ppm 
Food intake (glkg bw/d) m  283.7  308.3  311.8  276.4  286.1 
f  378.4  366.4  356.5  394.7  323.2 
Water intake (g/kg bw/d) m  281.7  298.3  316.2  297.7  385.0 
f  331.9  344.7  366.1  367.8  362.5 
Haematolo2V. clinical chemistrv. urinalysis:  Haematology  tests  performed  at  the  end  of the  study 
afforded no evidence of treatment-related effects on the red blood cell population at levels up to 1111  ppm. 
Leukocyte counts (LEUCO) in both sexes were slightly elevated, but the differential blood count remained 
unaffected t;lt  1111 ppm.  Significantly fewer thrombocytes (THRO) were counted in the high-dose group than 
in  the  other  groups.  The  results  for  urea  and  cholesterol  (CHOL)  were  situated  within  the normal 
physiological range at levels up to Ill  ppm, but were elevated (urea) or depressed (cholesterol) to a statistically 
significant extent at the high dose in both sexes (Table 5.3~2.2-2). 
Gross pathology, organ weights, histopathology:  Increased centrilobular fatty change of  the hepatic lobules 
(in  isolated  females  at  Ill  ppm  and  above),  as  well  as  elevated  liver  weights  (Table 5.3.2.2-3)  and 
hepatocellular hypertrophy (both at 1111  ppm) (Table 5.3 .2.2-4) were interpreted as evidence of a change in 
metabolic function in the liver.  The epithelium of the urinary bladder and renal pelvis exhibited hyperplastic 
changes  in the  1111, ppm group  mice.  Effects on the kidneys  such  as elevated  relative kidney  weights, 
increased water intakes and elevated urea levels were found in high dose group animals. 
Table 5.3.2.2-2: Results of a 13-week feeding study in mice: Haematology and clinical chemistry 
Oppm  l ppm  Unm  Ul_ppm  1111 ppm 
Males 
LEUCO [10
9/1]  6.7  5.4  5.8  6.7  8.3 
THRO rt0
11/ll  1238  1194  1259  1230  1057 ++ 
UREA (nunoi/J]  14.68  15.45  14.89  14.50  20.48 ++ 
CHOL (nunoi/J]  2.90  2.78  2.73  2.67  1.75 ++ 
Females 
LEUCO [ 1  0
11/1]  3.0  3.5  ',  3.8  3.6  5.2++ 
THRO [10!111]  1054  1045  1039  1099  950+ 
UREA [nunoi/J]  8.89  10.01  10.11 ++  9.68  13.70 ++ 
CHOL [nunolll]  2.37  2.26  2.29  2.35  1.32 ++ 
+  U-test. 1 % significance level~ ++ U-test, 5 % significance level -114-
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Table 5.3.2.2-3: Results of a 13-week feeding study in mice: Organ weights 
Oppm  1 ppm  11 ppm  111 _p_pm 
LIVER WEIGHT 
Absolute (mg)  m  1440  1364  1338 +  1375 
f  1465  1410  1389  1380 
Relative (mgiiOOg)  m  4931  4838  4767  4912 
f  5368  5112  4982+  5205 
KIDNEY WEIGHT 
Absolute (mg)  m  501  490  499  484 
f  433  435  458  421 
Relative (mgl100g)  m  1714  1737  1775  1729 
f  1591  1580  1640  1586 
+ U-test, 1% significance level;++ U-test, 5% significance level 
Table 5.3.2.2-4:  Results of a 13-week feeding study in mice: Incidence of  treatme~t related 
histopathological findings 
Oppm  1ppm  11ppm  111 ppm 
m/f  m/f  m/f  m/f 
SKIN (no. examined)  10 I 10  10 I 10  10 I 10  10 I 10 
- epidermal hyperplasia auricle  010  010  010  610 
- epidermal hyperplasia tail  010  010  010  010 
KIDNEY (no. examined)  10 I 10  10 I 10  10 I 10  10 I 10 
-_epithelial hyperplasia  010  010  010  010 
URINARY BLADDER (no. examined)  10 I 10  10/10  10 I 10  10/10 
- Simple hyperplasia  010  010  010  010 
LIVER (no. exaniined)  10/10  10 I 10  10 I 10  10 I 10 
- hepatocellular hypertrophy  010  010  010  117 
- fatty change  317  819  316  419 
grade 1  311  819  316  316 
grade 2  010  010  010  013 
grade 3  010  010  010  010 
page  of 
1111 pp_m 
1646 + 
1595 
5961 ++ 
5927+ 
526 
441 
1908 ++ 
1639 
1111 ppm 
m/f 
10 I 10 
9 I 10 
419 
10 I 10 
4/7 
10 I 10 
919 
10/10 
013 
819 
815 
013 
011 
Conclusion:  NOEL: 11 ppm for males, 11 ppm for females, equivalent to 1.1 mglkg bw/day 
(males)  and  11.1  mglkg  bw/day  (females),  respectively,  based  on  the 
morphological liver findings at 111 ppm in females.  LOEL (males): 11.1 mglkg 
bw/day 
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5.3.2.3  Mouse 
Report:  R.  Elbers,  E.  Hagen,  U.  Sale  (1992):  XXXX  - Subchronic toxicological  study  in 
B6C3F 1 mice  to  examine effects  on  the  skin,  kidneys.  liver and  urinary bladder 
(thirteen-week administration by gavage and eight-week recovery period).  Organics 
Inc, unpublished report No.:  21330 (August 21,  1994~ report) and 21644A (July 07, 
1996~ addendum)~ Organics Inc, Institute of Toxicology,  Castlebar~ Ireland, (Dates 
of  experimental work: April1991- May 1991). 
Guidelines:  67  /548/EEC. 
GLP:  yes (certified laboratory) 
Deviations:  The  study  methodology  confonned  to  the  current  guideline  requirements  for 
subchronic toxicity testing.  The main deviations were:  the number of animals was  ,. 
only 5 per dose group; organ weights were not determined  .. 
Material and methods:  Groups of  five male and five female B6C3Fl mice were administered 0, 11, Ill or 
1111  mglkg bw doses of XXXX (purity 93.6 %; specification 00 - Document J) by 
gavage  over  a  period  of 13  weeks.  Five  additional  animals  of each  sex  were 
included in the 0, Ill and 1111 mglkg groups, and following the 13-week treatment 
period were left untreated for observation over an eight  -week recovery period. 
Findings: 
General observations:  No treatment-related clinical signs were observed at doses up to  111  mglkg bw/di 
High-dose mice exhibited extension spasms shortly after treatment.  The body weight development, mortality, 
and food and water intakes underwent no significant effect over the examined range of  doses. 
Haematolo2V. clinical chemistrv. urinalysis:  Depressed cholesterol levels were determined in the male 
and female 1111 mglkg bw/d group animals during the 13th week, but could not be statistically verified due to 
the small numbers of animals.  No significant deviations in this parameter were apparent at the end of the 
recovery period.  Induction of microsomal mono-oxygenases in the liver (7-ethoxycoumarin deethylase (EOD)~ 
7-ethoxyresorufi.n  deethylase  (ERD);  aldrin  epoxidase  (ALD);  epoxide  hydrolase  (EH);  glutathione-S-
transferase  (GSH-T);  UDP-glucuronyl  transferase  (GLU-T)  were  noted  in  all  treatment  groups .. 
Morphological evidence for liver stress (hepatocellular hypertrophy and reduced glycogen levels) was found at 
Ill mglkg bw/d and above.  In addition, single-cell necroses also occurred at 1111  mglkg bw/d, and lower 
cholesterol levels (CHOL) were determined in the plasma (Table 5.3.2.3-1). 
Gross pathology. histopathology:  Urinary tract epithelial hyperplasia was detected in the bladders of the 180 
and 1111  mglkg bw/d dose group mice.  Mice in the high-dose group exhibited hyperplastic changes in the 
epidermis of  the auricles and (males only) tails (Tab.: 5.3.2.3-2).  The effects on the liver, urinary bladder and 
epidermis described, were found to be reversible. -116-
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Table 5.3.2.3-1: Results of a 13-week gavage study in mice: Clinical chemistry 
Om!lk2 bw  ll  m11k! bw  111 m1/k£ bw  1111 mg~bw 
Males 
CHOL [rnmol/1] 
-main group  3.61  3.29  3.2S  2.S3 
- recovery group  3.28  - 3.0S  2.96 
EOD (runollglmin] 
-main group  13.0  19.4  28.9  30.S 
- recovery group  1S.2  - - 16.6 
EOR [runollglmin]  ) 
-main group  0.81  I.S9  1.82  1.3S 
- recovery group  2.05  - - l.S3 
ALD [runollglmin] 
-main group  32.8  109.7  1S6.4  I  11S.8 
- recovery group  42.0  - - 41.8 
GSH-T (,.unollglmin]  295.8  267.6  332.0  323.9 
.  GLU-T [runollglmin]  54  63  74  74 
Females 
CHOL [rnmol/1] 
-main group  2.71  2.66  2.49  2.13 
- recovery group  2.36  - 2.48  2.44 
EOD [runol/glmin]  I 
-main group  23.S  18.8  38.7  31.8 
- recovery group  21.4  - - 23.6 
EOR [runol/glmin] 
-main group  1.27  1.17  2.84  2.15 
- recovery group  1.67  - - 1.39 
ALD [runollglmin] 
-main group  74.2  82.9  239.7  216.8 
- recovery group  41.2  - - 46.6 
GSH-T [,.unollglmin]  137.S  128.9  1Sl.1  1SO.O 
GLU-T frunol/glmin]  88  99  79  68 
Table 5.3.2.3-2:  Results of a 13-week feeding study in mice: Incidence of treatment related 
histopathological findings 
Omglkgbw  11 mgJkcbw  111 mglkgbw  1111 mglkg bw 
m/f  m/f  m/f  m/f 
SKIN (no. examined)  SIS  SIS  SIS  SIS 
- epidermal hyperplasia ears  010  010  010  311 
- epidermal hyperplasia tail  010  010  010  210 
STOMACH (no. examined)  SIS  SIS  SIS  SIS 
- hyperceratosis  010  010  110  313 
URINARY BLADDER (no. examined)  SIS  SIS  SIS  SIS 
- Simple hyperplasia 
LIVER (no. examined) 
- hepatocellular hypertrophy 
- single cell necrosis 
- glycogen reduced 
Conclusion: 
010  0/0  110  411 
SIS  SIS  SIS  SIS 
010  010  110  310 
010  010  010  1 I 1 
1 I 1  010  412  513 
NOAEL: 11  mglkg bw.  As evidence of liver enzyme induction was seen in all 
treatment groups, the no-observed effect level was< 11  mglkg bw/day.  This 
dose can be regarded as a no-observed adverse effect level. 
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5.3.2.4  Dog 
Report:  R.  Jones, L.  Elcock (1994):  XXXX- 13-Week subchronic feeding  study  in beagle 
dogs.  Organics Inc,  unpublished report No.:  MR7442  (July 07,  1996); Organics 
Inc, Institute. of Toxicology,  Castlebar, Ireland, (Dates of experimental work:  April 
1991-May 1991). 
Guidelines:  OECD 409 » FIFRA § 82-1 » 87/302/EEC, Part B. 
GLP:  yes (certified laboratory) 
Deviations:  The dogs were not of  a defined breed and differed considerably in body weight.. 
Material and methods:  :XXXX (purity 93.5- 94.9%; specification 00-Document J) was administered in the 
diet  to  Beagle  dogs  at nominal  concentrations of 0,  11,  Ill and  1111  ppm for 
thirteen  weeks.  Four  animals  per  sex  and  dose  level  were  used.  In order  of 
increasing doses the treated dogs ingested the equivalent of:  males:  1.1,  11.1, and 
11.1 mglkg bw/day; females:  1.1, 11.1 and 11.1 mglkg bw/day of  XXXX. 
Findings: 
General observations:  There was  no difference  with  regard  to body  weight gain and feed  consUmption 
between  treated and control  groups.  Only  incidental  clinical  signs were  observed,  none  of which  were 
·considered treatment-related.  There were no treatment-related ophthalmological findings. 
Haematology, clinical chemistry, urinalysis:  The following changes in clinical pathology parameters 
at 1111 ppm were considered to be compound-related (Table 5.3.2.4-1): 
•  decreased albumin levels (both sexes), 
•  increased alkaline phosphatase levels (females), 
•  decreased triglyceride levels (females). 
Table 5.3.2.4-1: Results of a 13-week feeding study in dogs: Clinical chemistry 
Oppm  11 ppm  111 ppm  1111 ppm 
Males 
Albumin [gldL]  3.3  3.2  3.2  2.6 * 
Females 
Albumin lgldLl  3.3  3.2  2.9 *  2.6 *· 
SAP lull]  64  70  89  168 * 
Triglycerides rmgldLl  59  61  52  46. 
Anova +Students t-tests (two-sided):* p ~  5% 
Gross pathology. organ weights. histopathology:  Statistical significant increases in the relative liver weight 
were evident in the Ill and in 1111  ppm males and the 1111  ppm females (Table 5.3.2.4-2).  Microscopic 
observation  of minimal  diffuse  hepatocytomegaly  (111  &  1111  ppm  males,  and  1111  ppm  females)  also 
suggested that the liver was the target organ (Table 5.3.2.4-3). -l18-
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Table 5.3.2.4-2: Results of a 13-week feeding study in dogs: Organ weights 
Oppm  11 ppm  111 ppm  1111 ppm 
LIVER WEIGHT 
Relative (mg!lOO_g}_  m  2.827  3.056  3.749.  3.645. 
f  2.969  2.906  3.204  3.791. 
Anova +Students t-tests (two-sided): *  p ~  5% 
Table 5.3.2.4-3: Results of a 13-week feeding study in dogs: Incidence of histopathological findings 
Oppm  11 ppm  111 ppm  1111 ppm 
m/f  m/f  m/f  m/f  I  LIVER (no. examined)  4/4  4/4  1/4  4/4 
-h  ~·  egaly  0/0  0/0  2/0  4#/4# 
# =  significantly different from control (p ~  0.05) 
Conclusion: 
5.3.3  Other routes 
No-obsenred-effect  level:  11  ppm; equal to  0.11  mglkg  bw/day  (males);  0.11 
mglkg bw/day (females)- based on the findings at 111 ppm in males (increased 
relative liver weight) 
5.3.3.1  Subacute inhalation studies on rats 
Report: 
Guidelines: 
GLP: 
J. Parker (1992): XXXX Aerosol- Subacute inhalation toxicity in the rat according 
to OECD Guideline No.  412.  Organics Inc, unpublished report No.:  21785  (July 
07,  1996);  Organics  Inc,  Institute  of Toxicology,  Castlebar,  Ireland,  (Dates  of 
experimental work: April1991-May 1991). 
OECD 412 » FIFRA § 82-4 » EEC B.8. 
yes (certified laboratory) 
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Deviations:  The exposure time was 1 hour a day for 5 days per week only.  Test conditions and  I 
exposure data were not reported in detail. 
Material and methods:  Groups  of 10  male and  10  female  Wistar  rats  were  exposed  to  XXXX aerosol  I 
concentrations (purity  95.3%~ specification 00- Document J) of 1.1,  11.1  or 111.1 
mg/m
3 air (mean content. analytically determined) under dynamic conditions for one 
Findings: 
hour per day, five days per week over a period of  four weeks.  The aerosol exhibited  I 
particle  characteristics  rendering  it  respirable  to  the  rat  in  all  groups.  The 
technique corresponded to  head nose-only exposure.  Rats exposed to conditioned 
air or to an aerosol  of the vehicle (blend of polyethylene glycol  400 and ethanol)  I 
under identical test conditions were used as control animals. 
Physical parameters - test atmosphere:  The results show that exposure conditions which met the standards  I 
for stability and exhibited the necessary degree of reproducibility existed throughout the exposure period. 
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Table 5.3.3.1-1: Results of a 4-week inhalation study on rat: Physical parameters-test atmosphere 
Nominal concentration  0  0  1.1  11.1  111.1 
(mg PEl m
3 air  (airl  (veh.] 
Aerosol concentrations  0  0  1.1  11.1  1111.1 
(mg/m
3 airl 
[air] =air control group~ [veh.] =vehicle control group 
General observations:  Rats exposed to. levels of 1.1 and 11.1 mg/m
3 air tolerated the treatment without test 
substance-induced clinical symptoms or mortality.  No evidence of neurological changes was observed (reflex 
tests).  A toxicologically significant effect on rectal temperature was observed, as were effects on body weight 
gain.  Rats exposed to a level of 111.1  mg/m
3  air exhibited ungroomed· fur and decreased motility during 
exposure weeks zero and one.  Clinical symptoms could be  observed starting at the beginning of exposure 
week  two  (among  othe.rs:  staggering gait,  decreased  motility,  narrowed  palpebral  fissure,  hypersalivation, 
ungroomed fur and piloerection, reddened conjunctivae, reddened and bloody rhinal zone, transient breathing 
sounds, abnormal digging and preening activities and an upright tail).  Local dermal reactions, particularly at , 
the less densely haired at the test substance aerosol contact sites, were predominant near the end of the study. 
The ophthalmic examinations afforded evidence for test substance-induced corneal damage in this group.  No 
evidence of  a change in reflex pattern was observed.  Rectal temperature was depressed in the rats exposed to 
111.1 mg/m
3 air.  A summary ofthe results obtained are provided in Table 5.3.3.1-2. 
Table 5.3.3.1-2: Results of a 4-week inhalation study on rat: Rectal temperatures 
mg/m3  0 [air]  0 [veh.]  1.1  11.1  111.1 
Rectal temperatures [
0Cj - males 
DayO  37.6  37.2  37.2  37.4  37.2 
Day7  37.9  38.1  37.5  37.8  36.1 + 
Day21  37.9  37.4  37.6  37.6  36.1 + 
Rectal tem~eratures rg  -females 
DayO  37.0  36.3  37.2  37.4  36.1 
Day7  38.0  37.5  38.1  37.9  36.2 + 
Day21  38.4  38.0  37.9  37.9  36.0+ 
Haematolo2V:  Examination of the differential diagnostically significant haematology parameters showed an 
increase  in  the ·blood  coagulation  time  (H-Quick),  depressed  thrombocyte  (THR.O)  and elevated  leukocyte 
counts (LEU) in the 111.1 mg/m
3 air group animals.  The differential blood count exhibited a relative increase 
in the polymorphonuclear granulocyte fraction  (SEGM)  and a  relative decrease in the lymphocyte fraction 
(L YM) at  levels  of 11.1  mg/m
3  air and above.  These  effects  are  regarded  as  causally  related  to  the 
inflammatory changes which occurred in the skin areas.  Marginal decreases in the haemoglobin level (HGB) 
and hematocrit (HCT)  reading were determined in female animals at levels of 11.1  mg/m
3  air and above. 
With respect to changes in the haematology, a level of 1.1  mg/m
3 air was tolerated without effect.  The results 
are listed in Table 5.3.3.1-3. 
Clinical chemistry:  An  effect  on  specific  blood  parameters  was  observed,  particularly  in the  111.1 
mg/m
3 .air group rats, in the clinical chemistry blood tests performed at the end of the study: elevated serum 
ALAT  and  ASAT  activities.  depressed  plasma  cholinesterase  activity  (CHE,  females  only),  reduced  total 
protein (PROT) and albumin levels, and an increase in the globulin fraction (GLOB) and relative reduction in 
the  albumin fraction  in protein  electrophoresis.  The  cholesterol  level  (CHOL)  underwent  concentration-
related  reduction  at levels  of 11.1  mg/m
3  air and above.  Evidence  for  a  significant  change  in  the  N-
demethylase/0-demethylase (N-DEM/0-DEM) or cytochrome P-450 activities (P 450) was only found in the Appendix 7  Format for the Compilation of Tier II 
Summaries - Annes II 
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I 
I 
I 
Ill~ I mg/m
3 air group (N-DEM/P-450 depressed in males, not affected to a toxicologically significant extent  I 
in females; 0-DEM slightly elevated in males and females).  The results are listed in Table 5.3.3.1-4. 
Table 5.3.3.1-3: Results of  a 4-week inhalation study on rat: Haematological parameters  I 
me/IW  0 (air)  O[veh.J  1.1  11.1  111.1 
Males 
HQUICK [sec]  33.1  33.8  32.9  34.S  37.1 ++ 
LEU [10E9/l]  6.4  6.0  6.0  5.1  8.1 
THRO [l  OE911J  918  986  896  983  831 
SEOM [%]  8.3  9.6  10.1  13.0 ++  28.8++ 
LYM[%  87.5  8S.l  86.8  84.0+  67.6 +~ 
HOB (gil_.]_  146  IS4+  ISO  144  138 
HCT [Ill}  0.479  0.497  0.485  0.468  0.448+ 
Females 
HQUICK (secl  29.7  30.3  30.6  28.9  33.7 ++ 
LEU [IOE9/I]  3.8  .  4.6  S.6  4.1  6.5 + 
THRO [10E9/l]  9SI  10S2  1027  908  777++ 
SEOM[o/c,l  8.4  9.S  9.9  12.2  27.4++ 
LYM [%)  88.0  88.0  86.8  85.4  69.9 ++ 
HOB [gil.]  140  139  I4S  131 +  127+ 
HCT  Ill  0.446  0.443  0.471  0.42S  0.41S 
+ U-test, 1 % significance level; ++ U-test,· 5 % significance level 
Table 5.3.3.1-4: Results of a 4-week inhalation study on rat: Clinical chemistry parameters 
me/m
3  0 (air]  0 [veh.)  1.1  11.1  111.1 
Males 
ASAT [l!_/1]  51.6  S1.4  54.1.  56.2  7S.4 ++ 
ALAT JU/11  43.9  47.0  46.0  45.4  84.4 ++ 
ALBUMIN [gill  31.7  32.4  31.7  31.0  27.6 ++ 
N-DEM [mUlg]  12l.S  130.9  119.0  121.5  94.8 ++ 
P4SO [nmollg]  40.5  39.9  41.4  42.1  31.2 ++ 
Females 
ASAT (GOn JUII]  62.9  S7.2  S6.4  52.9  88.4 ++ 
ALAT (OPT) [U/1]  39.6  43.2  41.6  4S.3  86.1 ++ 
ALBUMIN [gil]  31.8  33.3  31.8  32.5  25.7 ++ 
CHE [kU/1]  1.66  1.78  1.71  1.47  (}.78++ 
0-DEM [mU/g]  10.2  9.7  11.1  11.3  13.4 ++ 
N-DEM lmU/g]  78.7  67.4  63.5  69.0  88.5 
P450 _[nmollg]  32.3  32.1  34.8  3S.3  31.7 
+ U-test, 1 o/o significance level;++ U-test, 5% significance level 
Urinalysis:  Elevated levels of proteins (PROT),  bilirubin  (BILl),  ketone bodies  (KETO),  ammonium-
magnesium  (triple)  phosphate and corpuscular  components  were  observed  in the  111.1  mg/m
3  air group 
animals.  A concentration-related increase in the triple phosphate level was present in female rats at levels of 
11.1 mg/m
3 air and above.  The results are listed in Table 5.3.3.1-5. 
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Table 5.3.3.1-5: Results of~  4-week inhalation study on rat: Urinalysis 
m2/m3  0 (air)  O(veh.]  l.l  ll.l  1ll.l 
Males 
PROT (GRADE 3)  1110  0/10  '0/10  0/10  6/10 + 
BILl  (GRADE 1)  2/10  0/10  0/10  0/10  9/10 ++ 
KETO  (GRADE 1)  6/10  7/10  3/10  1110  10/10 + 
Females 
PROT  (GRADE 3)  0/10  0/10  0/10  0/10  6/10 ++ 
BILl  (GRADE 1)  0/10  0/10  0/10  0/10  8/10 ++ 
KETO  (GRADE 1)  1110  0/10  0/10  0/10  6/10 + 
+  U-test, 1% significance level;++ U-test, 5% significance level 
Organ weights:  Toxicologically and statistically significant changes in the organ-to-body weight relationship 
occurred in rats exposed to 111.1 mg/m
3 air.  A large reduction in thymus weight was observed in both males 
and  females.  In  males  only,  a  marginal  reduction  in  heart  and  spleen  weights  was  reported.  A 
toxicologically significant increase in liver and kidney weights, was observed  in the female  animals of this 
group.  The results are listed in Table 5.3.3.1-6. 
Table 5.3.3.1-6: Results of a 4-week inhalation study on rat: Absolute organ weights 
11121m
3  0 lair]  0 rveh.J  1.1  11.1  111.1 
Males 
Thymus  308  290  338  268  94++ 
Heart  824  826  858  788  723++ 
Spleen  460  398  464  422  301 ++ 
Females 
Liver  5399  5625  5740  5593  6341  'T 
Thymus  204  194  204  206  73 ++ 
+  U-test, 1%  significance level;++  U-test, 5% significance level 
Pathology:  On  histopathological  examination  of the  111.1  mg/m
3  air  group,  squamous  epithelial 
metaplasia in the nasal cavity was observed, as well as epithelial hyperplasia and hyperkeratosis in the larynx 
zone.  An elevated rate of bronchiolo-alveolar proliferation with an increase in alveolar macrophages was 
noted in the lungs, and hyperkeratosis in the oesophagus.  The eyes  exhibited corneal hyperplasia, and the 
eyelids  hyperplasia  accompanied  by· hyperkeratosis.  The  severest  local  dennal  lesions  - hyperkeratosis. 
epithelial  hyperplasia,  and extended inflammatory  infiltration  and  scab  - were  found  in the  muzzle  zone. 
Hyperkeratosis and epithelial  hyperplasia were also  seen  in  the mamma zone  and on the tail.  The male 
animals exhibited atrophic thymus changes which are considered to represent a secondary stress-related effect. 
The urinary bladder urothelium exhibited hyperplastic lesions in the  111.1  mg/m
3  air group animals.  The 
results are listed in Table 5.3.3.1-7. -122-
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Table ~.3.3.1-7: Results of a 4-week inhalation study on rat: Incidence of histopathological findings 
mg/m3  0 lair)  0 (veh.)  1.1  11.1  111.1 
Se1  m/f  m/f  m/f  m/f  m/f 
EYES AND EYELIDS 
Jno. of  animals examined}  10/10  10/10  10 I 10  10/10  10 I 10 
corneal hyperplasia  010  010  010  0/1  414 
eyelid hyperplasia  010  0/0  010  0/0  9+/9+ 
eyelid hyperkeratosis  0/0  0/0  0/0  0/0  10+/10+ 
NASAL/ PARANASAL CAVITIES 
(no. of  animalS examined}  10 I 10  10 I 10  10 I 10  10 I 10  10 I 10 
squamous-cell hyperplasia  1/4  1/5  2/2  3/4  8+/3 
goblet-cell hyperplasia  014  3/5  4/4  215  2/5 
hyperaemia  6/8  7/7  315  8/7  514 
LARYNX 
_(no. of  animals examined)  10 I 10  10 I 10  10 I 10  10 I 10  10 I 10 
hyperplasia  010  010  0/1  3/2  7+/8+ 
hyperkeratosis  010  010  011  212  7+/7+ 
round-cell infiltration  0/1  010  012  .  0/1  6+1 5 
LUNGS 
(no. of  animals examined}  10 I 10  10 I 10  10 I 10  10 I 10  10 I 10 
hyperaemia  415  118  6/7  815  819 
bronch.lalveol. prolif  010  1/0  010  010  7+/2 
thickening of  septa  110  1/0  I I 1  013  8+ I 1 
OESOPHAGUS 
(no. of  animals examined)  10 I 10  10 I 10  10 I 10  10 I 10  10 I 10 
hyperkeratosis  010  010  010  0/0  218+ 
LIVER 
(no. of  animals examined)  10 I 10  10 I 10  10 I 10  10 I 10  10 I 10 
hyperaemia  214  316  3/2  215  8+11 
vacuolation h  016  5+11  2/4  . 5+1 1  9+/ 5 
MESENTERIAL LYMPH NODES 
_(no. of  animals examined).  10 I 10  10 I 10  10 I 10  10 I 10  10 I 10 
sinus catarrh  316  312  9+1 5  114  10+1 4 
BLADDER 
(no. of  animals examined).  10 I 10  10 I 10  10 I 10  10 I 10  10 I 10 
hyperplasia  010  0/0  010  0/0  41 5+ 
+  U-test, 1 %Significance level~++  U-test, 5% Significance level 
Conclusions:  NOEC:  11.1  mglm
3  air; equivalent to  approx.  1.1  mg XXXX/kg bw/exposure 
day,  based  on  haematology  and  clinical  chemistry  effects  at  11  mglm
3  air 
(increase  in  the  polymorphonuclear  ~ranulocyte  fraction,  haemoglobin, 
haematocrit, cholesterol) 
A subchronic inhalation study is  not  nccessaf1. since the 28-day study showed 
low toxicity based mainly on local effects.  Furthermore the vapour pressure is 
< 1o-1 Pa. 
5.3.3.2  Subacute dermal study on rabbits 
Report: 
Guidelines: 
H.  Voss, M. Rink (1995): XXXX- Subacute dermal toxicity in the rabbit.  Organics 
Inc.  unpublished  report  No.:  23710  (July  07,  1996)~ Organics  Inc,  Institute  of 
Toxicology,  Castlebar,  Ireland,  (Dates  of experimental  work:  April  1991  - May 
1991). 
OECD 410 » FIFRA § 82-2 » EEC B.9. 
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GLP:  yes (cenified laboratory) 
Deviations:  The test groups each consisted of 3 animals/sex with intact skin and 3 animals/sex 
with abraded skin. 
Material and methods:  The  local  and  systemic  tolerance  of XXXX  (purity. 95.5  %;  specification  00  -
Document J) was examined in a subacute dennal toxicity study on rabbits.  The test 
substance  was  formulated  with  Cremophor  EL  (2%  v/v)  in  sterile  physiological 
saline solution.  The animals were treated with the test compound in doses ofO, 0.1, 
1 and 11  mglkg bw for 6 hours per day over a period of 3 weeks (the corresponding 
concentrations were:  0,  0.011,  0.01  and 0.11  %).  Five males and 5 females  were 
used per group.  A satellite group (1  mglkg bw) and a further control group were 
observed over a 14-day post-treatment phase to test for any lasting or reversible toxic 
effects. 
Findings: 
The appearance, behaviour, feed consumption and body weights of the dose animals corresponded to those of 
the control animals.  There were no  mortalities.  Skin erythema occurred in nearly all animals in the test 
substance groups (Table 5.3.3.2-1). 
Table 5.3.3.2-1: Results of a subacute dermal study in rabbits: Mean degree of skin erythema 
DOSE [m1/kel  sex  dayl  daylO  daylO  d")'ll 
0  m  0  0  0  0 
0.1  m  0  0.4  0.4·  0.4 
1  m  0  0.6  1.0  0.8 
11  m  0  3.7  3.7  3.3 
0  f  0  0  0  0 
0.1  f  0  0.2  0.2  0.2 
1  f  0  1.0  0.6  0.8 
11  f  0.1  3.5  3.9  3.6 
Other findings such as scales, swelling, hardening and cracking occurred among all animals in the highest 
dose group, in some females in the mid-range dose group and in one male in the lowest dose group.  Skin fold 
thickness was significantly increased among both sexes at the highest dose and among the females at the mid-
range dose.  No treatment-related haematological or clinical chemistry effects occurred. No treatment-related 
changes to the examined organs were observed in terms.of gross pathological, gravimetric or histopathological 
findings. 
The following histopathological changes of the skin were observ'ed in all treated animals: 
•  diffuse epidennal hyperplasia, 
•  focal epidermal hyperplasia, 
•  hyperkeratosis, 
•  iirllammation reaction. 
These effects were mainly reversible at the end of the post-treatment period. -124-
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Table 5.3.3.2-2: Incidence of local ~kin findings 
Local skin  Omg  0.1 mg  1mg  11 mg 
ftndin!S *  (n =  10)  (n=S)  (n-=S)  (n-=10) 
M  F  M  F  M  F  M  F 
Scaly_ inplaces  I  2  10  10 
Scaly_  1  6  6 
Slightly swollen  10  9 
Swollen in places  1 
Swollen  10  8 
Cracked in places  1  9  8 
Cracked  3  2 
Hardened in plaees  2  4 
Hardened  3  5 
*  where a finding occurs more than once during the course of the study (also each summarised finding where 
an incidence greater than N = 5 is possible), it is only shown once per animal in the incidence table. 
DOSE [mgJk2] 
0 
0.1 
1 
11 
0 
0.1 
1 
11 
Conclusion: 
Table 5.3.3.2-3: Mean skin fold thickness [mm] 
se1 
m 
m 
m 
m 
f 
f 
f 
f 
NOEL: systemic: 
local: 
0  6 
2.74  2.74 
3.14  3.16 
2.78  2.94 
3.07  3.17 
2.21  2.31 
2.16  2.32 
2.12  2.24 
2.37  2.51 
> 11 mglkg bw/day 
< 1.1 mglkg bw/day 
13'  20 
2.93  3.17 
3.04  3.38 
3.18  3.62 
3.52  5.38 
2.26  2.34 
2.48  2.78 
2.44  3.00 
2.90  4.50 
I 
• 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I I 
• 
I 
i 
I 
I 
I  I. 
1-
I 
I 
.I 
I 
I  I· 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
-125-
Appeodix 7  Format for the Compilation of Tier II 
Summaries - Annex II 
Part 3  Section 3  Tos:icological and MetaboUsm Studies 
on the Active Substance 
Company name  Month and year  Active Substance (Name)  page  of 
5.3.4  Summary of short-term toxicity studies 
Type of study  Animal  Dose range tested  ·NOEL  Reference 
species 
oral, 4 weeks  rat  0, 11, 111 or 111 ppm,  11 ppm  Keller and Gears 
equivalent to 0,  1.1~ 11.1 and  (1992) 
11.1 mglkg bw in males and to 
0, I.  I. II.  I and II.  I mglkg bw 
in females 
oral. 4 weeks  rat  0, 11, 11 or 11 mglkg bw  11 mglkg bw  Keller and Hagen 
(1992) 
oral, 13 weeks  rat  0, 11, 111 or 111 ppm  11 ppm  Elbers and Hagen 
equivalent to 0, 1.1, II.  I and  (1992a) 
11.1 mglkg bw in males and to 
0, 1.1, 11.1 and 11.1 mglkg bw 
in females 
oral, 13 weeks·  mouse  0, 11, 11, Ill  or 1111 ppm  11 ppm  Elbers and Hagen 
(1992b) 
oral, 13 weeks  mouse  0, 11, Ill  or Ill  mg/kg bw  11 mglkg bw  Elbers eta/. (1992 
oral, 13 weeks  dog  0, ll, Ill  and llll  ppm  11ppm  Jones and Elcock 
equival~mt to 0, 0.1, 1.1 and 11.1  (1994) 
mglkg bw in males and to 0, 0.1, 
1.1 and ILl  mglkg bw in 
females 
inhalation, 4 weeks  rat  11.1, 11.1 or 111.1 mg/m
3 air  11.1 mglm
3 air  Parker ( 1992) 
dermal, 3 weeks  rabbit  0, 0.1, 1 and 1 mg/kg bw/day  local: 0.1, systemic: 1  Voss and Rink 
mglkg bw/day  (1995) 
Following repeated oral administration of high doses of :XXXX, no evidence for cumulative toxicity was seen 
in rats, mice and dogs.  A-daily dose of Ill  mglkg bw (which is equivalent to about 1/6 of the LD50 )  was 
tolerated in a 4-week study by rats without increased mortality.  In rodents unspecified clinical signs such as 
reduced body weight development, reduced feed intake and poor general condition were observed. 
In the three species investigated, the liver was the main target organ.  In the mouse signs of liver enzyme 
induction occurred at doses of Ill  mglkg bw/day.  At higher doses hypertrophy of hepatocytes, degenerative 
alterations  (single cell  necrosis,  centrilobular fat  deposition)  and liver weight increase were  seen.  Fatty 
changes of hepatocytes were found in the iat and the dog together with an increase of  transaminases activity in 
the serum.  Investigation using recovery groups have shown that the liver effects were reversible following 
cessation of  compound administration. 
No systemic toxicological effects occurred in rabbits following daily dermal application of II mglkg bw/day 
over a period of  3 weeks. Appendix 7  · Format for the Compilation of  Tier 11 
Summaries - Anne1 II 
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As in the case of  oral adniinistration. the liver was a target organ following subacute inhalation.  11.1  mg/m
3 
air was a clear no-observed effect concentration. 
5.4  Genotoxicity testing 
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PART4 
Section 4  Format for the Presentation of Residue Date in Summary Form (Annex D, Point 6) 
The example of  a summary and assessment of  data which follows is intended to illustrate the approach 
recommended for the preparation of Tier II summaries and assessments.  The material included has not been 
critically ass~ssed for its technical content.  Although based on a real submission, the data included in the 
following summary and evaluation has been amended to protect the commercial interests of  the owner of  the 
data.  I 
Applicant should be aware that these guidelines are intended to provide a degree of  flexibility.  Where in 
particular cases, it is more appropriate to present the data and information in another format, applicants may 
do so.  In such cases it is recommended that the applicant discuss the format proposed with the Competent 
Authority of  the Member State to which application is to be made. 
1  Suggested format for the presentation of GAP information 
Crop  Country  Formulation  Application 
type (code) and 
content of  active 
substance  Method  Rate  Spray cone, Number 
(glkg)  kg aslha  kg aslhL 
Barley  France  1.5 
Beans  Greece  WP500  foliar  0.6-1.5  0.1-0.25  3-4 
Beans  Portugal  WP500  foliar  0.13  1-2 
Beans, green  Spain  , WP 500  foliar  1.6  0.16-
Brassica  Italy  WP500  foliar  0.35-0.40 
vegetables 
Lettuce  France 
1  WP500  foliar  0.6-' 
Lettuce  Israee  WP500  foliar  :!CI  weekly 
I  g. glasshouse use.  :z  Sununer PHI 21  days, wmter PHI41 d.l''  proposed regtstratlon. 
Notes: 
2 
Remarks can be added as footnotes, as in the example 
Suggested abbreviations for footnotes to the GAP tahlc: 
a 
fg 
g 
gs 
Po 
aerial application 
field and glasshouse use 
glasshouse use only 
growth stage restriction 
post-harvest use 
pr  proposc.-d u:gastrahon 
st  seed treatment 
table grapes only 
w  \\i.ne grapes only 
3  Application rates should be reported using the follo\\i.ng units: 
field treatment 
grain treatment, post-harvest 
furrow treatment 
space ~gation 
spray concentration 
kg aslha 
g as/t 
gaslm 
g aslm
3 
kg aslhL 
PHI, 
days 
21 
7 
7 
21 
10 
21-4e 
11 Appendix 7  F.onnat for the Compilation of Tier II 
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Data in Summary Fonn 
2  Suggested Format for the Presentation of Residue Data 
CROP  Application  Portion  Residues, mg/kg  Reference 
country, year  Analyzed  after Pm davs 
Formulation  No  kg aslha  kg aslhL  0  4  7  14  21 
(type and 
content of  as) 
BROCOLLI 
Gennany,l976  PBH360n7 
Netherlands,  RIAOI-90NL 
1980 
CABBAGES, HEAD 
Canada, 1986 
Gennanv, 1978 
Notes:  1 
2 
3 
4 
8013.86a 
PBJ287n8 
Include individual residue results in as far as is possible.  If  results are grouped avoid wide ranges.  If 
there are a nwnber of values at the same level they can be recorded as <0.05 (7), where there are 7 
values of< 0.05 mg/kg. 
Underline residues resulting from treatments within GAP, but wherever such mtderlining is used its 
meaning must be explained in a footnote, a note in the table caption, or a note in the introduction to the 
tables. 
Romtd  nwnbers  in  tables  to  a  practical  level,  usually  2  significant  figures.  A  formulation 
concentration should be reported as 250 gas/kg, not 250.00 gas/kg.  Residues should be reported as 
0.36 and 4.5 mglkg, not 0.363 and 4.47 mg/kg. 
Near the LOQ (limit of  quantification - determination) romtding to 1 significant figure is recommended. 
For example, if  the LOQ is 0.05 :mg/kg, report residue data from  0.05 to  0.09 mg/kg to  I  significant 
figure. 
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3  Alternative  Format for  tbe Presentation of Residue  Data - wbere  metabolite  levels  are also 
reported 
CROP  Application  Residues, mglkg  Reference 
Country, year 
Formulation  No  kgaslba  kg aslbL  PHI Parent  Metabolite 
(type and  compound 
content of as) 
BROCCOLI 
Germany, 1976  0  PBH360177 
4 
7 
14 
21 
Netherlands, 1980  0  RL401-90NL 
4 
7 
14 
21 
CABBAGES, HEAD 
Canada, 1986  0  8013.86a 
4 
7  .' 
14 
21 
Gennany, 1978  0  PBJ287/78 
4 
7 
14 
21 - JJO- I 
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PARTS 
Section 5  Fate and Behaviour in the Environment (Annex D, Point 7) 
The example of a summary and assessment of  data which follows is intended to illustrate the approach 
recommended for the preparation of Tier II summaries and assessments.  The material included has not been · 
critically assessed for its technical content.  Although based on a real sub,mission, the data included in the 
following summary and evaluation has been amended to protect the commercial interests of  the owner of  the 
data. 
Applicant should be aware that these guidelines are intended to provide a degree of  flexibility.  Where in 
particular cases. it is more appropriate to present the data and information in another format, applicants may 
do so.  In such cases it is recommended that the applicant discuss the format proposed with the Competent 
Authority of  the Member State to which application is to be made. 
. 7.1  Fate and behaviour in soil 
The fate  and behaviour of XXXX in soils was  investigated using  [cyclopropyl-1-
14C]-labelled compound -
radiochemical purity > 99 %, specific radioactivity 1.11 ~Bq/mg  (Specification 00 - Document J). 
*  indicates position of label . 
7.1.1 
7.1.1.1 
7  .1.1.1.1 
Report:  . 
,  Guideline: 
GLP: 
Report: 
Guideline: 
GLP: 
Route and rate of degradation 
Route of degradation 
Aerobic degradation 
Schulz,  K.  (1995b):  Aerobic  degradation of XXXX  in soil.  Organics  Inc,  unpublished 
report No. 98476 
BBA-Guidelines  for  the  Testing  of Plant  Protection  Products  in Registration  Procedures, 
Part IV, 4-1 (December 1986), no deviations. 
yes (certified laboratory) 
Schulz, K.  (1995d):  Aerobic degradation and metabolism of XXXX  in soil.  Organics Inc, 
unpublished report No. 92564 
BBA-Guidelines  for  the  Testing  of Plant Protection Products  in Registration. Procedures, 
Part IV, 4-1  (December 1986), no deviations. 
yes (certified laboratory) Appeodix 7  Format for tbe Compilation of  Tier II 
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Environment 
Company name  Month and year  Adlve Substance (Name)  pa1e  of 
Test System:  The metabolism of [cyclopropyl-1-14C]XXXX was investigated in 4 soils in accordance with 
the BBA  Guidelines.  In one study (Schulz, 1995d) 3 soils were  used  (silt loam,  2 sandy 
loams),  whilst  in  a  further  study  (Schulz,  1995b)  a  loamy  sand  was  used.  The  soil 
characteristics are summarized in Table 7  .1.1.1.1-1.  In all cases, the concentration of test 
substance  used,  corresponded  to  the  maximum  field  application  rate  of  700 g aslha; 
assuming  100 % soil  interception and a soil  depth of 10  em.  The incubation conditions 
were:  aerobic;  dark;  40 % max.  water holding  capacity  (exc.  Howe  Indiana;  48  %);  and 
temperature 20 ± 2 oc. 
Table 7.1.1.1.1-1:  Soils used to investigate degradation and metabolism of  XXXX 
Soil designation  1  Location 1  2  Location 2  3  Location 3  4  Location 4 
Origin  Hamburg (D)  Kent (UK)  Indiana (USA)  Mainz (D) 
Soil type  silt loam  sandy loam  sandy  loam  loamy sand 
Textural analysis (USDA) 
2000-50 J.Lm,  sand  36.9%  58.2%  65.5%  83.0% 
< 50 - 2 J.Lm,  silt  51.1  %  31.0%  26.3%  13.0% 
< 2 J.Lm,  clay  12.0%  10.8%  8.2%  4.0% 
pH value  Water  8.1  6.5  7.1  6.3 
CaCl2, 0.01 N  7.3  6.3  6.8  5.5 
Organic C  0.9%  1.98%  1.09%  2.15% 
Cation exchange capacity (meq/100 g)  10.0  10.0  10.0  10.0 
Particle density (g/ml).  2.55  2.45  2.54  2.46 
40  % of  maximum water holding  13.1 g  16.6 g  11.3 g  17.67 g 
capacity (g H20 for 100 g dry soil) 
Microbial biomass  307  246  285  256 
(mg microbial carbon/kg soil) 
Reference  Schulz, 1995d  Schulz, 1995b 
Findings:  The  results  obtained,  in terms of distribution of radioactivity and metabolites at different 
sampling  dates  are  summarized  in Table  7 .1.1.1.1-2.  Average  total  recoveries  were  high  throughout, 
ranging from  99-101  %.  The amount of radioactivity bound to soil increased during the early part of the 
experiment.  In most cases binding attained a maximum after 30 days, and decreased towards the end of the 
study.  However, in the case of loamy sand soil, the initial increase in bound residues was slower.  XXXX 
was both degraded in the soil and bound to the soil during the period of incubation.  In view of the fact that 
in 3 out of 4 soils,  the bound residue reached a maximum after 30 days of incubation,  it js evident that the 
bound residue was bio-available for degradation (mineralization) by micro-organisms. 
The  results  obtained  in  these  laboratory  studies  indicated  that  aerobic  metabolism  of  [cyclopropyl-1-
14C]XXXX  proceeds  via different pathways.  Six  metabolites  (including C02)  were  identified.  All  the 
metabolites  (excluding  C02)  occurred  at  levels  lower  than  9 % of the  applied  radioactivity  ( <  0.06 mg 
metabolite/kg  soil)  at  all  time  intervals.  The  ultimate  degradation  product  was  carbon  dioxide  which 
accounted for 20-40 % of the applied radioactivity after 100 days. 
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Table 7.1.1.1.1-2:  Recovery of  radioactivity in  % and distribution of  metabolites after application of 
[cyclo-propyi-1-
14C]XXXX to soil 
Soil  Days  14co2  Vol.  xxxx  M1  M2  M3  M6  Mll  Bound  Paper  Un- Total 
after  org.  XXX XX  xxxx  XX  resi- filter  known 
appl.  com- dues 
pounds 
(%)  (%)  (%)  (%)  (%)  (%)  (%)  (%)  (%)  (%)  (%)  (%) 
1  0  - <0.1  11.1  1.1  1.1  1.1  1.1  1.1  11.1  1.1  - 99.9 
1  11.1  <0.1  11.1  1.1  1.1  1.1  1.1  1.1  11.1  1.1  - 99.9 
3  11.1  <0.1  11.1  1.1  1.1  1.1  1.1  1.1  11.1  1.1  - 99.9 
7  11.1  <0.1  11.1  1.1  1.1  1.1  1.1  1.1  11.1  1.1  1.1  99.9 
14  11.1  <0.1  11.1  1.1  1.1  1.1  1.1  1.1  11.1  1.1  - 99.9 
30  11.1  <0.1  11.1  1.1  1.1  1.1  1.1  1.1  11.1  1.1  1.1  99.9 
60  11.1  <0.1  11.1  1.1  1.1  1.1  1.1  1.1  11.1  1.1  - 99.9 
100  11.1  <0.1  11.1  1.1  1.1  1.1  1.1  1.1  11.1  1.1  - 99.9 
2  0  - <0.1  11.1  1.1  1.1  - - - 11.1.  1.1  *  99.9 
1  11.1  <0.1  11.1  1.1  1.1  - - - 11.1  1.1  *  99.9 
3  11.1  <0.1  11.1  1.1  1.1  - - - 11.1  1.1  *  99.9 
7  11.1  <0.1  11.1  1.1  1.1  - - - 11.1  1.1  *  99.9 
14  11.1  <0.1  11.1  1.1  1.1  - - - 11.1  1.1  *  99.9 
30  11.1  <0.1  11.1  1.1  1.1  - - - 11.1  1.1  *  99.9 
60  11.1  <0.1  11.1  1.1  1.1  - - - 11.1  1.1  *  99.9 
100  11.1  <0.1  11.1  1.1  1.1  - - - 11.1  1.1  *  99.9 
3  0  -·  <0.1  11.1  1.1  1.1  - - - 11.1  1.1  *  99.9 
1  11.1  <0.1  11.1  1.1  1.1  - - - 11.1  1.1  *  99.9 
3  11.1  <0.1  11.1  1.1  1.1  - - - 11.1  1.1  *  99.9 
7  11.1  <0.1  11.1  1.1  1.1  - - - 11.1  1.1  *  99.9 
14  11.1  <0.1  11.1  1.1  1.1  - - - 11.1  1.1  *  99.9 
30  11.1  <0.1  11.1  1.1  1.1  - - - 11.1  1.1  *  99.9 
60  11.1  <0.1  11.1  1.1  1.1  - - - 11.1  1.1  *  99.9 
100  11.1  <0.1  11.1  1.1  1.1  - - - 11.1  1.1  *  99.9 
4  0  - <0.1  11.1  - 'r  - - - 1.1  1.1  *  99.9 
1  11.1  <0.1  11.1  1.1  - 1.1  - - 1.1  1.1  *  99.9 
3  11.1  <0.1  11.1  1.1  1.1  1.1  - - 1.1  1.1  *  99.9 
7  11.1  <0.1  11.1  1.1  1.1  1.1  1.1  - 11.1  1.1  *  99.9 
14  11.1  <0.1  11.1  1.1  1.1  1.1  1.1  - 11.1  1.1  *  99.9 
30  11.1  <0.1  11.1  1.1  1.1  1.1  1.1  - 11.1  1.1  *  99.9 
60  11.1  <0.1  11.1  1.1  1.1  1.1  1.1  - 11.1  1.1  *  99.9 
100  11.1  <0.1  11.1  1.1  1.1  1.1  1.1  - 11.1  1.1  *  99.9 
*  analysis of as and main metabolites only Appendix 7  · Format for the Compilation of Tier II 
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Report:  Schulz, K.  (1994): Leaching behaviour of XXXX aged in soils.  Organics Inc, unpublished 
report No. 63489 
Guideline:  BBA:  Versickerungsverhalten von Pflanzenschutmitteln (  4-2)  1986, Teil IV.  Deviations: 
during irrigation, leaching columns (A,  B from  the application rate 700 g aslha,  soil from 
location 1)  became partly blocked (both on day  32).  Irrigation continued for 23  days  (7 
days for the first 200 ml).  Consequently, a study with a third column was performed using 
the  irrigation  time  of 2  days  specified.  The  soil  sample  originally  set  aside  for  the 
determination of microbial biomass at the end of the study, was instead used for a leaching 
experiment. 
GLP:  yes (certified laboratory) 
Test System:  Information on the degradation of XXXX was derived from a study on leaching behaviour of 
the compound aged in soils using [cyclopropyl-1-
14C]XXXX.  Three soils were used: loamy 
sand,  location  1;  sand,  location 2;  silty  loam,  location  3.  The  soil  characteristics  are 
summarized  in Table 7.1.1.1.1-3.  The concentration of test  substance  corresponded  to 
either 350 g aslha (loamy sand and silty loam) or 700 g aslha (sand), assuming 100 % soil 
interception and a soil depth of about 4 em.  The incubation conditions were as follows: 
aerobic; dark; 40 % water holding capacity; a temperature of 20 ± 1  °C. 
Table 7.1.1.1.1-3: 
Soil Details 
Batch 
clay(%) 
silt(%) 
sand(%) 
pH 
Org C (%) 
Microb. Bio.  m~  C/k~ 
Application rate (as) 
Ageing days 
% Applied radioactivity 
14co2 
xxxx 
Metabolite 1 
Metabolite 2 
Metabolite 3 
Metabolite 6 
Metabolite 11 
Metabolite 12 
Metabolite 15 
unknown 
bound residues 
!paper filter 
Total 
Recovery  of radioactivity  and distribution  of metabolites  after  application  of 
[cyclopropyt-1J
4C]XXXX.  to  soil  and incubation  under aerobic  conditions  (/or 
codes of  metabolites see Figure 7.1.1.1) 
Location 1  Location 2  Location 3 
SP 149  SP 1121  -
5.3  0.1  11.0 
8.8  10.5  52.5 
85.9  89.4  36.5 
6.0  6.1  7.0 
0.54  0.57  1.08 
81  84  310 
73.6 J.Lg/100 J soil  146.7 J.L_g/100  g soil  73.7 J.Lg/100 1 soil 
0  30  62  0  32  60  0  30  62 
1.1 
11.1  11.1  11.1  11.1  11.1 
11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1 
1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1 
1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1 
1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1 
1.1  0.1  1.1  1.1  1.1  1.1 
1.1  0.1  1.1  1.1  1.1  1.1 
1.1  0.1  1.1  1.1  1.1  1.1 
0.1  1.1  1.1 
0.1  1.1  1.1 
11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1 
1.1  1.1  1.0  1.1  1.1  1.1  1.1  1.1  1.1 
99.9  99.9  99.9  99.9  99.9  99.9  99.9  99.9  99.9 
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Findings:  Results  obtained,  in  tenns  of distribution  of radioactivity  and  metabolites  after  ageing 
periods of 0 days,  l and 2 months are presented in Table 7  .1.1.1.1-3.  Average total recoveries ranged from 
99.9- 101  %.  In the case of each of the soils tested,  the level of bound residue increased with time, and by 
day 60 to 62, had reached 11.1-22.2 %. 
The metabolic profile observed,  was essentially similar to  that established in the aerobic  degradation studies 
reported earlier in this section, however two additional trace metabolites were identified and quantified. 
Report:  Bird,  K.  (1995):  (Cyclopropyl-l-
14C)}CXXX  re.sidues  in  following  crops.  Organics  Inc, 
unpublished report No. 65489 
Guideline:  SET AC - Procedures for assessing the environmental fate and ecotoxicity of pesticides 
GLP:  yes (certified laboratory) 
Test System:  Further information on the metabolism of XXXX in soil can be derived from  the controlled 
rotational  crop  study  reported.  Residues  in following  crops  were  investigated  following 
application of [cyclopropyl-1-
14C]XXXX fonnulated as a SC 400,  to the surface of a sandy. 
loam soil at an application rate equivalent to  1.4 kg aslha.  The proposed maximum annual 
rate of application is 1.1 kg aslha.  Swiss chard, turnips and wheat were sown after ageing 
periods of 30 days (1st interval) and  161 days  (2nd interval)  following  application.  Each 
crop was harvested at maturity.  Soil samples were taken at days 0,  30 and  161  following 
application. ~ 
Findings:  The findings are summarized in Table 7.1.1.1.1-4.  Total residues in the 0-15 em soil layer 
amounted to 1.11 mg/kg on day 0, 0.11 mg/kg on day 30 and 0.01 mg/kg on day  161.  Residues consisted 
mainly of unchanged parent compound although some metabolites were present in low concentrations (at any 
one  time  less  than 7 % of the  radioactivity in  the  soil).  The  occurrence  of tertbutylketone  is an artefact 
resulting from soil extraction with hot acetonitrile. 
Table 7.1.1.1.1-4: 
Metabolite/ Fraction 
xxxx 
Metabolite 1 
Metabolite 2 
Distribution  of metabolites  after  application  of [cyclopropyl-l-
14C]XXXX to  a 
sandy loam soil in a controlled rotational crop study (for codes of  metabolites see 
Figure 7.1.1.1) 
Days after application 
30  161 
%  mg/kg  %  mg/kg 
1.1  1.11  1.1  1.11 
1.1  1.11  1.1  1.11 
1.1  1.11  1.1  1.11 
Artefacts and unknown metabolites  1.1  1.11  1.1  1.11 
Solids  1.1  1.11  1.1  1.11 
Total  100.0  1.11  100.0  1.11 Appendix 7 
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Supplementary studies 
Anaerobic degradation 
PartS  Section S  Fate and Behaviour In the 
Environment 
Given the proposed usage pattern for XXXX, as a fungicide for post-emergence application in the form of a 
spray to cereal crops, it is suggested that an anaerobic soil degradation study is not required.  Information on 
the degradation of XXXX in aquatic systems is included at point 7 .2.1.3.2.  · 
7 .1.1.1.2.2 
Report: 
Guidelines: 
GLP: 
• Test System: 
Soil photolysis 
Bond, B. (1995b): Photolysis of XXXX on soil surfaces (according to the EPA guidelines). 
Organics Inc, unpublished report No. 36544 
US EPA Guidelines, § 161-3: Photodegradation Studies on soil.  Deviations: none. 
yes (certified laboratory) 
The photodegradation of XXXX was studied on thin layers of the Californian loam soil "X 
Ranch".  The  test material  was  [cyclopropyl-1-
14C]XXXX  at a  concentration of about 
11.1 J.Lg/g soil (dry weight).  This equates to a field rate of ca 2.0 kg aslha, i.e.  greater than 
maximum recommended dose rate. The thin layers of soil were continuously irradiated with 
a  Xenon lamp for the duration of the test period - 11  days.  The temperature of the test 
system was maintained at 25 ± 1 °C.  The water content of samples was adjusted to 75 % 
of the 113 bar moisture of the soil.  Duplicate samples were taken for analysis at 0, 3, 7, 10 
and 11 days after treatment. 
Findings:  Under the experimental  conditions used,  XXXX  degraded  with an experimental  half-life 
(DTso) of 9.9 days.  A  total of eight degradation products was observed in the soil extracts along with the 
parent compound.  XXXX was degraded throughout the course of the experiment.  The major metabolites 
were found to be Metabolite 1, Metabolite 2, Metabolite 3 and Metabolite 4.  Each of them accounted for far 
less than 10 % of the applied radioactivity.  Those metabolites appear in the proposed metabolic pathway for 
XXXX in soil, as presented in Figure 7 .1.1.1. 
Metabolite 3 was possibly in equilibrium with as and/or it  wa~ an  im~nu~diatc: to the  1- or 2- metabolites. 
During the test period of 11  days an amount equivalent to  I. I  ~.;  ',,  th~ appl ic:d  radioactivity was degraded. to 
carbon dioxide in both the irradiated as well as the dark sample:~  Tht:  illlllt •uru  of non-extracted radioactivity 
slightly increased to the end of the experiment and reached  J I  .. I  r~  ot tht·  .tflflh~d radiocarbon in the irradiated 
samples  and  11.1 % in  the  dark  samples.  Recovery  rang~J  trnm  QQ 0  co  I 01.1  % of the  applied 
radioactivity. Degradation of XXXX observed in the datk sample' "a'  ''n"~r· than in the irradiated samples. 
Route of degradation- summarl and conclusions 
The following are the reactions that are believed to be involved in the breakdown of XXXX in soils:-
- desalkylation of the parent compound (formation of Metabolite 1 and Metabolite 2) 
- oxidation of the parent compound (formation of  Metabolite 3) 
-hydrolysis of the parent compound and metabolites (formation of Metabolite 4) 
- ring cleavage followed by formation of C02 
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Figur~ 7.1.1.1:  Metabolism of  XXXX in soil 
~  xxxx 
/  ~ 
}>-<  }>-< 
Metabolite 1  Metabolite 2 
l  l 
}>-<  l  MernOOlire 4 
Metabolite 5 
~co/ 
l 
}>-< 
Mctahohte 6 
Proposed definition of the residue of relevance for the environment 
On the basis of the studies and data presented in this section, it is evident that .the parent compound only is the 
relevant residue for quantification in soil. Appeadix 7  Format for the Compilation of Tier 11 
Summaries - Allne1 II 
-138-
Part S  Section S  Fate and Behaviour in the 
Environment 
Company name  Month and year  Active Substance (Name)  page  of 
7.1.1.2 
7.1.1.2.1 . 
Report: 
Guideline: 
GLP: 
Report: 
Guideline:  · 
GLP: 
Rate of degradation 
Laboratory studies 
Schulz,  K.  (1995b):  Aerobic  degradation of XXXX  in soil. 
report No. 98476 
Organics  Inc,  unpublished 
BBA-Guidelines  for  the  Testing  of Plant Protection Products  in Registration Procedures, 
Part IV, 4-1 (December 1986).  Deviations: none 
yes (certified laboratory) 
Schulz, K.  (1995d): Aerobic degradation and metabolism of XXXX in soil.  Organics Inc, 
unpublished report No. 92564 
BBA-Guidelines  for the  Testing of Plant  Protection Products  in Registration Procedures, 
Part IV, 4-1 (December 1986).  Deviations: none. 
yes (certified laboratory) 
Findings:  A summary of the  results obtained on the  rate of chemical  and  biological degradation of 
XXXXX in soil under laboratory conditions, for a number of soils, is provided in Table 7.1.1.2.1 and Figure 
7 .1.1. 2.1.  In all cases the studies reported relate to aerobic degradation.  The amounts  of test material used 
were equivalent to the maximum field rate of 700 g aslha, assuming 100 % soil interception and a soil depth 
of 10 em.  Under the test conditions, the DTso values were to range from 33-44 days.  The shortest half-life 
was  obtained  from  the  soil  with  the  highest biomass  value.  Since  the  DT  90  was  not reached  within the 
incubation period of 100 days,  an estimation was  not made  as  to  the  disappearance  time  of 90 % of the 
applied compound. 
The degradation of XXXX  at lower temperature  is  covered  by  field  experiments  in the  area of Northern 
Europe (see 7  .1.1.2.2). 
Table 7.1.1.2.1: Summary of  laboratory studies on aerobic degradation of  [cyclopropyl-1_1
4C]XXXX in four 
soils (dark conditions, temp.  18 to 22  "C) 
Report  Soil  DTso in days  Remark 
Source  T_m_e  (sand %)  % Ort. C  TLC S_ystem 
Schulz, 1995d  Location 1  silt loam (36. 9)  0.9.  33  1.5th Order 
Location 2  sandy loam (58.2)  1.98  33  2nd Order 
Location 3  sandy loam (66.5)  1.09  44  2nd Order 
Schulz,  1995b  Location 4  loamy sand (83.0)  2.15  44  Sqrt 1st Order 
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Figure 7.1.1.2.1: 
to 22  '(' 
Aerobic degradation of  [cyclopropyl-1-
14C]XXXX, in four soils, in the dark, at 18 
90 
)( 
)( 
)( 
)( 
cu 
60  > 
i3  •  50  .2  ., 
•  40  ~  - 0 
~ 30 
cu 
>  20  0  u  cu  a::  10 
0 
7.1.1.2.2 
Report: 
Guidelines: 
GLP: 
Report: 
Guidelines: 
GLP: 
Report: 
0 
-
3  7  14 
Days after application 
. Field studies 
30  60  100 
~Location  1 
~Location2 
-x-Location 3 
-o-Location 4 
Winter, H.  (1995a):  Dissipation of XXXX  in soils under field  conditions.  Organics Inc, 
unpublished report No. 2078 
BBA Guideline, part IV, 4-1  (1986).  Deviations: none. 
yes (certified laboratory) 
Winter, H.  (1995b):  Dissipation of XXXX  in soils under field conditions.  Organics Inc, 
unpublished report No. 2002 
BBA Guideline, part IV, 4-1 (1986).  Deviations: none. 
yes (certified laboratory) 
Winter, H.  (1995c):  Field rotational crop study with XXXX 500 EC in Germany and Great 
Britain.  Organics Inc, unpublished report No. 2120 Appendix 7 
Company name 
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GLP: 
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BBA Guideline IV, 3-10 (1988), ECPA Guideline (1993).  Deviations: none. 
yes (certified laboratory) 
Winter,  H.  (1995d):  Dissipation of XXXX  in soils under field  conditions.  Organics Inc, 
unpublished report No. 2132 
Guidelines:  BBA Guideline, part IV, 4-1  (1986).  Deviations: none. 
GLP:  yes  (c~rtified laboratory) 
Test System:  A number of field  studies  have  been  performed  in Northern  Europe  (Germany,  UK  and 
France)  to  investigate degradation and  dissipation of XXXX  in soil  and  to  determine  the 
concentrations  of Metabolite  1  and  Metabolite  2  in  soil  under  conditions  relevant  to 
commercial usage (Winter, 1995a, b, d).  These trials were performed using the formulated 
product XXXX SC 400 (containing 402.2 g of XXXX per litre).  Soils at 6 9f the locations 
did not have vegetation cover while the soils at 8 locations did have vegetation cover. 
Findings:  The  results  obtained  are  presented in summary  form  in Table 7 .1.1.2.2-1.  Information 
derived from field rotational crop studies (4 sites; Winter 1995c) has also been included.  In trials performed 
without vegetation (bare soil),  application of 0. 7 kg  aslha in the spring period resulted in DT  .50  values  for 
XXXX ranging from  11 to 11 days.  DT  go values for XXXX determined in bare soil studies, ranged from  111 
to  111  days.  In trials performed with  vegetation,  application of 0. 7 and  1.4 (two  trials)  kg  aslha in the 
spring period  resulted  in DT  .50  values  for  XXXX  ranging  from  11  to  11  days.  DT  go  values  for  XXXX 
determined in studies with vegetation, ranged from  111  to  111 days.  On the basis of these results it can be 
concluded that rates of dissipation of XXXX in cropped and bare soil are essentially similar, however, there 
was some evidence to suggest that dissipation rates were faster with vegetation. 
Following application of XXXX,  residue concentrations declined with time.  Starting from  an application 
rate of 700 g XXXX/ha and a soil density of 1.5 g/cm3  a theoretical  XXXX  concentration of 0.5 mg as/kg 
was  evenly  disturbed  in the  0-10 em  soil  layer.  Within  111  to  222  days  residues  of XXXX  declined  to 
between  < 0.005 and 0.05 mg/kg (0.005 mg/kg = limit of determination).  Taking account of the highest 
remaining residue, about 90  % of the applied XXXX was degraded within a growing season.  Concentrations 
of the corresponding metabolites 1 and 2 declined to an amount of 0.01  and 0.01 mg/kg, respectively, at the 
end of the experimental period. 
Although not designed to address the rate of degradation in soil,  the results obtained in field crop rotational 
studies. confirmed the fairly rapid rate of  degradation of XXXX. 
Taking into account the relatively low concentrations remaining in soil after a growing season, the absence. of 
phytotoxic effects even at higher concentrations and  the  lack of leaching potential into deeper soil  layers,  a 
soil accumulation study is not necessary. 
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Table 7.1.1.2.2-1:  Field dissipation of  XXXX (as SC 400 formulation) in Northern Europe 
Refe- Soil source  Cropping  Appl  Soil type  Soil properties  Statistical Evaluation 
renee  situation  rate  xxxx 
as/ha  Organic  pH  DTso  DT,.,  Function 
carbon%  (days)  (days) 
Winter,  Location 1, UK  cropped soil  0.7  Sandy loam  1.14  7.5  11  111  Sqrt 
1995a  1.5th order 
Location 2, UK  cropped soil  0.7  Loamy sand  0.88  7.3  11  111  Sqrt 
-1. 5th order 
Location 3,  bare soil  0.7  Silt loam  0.97  6.5  11  111  Sqrt 
Germany  1st order 
Location 4,  cropped soil  0.7  Loam  1.08  6.8  11  111  2nd order 
Germany 
Winter,  Location 4,  bare soil  0.7  Silt loam  0.87  6.4  11  111  2nd order 
1995b  Germany 
Location 3,  bare soil  0.7  Sandy loam  1.21  6.6  11  111  Sqrt 
Germany  · 1st order 
Location 5,  bare soil  0.7  Sandy loam  1.27  5.9  11  111  Sqrt 
Germany  2nd order 
Location 6,  bare soil  0.7  Silt loam  1.00  6.7  11  111  Sqrt 
Germany  1st order 
Location 7,  bare soil  0.7  Silty clay  1.40  7.8  11  111  Sqrt 
Germany  loam  1st order 
Winter,  Location 1, UK  cropped soil  1.4  Sandy loam  1.08  7.4  11  111  Sqrt 
1995d  2nd order 
Location 2, UK  cropped soil  1.4  Sandy loam  1.88  7.0  11  111  Sqrt 
1st order 
Location 1, UK  cropped soil  0.7  Sandy loam  1.08  7.4  11  111  Sqrt 
2nd order 
Location 2, UK  cropped soil  0.7  Sandy loam  1.88  7.0  11  111  Sqrt 
1st order 
Location 1,  .  cropped soil  0.7  Silt loam  1.29  7.2  11  111  - Sqrt 
France  1st order Appendix 7 
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Storage stability of soil residues 
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Winter,  H.  (1995e):  Storage stability of XXXX.  Orgimics  Inc,  unpublished  report  No. 
747/95 
No official guideline available 
I 
4f 
I  .. 
I 
I 
I 
GLP:  yes (certified laboratory)  I 
Test System:  XXXX and the metabolites  1 and 2 were applied to soil at 400  tJ.g/kg.  The treated soil 
1 
samples  were  stored at a  temperature  below  -18  °C.  After 364  days  the  samples  were 
analyzed using the methods 00111 and 00222 (Winter,  1994a, b- cross references 4.2.2 /01 
and 4.2.2 /02). 
Findings: .  The results obtained demonstrate that there is no significant degradation of XXXX and the 
metabolites 1 and 2 in soil over a period of one year during storage below -18 °C:-
7.1.2 
Report: 
Recovered amounts (%) 
Days after treatment  0  364 
xxxx  100.1  99.9 
Metabolite 1  100.1  99.9 
Metabolite 2 ·  100.1  99.9 
Adsorption and desorption 
Bond,  B  (1995a):  Adsorption/desorption  of XXXX  in  soil.  Organics  Inc,- unpublished 
report No.: 27566 
Guidelines:  US EPA-guideline§ 163-1 of October 18, 1982.  Deviations: none. 
GLP:  yes (certified laboratory) 
Test System:  Adsorption and  desorption of XXXX  was  measured  using  a  batch  equilibrium  procedure 
(based on EPA Guideline § 163-1) to  determine the Kd  and Koc  values of [cyclopropyl-1-
14C]XXXX  in five  soils,  including one subsoil.  Details of the  soils used are provided in 
Table 7.1.2. 
Findings:  A summary of the results obtained can be found in Table 7  .1 .. 2.  The adsorption process for 
XXXX, in the concentration range studied (0.01-5 mg as/ml), can be described with a high degree of accuracy 
using the Freundlich equation.  The adsorption constants Kd calculated from the Freundlich isotherms for the 
five test soils range from 1.11 to 11.11.  Koc values of 111-1111 were obtained. 
The percentage adsorption of parent compound varied between 11.1  and  11.1  % of the applied as  depending 
on soil  type  and concentration.  A single desorption determination with 0.01  M CaCh solution resulted in 
1.1-11  % of absorbed as being desorbed.  The calculated desorption Kd values obtained ranged from  1.11  to 
11.11, with corresponding Koc values of 1111 to 1111. 
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Adsorption and Desorption of  [cyclopropyl-J}
4C] XXXX on a range of  soils 
Adsorption  Desorption 
Soil Type  Org. C  Kd  1/n  Koc  Kd  1/n  Koc 
(%)  (ml/g)  (ml/2)  (ml/2)  (ml/g) 
loamy sand  1.8  11.11  0.1111  111  11.11  0.1111  1111 
0-30 em horizon 
Location 1,  loamy sand 0.3  11.11  0.1111  1111  1.11  0.1111  1111 
30 - 60 em horizon 
Location 2 
Location 3 
BBA 2.1 
Conclusion: 
silt loam  2.4  11.11  0.1111  1111  11.11  0.1111  1111 
silty clay  0.64  11.11  0.1111  1111  11.11  0.1111  1111 
sand  0.7  11.11  0.1111  111  1.11  0.1111  1111 
On the basis of these findings XXXX should be classified as being of low mobility to 
immobile. 
-I  7  .1.3  Mobility in soil 
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7  .1.3.1  Column leaching studies 
In  the  light  of the  findings  reported  in  under  point  7 .1.2  with  respect  to  absorption  and  desorption 
characteristics of XXXX, column leaching studies are not required. 
7 .1.3.2 Aged residue column leaching 
Report:  Schulz, K.  (1994): Leaching behaviour of XXXX aged in soils.  Organics Inc, unpublished 
repon No.: 63489 
Guidelines:  BBA:  Versickerungsverhalten von Pflanzenschutmitteln  (4-2)  1986 Teil  IV.  Deviations: 
during irrigation, leaching columns (A.  B from  tht=  application rate 700 g aslha,  soil  from 
location  1)  became partly blocked (both on day  32).  Irrigation continued for 23  days  (7 
days for the first 200 ml).  Consequently. a study with a third column was performed using 
the  irrigation  time  of 2  days  specified.  Tht=  soil  sampk  originally  set  aside  for  the 
determination of microbial biomass at the end of tht=  study.  wa\ instead used for a leaching 
experiment. 
GLP:  yes (certified laboratory) 
Test System:  The leachiilg characteristics of aged [cyclopropyl-l-
14C)XXXX was studied using three soils: 
Location  1:  loamy  sand,  location  2:  sand.  location  3:  silty  loam.  Details  of the  soil 
characteristics are included in Table 7  .1.1.1.1-1.  Soil  samples containing labelled XXXX 
(at rates equivalent to  350 and  700 g aslha,  the  latter being  the  maximum  field  rate) were 
incubated in the dark for 0, 30-33  and  60-62 days at a  temperature of 20 ± 1  °C,  at 40 % 
water holding capacity.  After ageing  the  incubated  soil  was  packed on top  of a column 
(inner diameter 5 em) containing fresh soil.  Water was applied to simulate rainfall (300 ml 
in two days).  The leachate was collected in two fractions of about 180 m1 each. -144-
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Findings:  The results obtained for all tests are summarised in Table 7 .1.3.2. 
Table 7.1.3.2:  Leaching  behaviour  of [cyclopropyl-J.l
4C]XXXX  in  soil  (Values  in  %  of applied 
radioactivity, except "Total residue" and "pg as/leachate") 
Applied amount  350 glha as  700 glha as  350 glha as 
Soil (type)  Location 1 ~ loamy sand)  Location 2 (sand)  Location 3 "silty loam) 
A~ein~ (days)  30  62  32  33  60  30  62 
Individual test  A  B  A  B  A  B  c  A  B  A  B  A  B 
1. Volatile  1.1  1.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1 
compounds 
t4co2  1.1  l.i  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1 
2. Soil (total)  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1 
Segment I  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1 
extract  11.1  11.1  11.1  1.1.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1 
as  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1  11.1 
Segment IT  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1 
Segment Ill  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1 
3. Leachate (total  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1  1.1 
asand~5 
metabolites) 
Total residue  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11  .11  1.11  1.11  1.11 
(J,Lg) 
Fraction a  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11 
Fraction b  1.11  1.11  1.11  ·1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11 
as  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11 
J,Lg as/leachate  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11  1.11 
(200 ml) 
l: (1-3) Total  99.9  99.9  99.9  99.9  99.9  99.9  99.9  99.9  99.9  99.9  99.9  99.9  99.9 
XXXX  and  its  metabolites  displayed  a  very  limited  leaching  capacity.  Following  overhead  irrigation, 
segments II and III of the soil columns contained 1-11  % of the applied radioactivity.  Almost all the total 
radioactivity still present, remained in the upper soil segment.  The upper segments were processed separately 
and were found to contain 11-11  % (Location 1) and  11-11  % (Location 3) parent compound, respectively. 
The radioactivity in segment II ( <  5 %)  was somewhat higher in the experiment with the higher application 
rate but the radioactivities in segments III were nearly identical ( < 1 % after 60 days). 
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APPENDIX8 
FORMAT FOR THE COMPILATION OF TIER 11 SUMMARIES- ANNEX m 
PART1 
Section 1  Identity of the ~lant Protection Product; Physical, Chemical and Technical Properties 
of the Plant Protection Product; Data on Application; Further Information on the Plant 
Protection  Product;  Proposals  including  Justification  of  the  Proposals  for  the 
Classification and Labelling of the Plant Protection Product; Proposals for Risk and 
Safety Phrases in Accordance with Article 16 (1)  (g) and (b)_ and the Proposed Label 
(Annex m, points 1 to 4 and 12) 
The example of  a summary and assessment of  data which follows is intended to illustrate the approach 
recommended for the preparation of Tier II summaries and assessments.  The material included has not been 
critically assessed for its technical content.  Although based on a real submission, the data included in the 
following summary and evaluation has been amended to protect the commercial interests of  the owner of  the 
data.  -
Applicant should be aware that these guidelines are intended to provide a degree of  flexibility.  Where in 
particular cases, it is more appropriate to present the data and information in another format, applicants may 
do so.  In such cases it is recommended that the applicant discuss the format proposed with the Competent 
Authority of  the Member State to which application is to be made. 
1  Identity of  the plant protection product · 
1.1  Applicant:  name and address 
1.2  Manufacturer: ·  name and address 
Location of plant: name and address 
Person to contact: 
Telephone No 
Telefax No 
xxxxxxxxx xxxxxxxxxx 
111111111111111 
111111111111111 
Contact point - as applicant 
Person to contact: 
Telephone No 
Telefax No 
xxxxxxxxx xxxxxxxxxx 
1111  1111111 
1111  1111  1111111 
Manufacturer of the active ingredient:  name and address 
Person to contact:  xxxxxxxxx xxxxxxxxxx 
11111111 1111111 
1111  1111  1111111 
1.3  Trade name: 
Manufacturer's code number: 
1.4  ·  Composition of the preparation 
Identity of active substance 
CAS, EU and CIPAC numbers: 
Telephone No 
Telefax No 
XXXX1 
0122915 (development number) 
xxxx 
CAS:  111111-11-1 
EINECS:  not allocated 
CIPAC:  not allocated 
ELINCS:  not allocated -146-
Appendix 8  Fonnat for the CompUation of  Tie II 
Swnmaries - Annex III 
Company name  Month and year 
Content of active 
substance 
Active Substance (Name) 
content of  pure active substance: 
content of  technical active substance: 
Part 1  Section 1 
page  of 
400 giL XXXX (declared) 
431.9 giL XXXX technical 
at a typical purity of  the technical as of  94 %. 
Identity and content 
of formulants: 
refer to file of  confidential information provided ~parately (Document J) 
1.5  Physical state:  liquid : suspension concentrate  [Code: SC] 
1.6  Function  fungicide 
2  Physical, chemical and  technical  properties of  the plant  protection product 
Test or Study  Guideline  Test material  Findings  Comments  GLP  Reference 
&  and  purity and 
Annex point  method  specification  YIN 
Colour and 
physical state 
(IDA 2.1) 
Odour 
(IllA 2.1) 
Explosive 
properties 
(IllA 2.2.1) 
Oxidizing 
properties 
(IllA 2.2.2) 
Flash point 
(IllA 2.3) 
Flanunability 
(IllA 2.3) 
Auto-
flanunability 
(IllA 2.3) 
Acidity or 
alkalinity and 
pH 
(IllA"2.4.1) 
pH of  a 1% 
aqueous 
dilution, 
emulsion or 
dispersion 
(IDA 2.4.2) 
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Company name  Month and year  Active Substance (Name) 
Test or Study  Guideline  Test material  Findings 
&  and  purity and 
Annex point  method  specification 
Kinematic 
viscosity 
(IDA 2.5.1) 
Viscosity 
(IliA 2.5.2) 
Surface tension 
(IliA 2.5.3) 
Relative 
density 
(IliA 2.6.1) 
Bulk or tap 
density 
(IliA 2.6.2) 
Storage 
stability after 
14 days at 54 
oc 
(IIIA2.7.1) 
Stability after 
storage for 
other periods 
and at other 
temperatures 
(IDA2.7.1) 
Minimmn 
content after 
heat stability 
testing 
(IliA 2.7.1) 
Effect of low 
temperatures 
on stability 
(IliA 2:7.2) 
Ambient 
temperature 
shelf life 
(IliA 2.7.3) 
Wettability 
(IliA 2.8.1) 
Persistence of 
foaming 
(IliA 2.8.2) 
Suspensibility 
(IliA 2.8.3) 
Spo~taneity of 
dispersion 
(IIIA 2.8.3) 
Part 1  Section 1 
page  of 
Comments  GLP  Reference 
YIN 
-Appendb:8  Fonnat for the Compilation of  Tier II 
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Company name  Month and year  Active Substance (Name) 
Test or Study  Guideline  Test material  Findings 
&  and  purity and 
Annex point  method  specification 
Dilution 
stability 
(IllA 2.8.4) 
Dry sieve test 
(IllA 2.8.5) 
Wet sieve test 
(IllA 2.8.5) 
Particle size 
distribution -
nominal size 
range of 
granules 
(IDA 2.8.6.1) 
Dust content 
and particle 
size of  dust 
(IllA 2.8.6.2) 
Friabilty and 
attrition 
(IDA 2.8.6.3) 
Emulsifiability. 
emulsion 
stability andre-
emulsifiability 
(IllA 2.8. 7.1) 
Stability of 
dilute 
emulsions 
(IllA 2.8.7.2) 
Flowability 
(IllA 2.8.8.1) 
Pourability 
(including 
rinsed residue) 
(IllA 2.8.8.2) 
Dustability 
following 
accelerated 
storage 
(IliA 2.8.8.3) 
Physical 
compatibility of 
tank mixes 
(IliA 2.9.1) 
Chemical 
compatibility of 
tank mixes 
(IDA 2. 9.1) 
Part 1  Section 1 
page  of 
Comments  GLP  Reference 
YIN 
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Summaries -Annell Ill 
Part 1  Sedion 1 
Company name  Month and year  Active Substance (Name)  page  of 
Test or Study  Guideline  Test material  Findings  Comments  GLP  Reference 
&  and  purity and 
Annex point  method  specification  YIN 
Adhesion to 
seeds 
(IliA 2.10) 
Distribution in 
seed 
(IliA 2.10) 
2.11  Summary and evaluation of data presented under points 2.1 to 2.10 
XXXX 400 SC is not eXplosive, oxidising, or flammable.  Its pH is within the range that occurs naturally e.g. 
in soil.  Its stability allows storage under practical and normal commercial conditions.  Its technical properties 
indicate that no particular problems are to be expected, when it is used as recommended. 
3 
3.1 
3.2 
3.3 
3.4 
3.5 
Data on application 
Field of use: 
Nature of the effects on harmful organisms: 
Details of intended use 
Crop  Crop code 
Barley, spring and winter  HORVS, HORVW 
Winter wheat  TRZAW 
agriculture 
fungicidal 
XXXX is absorbed to a limited degree in plants 
and is translocated in the apoplast 
Disease code 
Disease 
Rhynchosporium secalis  RHYNSE 
Septoria tritici  SEPITR 
Rate of application per unit treated, in terms of g or kg of preparation and active substance 
1.5 L product /ha= 0.6 kg aslha 
Concentration of active substance in material used (diluted spray) in giL 
1.5-3 giL  (1.5 L product= 0.6 kg as. in 200-400 L water lha) -150-
Appendh8  ·  Fonnat for the Compilation of  Tie II 
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Part 1  Section 1 
Company name  Month and year  Active Substanc:e (Name) 
3.6  Description of the method of application, type of equipment used and type and volume of 
diluent per unit of area or volume 
3.7 
3.8 
3.9 
Spray application with standard tractor mounted hydraulic field sprayers, water volume 200 - 400 
Llha 
Maximum number of applications and their timing 
2 applications  first application: at appearance of  disease, 
last application:  in barley at the beginning of  flowering (GS 61) 
·  in wheat at the end of  flowering (GS 69) 
For each application, growth stages 
of the crop or plants to be protected: 
For each application, development stages 
of the harmful organism concerned: 
Duration of protection afforded by 
each application: 
Duration of protection afforded by 
the maximum number of applications: 
Minimum waiting periods or other 
precautions between last application and 
sowing or planting succeeding crops 
Limitations on choice of succeeding crops, 
if any 
Proposed instructions for use as printed 
or to be printed, on labels: 
For the first application the crop stage is not 
important, for the last application see above 
At appearance of  disease 
3 - 6 weeks depending on disease pressure 
6 - 12 weeks depending on disease pressure 
No waiting period needed 
No limitations 
Pro\'idcd • sec document C 
4  Further information on the plant  protection product 
4.1.1  Description and specification of the packaging and materials used in packaging, size, capacity, 
size of openings, types of closure and seals 
1 L bottle:  Material:  HDPE-COEX with barrier of EN  AL or PA 
· alternative: HDPE bottle 
Shape/size:  Round I 88.5 x 234 
Opening:  42 mm diameter 
Closure:  Screw cap with additional tamper evident, e.g.  sealing disk 
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Sununarles- Annex Ill 
Part 1  Section 1 
Company name  Month and year  Active Substance (Name)  page  of 
4.1.2 
4.1.3 
4.2 
4.3.1 
5 L container:  Material:  HOPE 
alternative: HDPE-COEX with barrier of EN  AL or PA-
Shape/size:  Square I 194 x 112 x 362, handle isolated from the content 
Opening:  54.7·mm diameter (GIFAP 63) 
Closure:  Screw cap with additional tamper evident, e.g.  sealing disk 
Suitability of the packaging and closures 
Strength, leakproofness, resistance to normal transport and handling 
Test results:  Satisfactory (ADR) 
UN registration Nos.  I litre bottle  xxxxxx  (10 x 1 L), 
xxxxxx  (20 X 1 L) 
5 litre container  xxxxxx (  4 x. 5 L) 
Resistance of the packaging material to its contents 
The  material  proposed  for  use  is  known  from  experience  to  be  very  resistant  to  influences  of 
chemicals: product odours from  such container have never developed with any of our products; the 
material  used  in its construction is  not_ penneable to  solvents  - including  aromatic  hydrocarbons; . 
reactions of the product with oxygen are avoided by replacing all remaining air in the container with 
nitrogen before closing and sealing. 
Procedures for cleaning application 
equipment and protective clothing: 
Effectiveness of_the. cleaning procedures: 
Rinsing with water and detergent 
The product is suspensible in water.  It can  be 
removed from surfaces with water.  The addition 
of  detergent enhances the cleaning process. 
Pre-harvest intervals, re-entry intervals or withholding periods to minimize residues in crops, 
plants, plant products, treated areas or spaces 
Pre-harvest interval (in days)  Barley: 
for each relevant crop 
Wheat: 
Re-entry period (in days) for livestock, 
to areas to be grazed: 
latest application at the beginning of  flowering 
(GS 61) 
latest application at the end of  flowering (GS 69) 
Not relevant, no grazing -152-
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Part 1  Section 1 
Company name  Month and year  Active Substance (Name)  page  of 
Re-entry period (in hours or days) for man to crops, buildings or spaces treated 
XXXX has only a very limited tendency to volatilize under practical use conditions.  Estimates of the 
fate in the troposphere resulted in half lives < 6 hours.  Under practical conditions of use there is no 
reason for workers to enter a cereal crop shortly· after treatment.  Therefore a specific re-entry period 
is not required. 
Withholding period (in days) for animal  Not relevant. no use as a feedingstuff before 
harvest  feedingstuffs:  ' 
Waiting period (in days) between application 
and handling treated products:  Not relevant, crop is not handled before harvest 
Waiting period (in days) between last 
application and sowing or planting 
succeeding crops: 
Not relevant. no phytotoxicity and no residue. 
exposure for .succeeding crops 
4.3.2  Information on any specific agricultural, plant health or environmental conditions 
under  whic~  the preparation may or may not be used 
None of  the test results obtained or observations made were such that restrictions should be imposed. 
4.4  Statement of the risks arising and the recommended methods, precautions and handling procedures 
to minimize those risks, relating to 
Handling and storage 
Information on safe handling: 
Information on storage: 
Transport information 
GGVSee/IMDG Code:  1.1 
PG:  III 
GGVE/GGVS: Class 3 No. 
Warning sign: Hazard no. 
ADNR:  Class 3 
Declaration for land shipment: 
When  using  open  containers,  use  local  exhaust  ventilation  to 
prevent vapours from spreading.  Make provision for product and 
fire-fighting water to be retained. 
To  maintain  quality,  sto~e  in  a  chy  place.  Store  so  that 
unauthorised persons do not have access.  Keep away from  food, 
drink and animal feeding stuffs. 
UNNo.: 1111  :tvfFAG:  111  EmS:  1  11 
:rv.tPO: NO 
llC  RID/  ADR: Class 1 No.  11 C . 
030  Substance no.  1111 
No.  1  Cat 1  ICAOIIATA-DGR:  1  1111 III 
1.1% XXX 1111 I SOL VENT -SUSPENSION  . 
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Swnmaries - ADne1 Ill 
Part 1  Section 1 
Company name  Month and year  Active Substance (Name)  page  of 
4.5 
Declaration for sea shipment:  1.1% XXX 1111 I SOL VENT  -SUSPENSION 
Declaration for shipment by air:  ICAO/IATA -labels: 4.1 (flanuruible solids) UN-Nr.:xxxx 
Other information:  Flammable,  flash  point +  00  °C.  Irritating to  skin and eyes. 
Avoid heat above+ 00 °C.  Keep separated from foodstuffs. 
Well ventilated areas: 
Enclos~  premises: 
full  face  mask  with  combination  filter, 
e.g.  ABEK-P2 (offers no protection from 
carbon monoxide!) 
respirator with independent air supply. 
Contain fire fighting water. 
Protective clothing and equipment proposed 
If  product is handled while not enclosed, 
and if  skin contact may occur: 
Respiratory protection:  full mask with filter ABEK-P2 
Hand protection: protective gloves for chemicals 
Keep work area clean. 
Avoid contact with product. 
Keep working clothes separate from other clothing. 
Change badly soiled or soaked clothing. 
Wash hands before breaks and at end of  work. 
Fire-fighting measures:  Extinguishing media:  sprayed  water  jet,  foam,  extinguishing 
powder, C02, sand. 
Fight  fire  in early  stages  if safe  to  do  so.  Wear  respiratory 
protection. 
Procedures to minimize the 
generation of waSte: 
Information on combustion products 
likely to be generated in the event 
of fire: 
Only purchase and store quantities of  product required in 
the short term.  Do  not open  larger containers than  is 
necessary for  immediate requirements.  Do  not a mix a 
volume  of spray  solution  greater  than  is  required  for 
immediate use. 
In the event of  fire, the formation of hydrogen cyanide, 
carbon monoxide and nitrogen oxides must be anticipated. 
Detailed procedures for use in the event of an accident during transport, storage or use 
Prevent entry into drains, waters or soil.  Use adsorbent material to  collect spillage (e.g.  sawdust, 
peat, chemical binder).  Place contaminated adsorbent in closable containers.  Use a damp cloth to 
clean floors and other objects after removal of contaminated adsorbent.  Also  place used cleaning 
materials into closable receptacles.  · -1S4-
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Part 1  Section 1 
\  . 
Company name  Month and year  Active Substance (Name)  page  or 
Protection of emergency workers 
and bystanders: 
First aid measures: 
General information: 
Upon ~nhalation: 
Following skin contact: 
Following eye contact: 
Upon swallowing: 
Use the personal protective equipment proposed above. 
Remove victims from the danger zone.  Remove soiled or 
soaked clothing immediately. 
Bring accident victims out into the fresh air.  Call doctor 
immediately. 
Wash skin immediately with copious amounts of  water 
and soap.  Then seek medical advice. 
Rinse eyes thoroughly with water.  Consult an eye 
specialist. 
Call emergency doctor immediately. 
4.6.1  Neutralization procedures (e.g.  reaction with alkali to form less toxic compounds) for use 
in the event of accidental spillages 
A neutralization.procedure cannot be proposed (see Annex II, 3.9). 
4.6.2  Pyrolytic behaviour of the active substance under controlled conditions at 800° C 
and the content of polyhalogenated dibenzo-p-dioxins in the products of pyrolysis 
4.6.3 
Not applicable, as the product does not contain halogens. 
Detailed instructions for safe disposal of the plant protection product and its packaging 
Package  product wastes.  Close and label  waste  receptacles  and,  likewise,  any  uncleaned empty 
containers.  Dispose of them at a suitable waste incineration plant in accordance with the official 
regulations.  Where large quantities are concerned, consult the supplier. 
Waste code number:  11111  old  stock  and  remainders  of crop  protection  and  pest  control 
products. 
11111 production waste from crop protection and pest control products. 
Methods other than controlled incineration for disposal of the plant protection product, 
contaminated packaging and contaminated materials 
No other methods· are currently available 
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Company name  Month and y~ar  Active Substance (Name) 
12.3 
Part 1  Section 1 
pa~e  of . I 
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PART2 
. 
Section 3  Toxicological Studies (Annex m, Point 7) 
The example of  a summary and assessment of  data which follows is intended to illustrate the approach 
recommended for the preparation of Tier II summaries and assessments.  The material included has not been 
critically assessed for its technical content.  Although based on a real submission, the data included in the 
following summary and evaluation has been amended to protect the commercial interests of the owner of  the 
data. 
Applicant should be aware that these guidelines are intended to provide a degree of  flexibility.  Where in 
particular cases, it is more appropriate to present the data and information in another format, applicants may 
do so.  In such cases it is recommended that the applicant discuss the format proposed with the Competent 
Authority of  the Member State to which application is to be made. 
7.2  Data on exposure 
7.2.1  Operator exposure 
7.2.1.1  Estimation of operator exposure 
7.2.1.1.1  Estimation of operator exposure using the German model 
XXXX 400 SC is applied using tractor mounted field crop sprayers with hydraulic boom and nozzles.  Only 
applications to field  crops are intended.  ' Operator exposure estimates were calculated using the following 
model: 
Uniform Principles for Safeguarding the Health of  Applicators of  Plant Protection Products 
(Uniform  Principles  for  Operator  Protection);  .\litteilunf!en  aus  der  Biologischen 
Bundesanstalt jar Land- und Forstwirtschaft,  Berlin-!Jah/em.  no.  277,  1992  ("German 
model'') 
Data used for the calculation 
The following assumptions have been made in calculating operator exposure: 
the area treated in one day is: 
the application rate is: 
20 hal  day for field crops I tractor mounted 
750 g as/ha for field crops 
The estimation  of operator exposure  was  completed for  two  situations  with  regard  to  personal  protective 
equipment (PPE): 
no PPE:  disregarding the  recommendations on  the  label.  no  personal  protective equipment 
used when handling the undiluted product and during application Appendb8  Fonnat for the CompUatlon of  Tin II 
Summaries - Anne:.: Ill 
-158-
Part 2  Section 3  ToJ:icological Studies (Anne:.: Ill, 
Point 7) 
Company name  Month and year  Active Substance (Name)  page  of 
withPPE:  the following ~rsonal protective equipment used 
when· handling the undiluted product: gloves,  standard protective gannent 
(plant protection) and sturdy footwear 
when  handling  the  diluted  product:  standard  protective  gannent  (plant 
protection) and sturdy footwear. 
It should be noted that this selection of  protective measures is not intended to be a recommendation for the PPE 
necessary PPE when handling XJ90{ 400 SC.  It does not take into account specific requirements which may 
arise in individual Member States or the necessity to wear tight-fitting goggles because of irritant effects for 
eyes.  Additional PPE can be used to further reduce the exposure of  the operator. 
Calculation for field crops I tractor mounted 
Amount handled per day= treated area x use rate= 20 halday x 0.75 kg aslha = 15.0 kg as/day 
NoPPE 
Im 
Dm 
Ia 
Da(c) 
Da(h> 
Da(b) 
WithPPE 
Im 
Dm 
Ia 
Da(c) 
Da(h) 
Da(b) 
Abbreviations: 
= 0.0006 
=2.4 
= 0.001 
=0.06 
=0.38 
= 1.6 
= 0.0006 
= 2.4 
= 0.001 
=0.06 
= 0.38 
= 1.6 
mglkg as x 15.0 kg as/day 
mglkg as x 15.0 kg as/day  = 
mglkg as x 15.0 kg as/day  = 
mglkg as x 15.0 kg as/day 
mglkg as x 15.0 kg as/day 
mglkg as x 15.0 kg as/day 
mglkg as x 15.0 kg as/day 
mglkg as x 15.0 kg as/day x 0.01* = 
mglkg as x 15.0 kg as/day 
mglkg as x 15.0 kg as/day 
mglkg as x 15.0 kg as/day 
mglkg as x 15.0 kg as/day x 0.05* = 
0.009 
36.0 
0.015 
0.90 
5.70 
24.0 
0.009 
0.36 
0.015 
0.90 
5.70 
1.20 
I= estimated inhalation exposure;m =during mixinglloading;  a= during application 
D =estimated dennal exposure  (c)= head;  (h)= hands; 
(b) body  *  reduction coefficient 
A summary of  the expected operator exposures is provided in the following tables 
Table 7.2.1.1.1-1: Estimated operator exposure /no PPE 
Dennpl exposure 
Mixing/loading 
Application 
Total 
Inhalation exposure 
Mixing/loading 
Application 
Total 
[mg/person/day] 
36.0 
30.6 
66.6 
0.009 
0.015 
0.024 
mg/person and day 
mg/person and day 
mg/person and day 
mg/person and day 
mg/person and day 
mg/person and day 
mg/person and day 
mg/person and day 
mg/person and day 
mg/person and day 
mg/person and day 
mg/person and day 
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Table 7.2.1.1.1-2: Estimated operator exposure I with PPE 
Dermal exposure 
Mixing/loading 
Application 
Total 
Inhalation exposure 
Mixing/loading 
Application 
Total 
[mg/personlday] 
0.36  ' 
7.80 
8.16 
0.009 
0.015 
0.024 
Determination of the tolerable exposure (see also 5.10.2.2 of Annex II, Tier II) 
The following NOELs were obtained in toxicological studies relevant to operator safety with XXXX: 
Study type  NOEL 
subacute dermal rabbit  5 mglkg bw/day (systemic NOEL) 
subacute inhalation rat  14.3 mg/m
3 air (corresponding to 5.1 mglkg bw/day) 
page  of 
In  the  subacute  dermal  study,  5  mglkg  bw/day  was  the  highest  dose  tested,  because  of animal  welfare 
considerations  - the irritant action of XXXX.  It can be assumed from  the results  of the subacute  and 
subchronic oral toxicity studies that the actual systemic NOEL after dermal application is substantially higher 
than 5 mglkg bw/day. 
Using a safety factor of  25 the tolerable dermal <Dtoi) and inhalation exposure (lto1 ) are calculated to be: 
Dtoi =· 5 mglkg bw x 70 : 25 =  14 mg/personlday 
ltol = 5.1 x 70 : 25 = 14.28 mg/personlday 
Comparison of estimated and tolerable exposure 
Using the following  equation,  the total  degree of exposure (E)  can be  calculated for the two conditions of 
operator protection assumed~ values of  E < 1 indicate that no risk for the applicator exists. 
I  D 
E=-+--
Itol  Dtol -160-
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a)  noPPE 
0.0017 +4.757 =  4.76 
b)  withPPE 
0.0017 + 0.583 =  0.58 
Assessment 
The results of the calculations using the Gennan model show, that inhalation exposure is not critical.  When 
assessing the risk of dermal exposure to XXXX, it must be taken into account that the highest dose tested in 
the subacute dermal study was determined in the light of the irritation potential for' rabbits.  The actual 
systemic  NOEL  is  assumed to  be substantially higher.  Nevertheless,  when applying  the model  with the 
available NOEL, a sufficient margin of safety exists for XXXX with regard to systemic toxicity if  standard 
protective equipment is used. 
7.2.1.1.2  Estimation of operator exposure using the UK model 
XXXX 400 SC is applied using tractor mounted field crop sprayers with hydraulic boom and nozzles.  Only 
applications to field  crops are intended.  Operator exposure  estimates were done  using the "UK model" 
(Predictive Operator Exposure Model (POEM), UK MAFF, 1992). 
Data used for the calculation  Area treated per day:  50 ha 
Application dose:  750 g aslha 
Container:  5 litres with 51 mm opening 
Penetration of gloves 
Results of tests to measure the penetration of XXXX 400 SC through gloves have shown that only extremely 
low amounts penetrate (Maasfeld, 1995).  Therefore, no relevant exposure of  the operator's hands is expected 
when gloves are worn.  The 5% penetration value used for the calculation (mixing/loading and application) 
must be regarded to be a worst case assumption which overestimates exposure. 
Absorption data 
The absorbed dose, following inhalation exposure, was calculated on the basis of the assumption that there is 
100 % retention and absorption of  inhaled material. 
The dermal absorption of  XXXX from the product (XXXX 400 SC) was investigated under in vivo conditions 
in the rat and in  vitro using rat and human skin.  Tests were done with the undiluted product and a  1:100 
dilution, which slightly exceeds the maximum field use concentration (1.5 : 200). 
A summary of  the dermal absorption data on X:XXX 400 SC is provided at point 7.3. 
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The  calculations  that follow  were  done  using  a  5 %  skin  absorption  figure  for  both  mixing/loading  and 
application. 
Personal protective equipment 
The calculation of the estimated operator exposure was made for different scenarios with respect to personal 
protective equipment (PPE): 
noPPE:  disregarding the recommendations on the label,  no personal -protective equipment 
used, when handling the undiluted product and during application 
withPPE:  gloves,  standard protective garment (plant  protection)  and sturdy footwear,  worn 
when handling the diluted and the undiluted product 
gloves:  during mixing/loading and during application. 
Poem calculations 
The calculations were performed using the relevant spreadsheet.  Results obtained are given in the following 
table. 
Table 7.2.1.1.2-1: POEM calculation for tractor mounted  field crop application 
A  PRODUCT DATA 
I  Product name 
2a Active in~edient 
2b Concentration 
3  F  onnulation type 
4a Main solvent 
4b  Concentration of  solvent 
5  Maximwn in-use as concentration 
XXXX400SC 
xxxx 
500  mg/ml 
·Ec 
na 
3.750  mg/ml 
B  EXPOSURE DURING MlXING AND LOADING 
1  a  Container size 
I b  Hand contamination/operation 
2  Application dose 
3  Workrate 
4  Nwnber of  operations 
5  Hand contamination 
6  Protective clothin2 
7  Transmission to skin 
8  Dennal exposure to fonnulation 
9  Concentration of  as 
I  0  Dennal exposure to as 
II  Percent absorbed 
12  Absorbed dose 
5  litres 
0.01  m1 
1.5  litres product/ha 
50  ha/day 
15  /day 
0.15  rnUday 
None 
100 
0.15 
500 
75.000 
5 
0.063 
37.5 k~  as/day 
Gloves 
5% 
0.0075  rnUday 
500  mg/ml 
3,  750  mg/day 
5% 
0.003  mg/k~  bw/day -162-
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C  EXPOSURE DURING SPRAY APPLICATION 
1  Application technique  -Vehicle with cab boom hydraulic nozzles 
2  Application volume  200  sprav/ha 
3  Volume of  surface contamination  10  mllh 
4  Distribution  Hands  Hands 
65  65 
5  Clothin~  NONE  GLOVES 
6  Penetration  100  5 
7  Dermal exposure  6.5  0.325 
8  Duration of  exposure  6  h 
PPE  GLOVES 
Trunk 
10 
PERMEABLE 
5 
0.05 
9  Total dermal exposure to spray 
I 0  Concentration of  as 
3  Dermal exposure to as 
II  Percent absorbed 
NONE 
41.55 
3.750 
155.8I3 
5 
0.130 
4.5  ml/day 
3.750  mwml 
16.875  mwday 
5  % 
12  Absorbed dose  0.014  melk2 bw/dav 
E INHALED EXPOSURE DURING SPRAY APPLICATION 
I  Inhalation exposure 
2  Duration of  exposure 
3  Concentration of  as 
4  Inhalation exposure to as 
5  Percentabsorbed 
6  Absorbed dose 
F  PREDICTED EXPOSURE 
1  No ~loves 
2  Gloves only when mixinWioadin~ 
3  Gloves only d~  spray application 
4  Gloves durin~ spray application & 
mixinW!oadin~ 
Determination of tolerable exposure 
0.01  mllh 
. 6  h 
3.750  mwml 
0.225  mwday 
100% 
0.004  lll2fk2 bw/day 
O.I96  mWkg bw/day 
0.137  mg/k~  bw/day 
0.077  mglk~  bw/day 
0.021  mg/k~  bw/day 
pa~e  of 
Le~s 
25  % 
PERMEABLE 
'15  % 
0.375  mllh 
For XXXX an acceptable operator exposure level (AOEL) of0.4 mglkg bw/day has been proposed (see Annex 
II point 5.10.2.2).  For a 60 kg person this corresponds to 24 mg active substance per day.  The AOEL is 
based on the systemic NOEL established in subacute/subchronic toxicological studies (10 mg/kg bw/day).  In 
the context of the quality, extent and consistency of the toxicological data base available and the results of the 
absorption, distribution, and excretion studies reported, a safety factor of 25 is considered to be appropriate for 
xxxx. 
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Assessment 
The portion of  the AOEL which is accounted for by the estimated exposure, was calculated to be as follows:-
Table 7.2.1.1.2-2:  Portion of  AOEL claimed by the expected 
operator exposures 
noPPE 
gloves only when mixing/loading 
gloves only during spray application 
gloves during mix/loading and spray 
application 
% of AOEL claimed 
49.00% 
34.25% 
19.25% 
5.25% 
The results of the POEM calculations show that only 50 % of the AOEL is accounted for under practical 
conditions of  use, where no personal protective equipment is used.  Therefore harmful effects from exposure to 
xxxX do not arise for operators wearing the recommended personal protective equipment.  However, because 
of the  skin  irritant  properties  of XXXX  400  SC  it  is  absolutely  necessary  to  wear  gloves  during 
mixing/loading.  Where gloves are worn during mixing/loading, the estimated exposure is no more $m 34 % 
of  the proposed AOEL. 
It can be concluded that XXXX 400 SC can be handled safely under the recommen"ed conditions of  use. 
7.2.1.2  Measurement of operator exposure 
Since the risk assessment carried out indicated that the health-based limit value (AOEL) will not be exceeded 
under practical conditions of use, a study to provide a measure of operator exposure to XXXX 400 SC under 
field conditions, was not necessary and therefore was not carried. 
7.2.2  Bystander exposure 
Given the low vapour pressure of  XXXX 400 SC and its low inhalation toxicity, problems for bystanders by the 
inhalation route are not anticipated.  Dermal exposure due to drift of spray material, calculated using spray 
drift rates established under practical conditions ·of use, indicated that the worst case exposure (person standing 
at the edge of the area being treated during a full working day) was likely to be less than 00 o/o of the AOEL. -164-
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7.2.3  Worker exposure 
XXXX 400 SC is normally used at times, when it is not necessary to enter crops shortly after spraying.  It is 
therefore not necessary to detennine a particular re-entry time for workers.  In cases where re-entry is not 
avoidable,  personal  protective  equipment  similar to  those  of the operator  (gloves  and  standard  protective 
garment) is regarded to provide sufficient protection. 
7.3  Dermal absorption 
The dennal absorption of XXXX from the product (XXXX 400 SC) was investigated under in vivo conditions 
in the rat and in vitro using excised rat and human skin.  Tests were done with the undiluted formulation and 
with a 1:100 dilution, a dilution rate which slightly exceeds the maximum field use concentration (1.5 : 200). 
The resUlts are summarised in the following table. 
Table 7.3-1:  Dermal absorption of  XXXX  in different test systems; results are 
expressed as % active ingredient absorbed during 8 and 24 h. 
neat  product  1:100  Reference 
in vivo- rat  8hr  13.1%  62.4%  Weber, 1994 
24 hr  23.6%  60.7% 
in vitro - rat skin  8hr  0.26%  5.18%  Brain eta/, 1994 
24 h  1.69%  26.8~ ~0 
in vitro- human skin  8hr  0.02%  0  10 ° 11  Brain et a/,  1994 
24 hr  0.35%  I K-1  CJII 
From these data,  dennal absorption figures for  "human skin  m  \'J\'(1''  can  be  caJculated,  using the following 
formula:-
in vitro human x in vivo rat 
in vivo human = 
in vitro rat 
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The calculated results obtained are given in the next table:-
Table 7.3-2:  · Dermal absorption of  XXXX 
extrapolated  for human skin in vivo 
neat product  1: 100 
8h  1.0%  3.6% 
24h  -4.9%  4.2% 
It is to be noted that the operator exposure calculations referred to at point 7.2.1, were done using a 5%  dermal 
absorption figure for mixing/loading and application. 
7.4 I 
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The example of  a summary and assessment of  data which follows is intended to illustrate the approach 
recorrunended for the preparation of Tier II surrunaries and assessments:  The material included has not been 
critically assessed for its technical content.  Although based on a real submission, the data included in the 
following summary and evaluation has been amended to protect the corrunercial interests of  the owner of  the 
data. 
Applicant should be aware that these guidelines are intended to provide a degree of  flexibility.  Where in 
particular cases, it is more appropriate to present the data and information in another format. applicants may 
do so.  In sue~ cases it is recommended that the applicant discuss the format proposed with the Competent 
Authority of  the Member State to which application is to be made. 
10.1  Effects on Birds 
Birds and mammals may be exposed to XXXXXX mainly by the consumption of contaminated feed.  The 
expected typical maximum residue levels on leaves, insects and seeds were calculated according to Hoerger and 
Kenaga (1972).  Information relating to crops, application rates and intervals is given in Table 10.1-1.  The 
values of the expected initial residue concentrations of XXXXXX and for the highest possible level of daily 
intake by birds and mammals are provided in Table 1,0.1-2 and 10.1-3. 
To calculate the highest possible level of  daily intake of  XXXXXX by birds and mammals, it was assumed that 
small birds (ca 20 g  bw) consume approximately 30% of their body weight per day, whereas bigger animals 
(>  100 g bw) ingest approximately 10% of  their body weight daily. 
Long term predicted environmental concentrations (PEClt),  were Calculated  as  the  time weighted average 
concentration for the .respective time interval according to the formula 
PEC  = PEC ..  DT50  (1- e<-trln(2)/DTso)) 
I  . 
1  t 1·ln(2) 
where  PECJt  = time  weighted  average  concentration,  PECi  = initial  concentration,  DT50 = half-life  for 
dissipation and t  1  = time period concerned. 
For these calculations, the mean of the measured half-life in plant material of XXXXXX in different crops of 
7.6 days was used (average from 21 studies, RA-reports: XXX. YYY, ZZZ .... ;see Annex II, point 6).  For the 
purposes of the  calculation,  the  application  rates  and intervals  given  in Table  10.1-1  were  used.  That 
application scenario was chosen in order to approach a realistic worst  -case situation relevant to commercial 
practice. 
The estimated time weighted average concentration in green mass was arrived at by extrapolation from  the 
normalized area under the curve for the actual estimated concentration values.  This concept is depicted in 
Figures 10.1-1 and 10.1-2, while the values are given in Tables 10.1-4 and 10.1-5. Appendb: 8 
Company name 
Table 10.1-1: 
Crop 
grapes 
tomatoes 
fruit trees 
berries 
Table 10.1-2 
Target 
culture I crop 
grapes 
tomatoes 
fruit trees 
berries 
-168-
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Crops, application rates and intervals 
Application  mean or highest rate assigned 
(maximum frequency)  g aslha 
3 applications/10d interval  500 
3 applications/1 Od interval  750 
4 applications/1  Od interval  750 
4 applications/10d interval  1000 
Exposure of  birds and mammals 
Application  typical maximum initial residue concentration  (mg as/kg feed) 
rate  according to Hoerger & Kenaga, 1972 
kg aslha  leaves  small insects  diet of  small + bigger  seeds or bigger 
insects  insects 
0.5  15.63  14.73  8.04  1.34 
0.75  23.44  22.10  12.05  2.01 
0.75  23.44  22.10  12.05  2.01 
1.0  31.25  29.46  16.07  2.68 
Table 10.1-3:  Exposure of  birds and mammals 
Target  Application  Maximum daily intake of  as (mglkg bwlday): 
culture I crop  rate  leaves I small insects I  diet of small and bigger insects I seeds or bigger insects 
kg aslha  small animals (ca 20 g bw) *  bigger animals(> 100 g bw) ** 
grapes  0.5  4.69  4.42  2.41  0.40  1.56  1.47  0.80  0.13  '. 
tomatoes  0.75  7.03  6.63  3.62  0.60  2.34  2.21  1.21  0.20 
fruit trees  0.75  7.03  6.63  3.62  0.60  2.34  2.21  1.21  0.20 
berries  1.0  9.38  8.84  4.82  0.80  3.13  2.95  1.61  0.27 
• 
•• 
for small animals (ca. 20 g bw) daily feed consumption of30% of  body weight is assumed, 
for bigger animals{> 100 g bw) daily feed consumption of 10% of  body weight is assumed 
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Spray schedule based on 3 applications with an interval of 10 days in between as used in grapes and tomatoes:-
Table  10.1-4:  Time course ofthe PEC ofXXXXXX  in plant material (example:  half  life 7.6 days) 
I 
(d)  actual concentration  time weighted average 
(% of  initial)  (% of  initial) 
0  100.00  100.00 
1  91.28  95.21 
2  83.33  91.06 
4  69.43  83.47 
5  63.38  80.00 
7  52.81  73.63 
14  97.32  80.70 
21  142.68  82.62 
28  75.35  88.23 
42  21.02  72.95 
60  4.07  54.15 
90  . 0.26  36.56 
91  0.24  36.16 
147  0.00  22.40 
161  0.00  20.46 
360  0.00  9.15 
Figure 10.1-1: Time course of  the PEC of  XXXXXX in plant material (example:  half  life 7.6 days) 
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Spray schedule based on 4 applications with an interval of 10 days in between as used in fruit trees and 
berries:-
page  of 
Table  10.1-5:  Time course of  the PEC of  XXXXXX in plant material (example:  half  life 7.6 days) 
(d)  actual concentration  time weighted average 
(% of  initial)  (% of  initial) 
0  100.00  100.00 
1  91.28  95.21 
2  83.33  91.06 
4  69.43  83.47 
5  63.38  80.00 
7  52.81  73.63 
14  . 97.32  80.70 
21  142.68  82.62 
28  75.35  88.23 
42  54.49  90.45 
60  10.55  71.31 
90  0.68  48.74 
91  0.62  48.21 
147  0.00  29.89 
161  0.00  27.29 
360  0.00  12.21 
Figure 10.1b:  Time course of  the PEC ofXXXXXX  in plant material (example:  half  life 7.6 days) 
% of initial P  EC 
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Guidelines: 
GLP: 
Summaries -Annn Ill  Point 1  0) 
Month and year  Active Substance (Name) 
Acute oral toxicity 
Grau, R. (1995): XXXXXX technical- acute oral toxicity to bobwhite quail. 
Bayer AG, unpublished report No: YYYY 
14 
EPA§ 71-1 
Deviations: Only two dose levels 
yes 
page  of 
Material and methods:  XXXXXX,  purity:  95.7%,  Specification  (see  Annex  II,  point  1),  single  oral 
administration in gelatine capsules without any carrier to adult Bobwhite Quail (26-week-old):  1050 or 2000 
mg as/kg bw; subsequent observation period of 14 days. 
Findings: 
Acute oral toxicity to birds 
Test substance  TGas 
TeSl object  Bobwhite quail (J &  ~ 
LDso mg as/kg bw  >2000 
Lowest observed effect level (LOEL) mg as/kg bw  2000 
Highest tested dose without toxic effect (NOEL) mg as/kg bw  1050 
Toxic threshold effect level, TEL (mean LOEL-NOEL) mg as/kg bw  1449 
Observations: The ~Dso value, the lowest observed effect level (LOEL), and the no effect dose (NOEL) are 
listed in the Table.  The LDso value was determined to be greater than 2000 mg as/kg bw. 
Single oral doses of 1050 and 2000 mg as/kg bw were given.  No mortalities were observed.  The no observed 
effect level (NOEL) was 1050 mg as/kg bw based on·dose dependent statistically significant· differences in body 
weight development over the full observation period in. female birds.  On the basis of visible symptoms, the 
NOEL was ~  2000 mg as/kg bw. 
Gross pathology: No visible effects on body organs were visible at post-rnoncm examination of  birds from the 
2000 mg as/kg bw treatment level. 
Conclusion: XXXXX has no  acute oral toxicity to birds.  In YiC\\ of these findmgs. further studies using the 
formulated product were not conducted 
Risk assessment:  The highest potential  levels  of intake of XXXXXX  by  small  birds are  associated with 
residues on seeds or insects (1: 1 ratio. small and bigger insects).  At application rates between 0.5 and 1.0 kg  · 
aslha the highest likely daily XXXXXX intake by small birds was calculated as 4.82 to 0.4 mg as/kg bw/day 
(Table 10.1-3). Accordingly, the minimum acute toxicity/exposure ratio (TERa = LDsoiETEi) for small birds is 
> 415 (insects) to> 4978 (seeds). 
Larger birds with a body weight.of greater than 100 g, that feed partly on leaves (diet of 10% leaves and 90% 
insects) may be ex"]>Osed to higher residue levels but their body weight/daily feed intake ratio is lower (assumed 
14 The description of  this test, which relates to the toxicity of  the active substance, is repeated here for the convenience of  the reader -172-
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to  be 0.1. or 10%).  In this case.  the TER. for application  rates between 0.5  and 1.0  kg as/ha  is >1137 to 
> 14933 based on intake figures for XXXXXX of 1.76 to 0.13 mg as/kg bw/day (Table 10.1-3). 
The  time  weighted  average  concentration for  a  time  period  of 5  days  is  expected  to  be  80  %  of initial 
concentration (cfTable 10.1-4 and 10.1-5).  On the basis of  diets of90% insects and 10% leaves or of seeds, 
the short term TERst (LC5o/PECsd) for birds is calculated to be> 355 and> 4667, respectively [see Annex II, 
chapter 8.1.2; 5-day dietary for Bobwhite quail and mallard duck LC50 > 5000 mg as/kg feed]. 
The time weighted average concentration  (cfTable 10.1-4 and 10.1-5) for a time period of23 weeks would be 
20.46  or 27.29 % of an initial concentration, based on 3 or 4  repeated applications for the different crops 
concerned.  Based on diets of 90 % insects and 10 % leaves or of seeds, the long term TE~t  (NOEC/PECI6Jd) 
for  birds  is  calculated  to  be between  432  and 7569  [see  Annex  II,  chapter 8.1.3;  23-week  reproduction 
Bobwhite quail NOEC =  2074 mg as/kg feed]. 
Furthermore.  it is  very  unlikely that birds under field  conditions would consume exclusively contaminated 
feed.  Therefore a risk to birds arising from dietary exposure can be excluded. 
10.1.2  Supenised cage or field trials 
Due to the high acute, short term and long term toxicity/exposure ratios (TER.,  TERst.  TE~t) for the active 
substance,  no further studies are considered necessary.  Risks to birds from  residues of XXXXXX can  be 
excluded. 
10.1.3  Acceptance of bait, granules, or treated seeds by birds 
Not applicable for plant protection products intended for application by spraying. 
10.1.4  Effects of secondary poisoning 
-Use of plant protection products containing active substances having a high bioaccumulation potential could 
theoretically result in risks for birds as a result of secondary poisoning.  The steady state bioconcentration 
factor for XXXXXX in a laboratory study with bluegill sunfish (whole fish), was determined to be in the range 
of 132-185 (mean 159,  see Annex II,  paragraph 8.2.3).  The initial aquatic PEC, based on 1m and 30 em 
water depth and different drift rates of 0.6-1.5 %,  is in the range of 0.45 to  3.75  flg asiL (cfTable 10.2-1). 
Theoretically, maximum concentrations in fish could, for a short time, reach a level of  about 0.072-0.596 mg 
as/kg (PEC - values multiplied by the mean BCF of 159).  Based on the acute toxicity for birds of XXXXXX 
(LDso of> 2000 mg as/kg bw- cfparagraph 10.1.1), the maximum concentration in fish of 0.072-0.596 mg 
t;tslkg and the assumption of a daily feed intake of 10 % of the body weight, the TER. was calculated to be > 
279525 to> 33543.  For short term exposure, a TERst  of> 69881 to> 8386 was calculated, based on the LC50 
for birds of >5000 mg as/kg feed  (see Annex II, paragraph 8.1.2) and on XXXXXX concentrations of 0.072-
0.596 mg as/kg fish. 
In conclusion, a risk to birds as a consequence of  the bioaccumulation of  XXXXXX does not arise. 
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10.2  Effects on aquatic organisms 
Aquatic organisms may be exposed to plant protection products as a result of  emissions from treated fields. The 
studies and date provided permit a risk assessment to be generated relevant to exposure to XXXXXX under 
practical conditions of  use of  plant protection products containing the compound. 
PECsw in standing water bodies 
15 
The initial maximum PEC value (PECi) was calculated on the basis of spray drift rates established for different 
crops by the German BBAIUBA (Ganzelmeier eta, 1995), for water depths of 0.3  and 1.0 min a standing 
water body. 
Relevant  information with respect to  crops,  application  rates  and intervals  is provided in Table  10.1-1. 
Assuming  first  order  kinetics  for  decline  in  concentrations,  longer  tenn  predicted  environmental 
concentrations  (PEC1)  were  calculated as the time weighted  average  concentration for  the  respective  time 
interval from first application onwards (cfTable 10.2-1). 
If  in such a scenario, the drift assumptions developed by  the German BBAIUBA are used (95  percentile of 
single point values in a water body),  the probability of reaching (or exceeding) the predicted concentrations 
after all applications will drop from 0.05 (5  % or once in 20 years) after 1 application to· 0.0025 (0.25 % or 
once in 400 years) after 2 applications and to 0.000125 (0.0125 %) after 3 applications. 
The time weighted average (TWA) was calculated according to the fonnula 
PEC =  PEC.  DT50  (1-e<-trln(2)/DT5o)) 
/ 
1  f1 •lfl(2) 
where  PEC1  = time  weighted  average  concentration,  PEC;  = initial  concentration,  DT50 = half-life  of 
dissipation and t  1  = considered time period. 
For these calculations, the half-life measured in the supernatant water of  the two water sediment studies 
reported (mean: 2.1 d =  50.4 h) was used (Brumhard, 1997). 
The  estimated  time  weighted  average  concentration  in  water  was  arrived  at  by  extrapolation  from  the 
normalized area under the curve for the actual estimated concentration values.  This concept  is depicted in 
Figures 10.2-1 and 10.2-2, while the values given in Tables 10.2-2 and 10.2-3. 
I  "  The PEC calculations provided in Ibis Annex m  Tier II  SUIIIIIIIIY. at point 9  .2. ..............  bore for the convenience of  the reader Appendb8 
Company name 
Table 10.2-1: 
Crop 
grapes  * 
tomatoes 
fruit trees * 
berries  o 
Format for the CompUation of  Tis II 
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Exposure of  aquatic organisms - ground application #  (standing water =worst case) 
Distance  Drift  Application rate  Portion of  drift  initial PECsw 
(m)  (o/o)  (as)  (as)  (Jtg  as/L) 
related to a water depth of 
kglha  mg/m2  kg/ha  mg/m2  lm  30cm 
10  1.5  0.500  50.0  0.008  0.750  -0.75  2.50 
5.  0.6  0.750  75.0  0.005  0.450  0.45  1.50 
20  1.5  0.750  75.0  0.011  1.125  1.13  3.75 
15  0.8  1.000  100.0  0.008  0.800  0.80  2.67 
# Ganzelmeier eta/, 1995  *  late growth stages  o more than 50 em high 
PECsw in slow moving water bodies 
15 
The initial concentration calculated for the purposes of risk assessment with respect to stagnant waters was 
based on measured drift rates (Ganzelmeier eta/, 1995).  The data are generally above the 95-percentile of 
downwind measured values and therefore represent a  worst-case  situation,  which can only be expected in· 
exceptional cases.  For the purposes of calculation it was also assumed that drift reaches standing shallow 
waters or the benches of  larger surface waters without water exchange or circulation. 
For the calculation of long-term  exposure  the  time  weighted  average  concentration,  taking  into  account 
degradation in aqueous systems, is provided.  This time weighted average concentration depends not only on 
the initial  concentration but also  on the half-life value of the substance in the water column of a  water-
sediment-system.  It must be emphasized that the use of  2 or 3 times the highest concentration (95 percentile) 
in a spray sequence is an unrealistic worst case (probability about zero).  This scenario is exceptionally used 
pending the availability of  more realistic calcuhttion methods which are under development. 
In principle the same assumptions are valid for moving waters.  Following similar levels of  contamination the 
half-life in moving waters· is  necessarily lower than in standing waters.  as in  addition  to  degradation and 
adsorption (e.g.  into the sediment) dilution occurs (inflow).  In addauon. exposure at the location observed is 
quickly diminished, since the contaminated water is carried fomard t outflo\\ )  .  Therefore both the extent and 
duration of  exposure are reduced, the faster the waters are mO\lng 
Consequently exposure in stagnant waters is regarded as the worst case  C  orrcsponding exposure calculations 
for moving waters always provide a more favourable result at equaJ  IC\ cis of contamination.  If  exposure, as 
calculated for  standing waters, does  not result  in any unacceptable  effects.  no  unacceptable effects  can be 
assumed in the case of moving waters.  Therefore the calculation of exposure in moving waters is deemed to 
be unimportant for the purposes of. risk assessment. 
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Spray schedule based on 3 applications with an interval of I  0 days in between as used in grapes and tomatoes 
(+remark on probability, point 10.2):-
Table  10.2-2:  Time course ofthe PEC ofXXXXXX  in  water (example: half  life 2.1 days) 
(d)  actual concentration  time weighted average 
(% of  initial)  (%of  initial) 
0  100.00  100.00 
1  71.89  84.01 
2  5i.68  72.20 
4  26.71  54.75 
5  19.20  48.29 
7  9.92  38.45 
14  27.69  37.37 
21  74.63  32.86 
28  7.40  31.82 
42  0.07  21.74 
58  0.00  15.74 
96  0.00  9.51 
. 
147  0.00  6.21 
Figure 10.2-1:  Time course ofthe PEC ofXXXXXXin water (example: half  life 2.1 days) 
% of initial PEC 
120.-------------------------------------------------------
- - -titre weighted,average 
100+---------------------4---------------------4----------------~  ~---------
--actual  concentration 
0  5  10  IS  20  25  30  35  40  45  so  55  60 
days -176-
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Spray schedule based on 4 applications with an interval of I 0 days in between as used in fruit trees and berries. 
(see remark on probability, point 10.2):-
Table  10.2-3:  Time course ofthe PEC ofXXXXXX  in  water (example: half  life 2.1 days) 
(d)  actual concentration  time weighted average 
(% of  initial)  (% of  initial) 
0  100.00  100.00 
1  71.89  84.01 
2  51.68  72.20 
4  26.71  54.75 
5  19.20  48.29 
7  9.92  38.45 
14  27.69  37.37 
21  74.63  32.86 
28  7.40  31.82 
42  1.98  28.91 
58  0.01  21.04 
96  0.00  12.71 
147  0.00  8.30 
Figure 10.2-2:  Time course of  the PEC of  XXXXXX in  water (example: half  life 2.1 days) 
% of initial P  EC 
lWy---------------------------r================!---
- - -tiire weighted average 
100 +-----+-----4-------&------J  ---actual  concentration 
0  5  10  15  20  25  30  35  40  45  50  55  60 
days 
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Company name  Month and year  Active Substance (Name} 
10.2.1  Acute toxicity to fish, aquatic invertebrates or effects on algal growth 
Acute toxicity to fish 
Report: 
Guidelines: 
GLP: 
Dorgerloh, M.(1996):XXXXXX WG 50- Acute toxicity (96 hours) to rainbow trout 
(Oncorhynchus mykiss) in a semi-static test. 
Bayer AG, unpublished report No: YYYY 
OECD 203 and EEC C.1 
Deviations: none 
yes (certified laboratory) 
page  of 
Material and methods:  XXXXXX  WG  50,  purity:  49  %,  Specification:  (Batch  No.:  0222  based  on 
04258/0214, Development No.:  170928),  rainbow trout (Oncorhynchus mykissl lot F3/ 96):  10 fish per test 
concentration (mean body length 4. 7 em, mean body weight 1.2 g) for 96 h under semi-static conditions. 
Findings: 
Toxicity to fish 
Test substance  50WG 
Test object  rainbow trout 
Exposure  96h, semi-static 
LCso mg as/L  1.30 
lowest tested cone. with effect (LOEC) mg as/L  0.92 
highest tested cone. without effect (NOEC) mg as/L  0.46 
Threshold effect concentration, TEC (mean LOEC-NOEC) mg as/L  0.65 
Observations:  The results are provided in summary form  in the Table.  Nominal test substance 
concentrations ranged from 0.94 to 15.0 mg/L.  Analytical data showed mean measured levels from 91-96% of 
the nominal values, so nominal values were used in reporting results.  The 96-hour LC50,  NOEC and LOEC 
values were 2.66, 0.94 and 1.88 mg test substance/L, equivalent to 1.30, 0.46 and 0.92 mg as/L respectively. 
In comparison to these results the LCso and NOEC values found in a similar test on rainbow trout but using 
XXXXXX t~chnical as were 1.24 and 0.94 mgas/L respectively  (cf  Annex II, paragraph 8.2.1). 
Conclusion:  XXXXXX 50 WG is of moderate toxicity to rainbow trout. 
Risk assessment:  The PECi varies depending on distance from and the depth of the water body.  For 
the use pattern presented in Table 10.1-1 and the distances from water body as well as the resulting drift rates 
presented in Table 10.2-1, initial concentrations of  between 0.45 and 3.75 IJ.g as/L for 1 m and for 30 em water 
depths were calculated (Table 10.2-1).  ,On the basis of the acute LC5o value for fish (1.3  mg as/L) and the 
PECi. acute TERs between 2889 and 347 were derived. 
The chronic toxicity of XXXX:XX technical, to early life stages of rainbow trout was detennined under flow-
through test conditions with a study duration of 96 days (cf  Annex II, paragraph 8.2.2.2).  The lowest NOEC 
for XXXXXX technical was found to be  101  11g  as/L,  on the basis of the most sensitive end point (time to 
S\\im-up). -178-
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Concentrations in natural water bodies decrease over time (cfFigures 10.2-1  and 10.2-2).  Consequently the 
PEClt for a specified time period (e.g.  duration of  the test) will be lower than the PECj (cfTables 10.2-1, 10.2-
2 and  10.2-3).  The time weighted average concentration for  the exposure period of the chronic test was 
calculated to  b~ 9.51  or 12.71  %of the initial PEC, based on 3 or 4  repeated applications for the different 
crops.  Accordingly, a long tenn TER (NOEC/PEC96d) for fish of212 to 2360 can be derived. 
Acute toxicity to Daphnia magna 
Report:  Heimbach, F.  (1995): Acute toxicity ofXXXXXX WG 50 to waterfleas (Daphnia magna). 
Bayer AG, unpublished report No: YYYY 
Guidelines:  OECD 202 and EPA;.fiFRA 72-2 
Deviations: none 
GLP:  yes (certified laboratory) 
Material and methods:  XXXXXX WG 50,  purity:  49.6 %,  Specification (Batch No.:  0222 according to 
4258/0214); first instars of Daphnia magna (< 24  h  old)  in a  static test system were exposed for 48  h  to 
nominal concentrations ranging from 2.02 to 202 mg fonnulation./L. 
Findings: 
Test substance  50WG 
Test object  Daphnia magna 
Exposure  48h, static 
ECso mg as/L  105 
lowest tested cone. with effect (LOEC) mg as/L  32 
highest tested cone. without toxic effect (NOEC) mg as/L  18 
Threshold effect concentration, TEC (mean LOEC-NOEC) mg as/L  24 
Obsenrations:  The results are provided in summaJ!  fonn  an  the Table.  Analytical data showed 
measured levels from 103- Ill% of nominal.  Nominal values \\Crc  therefore usc in  reporting results.  The 
48-hour ECso value for Daphnia magna exposed to XXXXXX WG  50 \\as 211  mgll. test substance, equivalent 
to 105 mg as/L.  The NOEC and LOEC values were 36 and 65 mg/L test  substance. equivalent to 18 and 32 
mg as/L. 
In comparison to the ECso and NOEC values found in a similar test on watcrflcas using XXXXXX technical as 
(> 18.8 and 10.1  mg as/L  respectively;  Annex II,  paragraph 8.2.4)  there  is  vel)'  close agreement with the 
values from the 50 WG study. 
Conclusion:  XXXXXX WG 50 has a low acute toxicity to Daphnia magna. 
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Risk assessment:  The PECi varies depending on distance from and the depth of  the water body.  For 
the use pattern presented in Table 10.1-1 and the distances from water body as well as the resulting drift rates 
presented in Table 10.2-1. initial concentrations between 0.45 and 3.75  JA,g asiL for 1 m and for 30 em water 
depth were calculated (cfTable 10.2-1).  On the basis of  the acute ECso value for Daphnia (105 mg as!L) and 
the PECi, acute TERs between 233333 and 28000 can be derived. 
The effect of XXXXXX technical on the reproduction of water fleas was determined in a  21-days laboratory 
study under semistatic test conditions (cf  Annex II, paragraph 8.2.5).  The highest concentration tested which 
was without toxic effect (NOEC) was 1.0 mg as!L. 
Concentrations in natural water bodies decrease over time (cfFigures 10.21  and 10.2-2).  Consequently the 
PEClt for a specified time period (e.g. duration of  the test) will be lower than the PECi (cfTables 10.2-l, 10.2-
2  and 10.2-3).  The time weighted average  concentration for  the exposure  period of the chronic test is 
calculated to be 32.86% of  the initial PEC value.  Accordingly, a long term TER (NOEC/PEC2td) for Daphnia 
of812 to 6763 can be derived. 
Effects on algal growth 
Report:  Anderson, J.P. E. (1995):Influence of:XXXXXX WG 50 on the growth of  the green alga, 
Selenastrum capricornutum. 
Guidelines: 
GLP: 
Bayer AG, unpublished report No: YYYY 
OECD 201, EEC Directive 79/831/E, ISO 8692 
Deviations: None 
yes (certified laboratory) 
Material and methods: XXXXXX WG 50, purity: 49.6 o/o,  Specification (Batch No.: 0222 after 4258/0214)~ 
Selenastrum capricornutum (strain 61.81) under static conditions (shake cultures) were exposed for 72 h  to 
concentrations (nominal) from 1.00 to 56.0 mg /L. 
F"  d"  10  mgs: 
Test Substance  50WG 
Test Object  Selenastrum capricornutum 
Exposure  72h,static 
ErCso (growth rate) mg asiL  5.52 
lowest tested cone. with effect (LOErC) mg asiL  0.89 
highest tested cone. without toxic effect (NOErC) mg asiL  0.50 
Toxic threshold effect concentration (mean LOEC-NOEC) mg asiL  0.66 
Obsenrations:  The results are provided in summary form in the Table.  Analytical data showed 
that the measured levels about 99 % of nominal, so nominal values were used in reporting results.  The 72-
hour ErCso was 5.52 mg as!L.  The NOEC and LOEC values were 0.5 and 0.89 mg as!L. 
Conclusion:  XXXXXX WG 50 is moderately toxicity to Selenast"'!m. Appendb:8 
Company name 
· Fonnatror the CompUation of  Tier II 
Summaries - Anne1 Ill 
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Risk assessment:  PECi values vary depending on distance from and the depth of  the water body.  For 
the use pattern presented in Table 10.1-1 and the distances from water body as well as the resulting drift rates 
presented in Table 10.2-1, initial concentrations ofbetween 0.45 and 3.75 J,tg asiL for 1 m and for 30 em water 
depth were calculated (c[Table 10.2-1).  On the basis of the growth rate EC50 value for algae (5.52 mg as/L) 
and the PECi value, acute TERs between 12267 and 1472 can be derived.  · 
The algae test is a chronic test with a short term exposure period.  Thus the TERst is deemed the appropriate 
figure for the formal  hazard assessment.  However,  in the case of XXXXXX,  the consideration the acute 
situation demonstrated safety factors high enough to exclude potential risks.  Therefore it can be concluded 
that a more detailed risk assessment is not necessary. 
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APPENDIX9 
FORMAT FOR THE LISTING OF END POINTS TO BE INCLUDED IN THE TIER Ill OVERALL 
SUMMARY AND ASSESSMENT 
16 
Chapter 1:  Identity, Physical and Chemical Properties, Details of Uses, Further Information, 
and Proposed Classification and Labelling  ·  · 
Active substance (ISO Common Name) 
Function (e.g.  fungicide) 
Rapporteur Member State 
Identity (Annex llA, point 1) 
Chemical name (IUP  AC) 
Chemical name (CA) 
CIPACNo 
CAS No 
EEC No (EINECS or ELINCS) 
F  AO Specification (including year of  publication) 
Minimum purity of  the active substance as 
manufactured (glkg) 
·  Identity of relevant impurities (of  toxicological, 
environmental and/or other significance) in the 
active substance as manufactured (glkg) 
Molecular formula 
Molecular mass 
Structural formula 
16  Other end points will be relevant in particular cases - decisions as to the additional end points to be included can onJy be made on a case by 
case basis. -182-
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Company name  Month and year  Active Substance (Name)  page  or 
Physical-chemical properties (Annex IIA, point 2) 
Melting point (state purity) 
Boiling point (state purity) 
Temperature of  decomposition 
Appearance (state purity) 
Relative density (state purity) 
Surface tension 
Vapour pressure (in Pa, state temperature) 
Henry's law constant (Pa m
3 mol-
1
) 
Solubility in water (gil or mgll, state temperature) 
Solubility in organic solvents (in gil or mgll, state 
temperature) 
Partition co-efficient (log Pow) (state pH and 
temperature) 
Hydrolytic stability (DT  so) (state pH and 
temperature) 
pH __  : 
~------------------------------- pH __  : 
~------------------------------- pH __  : 
--------------------------------
--------------------------------
pH __  : 
~------------------------------- pH __  : 
~------------------------------- pH __  : 
pH __  : 
~------------------------------- pH __  : 
I 
,.. 
I 
• 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
~pH~~------------------------- I 
Dissociation constant 
UVNIS absorption (max.) (if  absorption> 290 nm 
states at wavelength) 
Photostability (DT  so) (aqueous, sunlight, state pH) 
Quantum yield of direct phototransformation in 
water at A. > 2  90 nm 
Flammability 
Explosive properties 
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Appendb9  . Fonnat For The Listina Of  End Points to be Included in the Tie Ill  Overall Summary And Assessment 
Compan,- name  Month and year  Active Substance (Name) 
Classification and proposed labelling (Annex IIA, point 10) 
with regard to physical/chemical data 
with regard to toxicological data 
with regard to fate and behaviour data 
with regard to ecotoxicological data 
Chapter 2:  Methods of Analysis 
Analytical methods for the active substance (Annex llA, point 4.1) 
Technical as (principle of  method) 
Impurities in technical as (principle of  method) 
Plant protection product (principle of  method) 
Analytical methods for residues (Annex llA, point 4.2) 
Food/feed of  plant origin (principle of  method and 
LOQ for methods for monitoring purposes) 
Food/feed of  animal origin (principle of  method 
and LOQ for methods for monitoring purposes) 
Soil (principle of  method and LOQ) 
Water (principle of method and LOQ) 
Air (principle of method and LOQ) 
Body fluids and tissues (principle of  method and 
LOQ) 
page  of 
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Appendi19  Fonnat For The Listing Of  End Points to be Included in the Tier Ill  OveraU Summary And Assessment 
Company name  Month and year  Active Substance (Name) 
Chapter 3:  Impact on Human and Animal Health 
Absorption, distribution, excretion and metabolism in mammals (Annex IIA, point 5.1) 
Rate and extent of absorption: 
Distribution: 
Potential for accumulation: 
Rate and extent of excretion: 
Metabolism in animals 
Toxicologically significant compounds (animals, 
plants and environment) 
Acute toxicity (Annex IIA, point 5.2) 
Rat LDso oral 
Rat LDso dennal 
Rat LCso inhalation 
Skin irritation 
Eye irritation 
Skin sensitization (test method used and result) 
Short term toxicity (Annex IIA, point 5.3) 
Target I critical effect 
Lowest relevant oral NOAEL I NOEL 
Lowest relevant dennal NOAEL I NOEL 
Lowest relevant inhalation NOAEL I NOEL 
Genotoxicity (Annex IIA, point 5.4) 
page  of -186-
Appendix 9  Fonnat For The Listing or  End Points to be Included ln the Tier Ill Ovenll Summary And Assessment 
Company name  Month and year  Active Substance (Name) 
Long term toxicity and carcinogenicity (Annex IIA. point 5.5) 
Target/critical effect 
Lowest relevant NOAEL I NOEL 
Carcinogenicity 
-Reproductive toxicity (Annex IIA, point 5.6) 
Reproduction target I critical effect 
Lowest relevant reproductive NOAEL I NOEL 
Developmeptal target I critical effect 
Lowest relevant developmental NOAEL I NOEL 
Neurotoxicity I Delayed neurotoxicity (Annex IIA, point 5.7) 
page  or 
................................  ;  ..............................................  ~I  -------~ 
Other toxicological studies (Annex IIA, point 5.8) 
............................................................................... 1~-------J 
Medical data (Annex IIA, point 5.9) 
............................................................................... 
~------------------------------------~ 
Summary (Annex IIA, point 5.10) 
ADI 
AOEL 
Drinking water limit 
ARID (acute reference dose) 
Dermal absorption (Annex IliA, point 7.3) 
Value  Study  Safety factor 
............................................................................... 1....____ ___  -----J 
Acceptable exposure scenarios -(including method of calculation) 
Operator 
Workers 
Bystanders 
I 
• 
I 
• 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
·I· 
I 
I 
I 
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I 
I 
I 
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Appendix 9  · Fonnat For The Listing Of  End Points to be Included in the Tier Ill Overall Summary And Assessment 
Company name  Month and year  Active Substance (Name) 
Chapter 4:  Residues 
Metabolism in plants (Annex IIA, point 6.1 and '6.7, Annex IliA, point 8.1 and 8.6) 
Plant groups covered 
Rotational crops 
Plant residue definition for monitoring 
Plant residue definition for risk assessment 
Conversion factor (monitoring to risk assessment) 
Metabolism in livestock (Annex IIA, point 6.2 and 6.7, Annex IliA, point 8.1 and 8.6) 
Animals covered 
Animal residue definition for monitoring 
Animal residue definition for risk assessment 
Conversion factor (monitoring to risk assessment) 
Metabolism in rat and rumi~t  similar (yes/no) 
Fat soluble residue: (yes/no) 
Residues in succeeding crops (Annex IIA, point 6.6, Annex IliA, point 8.5) 
page  of 
........ ,  ...................................................................... 1.___ ____  ____,1· 
Stability of residues (Annex IIA, point 6 introduction, Annex IliA, point 8 introduction) 
............................................................................... ! 
~------------------------------------~ 
Residues from livestock feeding studies (Annex IIA, point 6.4, Annex IliA, point 8.3) 
Intakes by livestock ~  0.1 mglkg diet/day: 
Muscle 
Liver 
Kidney 
Fat 
Milk 
Eggs 
Ruminant:  I 
Poultry: 
yes/no  yes/no  J 
Pig: 
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Appendix 9  · Fonnat For The Listing Of  End Points to be Included In the Tie III  OveraU Summary And Assessment 
Company name  Month and year  Active Substance (Name) 
Consumer risk assessment (Annex IIA, point 6.9, Annex IliA, point 8.8) 
ADI 
TMDI (European Diet) (% ADI) 
NEDI (%ADI) 
Factors included in NEDI 
ARID 
Acute exposure (% ARID) 
Processing factors (Annex IIA, point 6.5, Annex IliA, point 8.4) 
Crop/processed crop  Number of  studies  Transfer factor 
page  of 
% Transference * 
*  Calculated on the basts of  distnbution m the different portions, parts, or products as determined through 
balance studies 
Proposed MRLs (Annex IIA, point 6.7, Annex IliA, point 8.6) -190-
Appendix 9  .  Fonnat For  The Ustin1 or  End Points to be Included in the Tie Ill  OveraU Summary And Assessment 
Company name  Month and year  Active Substance (Name) 
ChapterS:  Fate and Behaviour in the Environment 
Route of degradation (aerobic) in soil (Annex IIA, point 7.1.1.1.1) 
Mineralization after 190 days 
Non-extractable residues after 100 days 
Relevant metabolites - name and/or code, % of 
applied (range and maximum) 
Route of degradation in soil- Supplemental studies (Annex IIA, point 7.1.1.1.2) 
Anaerobic degradation 
Soil photolysis 
Rate of degradation in soil (Annex ITA, point 7  .1.1.2, Annex ITIA, point 9  .1.1) 
Method of calculation 
Laboratory studies (range or median, with n value, 
with ~  value) 
Field studies (state location, range or median with 
n value) 
Soil accumulation and plateau concentration 
Soil adsorption/desorption (Annex ITA, point 7.1.2) 
.KriKoc 
Kt 
pH dependence (yes I no) (if  yes type of 
dependence) 
DTsOlab (20°C, aerobic): 
DT  90lab (20°C, aerobic): 
DT  sOiab (1 ooc, aerobic): 
DT  solab (20°C, anaerobic): 
degradation in the saturated zone: 
DTsor: 
DT9or: 
Mobility in soil (Annex ITA, point 7.1.3, Annex IliA, point 9.1.2) 
Column leaching 
Aged residues leaching 
Lysimeter/ field leaching studies 
page  or 
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Appendu9  . Fonnat For The Listing Of  End Points to be Included In the Tie Ill  OveraU Summary And Assessment 
Company name  Month and year  Active Substance (Name) 
PEC (soil) (Annex IliA, point 9.1.3) 
Method of calculation 
Application rate 
Single 
application 
Single 
application 
Actual  Time weighted 
average 
Initial 
Short term  24h 
2d 
4d 
Long term  7d 
28d 
50d 
lOOd 
Route and rate of degradation in water (Annex ITA, point 7.2.1) 
Hydrolysis of  active substance and relevant 
metabolites (DT50)  (state pH and temperature) 
Photolytic degradation of active substance and 
relevant metabolites 
Readily biodegradable (yes/no) 
Degradation in  - DT  50 water 
water/sediment  - DT  90 water 
- DT  5o whole system 
- DT  9o whole system 
Mineralization 
Non-ex1ractable residues 
Distribution in water I sediment systems (active 
substance) 
Distribution in water I sediment systems 
(metabolites) 
pH __  : 
pH __  : 
pH __  : 
page  of 
Multiple  Multiple 
application  application 
Actual  Time weighted 
average -192-
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Company name  Month and year  Active Substance (Name) 
PEC (surface water) (Annex IliA, point 9.2.3) 
Method of  calculation 
Application rate 
Main routes of  entry 
PECcsw)  Single 
application 
Single 
application 
Actual  Time weighted 
Initial 
Short tenn  24h 
2d 
4d 
Longtenn  7d 
14d 
2ld 
28d 
42d 
PEC (sediment) 
Method of  calculation 
Application rate 
PEC<sed) 
average 
Single  Single 
application  application 
Actual  Time weighted 
Initial 
Short tenn 
Long tenn 
PEC (ground water) (Annex IliA. point 9.2.1) 
Method of  calculation and type of  study (e.g. 
modelling, monitoring, lysimeter ) 
Application rate 
average 
par:e  or 
Multiple  Multiple 
application  application 
Actual  Time weighted 
average 
Multiple  Multiple 
applicatiOn  application 
Acaual  Time weighted 
average 
I  .. 
I 
• 
I 
I 
I 
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Company name  Month and year  Active ~ubstance  (Name) 
PEC(gw) 
Maximum concentration 
Average annual concentration 
Fate and behaviour in air (Annex IIA, point 7.2.2, Annex III, point 9.3) 
Direct photolysis in air 
Quantum yield of direct phototransformation 
Photochemical oxidative degradation in air 
Volatilization 
PEC (air) 
Method of  calculation 
PEC<a> 
Maximum concentration 
Definition of the Residue (Annex IIA, point 7.3) 
Relevant to the environment 
I 
Monitoring data, if available (Annex IIA, point 7.4) 
Soil (indicate location and type of study) 
Surface water (indicate location and type of study) 
Ground water (indicate location and type of  study) 
Air (indicate location and type of study) 
Latitude: ............. 
from plant swfaces: 
from soil: 
page  of 
Season: .................  DTso .............. -194-
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Company name  Month and year  Active Substance (Name) 
Chapter 6:  Effects on Non-target Species 
Effects on terrestrial vertebrates (Annex IIA, point 8.1, Annex IliA, points 10.1 and 10.3) 
Acute toxicity to mammals 
Acute toxicity to birds 
Dietary toxicity to birds 
Reproductive toxicity to birds 
Toxicity/exposure ratios fo~  terrestrial vertebrates (Annex.IIIA, points 10.1 and 10.3) 
Application 
rate 
(kg aslha) 
Crop  Category 
(e.g.  insectivorous 
bird) 
Time-scale  TER 
Toxicity data for aquatic species (most sensitive species of each group) (Annex llA, point 8.2, 
page  of 
Annex VI 
Trigger 
Annex lliA, point 10.2) 
Group  Test substance  Time-scale  Endpoint  Toxicity 
(mg/1) 
--~~~~~!~!.Y.  ..  ~~-~~---····················· ··············································  ······································  ......................................................... ································ 
··Mi~~~c;~~~-~~-;~~~~~~-i~~~-.........................................  ······································  ························································· ································ 
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I 
I 
• 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I I 
~ 
I 
• 
I 
I 
I 
I 
I 
I 
I 
I. 
I 
I 
I 
I 
I 
I 
I 
I 
I 
-195-
Appendix 9  Fonnat For The Listing Of  End Points to be Included in the Tier Ill  Overall Summary And Assessment 
Company name  Month and year  Active Substance (Name) 
Toxicity/exposure ratios for the most sensitive aquatic organisms (Annex IliA, point 10.2) 
Application 
rate 
(kg aslha) 
Bioconcentration 
Crop 
Bioconcentration factor (BCF) 
Organism 
Annex VI Trigger for the bioconcentration factor 
Clearance time (CTso) 
(CT9o) 
Level of residues (%) in organisms after the 14 day 
depuration phase 
Time-scale  Distance 
(m) 
Effects on honeybees (Annex IIA, point 8.3.1, Annex IliA, point 10.4) 
TER 
page  of 
Annex VI 
Trigger 
Acute oral toxicity 
Acute contact toxicity  _·~-----1 -----1 
Hazard quotients for honey bees (Annex IliA, point 10.4) 
Application rate  Crop  Route  Hazard quotient  Annex VI 
............  ~8..!!~2  ............ ····················-····························  .........................................................................................................  !~88~!:  ................. . 
..  ~!!~~r.~~C?.ry  ..  ~~-~......... ..................................................  .  ..................................................................................... ····················································· 
·····•························.···························•·····•·•····•··•········•············  ...........................................................................................................................................  . 
Field or semi-field tests  .......................................................................................................................................................................................................................................................... -196-
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Effects on other arthropod species (Annex IIA, point 8.3.2, Annex IliA. point 10.5) 
Species  Stage  Test  Dose  Endpoint  Effect  Annex VI 
·  Substance  (kg as/ha)  Trigger 
--~-~~.Q!~!.~!:Y.  ..  !~.~~............................  ...............................  ...............................  ............................... .............................................  .. ......................... . 
................................ .................................  ................................  ...............................  ............................... ............................................. .  .....  ~ ................... . 
Field or semi-field tests 
Effects on earthworms (Annex ITA, point 8.4, Annex IliA, point 10.6) 
Acute toxicity 
Reproductive toxicity  .It---------1 
Toxicity/exposure ratios for earthworms (Annex IliA, point 10.6) 
Application rate  Crop  Time-scale 
(kg as/ha) 
TER  Annex VI 
Trigger 
.......................................................................................................................................................................................................................................  : ........... . 
Effects on soil micro-organisms (Annex IIA. point 8.5. Annex IliA, point 10.7) 
Nitrogen mineralization 
Carbon mineralization  r------------11 
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APPENDIX 10 
FORMAT FOR THE COMPILATION OF TIER Ill SUMMARIES AND OVERALL ASSESSMENTS 
1.1  Identity 
1.2 
1.3 
1.4 
2 
3 
3.1 
All  the  Annex  IIA  points  (active  substance)  and  IliA  points  (XXXXI,  XXXX2  and  XXXX3 
formulations) concerned have been addressed in the relevant Tier 11  Section 1 summaries. 
Physical and chemical  properties 
XXXX  is  an abc  fungicide  which  can  be  formulated  as  an  emulsifiable  concentrate,  suspension 
concentrate or wettable powder.  Data submitted on the active substance show no evidence of adverse 
physical and chemical properties although the compound is  highly photolabile in air and aqueous 
media.  Data submitted on the formulations indicate that they are stable under the accelerated storage 
conditions used (i.e.  do not appear to be photo  labile as formul~ted products in commercial packaging) 
although no data on shelf life are presently available. 
Details of  uses and  further information 
All the Annex IIA and IDA points concerned have been addressed in the Tier II Section 1 summaries. 
Classification and labelling 
Methods of  analysis 
Adequate  methodology  exists  for  the  determination  of XXXX  in  the  technical  substance,  pl(\Ilt 
protection products, plants, soil, water and products of animal origin.  Full details are provided in 
section 2 of the Annex II and Annex III Tier II summaries.  Some further data on the validation of 
these methods is required. 
Impact on human and animal health 
Effects having relevance to  human and animal health arising from exposure to  the active substance 
or to impurities contained in the active substance or to their transformation products 
XXXX and/or its metabolites have been shown to be rapidly and extensively absorbed,  metabolised, 
distributed and eliminated, following oral gavage dosing of rats.  Elimination was principally in the 
faeces  as a  ~esult of biliary excretion.  XXXX was poorly absorbed dermally in monkeys,  but was 
slightly better absorbed from formulations tested in rabbits.  There would appear to be a number of 
metabolic pathways yielding a large number of metabolites (see Figure 1  ). 
Figure 1  Metabolic pathways for XXXX in animals, plants, soil and water 
(pro memoria) - 198-
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XXXX is of  low acute toxicity by the oral and dermal routes.  XXXX may also be of low acute toxicity 
by the inhalation route but the available evidence is not conclusive.  The acute oral LDso value was 
**** mglkg bw for rats and > **** mglkg bw for mice.  The acute dermal LDso value was > **** 
mglkg bw for rabbits.  No deaths or overt signs of  toxicity were noted in rats exposed (nose only) to a 
solid particulate aerosol of* mg/1 (mass median aerodynamic diameter of 12  J.Lm). 
In according with the EU classification criteria, XXXX is neither a skin nor eye irritant - standard 
tests with rabbits.  It was found  not to  be  a  skin sensitizer when tested  using the  maximisation 
method of  Magnusson and Klingman. 
Following repeated dietary exposure of  rats for 3 months, there was some evidence of  toxicity (slightly 
reduced body weight gain in males and slightly increased fatty change in some animals) at the highest 
dose tested, **** ppm.  There was also evidence of hepatic enzyme induction at lower dose levels. 
The overall NOAEL was*** ppm (equivalent to approximately*** mglkg bw/day). 
Histological evidence of toxic effects in the liver and kidney (principally fatty change) was observed, 
as well as hepatic enzyme induction was observed in mice, following dietary administration of up to 
**** ppm XXXX for 3 months.  On the basis of  histological evidence of hepatic toxicity at *** ppm 
.and above, the NOAEL was found to be *** ppm (equivalent to approximately ** mglkg bw/day). 
XXXX was administered orally in gelatine capsules to dogs for up to 12 months.  No evidence of 
systemic toxicity was seen when doses up to  **  mglkg bw/day were administered for 3  months. 
Following administration of  up to *** mglkg bw/day for 12 months the principal adverse finding was 
mild bile stasis in a small number of  dogs at the top dose, an effect which was still present at the end 
of the 3-month recovery period.  ·There was also evidence of hepatic enzyme induction in animals 
administered with ***  mglkg bw/day.  The NOAEL in the  12  month dog study was ***  mglkg 
bw/day. 
Following repeated dermal application of**** mglkg bw/day to rabbits for 21  consecutive days, no 
treatment related adverse systemic effects, or effects at the site of  application, were noted. 
Long-term toxicity and carcinogenicity studies were conducted in ·rats and mice.  The liver was found 
to be the principle target organ, with fatty  change being the main finding.  Rats were the more 
sensitive species with an overall NOAEL for rats of **  ppm. (equivalent to  ***  mglkg bw/day),  in 
contrast to the NQAEL for mice of*** ppm (equivalent to approximately** mglkg bw/day).  On the 
basis of  the carcinogenicity studies reported, there is no evidence that XXXX is tumorigenic in rats or 
mice. 
The genotoxic potential of XXXX was investigated in a comprehensive range of in vitro and in vivo 
assays.  Although some of the studies were not conducted in accordance with current requirements 
and standards, on the basis of the overall weight of evidence, it can be concluded that XXXX is not 
genotoxic. 
In single/multi-generation studies, no adverse effects on reproduction were observed in either rats or 
mice.  In the rat studies, the NOAEL was found to be** ppm (equivalent to approximately* mglkg 
bw/day) and in the mice studies the NOAEL was found to be** ppm (equivalent to approximately* 
mg/kg bw/day). 
The only human toxicology information available is that derived from an evaluation of the medical 
records of ** employees involved in the manufacture of XXXX.  There was no evidence of adverse 
health effects as a  result of potential e:x..,osure  to XXXX, apart from three cases of transient rashes 
from skin contact and one case of transient nausea and vomiting following accidental ingestion.  The 
cases resolved without evidence of  residual medical effects. 
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3.2 
3.3 
3.4 
ADI 
In order to set an acceptable daily intake (ADI) for XXXX  it is relevant to  consider that although 
there is clear evidence of systemic toxicity in animals, as a result of prolonged dietary exposure, with 
the liver being the target organ, there is no evidence that XXXX is genotoxic or tumorigenic or toxic 
to reproduction. 
No suitable human data are available which would serve as a basis for setting an AD I. 
In chronic exposure dietary studies with rats and mice,  rats were the more sensitive species.  The 
overall NOAEL for rats ·in the chronic studies appeared to be ** ppm, equivalent to ** mglkg bw/day 
- based on increased fatty liver at ** ppm, the next highest dose level tested. 
It is appropriate to apply an uncertainty factor of 100 to the NOAEL of **  ntglkg bw/day and thus 
derive an ADI for XXXX of*** mglkg bw. 
AOEL 
The plant protection products XXXX1,  XXXX2  and XXXX3  are to  be applied by  mistblower or 
hydraulic sprayer.  Such means of application are likely to  lead to exposure of operators by the 
dermal route predominantly and to a lesser extent by the inhalation route.  Exposure by inhalation is 
not likely to result in significant, secondary oral exposure.  The exposure of operators is likely to 
occur repeatedly, but not persistently, throughout their life-tiltle. 
Oral absorption of  XXXX was extensive in rats at a relevant dose level (** % absorption within 24 h 
of a single oral dose of* mglkg bw/day).  Accordingly no  adjustment of any AOEL  proposed is 
necessary to take this factor into account.  .. 
No suitable human data are available on which to base and AOEL. 
A repeated exposure dermal study with rabbits exposed to**** mglkg bw/day is available.  However, 
the value of  using a dermal study to set a systemic AOEL can be questioned.  Since there was no clear 
evidence of  a compound related effect following dermal exposure for only 21  days, and adverse effects 
(including developmental toxicity) have been seen following subacute/ subchronic oral eXposure,  it is 
not appropriate to use this dermal study as a basis for setting an AOEL. 
The lowest NOAEL determined following subacute/subchronic oral  exposure was that observed in a 
12-month dog study (*** mglkg bw/day).  Bearing in mind the nature of the adverse effects seen in 
this study (principally mild bile stasis),  it is considered appropnate to  apply a  100-fold uncertainty 
factor to the NOAEL, thereby  deriving a short term AOEL for XXXX of** mglkg bw/day. 
ARJD -200-
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3.5  Drinking water limit 
No  suitable human data are available and there are no chronic exposure animal studies in which 
XXXX has been administered in drinking water.  The maximum allowable concentration (MAC) in 
drinking water therefore should be based on the ADI derived from dietary studies. 
I 
J 
I 
I 
I 
I 
In order to calculate the MAC for drinJQng water it is appropriate to divide the ADI by an additional 
uncertainty factor  of 10  and thus derive  a  daily  intake of ****  mglkg bw.  The International 
Programme on Chemical Safety (WHO, 1994) proposed that for risk assessment purposes, a reference  I 
human be considered to weigh 64 kg and to have a  daily intake of drinking water of 1.4  litres. 
Hence, a daily intake of**** mg XXXX/kg bw would be achieved by 64 kg human consuming** 
litre drinking water/day containing **** mg XXXX/litre.  Thus a MAC for XXXX in drinking water  I 
of** f.Lg/1 is derived.] 
3.6  Impact on human or animal health arising from  exposure to  the active substance or to  impurities 
contained in it 
3.6.1  Operators, bystanders and workers. 
3.6.1.1  Exposure as a proportion of  the AOEL, UK model. 
Plant Protection Product/ 
Application method 
XXXXl 
Orchard Broadcast Air Assisted Spray 
Hand Held Sprayer - low level crop 
Field Crop Sprayer 
XXXX2 
Orchard Broadcast Air Assisted Sprayer 
Hand Held Sprayer - low level crop 
Field Crop Sprayer 
:XXXXJ 
Orchard Broadcast Air Assisted Sprayer 
Hand Held Sprayer - low level crop 
Field Crop Sprayer 
Total systemic exposure 
60 kg person 
(mglkg bw/day) 
noPPE  PPE 
worn 
*** 
*** 
*** 
*** 
*** 
*** 
*** 
*** 
*** 
*** 
*** 
*** 
*** 2 
*** 2 
**** 2 
*** 2 
*** 
**** 
PPE is gloves during mixinglloading only unless where indicated otherwise 
2 
Gloves worn during application as well as mix/loading 
o/o of AOEL 
noPPE  PPE 
worn 
** 
** 
** 
** 
** 
** 
*** 
*** 
*** 
** 
** 
** 
** 2 
** 2 
*2 
** 2 
** 
* 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I' 
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3.6.1.2  Exposure as a proportion of  the AOEL, German model 
%ofAOEL 
Plant Protection Product/ 
Application Method 
Total systemic exposure 
60 kg person 
XXXXl 
noPPE 
worn 
PPE 
worn
1 
noPPE 
worn 
PPE 
worn
1 
Tree Broadcast Air Assisted Sprayer 
Hand Held Sprayer - high level crop 
Field Crop Sprayer 
*** 
*** 
*** 
**** 2 
**** 
*** 
** 
** 
•• 
*2 
* 
** 
XXXX2 
Tree Broadcast Air Assisted Sprayer 
Hand Held Sprayer - high level crop 
Field Crop Sprayer 
*** 
••• 
*** 
**** 2 
**** 
•••• 
•• 
•• 
•• 
*2 
*  • 
XXXX3 
Tree Broadcast Air Assisted Sprayer 
Hand Held Sprayer - high level crop 
Field Crop Sprayer 
*** 
*** 
••• 
*** 2 
•••• 
•••• 
** 
** 
** 
** 2 
* 
* 
1  PPE is gloves during mixing/loading only unless where indicated otherwise 
2 "Coverall" and sturdy footwear worn during application 
The operator exposure estimates generated using the UK and German models, generally indicate that 
the short term AOEL (** mglkg bwiday) will not be exceeded during mixing, loading and application 
of XXXXI,  XXXX2  and XXXX3  even when no PPE is  worn.  An exception  is the exposure 
estimated in the orchard sprayer use of  XXXXI which, using the UK model, is predicted to exceed the 
short  term  AOEL by up to  •  times.  Significant dermal  exposure  occurs  during application  in 
orchards using v~hicles without cabs.  If  the German model is used, the reduction in potential dermal 
exposure provided by wearing a coverall is sufficient to reduce the estimate of  actual dermal exposure 
(and hence total systemic exposure) to a level below the AOEL.  The UK  mo_del  does not have the 
facility to take account of the effect of the use of coveralls, but the protection afforded by the use of 
protective gloves is predicted to be' sufficient to reduce exposure to a level below the AOEL.  The use 
of coveralls (the use of which is recommended with the use of gloves) would reduce exposure still 
further. 
The UK  model outdoor low level knapsack data set is not appropriate for the estimation of eXposure 
associated with applications to tomato plants, and similar crops, since the higher level of the target is 
likely to increase the amount of potential exposure, and since there is also a  potential for exposure 
resulting from contact with treated foliage, an aspect that is not addressed by the model.  Similarly, 
estimates made using the German model high  ·level crop hand held sprayer scenario do not provide an 
estimate of  exposure likely in application to tomatoes in protected cropping situations.  The high level 
crop hand held sprayer scenario  relates  to  hand held  mist blower equipment.  A  data base on -202-
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exposure levels associated with application to protected crops (glass houses or polythene tunnels) is 
not available for use with either the UK or Gennan models. 
Reports of studies in which operator exposure levels were measured during application to grapes and 
apples  in the  USA,  and during  use  on glasshouse  grown  roses  in both  the  USA  and  UK,  were 
submitted.  ' 
. The predicted systemic exposure of operators not wearing PPE applying XXXXI to grapes was at or 
below the short term AOEL (** mglkg bw/day).  From studies using XXXX2 systemic exposure of 
operators applying XXXX2  to grapes.  and apples were predicted to  be  at or below the short. term 
AOEL when no PPE was worn,  or to be below •• % of the AOEL when gloves were worn during 
mixing and loading.  These conclusions  are based  on  the assumption  that  mixing,  loading and 
spraying continues for a  full  day  and the assumption  that large areas are covered.  The studies 
reported relating to glasshouse grown roses, sl_lowed that the systemic exposure of  operators was below 
the short term AOEL when gloves were used for mixing and loading.  Therefore it can be concluded 
that the risks to operators associated with these uses are at acceptable levels. 
The predicted levels of  exposure of bystanders present outside the treatment area, as a result of either 
contact with spray drift during application or contact with airborne XXXX  after application,  are 
below the short term AOEL (** mglkg bw/day), and therefore the potential risk is considered to be at 
_an acceptable level. 
Predicted  levels  of exposure  of workers  re-entering  treated  crops,  estimated  on  the  basis  of the 
estimates of initial levels  of dislodgeable  foliar  residues  (DFR)  present,  were  such  that levels  of 
exposure of  workers in both tomatoes and ornamental crops are at acceptable levels.  The upper limjts 
of the ranges of predicted exposures of workers in grapes and apples were •-• times higher that the 
short  term  AOEL  (**  mglkg  bw/day).  However,  actual  .measurements  of exposure  of workers 
trimming table grapes and harvesting apples in the USA indicated that exposures will be below the 
level of  the short term AOEL (** mglkg bw/day) (see point 7.2.3 for further details). 
3.6.2  Consumers 
The estimated consumer intake levels do not exceed the proposed ADI of ••• mglkg bw/day.  It can 
therefore be concluded that acceptable margins of  safety exist for consumers.  A further assessment of 
consumer intake levels, using proposed and adopted  MRLs  \\ill be  necessary as additional uses are 
proposed (TMDI calculations).  (see Section 7.1.2 for funhcr details) 
4  ·Residues 
4.1  Definition of  the residue relevant to MRLs 
Based on the metabolism data submitted for certain plants and domestic animals (where XXXX was 
the main component present or was present at levels which are appropriate for monitoring), residues 
for plants, plant products and products of  animal origin should be defined in terms of  XXXX alone. 
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4.2  Residues relevant to consumer safety 
4.2.1  Nature and levels of  residues 
In both apples and grapes, XXXX was metabolised to give a large number of metabolites which were 
present at very low levels.  It is considered highly likely that these metabolites are photodegradation 
products  as  they  generally  show  very  similar  chromatographic  pro~rties  to  the  products  of 
photodegradation of  XXXX in aqueous systems.  The major metabolic product in apples, grapes and 
cucumbers was XXXXx. 
In goats, a number of metabolites which were not detected in rats were formed.  These occurred at 
very low levels and would be unlikely to be present at levels > *** mglkg following feeding of apple 
pomace to domestic animals which had been treated according to current GAP.  XXXX was also 
detected in liver anc~ kidney samples at low levels.  In pigs, the major metabolic product was found to 
be XXXXx.  The identity of metabolites formed in chickens was not determined.  Current GAP is 
such that it is not likely that there could be significant intakes of XXXX (i.e.  >**  mglkg diet) by 
poultry. 
Based on the metabolism data submitted for certain plants and domestic animals (where XXXX was 
the main component present or was present at levels which are appropriate for monitonng), residues 
for plants, plant products and products of  animal origin should be defined in terms of  XXXX alone. 
Sufficient residue data were not submitted - further data are required to permit proposals to be made 
for the establishment of  :MRLs.  The highest residues detected in the residue trials reported was used 
to calculate theoretical consumer intakes. 
Residues present in wine, grapes and cherries were found to be stable for at least ***, *** and *** 
days, respectively, following storage at -20°C.  On the basis of extrapolation to other relevant crops, 
it can be assumed that residues of :XXXX  are stable at -20°C  in other crops within the group of 
'fruiting crops' (metabolism studies). 
Data provided with respect to the effects of processing on residues, demonstrated that there will be no 
adverse effects for consumer safety as a result of  concentration processes. 
Cattle and pigs were fed for** days at various rates including a rate equivalent to** N for cattle(* 
mglkg diet) (apple pomace is not fed to other domestic animals).  At this dose, residues of XXXX in 
all tissue except liver were.::;;*** mglkg.  Residues in liver reached a maximum level of*** mglkg. 
On the basis of the available residue data, it is apparent that intakes by domestic arumals are likely to 
be  low  (ca.  **  mglkg dietlday)  although residue  data for  all  contributors  to  animal  diet  are  not 
currently available (peas and pea haulm). 
4.2.2  Dietary exposure of  consumers 
Consumer intake  levels  were  estimated  using  the  highest  levels  recorded  in  currently  available 
supervised trials conducted in accordance with  the critical  GAP  identified.  Using the ~  total 
dietary model and the WHO  standard European diet, intakes were calculated to be.::;;  ***** mglkg 
bw/day (UK diet) and < ***** mglkg bw/day (WHO standard European diet).  Dietary intake levels 
resulting from any individual crop (based on the UK dietary model) were estimated to be  .::;;  ***** 
mglkg bw/day.  Full details of these estimates are provided in Section 4 of  the Tier II summary of  the 
Annex II dossier provided.  · -204-
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4.3 
4.3.1 
4.4 
The estimated intake levels do not exceed the proposed ADI of*** mglkg bw/day.  It can therefore 
be  concluded  that  acceptable  safety  margins  exist  for  consumers.  A  further  assessment  using 
proposed and adopted :MRLs is necessary and should be conducted once the additional residue data 
necessary to support ·such :MRLs are available (TMDI calculations). 
On the basis of the available residue data. it is clear that intake by domestic animals will be low (ca. 
*. * mglkg diet/day). 
Residues relevant to worker safety 
Exposure estimates for workers from dislodgeable foliar residues (DFR) 
Potential 
Crop  DFR  Transfer  dermal  Systemic 
mg/cm2  factor  exposure  exposure 
cm2/hr  mglkg bw/day  mglkg bw/day 
Apple  ***** (max)I  ****(min)·  ***  *** 
*****max)  **  *** 
Grape  ***** (max)I  *****(min)  ***  **** 
****** (max)  **  *** 
Tomato  *****)  ***(min)  *****  ****** 
****(max)  ****  ***** 
Ornamentals  *****2  ****  ***  **** 
1 
Based on maximum Day 0 residues from muhiple treatments (which are higher than estimates 1 and 2) 
2 
Estimate 4, above (which is higher than estimate 3) 
%AOEL 
(** mglkg 
·bw/day) 
**% 
***% 
**% 
***% 
**% 
*% 
**% 
The calculated potential dermal exposures are based on the predicted DFR immediately following 
application.  It can be expected that the level of  the potential dermal exposure falls as a result of loss 
of  DFR over time following application, as the residue level declines.  However, repeat applications 
are  likely.  Therefore the level  of DFR may  be  dependent  on  the DFR remaining from  previous 
applications.  This is taken into account where the maximum Day 0 residues are used as the basis of 
the estimate of  DFR.  The estimate for ornamentals is for a single application. 
These estimates, which can only be regarded as being approximate indications, suggest that: 
(i)  immediately following application predicted systemic exposures for workers in 
tomatoes and ornamental crops are below the AOEL (** mglkg bw/day); 
(ii) 
and 
exposure for workers in apple and grape crops ranges from less than twice the AOEL 
for apples and from less than to about 5 times the AOEL for grapes. 
Proposed EU  MRLs and compliance with existing EU  MRLs 
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· 4.5  Proposed EV import tolerances and compliance with existing EV import tolerances 
4.6 
5 
5.1 
5.2 
• 
Basis for differences, if  any,  in conclusions reached having regard to established or proposed CA C 
MRLs 
Fate and behaviour in the environment 
Definition of  the residue relevant to the environment 
In soil, residues consist primarily of  the parent. compound.  The levels of extractable metabolites and 
non-extractable residues fonned are likely to be low.  Due to the slow rates of degradation of  XXX:X 
the compound persists in soil  (DT  90 > * y).  A considerable number of different. metabolites are 
formed, none of  which are individually considered to be significant.  The residue should be defined in 
tenns of  XXXX alone. 
Fate and behaviour in soil 
XXX:X is persistent in soil.  In laboratory studies at **-**°C first order DTsotabvalues were***-**** 
days.  Shorter values  were  obtained  in six field  dissipation  studies  conducted  in Germany  and 
although some anomalies occurred which reduce the confidence that can be placed on the DT  50 field 
values (**-*** days),  it can be concluded that DT906etd  is more than one year,  thus exceeding the 
Annex VI trigger.  Photolysis was shown to occur at the soil surface but the rate of  photolysis was not 
deterinined.  Since  XXXX  is  to  be applied  after  a  crop  canopy  has fonned,  photolysis  is  not 
considered to be a significant mechanism for subsequent degradation in soil. 
Annual applications ofXXX:X could be as high as* kg aslha (XXXX2) on turf  which would give an 
initial  PECsoil  of ***  mg/kg if it is assumed  that all of the applied XXXX reached  the soil.  In 
horticulture annual applications could be  ****  g aslha  (XXXXl) in apple orchards but would be 
rather lower on other crops.  If  it is assumed that no interception of XXXX by apple  tree~ or by any 
ground cover occurs (orchards may not have a large amount of grass cover) initial PEC values in soil 
could be as high as*** mglkg. Based on these PECs and degradation rates, concentrations in the soil  · 
would reach a plateau of  ca * mg!kg and ca **  mg/kg for horticultural and turf use respectively after 
approximately four years.  It is submitted that on the basis of these predictions it is apparent that 
long-tenn concentrations in soil will be low and accumulation will not occur and that therefor a field 
accumulation study is not required. -206-
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5.3  Fate and behaviour in water 
5.3.1  CJ~uutdvvater 
On the basis of sorption (Koc ***-***) and column leaching (no significant radioactivity vvas leached 
from columns of  fresh or aged residues) studies provided, it is clear that the m&ility in soil of  XXXX 
is lovv uutder laboratory conditions.  In field dissipation studies one depth segment only vvas analysed 
and, hence, no conclusions could be dra\VIl concerning vertical movement of  XXXX.  Despite its long 
.  DT  50  value,  on the basis of computer simulations and expert judgement it  is  suggested that  no 
movement  to  grouutdvvater  will  occur following  any  of the  uses  proposed.  This conclusion  is 
consistent vvith  the lovv  risk use pattern for XXXX i.e.  use occurs only  in summer to crops vvith 
established canopies. 
5.3.2  Surface water 
XXXX  does  not hydrolyse  but is  somewhat photolabile  (half life  •• day).  The significance of 
aqueous photolysis is generally considered to be lovv  in turbid waters and as XXXX also partitions 
rapidly into sediment (partition DT50 in water<< •  day) the likelihood of significant degradation by 
photolysis is not high.  However, whether removal  is by photolytic degradation or partitioning to 
sediment, it is concluded that XXXX vvill  not persist in water.  Initial PEC values in surface water 
were detennined on the basis of overspray of a single application and were calculated to be **  JJ.gll 
from field crop uses, •• Jlgll for orchard uses and •• mgll for use on turf.  Over •• days these levels 
could be expected to decrease to •• ngll, •• ngll and •• ngll respectively.  These values are based on 
direct overspray of the highest application rate proposed and vvill therefore be reduced for other uses 
or if a buff~r zone is required.  The conclusion reached through a simulation study was that run-off 
water would not contain > ** % of  the applied dose and hence erosion and run-off are not likely to be 
a major route of  contamination of watercourses.  Studies_have sho\VIl that once in sediment, XXXX 
remains extractable.  Little degradation occurring over •• days. 
5.4  Fate and behaviour in air 
6  Effects on non-target species 
6.1  Effects on terrestrial vertebrates 
Exposure of  birds and mammals to XXXX is considered to arise mainly from feeding either on grass 
or fruit treated vvith XXXX or by feeding on XXX:X  contaminated insects or earthvvorms present in 
XXXX treated crops.  XXXX was ·generally of lovv toxicity to birds (LD50 > **** mg as/kg bvv) and 
mammals  (LDso  ****  mg  as/kg  bvv)  and  consequently  the  TER  values  vvere  greater  than  the 
91/414/EEC Annex VI triggers for uutacceptable effects.  It can therefore be concluded that the use of 
XXXX presents a low acute risk to vvild birds and mammals. 
E~.:posure of reproducing birds to  XXXX is  considered to  only  occur as a  result of the  multiple 
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applications made in orchards throughout the year.  Since the NOEC determined in reproductive  I 
toxicity testing was *** mg!kg, the reproductive TER value is above the 911414/EEC trigger (5) for  " I 
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unacceptable effects.  It can therefore be concluded that the risk to reproducing birds from the use of 
XXXX in orchards is low. 
6.2  Effects on aquatic species 
6.3 
Technical  XXXX and preparations containing XXXX were  of moderate acute toxicity  to  aquatic 
organisms with LCIEC50 values of ••• mg as/1,  ••• mg as/1  and ••• mg as/1 for the most sensitive 
fish, aquatic invertebrate and algal species tested, respectively.  Worst case assessments (overspray) 
showed that there was an acute risk (TER < ***) to all 3 aquatic groups associated with the use of 
XXXX,  particularly  its  uses  on turf and in orchards.  However,  on the basis of a  spray  drift 
assessment, it was evident that the risk to aquatic life associated with use on turf was acceptable, 
particularly when a DT  50 of  approx. • day for XXXX in the aqueous pbase' of water/sediment systems 
was taken into account.  Although a spray drift assessment indicated that the acute risks to fish and 
algae associated with the remaining agricultural/horticultural uses ,were acceptable, an acute risk to  . 
aquatic invertebrates wa8 identified for air assisted spray application such as those made in orchards. 
Consequently,  a  15m buffer zone restriction around watercourses is recommended for air assisted 
spray applications of  the formulation to tree/bush crops. 
XXXX was of moderate chronic toxicity to fish and aquatic invertebrates with NOECs of **** mg 
as/1  and •••• mg as/1  respectively.  On the basis of worst case overspray assessments,  it became 
apparent that there was a chronic risk,(TER <10) to fish and aquatic invertebrates associated with use 
of  XXXX on turf and with the agricultural/horticultural uses of  XXXX.  The more serious risks were 
associated  with  its  use  on turf and in orchards.  An assessment conducted  to  assess  the  risks 
associated ·with spray drift showed that risk associated with chronic exposure to both fish and aquatic 
invertebrates resulting from use on turf use was acceptable, particularly when the DT  5o of approx.  • 
day for xxxx  in the aqueous phase of water/sediment systems was taken into account.  :xxxx did 
not present a bioaccumulation risk since the fish maximum BCF was ••• and DT  50 for XXXX in the 
aqueous phase of  water/sediment systems was approx. • day. 
Although XXXX was rapidly removed from the ~queous phase of natural sediment water systems, it 
was found  to partition and persist in the sediment phase of such water sediment systems.  An 
overspray and a spray drift assessment carried out using Daphnia magna toxicity data as an indicator 
of the potential toxicity of :XXXX to sediment dwelling invertebrates indicated that there may be a 
chronic risk to sediment dwelling invertebrates associated with the use of  XXXX by air assisted spray 
application to tree/bush crops sucl_l  as orchards.  Therefore,  a  study to  permit assessment of the 
chronic toxicity of  XXXX has been initiated (to be submitted in June ****).  Pending the assessment 
of that study, a 15m buffer zone restriction around watercourses is proposed for application of  :XXXX 
to tree/bush fruit using air assisted spray applications equipment. 
Effects on bees and other arthropod species 
XXXX was of low acute toxicity to honeybees with acute oral and contact LD50 values of > •• and > 
••• J.Lg  as/bee respectively.  Although the hazard quotien~ associated with use on turf(<-***) may 
have exceeded the Annex VI trigger of 50, the risk to bees was considered to be low, given the timing 
of applications  - mainly  in winter/autumn when bees  were  unlikely  to  be foraging.  -The hazard 
quotients associated with the remaining uses were below 50 indicating a low risk to bees. 
Data are  not  presently  available  which  satisfy  the  Annex  II  and III  non-target  arthropod  data 
requirements.  Therefore, non-target arthropod toxicity data will be supplied in line with the current 
Annex II and III data requirements (to be submitted in June ****). -208-
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6.4  Effects on earthworms and other soil macro-organisms 
:XXXX was of moderate toxicity to earthworms with an acute LCso value of ••-•• mg as/kg soil and a 
reproductive NOEC of **** g as/ha.  On the basis of multiple overspray assessments, the acute and 
sub-lethal risk to earthworms associated with both the worst case turf (maximum application rate) and 
orchard (maximum multiple applications) uses,  was considered to be low.  dn the basis of the low 
risk associated with use of  :XXXX for earthworms and soil micro-organisms (below), the risk to other 
soil macro-organisms is also considered to be low. 
6.5  Effects on soil micro-organisms 
6.6 
The data provided showed that XXXX elicited no effect of  XXXX on soil respiration and nitrification 
processes at application rates of up to.** times the maximum recommended application rate.  On the 
basis  of the worst case  exposure  scenarios for  turf and  orchard uses  (representative  of worst  case 
multiple oversprays at maximum application rate) of XXXX as exposure estimates, it is clear the risk 
to soil micro-organisms associated with use of  XXXX is low. 
Effects on other non-target organisms (flora and fauna) 
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No data are available.  It is suggested data on the effects of XXXX on other non-target organisms  I 
(flora and fauna) are not necessary. 
6.7  Effects on biological methods of  sewage treatment 
It is  not  considered  likely  that the  normal  use  of XXXX  will  result  in  contamination  of sewage 
treatment .plants.  However, data were submitted which indicated that XXXX at concentrations up to 
****  ppm  had  no  effect  on  sewage  treatment processes.  This  indicates that the  risk to  sewage 
treatment processes from the use of  XXXX is considered low. 
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Overall conclusions 
An ADI ofO.Ol mglkg bw/day is proposed. 
An AOEL ofO.l mglkg bw/day, based on short-term exposure, is proposed. 
A drinking water limit- maximum allowable concentration (MAC)- 0.05 mg/1 is proposed. 
It is expected that residues of  XXXX. consequent on application consistent with good plant protection practice, 
will not have harmful effects on human or animal health or on groundwater or any unacceptable influence on 
the environment.  Such residues can be measured by methods using conventional analytical equipment.  Some 
further data are required to confirm this assessment. 
The following provisional EU MRLs are proposed:-
cereals 
citrus fruit 
bulb vegetables 
leafy vegetables 
flowering brassicas 
head brassicas 
leafy brassicas 
*** mglkg 
*** mglkg 
*** mglkg 
*** mglkg 
*** mglkg 
*** mglkg 
*** mglkg 
The following import tolerances are proposed:-
bananas  *** mglkg 
solanacea 
cucurbits (edible peel) 
cucurbits (inedible peel) 
root and tuber vegetables 
potatoes 
pulses 
ojl seeds 
tea 
*** mglkg 
*** mglkg 
*** mglkg 
*** mglkg 
*** mglkg 
*** mglkg 
*** mglkg 
*** mglkg 
It is expected that the use of  X:XXX, consistent with good plant protection practice, will not have any harmful 
effects of  human or animal health or any unacceptable effects on the environment.  However SOille further data 
are required to confirm this assessment. 
Proposed decision 
It is proposed that XXXX be included in Annex I of Council Directive 91/414/EEC and that the inclusion be 
conditional on:-
(i)  a minimum purity  of  95  %~  and 
(ii)  the tests and studies listed below being provided by the dates specified. 
It is also proposed that the following  restriction be  associated with  the  inclusion of X:XXX  in Annex I of 
Council Directive 91/414/EEC:-
that authorizations granted for preparations containing XXXX, which permit application by 
means  of air  assisted  spray  application  equipment  to  bush  or  tree  crops,  require  the 
maintenance of  a 15m buffer zone between water courses. drains and treated areas. -210-
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Further information to be submitted 
The following data will be provided within ..... months. 
Physical, chemical properties 
(i)  UVIVIS 8pectra of  pure XXXX, molecular extinction at relevant wavelengths (IIA 2.5) 
(ii)  solubility in organic solvents (IIA 2. 7) 
Methods of  analysis 
(i)  repeatability data for the determination of  XXXX in technical material and plant protection products  · 
(Annex IIA 4.1.3.4; Annex IliA 5.1.3.4) 
(ii)  confirmation of  the identity ofXXX:X residues in all substrates (Specificity) (Annex IIA 4.2.1; Annex 
ITIA 5.2) 
iii)  method for  determining the presence  of the  xxxxx  isomer of XXXX in the active  substance  as 
manufactured (annex ITA 4.1.2) 
Residues data  forth~ crops as indicated below (ITA 6.3) 
Crop  GAP  Recommendation 
Pears 
Peaches 
Cherries 
Wine grapes 
Table grapes 
Strawberries 
Raspberries 
Currants 
IS 
S  Further data required to support critical GAP (14 day Pill) (x trials) 
N  NoGAP 
S  Data from x tli3Is supports GAP.  Further data required (x trials) 
N  Further data required (x trials) 
S  NoGAP 
N  Data from x trials support GAP.  Further data required (x trials) 
S  Further data required to assess whether S GAP could give rise to higher levels than 
N GAP.  Since GAP for table grapes is identical these data will be submitted to 
support this use. 
N  Further data required.  Data from N GAP wine grapes will be used to support this 
GAP since Pill has little effect on XXXX residues in grapes. 
S  Further data required.  Since GAP for wine grapes is identical these data will be 
submitted to support use. 
N  Further data required (x trials) 
S  Further data required (extrapolation between NMS and SMS GAP proposed) 
N  Further data required (x trials) 
S  No GAP 
N  Further data required (x trials) 
S  NoGAP 
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Effects on non-target species , 
(i)  Study on the toxicity of  XXXX to both Aphidius rhopalosiphi and Typh/odromus pyri using 
application rates relevant to the maximum approved  application rate (IIA 8.3.2) 
I 
(ii)  Study on the toxicity of XXXX  to  both a ground dwelling predator species and a foliage  dwelling 
species at the relevant maximum recommended application rates for both the arable and horticultural 
uses of.XXXX Q:IA 8.3.2) 
(iii)  Extended laboratory or semi-field/field studies on the effect of multiple applications of  XXXX on 
non-target arthropods in orchards.  This study must reflect the proposed conditions of  use (e.g.  max 
application rate, minimum re-application interval). (IIA 8.3.2) 
(iv)  Laboratory  study  to  investigate  the  risks  associated  with  chronic  exposure  of sediment  dwelling 
invertebrates (e.g.  Chironomid sp.) resulting from application of  XXXX by means of  air assisted spray 
equipment to tree/bush crops. (IIA 8.2. 7) 
A listing of  the end points· relevant to the active substance, presented in the format specified in Appendix 9, 
should be attached to each Tier Ill  Summary and Overall Assessment submitted. I 
.  -212- ... 
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FORMS FOR USE IN CHECKING DOSSIERS FOR COMPLETENESS 
Evaluation Form 1 -
Active 10bstaKe: 
for_ U$e in checking that the required 
supporting documentation bas been provided 
Description of  the document - circumstances in which required 
AppUamt: 
Date: 
Statement of  the context in which the dossier is submitted -always 
required 
Documentation relating to the joint submission of  dossiers -
*  Claim that all reasonable steps were taken 
*  Documentation to sup~rt  the claim made 
- required for existing active substances for which there is more than one notifier, 
where a joint dossier was not submitted by all notifiers 
Existing or proposed labels, and where relevant leaflets for each 
preparation for which an Aiinex m  dossier is submitted .;, required 
where requested 
Existing or proposed labels relevant to the uses on the basis of 
which existing MR.Ls or import tolerances are supported or new 
MR.Ls or import tolerances are proposed -required where requested 
Details of  intended uses (supported by the applicant and for which 
data are provided or are to be provided) and the conditions of use. 
on food and feed crops, and on non food and feed crops. in the 
territory of  the EU, presented using the appropriate fomt- alv.a~-s 
required 
Document 
provided 
YIN# 
D-2  A list of  the authorized uses in the EU. an indication of whether 
actually used and of  the extent of use, presented using the 
appropriate form - required for existing active substances 
D-3  Details of  the intented uses (supported by the applicant and for 
which data are provided or are to be provided) and conditions of 
use (GAPs) in exporting countries, for which import tolerances are 
required, presented using the appropriate form - required for food or feed 
crops which are imported in significant quantities into the territory of  the EU 
•  To be completed by the Competent Authority of the Member State to which application is made 
11  Y =  yes~ N = no 
Official 
useonly* 
Data Gap 
yfN' -214-
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Supporting Documentation  for completeness 
Active substance:  AppUcant: 
Document 
E-1 
E-2 
F 
G 
H 
I 
J 
Description of the document - circumstances in which required 
Listing of  EU :MRLs, presented using the appropriate fonn -required 
for existing active substances 
Listing of  :MRLs  esta~lished by Member States, presented using the 
appropriate fonn -required for existing active substances 
Listing of  MRLs established in exporting countries, presented using 
the appropriate fonn - required where an import tolerance is proposed 
Listing of MRLs in non-EU OECD countries, presented using the 
appropriate fonn - required where an import tolerance is proposed 
A copy of  each notification submitted to the Commission -required 
for existing active substances 
Whether permitted in food, animal feeding stuffs, medicines or 
cosmetics in accordance with EU legislation -required for each 
formulant unless an Annex II dossier is provided for the formulant 
Safety data sheet prepared in accordance with Directive 
67  /548/EEC -required for each formulant 
Other available toxicological and environmental data on the 
formulant- required if  requested 
Confidential data and information, to include -
* A listing of the data and information for which confidentiality is 
requested, cross referenced to the relevant test and study reports, 
dossier summaries and supporting documentation - always required 
*  A justification for the claim to confidentiality for each item for 
which confidentiality is requested -always required 
*  Highlighting of information contained in relevant study reports, 
dossier summaries and supporting documentation·- required where 
the information concerned is provided in those documents 
* File containing confidential data and information -optional 
requirement 
Date: 
Document 
provided 
YIN 
Pagel ofl 
Official 
use only 
Data Gap 
Y/N 
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Appendix 11  Fonns for use in checking dossiers  Part2  Evaluation Form 2 
for completeness  ·  Dossier Summaries and Overall Assessment 
Part2  Evaluation Form 2 -
Active substance: 
Document 
for use in checking that the required 
Annex n and Annex m dossier summaries 
and an overall assessment, have been provided 
Description of  the document - circumstances in which required 
AppHcant: 
Date: 
L-11  Annex II, Tier I reports as to the quality of  individual test and study 
reports - always required 
L (Reference Listing of  test and study reports, test guidelines and published papers 
List)  relevant to the Annex II dossier:-
M-Il 
L-III 
- papers and reports submitted listed by Annex point 
- papers and reports submitted listed by alphabetically by author 
- list of  papers and reports not submitted, arranged alphabetically by 
author 
- always required 
Annex II, Tier II dossier summary and overall assessment -always 
required 
Annex m, Tier I reports as to the quality of  individual test ·and study 
reports for each Annex III dossier submitted -always required 
*  First preparation 
* Second preparation 
* Third preparation 
*Fourth preparation 
L (Reference Listing of  test and study reports, test guidelines and published papers 
List)  relevant to each Annex ill dossier -always required 
*  First preparation 
- papers and reports submitted listed by Annex point 
- papers and reports submitted listed by alphabetically by author 
- list of  papers and reports not submitted, arranged alphabetically by 
author 
* Second preparation 
- papers and reports submitted listed by Annex point 
- papers and reports submitted listed by alphabetically by author 
- list of  papers and reports not submitted, arranged alphabetically by 
author 
Document 
provided 
YIN# 
•  To be  compl~ted by the Competent Authority of the Member State to which application is made 
11  Y =  yes~ N =  no 
Official 
use only* 
Data· Gap 
YIN' -216- Pagel ofl 
Appendb 11  Partl  Evaluation Fonn 2  · Fonns for use in checking dossiers 
for completeness  Dossier Swnmaries and OveraU Assessment 
Active substance:  AppUcant: 
Document 
M-ill 
N 
Description of  the document -circumstances in which required 
* Third preparation 
- papers and reports submitted listed by Annex point 
- papers and reports submitted listed by alphabetically by author 
- list of papers and reports not submitted, arranged alphabetically by 
author 
*Fourth preparation 
- papers and reports submitted listed by Annex point 
- papers and reports submitted listed by alphabetically by author 
- list of papers and reports not subnutted, arrapged alphabetically by 
author 
Annex Ill, Tier II dossier summary and overall assessment -always 
required 
* First preparation 
* Second preparation 
*  Third preparation 
* Fourth preparation 
An overall summary and assessment of  the application -always required 
Date: 
Document 
provided 
YIN 
Official 
use only 
Data Gap 
YIN 
-· 
·-
I 
i 
• 
I 
I 
.I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I I 
""  I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
Appendix 11 
PartJ 
AnnexiiA 
point 
1.1 
1.2 
1.3 
1.4 
1.5 
1.6 
1.7 
1.8 
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Fonns for use in checking dossiers 
for completeness 
Part 3  Evaluation Fonn 3 
Evaluation Form 3 -
for use in checking that all test and study 
reports required in accordance with Annex 
DA have been provided 
Information, test or study -
circumstances in which required 
Applicant (name, address, contact, 
telephone and telefax numbers)-
always required 
Manufacturer(s) (name, address, 
contact, telephone and telefax 
numbers) - always required 
ISO common name proposed or 
accepted, and synonyms -always 
required 
Chemical name as in Annex I to 
Directive 67/548/EEC, if  not included 
in that Annex, in accordance with 
lOP  AC and CA nomenclature -always 
required 
Manufacturer•s code number(s), for the 
active substance and fonnulations, 
materials concerned, countries in 
which used and periods for which 
used - always r~quired 
Existing CAS, CIP AC, EINECS and 
ELINCS numbers -always required 
Molecular fonnula, molecular mass and 
structural fonnula - always required 
Method of manufacture (pathways, by-
products and impurities) for each 
plant, whether or .not relevant to a 
pilot plant - always required 
Information, 
test or study 
provided 
YIPIN# 
Annex IIA Test and Study Reports 
Active substance: 
Applkant: 
Date: 
Justification  Undertaki~g 
provided  provided 
LIN#  Date!N# 
Official 
useonly* 
Data Gap 
yfN' 
*  To be completed by the Competent Authority of  the Member State to which application is made 
#  Y =yes~ P =in  part~ N =no~ L =location (volume and page) where justification can be found~ Date= date report to be 
submitted Appendb ll  Fonns for use In eheeldng dossiers 
for eompleteness 
Aetive Substanee: 
AnnexiiA 
point 
1.9 
1.10 
Information, test or study -
circumstances in which required 
Minimum content (glkg) of pure active 
substance (excluding inactive 
isomers), whether or not relevant to 
a pilot plant - always required 
Inactive isomers
17 
-
*  IUP AC and CA names 
* ISO common name proposed or 
accepted 
*  CAS, CIP AC, EINECS and 
ELINCS numbers 
*  Molecular and structural formula 
*  Molecular mass 
*  Ratio of  the content of 
isomers/diastereo-isomers 
*  Maximum content in glkg 
* Whether or not relevant to a pilot 
plant 
- required for all inactive isomers 
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Annn IIA Tnt and Study Reports 
AppUeant:  Date: 
Information,  Justification  Undertaking 
test or study  provided  provided 
provided 
YIP  IN  LIN  Date/N 
Official 
use only 
Data Gap 
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Appendix 11  Fonns for use in checking dossiers 
·  for completeness 
Active Substance: 
Annex IIA 
point 
1.11 
2.1.1 
2.1.2 
Information, test or study -
circumstances in which required 
Impurities and additives 
17 
-
*  IUPAC and CA names 
*  ISO common name proposed or 
accepted 
*  CAS, CIP AC, EINECS and 
ELINCS numbers 
*  Molecular and structural formula 
*  Molecular mass 
*  Maximum coutent in glkg 
*  Whether or not relevant to a pilot 
plant 
*  In the case-of additives, their# 
function and trade names 
*In the case of impurities and by-
products of particular environmental 
concern, details of  the analytical 
methOds 
- required for all impurities and by-products of 
particular toxicological and environmental . 
concern 
- required for other components present in 
quantities > 1 glkg 
Analytical profile of  batches -always 
required 
Results of analyses of  batches 
produced in laboratory or pilot scale 
production systems and used in 
toxicological testing -required where 
available and relevant 
Melting point, freezing point or 
solidification point of purified active 
substance -always required 
Boiling Point of purified active 
substance - required for liquid and low 
melting substances 
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Part 3  Evaluation Form 3 
Annex IIA Test and Study Reports 
AppUcant:  Date: 
Information,  Justification  Undertaking 
test or study  provided  provided 
provided 
YIP IN  LIN  DatefN 
Official 
use only 
Data Gap 
YIN Appendb: ll  Fonns for use In checking dossiers 
for completeness 
Active Substance: 
Annex IIA  Infonnation, test or study -
point  circumstances in which required 
2.1.3  Temperature at which decomposition 
or sublimation occurs - required where 
melting and/or boiling point cannot be 
determined because of  decomposition or 
sublimation 
2.2  Relative density of  purified active 
substance - required for active substances 
which are liquids or solids 
2.3.1  Vapour pressure of purified active 
substance - always required 
2.3.2  Henry's law constant - required for solids 
and liquids 
2.4.1  Description of  the physical state and 
colour of  both the purified active 
substance and active substance as 
manufactured -always required 
2.4.2  Description of the odour of the 
purified active substance and active 
substance as manufactured -always 
required 
-llO'" 
Part 3  Evaluation Form 3 
Annes. IIA Test and Study Reports 
AppUcant:  Date: 
Infonnation,  Justification  Undertaking 
test or study  provided  provided 
provided 
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, Appendix 11  Fonns for use in checking dossiers 
for completeness  · 
Active Substance: 
Annex IIA 
point 
2.5.1 
2.5.2 
2.6 
Infonnation, test or study -
circumstances in which required 
Spectra, a table of signal 
characteristics and molecular 
extinction at relevant wavelengths 
for purified active substance 
*Ultraviolet/visible (UVMS) 
*  lllfulred (R) 
* Nuclear magnetic resonance (NMR) 
* Mass spectra (MS) 
- always required 
Wavelengths at which UVMS 
molecular extinction occurs, where 
appropriate, to include a wavelength 
at the highest absorption value above 
290 run -always required 
Optical purity -required for active 
substances which are resolved optical isomers 
Spectra for impurities 
* Ultraviolet/visible (UVMS) 
* Infrared (R) 
* Nuclear magnetic resonance (NMR) 
* Mass spectra (MS) 
-required for impurities of  toxicological or 
environmental concern 
Solubility of purified active substance 
in water detennined in the neutral 
range -required for compounds which do 
not form ions 
'  Solubility of purified active substance 
in water detennined in the acidic 
range (pH 4 to 6) and in the alkaline 
range (pH 8 to 1  0) -required for 
compounds which fonn ions 
• 221. 
Par13  Evaluation Fonn 3 
Anne1JIA Test and Study Reports 
AppUcant:  Date: 
Information,  Justification  Undertaking 
test or study  provided  provided 
provided 
YIP IN  LIN  Date/N 
PageS of41 
Official 
use only 
Data Gap 
YIN Appendix 11  Fonns for use In .:heeldng dossiers 
·  for completeness 
Active Substance:· 
Annex IIA  Information, test or study -
point  circumstances in which required 
2.7  Solubility in organic solvents at 15 to 
25° C-always required 
2.8  n-octanollwater partition coefficient -
always required 
Effect of pH (4 to 10) on the 
n-octanollwater partition 
coefficient -required for acids ofpKa 
value< 2, and bases ofpKa value> 2 
2.9.1  Hydrolysis rate of purified active 
substance at pH values 4, 7 and 9 
under sterile conditions, in the 
absence of  light 
Identity of hydrolysis products -always 
required 
Rate constant observed - always required 
Estimated DTso value -always required 
2.9.2  Direct phototransformation of purified 
active substance in water using 
artificial light (simulating sun!i"ght 
and excluding wavelengths 
A.< 290 run) under sterile 
conditions, to include 
*  Photochemical halflife 
* Mass balance to account for 90 % 
of  the applied radioactivity 
- required for compounds with a molar 
(decadic) absorption coefficient(.:)> 10 (1 x 
mo1"
1 xcm"
1
) 
Identity of breakdown products -
required for compounds which at any time 
during the study are present in quantities > 
10 % of  the active substance added , 
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AppUcant:  Date: 
Information.  Justification  Undertaking 
test or study  provided  provided 
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Appendix 11  . Forms for use in checking dossien 
for completeness 
Actin Substance: 
Annex IIA  Infonnation, test or study -
point  circumstances in which required 
2.9.3  *  Quantum yield of direct 
phototransfonnation 
*  Calculated theoretical lifetime in the 
top layer of  aqueous systems and 
the real lifetime of  the active 
substance 
- required where necessary to investigate direct 
phototransfonnation 
2.9.4  Dissociation in water of purified 
active substance 
*Dissociation constant(s) (pKa 
values) 
*  Identity of dissociated species 
fonned 
- required where dissociation in water occurs. 
*Dissociation constant(s) (pKa 
values) of the active principle-
required for active substances that are salts 
2.10  Estimated photochemical oxidative 
degradation -always required 
2.11.1  Flammability of  the active substance 
as manufactured -required for 
compounds which are solids, gases or which 
evolve highly flammable gases 
2.11.2  Auto-flammability of  the active 
substance as manufactured -required 
for gases, liquids and solids which are not 
explosive or which do not ignite 
spontaneously in contact with air at ambient 
temperature 
2.12  Flash point of the active substance as 
manufactured -required for compounds 
with a melting point below 40° C 
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AnnexiiA Test and Study Reports 
AppUcant:  Date: 
Infonnation,  Justification  Undertaking 
test or study  provided  provided 
provided 
YIP IN  LIN  Date!N 
Page 7 of41 
Official 
use only 
Data Gap 
YIN 
-Appendix ll  . Fonns for use in checking dosslen 
for completeness 
Aetive Substance: 
Annex IIA  Information. test or study -
point  circumstances in which required 
2.13  Explosive properties of  the active 
substance as manufactured -required 
for liquids, pastes and solids 
2.14  Surface tension of  the active substance 
as manufactured -always required 
2.15  Oxidizing properties of the active 
substance as manufactured -required 
except where examination of  its structural 
formula establishes beyond reasonable doubt 
that the active substance is incapable of 
reacting exothennically with a combustible 
material 
3.1  Function e.g. fungicide -always required 
3.2.1  Nature of  the effects on hannful 
organisms e.g. contact action -always 
required 
3.2.2  Whether or not translocated in plants 
and if  translocated whether such 
translocation is apoplastic, 
symplastic or both -always required 
3.3  Fields of use e.g. forestry -always 
required 
3.4.1  Details of  existing and intended uses 
(crops, groups of  crops, plants or 
plant products treated or protected) -
always required 
3.4.2  Details of hannful organisms against 
which protection is afforded -required 
where relevant 
3.4.3  Effects achieved e.g. sprout 
suppression -required where relevant 
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Applicant:  Date: 
Information,  Justification  Undertaking 
test or study  provided  provided 
provided 
YIP  IN  LIN  Date/N 
Page 8 of41 
Official 
use only 
Data Gap 
YIN 
'X '  ~ 
'' 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
Appendix 11  Fonns for use in checking dossiers 
for completeness 
Active Substance: 
Annex IIA  Information. test or study -
point  circumstances in which required 
3.5.1  Statement of the mode of action of the 
active substance in tenns of 
biochemical and physiological 
mechanism(s) and biochemical 
pathway(s) involved -required where 
and to the extent that it has been elucidated 
3.5.2  Details of actfve metabOlites and 
degradation products, cross 
referenced to the information 
provided under points 5.1, 5.8, 
5.10, 6.1, 6.3, 6.5, 6.9, 7.1, 7.2 
and 9, to include  _ 
*  IUPAC and CA names 
*  ISO common name proposed or 
accepted 
* CAS, CIP AC, EINECS and 
ELINCS numbers 
*  Molecular and structural fonnula 
*  Molecular mass 
- required where the active substance must be 
converted to a metabolite or degradation 
product following application or use of 
preparations containing it, to exert its 
intended effect 
3.5.3  Inforination relative to the formation 
of active metabolites and degradation 
products, to include 
*  The processes, mechanisms and 
reactions involved 
*  Kinetic and other data concerning 
the rate of conversion and if  known 
the rate limiting step 
*  Environmental and other factors 
effecting the rate and extent of 
conversion 
- required where relevant and available 
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Part 3  Evaluation Form 3 
AppUcant: 
Infonnation, 
test or study 
provided 
YIP  IN 
Anne1 IIA Test and Study Reports 
Date: 
Justification  Undertaking 
provided  provided 
LIN  Date!N 
Official 
use only 
Data Gap 
Y/N 
-
.:_ Appendilll  Fonns for use in checking dosslen 
for completeness 
Active Substance: 
Annex IIA  Information, test or study • 
point  circumstances in which required 
3.·6  Information on the possible 
occurrence of  the development of 
resistance or cross-resistance -
required where it is available 
3.7  A safety data sheet pursuant to Article 
27 of Council Directive 67  /548/EEC 
- always required 
3.8.1  Pyrolytic behaviour of  the active 
substance under controlled 
conditions at 800° C and the content 
of  polyhalogenated dibenzo-p-
dioxins in the products of  pyrolysis -
required for active substances with a halogen 
content greater than 60 o/o 
Detailed instructions for safe 
disposal - always required 
3.8.2  Methods other than controlled 
incineration for disposal of  the 
active substance, contaminated 
packaging and contaminated 
materials-
*  Detailed description of  such 
methods 
*  Data to establish their effectiveness 
and safety 
- required where available 
3.9  Procedures for the decontamination of 
water in the case of  an accident -
always required 
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AppUcant: 
Information, 
test or study 
provided 
Y/P/N 
Annex IIA T.est and Study Reports 
Date: 
Justification  Undertaking 
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Appendix 11  . Forms for use in checking dossiers 
for completeness 
Active Substance: 
AnnexiiA 
point 
4 
4.1.1 
4~1.2 
Information, test or study -
circumstances in which required 
* Analytical standards for pure ac~ve 
substance - required where requested 
*  Samples of  the active substance as 
manufactured - required where requested 
*  Analytical standards for relevant 
metabolites and other components 
included in the residue definition -
required where requested 
*  Samples of reference substances for 
relevant impurities -if  available, 
required where requested 
Description of  analytical methods for 
the analysis of  the active substance 
as manufactured -always required 
Applicability of  existing CIP  AC 
methods -always required 
Description of  analytical methods for 
the determination of  impurities (non-
active components arising from the 
manufacturing process or from 
degradation during storage) which 
are of  toxicological, ecotoxicological 
or environmental concern or which 
are present in quantities~ lglkg in 
the active substance as manufactured 
- always required 
Description of  analytical methods for 
the determination of  additives (e.g. 
stabilizers) in the active substance as 
manufactured -always required 
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Annex IIA Test and Study Reports 
AppUcant:  Date: 
Information,  Justification  Undertaking 
test or study  provided  provided 
provided 
YIP  IN  LIN  Date/N 
Official 
use only 
Data Gap 
'YIN 
·--Appendb 11  Fonns for use In cheeldng dosslen 
for completeness 
Active Substance: 
Annex IIA 
point 
4.1.3.1 
4.1.3.2 
4.1.3.3 
Information, test or study -
circumstances in which required 
For each method submitted (active 
substance and impurities)-
*Specificity 
* Extent of  interference by other 
substances present 
* Explantation of  interferences which 
contribute more than ± 3 % of  the 
total quantity determined 
- always required 
For each method submitted, linearity 
over an appropriate range -
* Equation of  the calibration line 
* Correlation co-efficient 
* Representative labelled 
documentation e.g. chromatograms 
- always required 
For each method submitted, 
accuracy-
* Pure active substance - always required 
*  Impurities - required for impurities of 
toxicological, ecotoxicological or 
envirorunental concern present in ampunts ~ 
I glkg in the active s':lbstance as manufactured 
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Applicant: 
Information, 
test or study 
provided 
YIP IN 
Annes IIA Test and Study Reports 
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Appendix 11  Fonns for use in checking dossien 
for completeness 
Active Substance: 
AnnexiiA 
.point 
4.1.3.4 
4.2.1 
Information, test or study -
circumstances in which required 
·For each method submitted, 
repeatability (at least 5 
determinations)-
* % relative standard deviation (RSD) 
- always required 
* Indication as to whether outliers 
identified have been discarded -
always required 
* reasons for the occurrence of 
outliers - must be attempted where outliers 
are discarded 
Description of  analytical methods for 
the determination of  residues (all 
components included in the residue 
definition proposed (see point 6) to 
enable compliance with :MRLs to be 
determined or to determine 
dislogeable residues - always required 
For each method and representative 
matrix-
*Specificity (using a confirmatory 
method, if  appropriate) 
*Repeatability 
* Validation - independent laboratory 
*  Limit of  determination 
*Individual and mean recovery, 
overall standard deviation and 
relative standard deviation at each 
fortification level 
- required for each method reported 
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Anne1IIA Test and Study Reports 
Applicant:  Date: 
Information,  Justification  Undertaking 
test or study  provided  provided 
provided 
YIP  IN  LIN  Date/N 
Official 
use only 
Data Gap 
YIN 
.r-·  -· Appendix 11  Fonns for use in checldnc dossien 
for completeness 
Active Substance: 
Annex IIA 
point 
4.2.2 
4.2.3 
Infonnation, test or study -
circumstances in which required 
Description of  methods for analysis of 
soil for parent compound and 
metabolites of  toxicological, 
ecotoxicological or environmental 
concern -always required 
For each method -
* Specificity (using a confinnatory 
method, if  appropriate) 
* Repeatability 
* Limit of  determination 
_*_Individual and mean recovery, 
overall standard deviation and 
relative standard deviation at each 
fortification level 
- required for each method reported 
Description of  methods for analysis of 
water (drinking water, ground water 
and surface water) for parent 
compound and metabolites of 
toxicological, ecotoxicological or 
environmental concern - always required 
For each method -
*Specificity (using a confinnatory 
m~thod, if  appropriate) 
* Repeatability 
* Limit of  determination 
* Individual and mean recovery, 
overall standard deviation and 
relative standard deviation at each 
fortification level 
- required for each method reported 
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Appendix 11  Fonns for use in checking dossien 
·  for completeness 
Active Substance: 
Annex IIA 
point 
4.2.4 
4.2.5 
Information, test or study -
circumstances in which required 
Description of methods for analysis of 
air for active substance and 
metabolites, formed during or shortly 
after application, of  toxicological 
concern  -required unless operator exposure, 
worker exposure or bystander exposure are 
unlikely to occur 
· For each method -
* Specificity (using a confirmatory 
method, if  appropriate) 
*Repeatability 
* Limit of  determination 
*  Individual and mean recovery, 
overall standard deviation and 
relative standard deviation at each 
fortification level 
- required for each method reported 
Analytical methods for parent 
compound and toxicologically, 
ecotoxicologicallyor 
environmentally significant 
metabolites in body fluids and tissues 
- required for active substances classified as 
Toxic or Very Toxic 
For each method-
*Specificity (using a confirmatory 
. method, ifnecessary) 
*Repeatability 
*  Limit of determination 
*Individual and mean recovery, 
overall standard deviation and 
relative standard deviation at each 
fortification level 
- required for each method reported 
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Applicant: 
Information, 
test or study 
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. Y/P/N 
Annex IIA Test and S~dy  Reports 
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YIN AppendU 11  - Fonns for use in ~hecldnc dossiers 
for ~ompleteness 
A~tive  Substan~e: 
Annex IIA 
point 
5.1 
Infonnation, test or study -
circumstances in which required 
Toxicokinetic studies -
* Single dose, oral route, in rats 
* Second single dose, oral route, in 
rats 
*  Repeated dose, oral route, in rats 
- always required 
5.2.1  Acute oral toxicity -always required 
5.2.2 
5.2.3 
5.2.4 
5.2.5 
Acute percutaneous toxicity -always 
required 
Acute inhalation toxicity - required 
where the active substance is 
. a gas or liquified gas. 
. is to be used as a fumigant, 
. is to be included in a smoke generating 
aerosol or vapour releasing preparation, 
. is to be used with fogging equipment, 
. has a vapour pressure > 1 x 1  o·
2 Pa and is 
to be included in preparations to be used in 
enclosed spaces such as warehouses or 
glasshouses, 
. is to be included in preparations which are 
powders containing a significant proportion 
of  particles of  diameter < SO J.Ull (> 1 % 
on a weight basis), or 
. is to be included in preparations to be 
applied in a manner which genei-ates a 
signifi.cant proportion of  particles or droplets 
of  diameter < SO  J.Ull (> 1 % on a weight 
basis) 
Skin irritation -required ex~t  where 
severe skin effects may be produced or 
effects can be excluded (see EEC Method B4) 
Eye Irritation - required except where 
severe effects may be produced (see EEC 
Method BS) 
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Appendix 11  . Fonns for use in checking dossiers 
for completeness  · 
Active Substance: 
Annex IIA 
point 
5.2.6 
5.3.1 
5.3.2 
5.3.3 
Information, test or study -
circumstances in which required 
Skin sensitization - required except where 
the active substance is a knowp sensitizer 
Oral 28-day toxicity - where conducted, 
must be submitted 
Oral 90-day toxicity (rat) -always 
required 
Oral 90-day toxicity (dog) -always 
required 
Oral 1 year toxicity (dog) - required 
where in 90-day studies, the dog is more 
sensitive than the rat, where such data are 
likely to be of  value in extrapolating results 
obtained to man 
28-day inhalation toxicity (rat) -for 
volatile substances (vapour pressure > 10"
2 
Pa), expert judgement required to determine 
whether testing by the oral or inhalation is 
required 
90-day inhalation toxicity (rat) -for 
volatile substances (vapour pressure> 10"2 
Pa), expert judgement required to determine 
whether testing by the oral or inhalation is 
required 
Percutaneous 28-day toxicity (rat) -
required where operator exposure by the 
percutaneous route is significant, except 
where a 90-day percutaneous study is 
conducted 
Percutaneous 90-day toxicity (rat)-
required where operator exposure by the 
percutaneous route is significant except where 
the results of  percutaneous 28-day toxicity 
testing indicate low toxicity by the 
percutaneous route 
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Active Substance: 
Arinex IIA 
point 
5.5 
lnfonnation, test or study -
circumstances in which required 
Long-tenn (2 years) oral toxicity in 
the rat (can be a combined long-tenn 
and carcinogenicity study) -required 
unless it is shown that exposure does not 
occur, viz toxicokinetic data demonstrates that 
absorption from the gut. through the skin or 
via the pulmonary system does not occur 
Carcinogenicity study in the rat (can 
be a combined long-tenn and 
carcinogenicity study) -required unless 
it is shown that exposure does not occur, viz 
toxicokinetic data demonstrates that 
absorption from the gut, through the skin or 
via the pulmonary system does not occur 
Carcinogenicity study in the mouse -
required unless it is shown that exposure does 
not occur, viz toxicokinetic data demonstrates 
that absorption :from the gut, through the skin 
or vza the pulmonary system does not occur 
Mechanism of  action and supporting 
data - required where a non-genotoxic 
mechanism for carcinogenicity is suggested 
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Active Substance: 
Annex IIA 
point 
·5.6.1 
5.6.2 
5.7 
5.8.1 
Information, test or study -
circumstances in which required 
Two generation reproductive toxicity 
in the rat -always required 
Supplementary studies -
*  Separate male and female studies 
*  Three segment designs 
*  Dominant lethal assay for male 
fertility 
* Cross-matings of  treated males with 
untreated females and vice versa 
*  Effect on spermatogenesis 
*  Effects on oogenesis 
*  Sperm motility, mobility and 
morphology 
*  Investigation of  hormonal activity 
- required where necessary for a better 
interpretation of  effects on reproduction 
Teratogenicity test by the oral route in 
the rat -always required 
Teratogenicity test by the oral route in 
the rabbit - always required 
Delayed neurotoxicity following acute 
exposure -required for substances of 
similar or related structures to those capable 
of  inducing delayed neurotoxicity such as 
organophosphates 
Toxicity studies on metabolites -
required where as a result of  metabolism in 
plants or as a result of  processing, 
metabolites not fonned in animals occur, 
unless it is shown that a health risk does not 
arise for consumers or workers 
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for completeness 
Active Substance: 
Annex IIA  Information, test or study -
point  circumstances in which required 
5.8.2  Supplementary studies -required in 
particular cases, depending on the results of 
the available toxicological and metabolism 
studies and the most important exposure 
routes 
5.9.1  Report on medical surveillance on 
manufacturing plant personnel -
always required 
5.9.2  Report on clinical cases and poisoning 
incidents -always required 
5.9.3  Observations on exposure of  the 
general population and 
epidemiological studies -required 
where available 
5.9.4  Clirucal signs and symptoms of 
poisoning and details of clinical tests 
- always required 
5.9.5  First aid measures -always required 
Therapeutic regimes -always required 
5.9.6  Expected effects and duration of 
poisoning as a function of  the type, 
level and duration of exposure or 
ingestion -always required 
Expected effects and duration of 
poisoning as a function of varying 
time periods between exposure or 
ingestion and commencement of 
treatment - always required 
5.10  Summary of mammalian toxicity and 
overall evaluation -always required 
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Appendb 11  Fonns for use in cheeldng dosslen 
for completeness 
Active Substance: 
Annex IIA 
point 
6 
6.1 
6.2 
Information, test or study -
circumstances in which required 
Stability of residues during storage of 
samples - required for  . 
.  compounds known to be volatile or labile 
.  samples not frozen within 24  hours of 
sampling or not analyzed within 30 days of 
sampling or in the case of  radio labelled 
material, not analyzed within 6 months of 
sampling 
Stability of  residues in sample extracts 
- required where samples are not analyzed 
within 24 hours of  extraction 
Metabolis~ distribution and 
expression of  residues in plants, in 
at least three crops representative of 
the different categories of  crop (root 
vegetables; leafy crops; fruits; 
pulses and oilseed; cereals) -required · 
unless residues do not re1na.in on plants Or plant 
products used as food or feed 
Metabolism, distribution and 
expression of  residues in livestock -
*  Poultry or lactating ruminants (goat 
or cow) -required where there are 
significant residues in feed(~  0.1 mglkg of  the 
total diet as received) except in special cases 
(e.g. accumulation of active substance) 
*  Pigs - required where metabolic patterns in 
ruminants differ significantly from those in the 
rat 
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Active Substance: 
Annex IIA 
poilit 
6.3 
Information, test or study -
circumstances in which required 
Residue trials (supervised field trials) 
for crops or plant products used as 
food or feed on which use is 
proposed or where residues from 
soil can be taken up 
*  Pre-harvest use on major crops -
trials over two seasons are required; if  use is 
proposed in both regions, at least 8 trials 
representative of  the northern European 
region and a further 8 trials representative of 
the Mediterranean region, are required. 
unless it can be justified that there are no 
residues in the edible part of  the plant, or 
unless extrapolation from adequate data on 
another crop is possible; the number of  trials 
can be reduced where it can be justified that 
the residue levels in plants and plant 
products are lower than the LOQ; where a 
significant part of  the consumable crop is 
present at time of  application, residue 
disappearance curves for half  of  the trials 
are required 
*  Pre-harvest use on minor crops -
trials over two seasons are required; if  use is 
proposed in both regions, at least 4 trials 
representative of  the northern European 
region and a further 4 trials representative of 
the Mediterranean region, are required. 
unless it can be justified that there are no 
residues in the edible part of  the plant, or 
unless extrapolation from adequate data on 
another crop is possible; the number of  trials 
can be reduced where it can be justified that 
the residue levels in plants and plant 
products are lower than the LOQ; where a 
significant part of  the consumable crop is 
present at time of  application, residue 
disappearance curves for half of  the trials 
are required 
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Appendb: 11  Fonns for use In checking dossien 
for completeness 
Active Substance: 
Annex IIA 
point 
6.4 
Infonnation, test or study -
circumstances in which required 
*  Post -harvest uses - at least 4 trials 
carried out at different locations in one 
growing season and with different cultivars 
are required for each application method and 
store type, unless extrapolation from 
adequate data on another stored crop is 
possible 
Livestock feeding studies -
*  Poultry and/or lactating ruminants 
(goat or cow) -required 
. where significant residues occur in crops or 
part of  the crop fed to animals ~  0.1 mglkg of 
the total diet as received) except in special 
cases (e.i. accumulation of  active 
substance), and 
. on the basis of  the metabolism studies it is 
evident that significant residues~ 0.01 
mg/lcg or greater than the LOQ if  that is  > 
0.01 mg/lcg) occur in any edible animal 
tissue, taking into account the residue levels 
in potential feedingstuffs performed at the 
lx dose rate 
*  Pigs - required where metabolic patterns in 
ruminants differ significantly from those in the 
rat, unless the expected intake by pigs is not 
significant 
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Active Substanee: 
Annex IIA 
point 
6.5.1 
6.5.2 
lnfonnation, test or study -
circumstances in which required 
Effects of industrial processing and/or 
household preparation  · 
{representative processing situations) 
on the nature of  the residue - required 
unless 
. the plant or plant product is mostly eaten 
raw (except products with inedible portions 
such as citrus, banana or kiwi fiuit  ), 
. the total TMDI is less than 10 o/o ofthe ADI, 
. no significant residues (> 0.1 mglkg) occur in 
the plant or plant product to be processed, 
or 
. no analytically determinable residues occur 
in the plant or plant product processed 
- required for determinable residues below 0.1 
mglkg where the active substance has high. 
acute toxicity or a low ADI 
Distribution of  the residue in peeVpulp 
- may be required for plant products with inedible 
portions such as citrus, banana or kiwi fiuit 
Effects of industrial processing and/or 
household preparation on residue 
levels 
* Balance studies on a core set of 
representative processes -required 
unless 
. the plant or plant product is mostly eaten 
raw (except products with inedible portions 
such as citrus, banana or kiwi fruit), 
. the total TMDI is less than 10 o/o ofthe ADI, 
. no significant residues (> 0.1 mglkg) occur in 
the plant or plant product to be processed, 
or 
. no analytically determinable residues occur 
in the plant or plant product processed 
- required for determinable residues below 0.1 
mglk.g where the active substance has high 
acute toxicity or a low ADI 
*Follow-up studies to determine 
concentration or dilution factors -
required where the processed product is 
an important part of  the diet and if  a significant 
transfer of  residue into the processed products 
could occur 
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Appendix 11  Fonns for use In checking dossiers 
for completeness 
Active Substance: 
Annex IIA 
point 
6.6 
6.7 
Information, test or study -
circumstances in which required 
Residues in succeeding crops 
*  Theoretical consideration of  the 
nature and level of  the residue-
residue required where data generated in 
accordance with point 7.1, or generated in 
accordance with Annex IliA, point 9.1, show 
that significant residues(> 10% ofthe applied 
active substance as a total of  unchanged active 
substance and its relevant metabolites or 
degradation product) remain in soil or in plant 
materials (e.g. straw or organic material) up to 
sowing OJ:' planting time of  succeeding crops 
and which could lead to residues above the 
LOQ at harvest 
*  Metabolism and distribution studies 
on representative crops - required if  the 
likelihood of  residues in succeeding crops can 
not be excluded 
*  Field trials on representative crops -
required where necessary 
Proposed residue definition -always 
required 
Proposed maximum residue levels 
(MR.Ls) and justification of  the 
acceptability of the levels proposed, 
including details of statistical 
analyses used -always required 
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Active Substance: 
Annex IIA 
point 
6.8 
6.9 
6.10 
Information, test or study -
circumstances in which required 
Proposed pre-harvest intervals, re-
entry intervals or withholding 
periods to minimize residues in 
crops, plants, plant products, treated 
areas or spaces and a justification 
for each proposal 
*Pre-harvest interval (in days) for 
each relevant crop 
*Re-entry period (in days) for 
livestock. to areas to be grazed 
*Re-entry period (in hours or days) 
for man to crops, buildings or 
spaces treated 
*Withholding period (in days) for 
animal feedingstuffs 
*Waiting period (in days) between 
last application and sowing or 
planting the crop to be protected 
*·Waiting period (in days) between 
application and handling treated 
products 
*Waiting period (in days) between 
last application and sowing or 
planting succeeding crops 
- required where risks to man or livestock may 
arise 
Estimation of the potential and actual 
exposure through diet and other 
means-
* TMDI calculations -always required 
* NED I calculations - required unless the 
TMDI calculations demonstrate that the ADI 
will not be exceeded 
Summary and evaluation of residue 
behaviour  - always required 
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Appendb 11  Fonns for use in checkin1 dossiers 
for completeness 
Active Substance: 
Annex IIA  Information. test or study -
point  circumstances in which required 
7  .1.1.1.1  Aerobic degradation in (one) soil -
required except where the manner of  use of 
preparations containing the active substance 
precludes soil contamination 
7  .1.1.1.2  Supplementary soil degradation 
studies-
* Anaerobic degradation -required, if 
exposure to anaerobic conditions is likely 
following use of  preparations containing the 
active substance 
* Soil photolysis -required where 
deposition of  the active substance at the soil 
surface is likely 
7.1.1.2.1  Rate of  degradation in soil-
laboratory studies 
* Aerobic degradation of  the active 
substance at 20 °C in 3 soils 
(additional to the soil used in the 
study at 7  .1.1.1.1) - required except 
where the manner of  use of  preparations 
containing the active substance precludes soil 
contamination, 
* Aerobic degradation of  the active 
substance at 10 °C in 1 of the soils 
used to investigate degradation at 
20 °C -required to investigate the 
Influence of  temperature on degradation, 
except where the manner of  use of 
preparations containing the active substance 
precludes soil contamination (until a 
validated Community validation model 
becomes available) 
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Active Substance: 
Annex IIA 
point 
Information, test or study -
circumstances in which required 
* Aerobic degradation of relevant 
metabolites, degradation and 
reaction products in 3 soils 
(additional to the soil used in the 
study at 7  .1.1.1.1) -required for 
compounds which at any time d1,1ring the 
studies account for more than 10 o/o ofthe 
active substance added except where their 
DT  so values were determined from the 
results of  studies with the active substance 
*  Anaerobic degradation in the soil 
used in the study reported under 
point 7  .1.1.1.2 - required if  exposure to 
anaerobic conditions is likely following use 
of  preparations containing the active 
su!;»stance 
*  Anaerobic degradation of  relevant 
metabolites, degradation and 
reaction products in the soil used in 
the study reported under point 
7  .1.1.1.2 - required for compounds which 
at any time during the studies account for 
more than 10 o/o ofthe active substance 
added except where their DT  so values were 
determined from the results of  studies with 
the active substance 
7.1.1.2.2 ·  Rate of degradation in soil -field 
studies 
Soil dissipation testing in a range of 
representative soils - normally 4 
soils 
- required where DT  solAb determined at 20° 
C and a soil moisture content equivalent to a 
pF value of2 - 2.S > 60 days 
- where use is envisaged in cold climates, 
required where DT  solAb > determined at 
I 0° C and a soil moisture content equivalent 
to a pF value of2- 2.5 > 90 days 
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Appendix 11  Fonns for use In checldn1 dossiers 
for completeness 
Active Substance: 
Annex IIA 
point 
7.1.2 
Infonnation, test or study -
circumstances in which required 
Soil residue testing -required where 
DT  sol..ab is greater than one third of  the 
period between application and harvest and 
where absorption by the succeeding crop is 
possible, unless • 
. soil residues at sowing or planting of  a 
succeeding crop can be  reliably estimated 
ftom the data on soil dissipation. or 
.  it can be shown that the residues concerned 
will not be phytotoxic to or leave 
unacceptable residues in rotational crops 
Soil accumulation, testing on 2 relevant 
soils -required where on the basis of  8oil 
dissipation studies, DT  90f > 1 year and 
repeated application in the same or 
succeeding years is intended, unless reliable 
infonnation is provided using a model 
calculation or another appropriate assessment 
Adsorption and desorption of the 
active substance in four soils -
required except where the manner of  use of 
preparations containing the active substance 
precludes soil contamination 
Adsorption and desorption of all 
relevant metabolites, degradation 
and reaction products in 3 soils -
required for compounds which at any time 
during the soil degradation studies account 
for more than 10% ofthe active substance 
added 
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Active Substance: 
Annex IIA 
point 
7.1.3.1 
7.1.3.2 
7.1.3.3 
Information, test or study -
circumstances in which required 
Column leaching studies with the 
active substance using 4 soils -
required where in the adsorption and 
desorption studies reliable adsorption 
coefficient values were not obtained 
Column leaching studies with relevant 
metabolites, "degradation and 
reaction products using 4 soils -
requiTed where testing is possible for 
compounds which at any time during the soil 
degradation or soil dissipation studies account 
for more than I 0 % of  the active substance 
added, where in the adsorption and 
desorption studies reliable adsorption 
coefficient values were not obtained 
Aged residue column leaching -
required except where -
. the manner ofuse of  preparations 
containing the active substance precludes 
soil contamination, or 
.  separate studies for the metabolites, 
degradation or reaction products were 
performed in accordance with points 7.1.2 
or7.'I.3.1 
Lysimeter studies -expert judgement 
required to decide iflysimeter or field 
leaching studies are required 
Field leaching studies -expert judgement 
required to decide if  field leaching or 
lysimeter studies are required 
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Appendix 11  . Forms for use in checking dosslen 
for completeness 
Active Substance: 
Annex IIA 
point 
7.2.1.1 
7.2.1.2 
Information. test or study -
circumstances in which required 
Hydrolysis rate of relevant 
metabolites, degradation and 
reaction products at pH values 4, 7 
and 9 under sterile conditions, in the 
absence of light 
*  Identity of hydrolysis products 
*  Rate constant observed 
*  Estimated DTso value 
•  required for compounds which at any time 
account for more than 10 o/o of  the active 
substance. unless sufficient information on 
their degradation is available from testing on 
the active substance (point 2.9.1) 
Direct phototransformation of relevant 
metaboUtes, degradation and 
reaction products in water using 
artificial light (simulating sunlight 
and excluding wavelengths A. < 290 
nm) under sterile conditions, to 
include 
*  Photochemical halflife 
*  Mass balance to account for 90 % 
of  the applied radioactivity -unless 
sufficient information on their degradation is 
available from testing on the active 
substance (point 2.9.2 and 2.9.3 
- required for compounds which at any time 
. account for more than 10 o/o of  the active 
substance, and have a molar (  decadic) 
absorption coefficient (E)> 10 (1 X  mor1 X 
em·'), 
*  Identity of breakdown products -
required for compounds which at any time 
during the study are present in quantities > 
10 o/o of  the substance added 
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Part 3  Evaluation Form 3 
AppUc:ant: 
Information, 
test or study 
provided 
YIP IN 
Annex IIA Test and Study Reports 
Date: 
Justification  Undertaking 
provided  provided 
LIN  Date/N 
Official 
use only 
PataGap 
YIN 
·-Appendh 11  Forins for use in checking dossiers 
for completeness 
Active Substance: 
Annex IIA 
point 
Infonnation, test or study -
circumstances in which required 
*  Quantum yield of  direct 
phototransfonnation 
* Calculated theoretical lifetime in the 
top layer of  aqueous systems and 
the real lifetime of  the substance 
added 
- required where necessary to investigate direct 
phototransfonnation 
7.2.1.3.1  · Ready biodegradability of  the active 
substance - required where conducted 
pursuant to the provisions of  Directive 
67/548/EEC 
7.2.1.3.2  Water/sediment study-required unless it 
is justified that contamination of  surface 
water will not occur 
7.2.1.4  Degradation in the saturated zone of 
active substance, metabolites, 
degradation and reaction products -
expert judgement required to determine when 
necessary 
7.2.2  Rate and route of  degradation in air 
7.3 
7.4 
(as far as not covered by point 2.10) 
- no requirements currently specified 
Definition of  the residue - always 
required 
Monitoring data concerning fate and 
behaviour of  the active substance 
and of relevant metabolites, 
degradation and reaction products -
available data must be reported 
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AppUcant: 
Infonnation, 
test or study 
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YIPIN  · 
Annes IIA Test and Study Reports 
.  Date: 
Justification  Undertaking 
provided  provid~ 
LIN  Date!N 
Official 
use only 
Data.Gap 
YIN 
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Appendi.lll  Forms for use ln checking dossiers 
for completeness 
Active Substance: 
Annex IIA 
point 
8.1.1 
8.1.2 
8.1.3  ; 
8.2.1 
Information, test or study -
circumstances in which required 
Acute oral toxicity to a quail species 
(Japanese or Bobwhite), or to 
mallard duck -required unless use is 
intended solely in enclosed spaces 
Avian dieta.Iy toxicity (5-day) test in 
a quail species or in mallard duck -
required unless use is intended solely in 
enclosed spaces or testing in accordance with 
point 8.1.3 is reported 
Avian dieta.Iy toxicity (5-day) test in a 
second unrelated species -required 
where the acute oral NOEL is S 500 mglkg 
body weight or the 5-day NOEC < 500 
mglkgfood 
Subchronic and reproductive toxicity 
to birds -required unless it is justified that 
continued or repeated exposure of  adults or 
of  nest sites during the breeding season is 
unlikely to occur 
Acute toxicity of the active substance. 
to fish-
*  Rainbow trout (Oncorhynchus 
mykiss) 
*  Warm water fish species 
- always required 
Acute toxicity of metabolites, 
degradation or reaction products to 
the more sensitive of the fish species 
used to test the acute toxicity of the 
active substance -required where such 
compounds constitute a relevant risk to flsh 
and their effects are not covered by the tests 
using the active substance 
Analytical data on concentrations in 
the test media -required for all tests 
reported 
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~ex  IIA Test and Study Reports 
Applicant:  Date: 
Information,  Justification  Undertaking 
test or study  ·provided  provided 
provided 
YIP  IN  LIN  Date!N 
Official 
use only 
Data Gap 
Y/N Appendix 11  Fonns for use in checking dossien 
for completeness 
Active Substance: 
AnnexiiA 
point 
8.2.2.1 
8.2.2.2 
8.2.2.3 
8.2.3 
Information, test or study -
circumstances in which required 
Clrronic toxicity (28 day exposure) to 
juvenile fish - growth and behaviour 
- expert judgement necessary to decide if 
testing is required 
Analytical data on concentrations in 
the test media - required for all tests 
reported 
Fish early life stage toxicity test -
expert judgement necessary to decide if 
testing is required 
Analytical data on concentrations in 
the test media - required for aU tests 
reported 
Fish life cycle test - expert judgement· 
necessary to decide if  testing is required 
Analytical data on concentrations in 
the test media - required for all tests 
reported 
Bioconcentration potential of  the 
active substance in fish - required 
where the n-octanol/water partition 
coefficient log Pow~  3, unless it is 
justified that prolonged or repeated exposure 
is unlikely to occur 
Bioconcentrati6n potential of 
metabolites, degradation and 
reaction products - required where the 
n-octanol/water partition coefficient log Pow 
~  3, unless it is justified that prolonged 
exposure is unlikely to occur 
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Annex IIA Test and Study Reports 
AppUcant:  Date: 
lnfonnation,  Justification  Undertaking 
test or study  provided  provided 
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YIP  IN  LIN  Date/N 
Official 
use only 
PataGap 
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Appendix 11  Fonns for use in checking dossiers 
for completeness 
Active Substance: 
Annex IIA 
point 
8.2.4 
Infonnation, test or study -
circumstances in which required 
Acute toxicity to aquatic 
invertebrates -
Acute toxicity (24 and 48 hour) for 
Daphnia preferably (Daphnia 
magna) -always required 
Acute toxicity (24 and 48 hour) for at 
least one representative species from 
each of  the following groups -
*Aquatic insects 
*Aquatic crustaceans (species 
unrelated to Daphnia) 
* Aquatic gastropod molluscs 
- required where preparations containing the 
active substance are to be used directly on 
surface water  -
Analytical data on concentrations in 
the test media -required for all~ 
reported 
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AnnuiiA Test and Study Reports 
AppUcant:  Date: 
lnfonnation,  Justification  Undertaking 
test or study  provided  provided 
provided 
YIP  IN  LIN  Date!N 
Official 
use only 
Data Gap 
Y/N Appendh 11  Fonns for use in checking dossiers 
for completeness 
Active Substance: 
AnnexllA  Information, test or study -
point  circumstances in which required 
'8.2.5  Chronic toxicity to aquatic 
invertebrates -
Chronic toxicity in Daphnia magna 
(21-day) • required unless it is justified that 
continued or repeated exposure is unlikely to 
occur 
Chronic toxicity for at least one 
representative species frOm each of 
the following groups -
*  Aquatic .insects 
• Aquatic gastropod molluscs 
- required unless it  is justified that continued or 
repeated exposure is unlikely to occur 
Analytical data on concentrations in 
the test media -required for all tests 
reported 
8.2.6  Effects on algal growth and growth 
rate -always required 
Effects on algal growth and growth 
rate in a second species -required for 
herbicides 
Analytical data on coacentrations in 
the test media -required for all tests 
reported 
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Anne1 I  lA Test and Study Reports 
AppUcant:  Date: 
Information,  Justification  Undertaking 
test or study  provided  provided 
provided 
YIP  IN  LIN  Date/N 
Official 
use only 
Data Gap 
YIN 
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Appendix 11  Fonns for use in ehecldng dossien 
for eompleteness 
Active Substance: 
Annex IIA  Information, test or study -
point  circumstances in which required 
8.2.7  Effects on sediment dwelling 
organisms 
*Acute test 
* Chronic test 
- required where the active substance is likely 
to partition to and persist in aquatic sediments 
- expert judgement necessary to determine 
whether acute or chronic testing is required , 
Analytical data on concentrations in 
the test media -required for all tests 
reported 
8.2.8  Effects on aquatic plants -required for 
herbicides 
Analytical data on concentrations in 
the test media -required for all tests 
reported 
8.3.1.1  Acute toxicity to bees -
* Acute oral toxicity 
* Acute contact toxicity 
- required except where preparations containing 
the active substance are for exclusive use in 
situations where bees are not exposed 
. food storage in enclosed spaces 
.  non-systemic seed dressings 
.  non-systemic preparations for application to 
soil 
. non-systemic dipping treatments for 
transplanted crops and bulbs 
. wound sealing and healing treatments 
. rodenticidal baits 
. use in glasshouses without pollinators 
8.3.1.2  Bee brood feeding test -required for 
active substances which may act as an insect 
growth regulator. unless it can be justified 
that exposure is unlikely 
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Applicant: 
Infortnation, 
test or study 
provided 
YIP IN 
Annes IIA Test and Study Reports 
Date: 
Justification  Undertaking 
provided  provided 
LIN  Date!N 
Official 
use only 
Data Gap 
YIN 
-
-
-Appendix 11  . Fonns for use In eheddng dossiers 
for completeness 
Active Substance: 
Annex IIA 
point 
8.3.2 
Information, test or study -
circumstances in which required 
Effects on non-target terrestrial 
arthropods using artificial substrates 
* Parasitoid (e.g. Aphidius 
rhopalosipht) 
*Predatory mites(e.g. Typhlodromus 
pyn) 
* Ground dwelling predatory species 
(selected to be relevant to the 
intended uses of  preparations) 
* Foliage dwelling predatory species 
(selected to be relevant to the 
intended uses of  preparations) 
- required unless adverse effects can be clearly 
predicted from other studies, except where 
preparations containing the active substance 
are for exclusive use in situations where 
exposure does not occur 
. food storage in enclosed spaces 
. wound sealing and healing treatments 
. rodenticidal baits 
Effects on non-target terrestrial 
arthropods in extended 
laboratory/semi field tests 
* Parasitoid (e.g. Aphidius 
rhopalosipht) 
* Predatory mites (e.g.  Typhlodromus 
pyn) 
* Ground dwelling predatory species 
(selected to be relevant to the 
intended uses of preparations) 
*Foliage dwelling predatory species 
(selected to be relevant to the 
intended uses of preparations) 
- required for species relevant to proposed uses 
of  preparations, where effects are observed in 
testing with artificial substrates, or where 
adverse effects were predicted from other 
studies and testing using artificial substrates 
was not carried out 
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AppUeant: 
Information, 
test or study 
provided 
YIP IN 
Anne:~IIA  Test and Study Reports 
Date: 
Justification  Undertaking 
provided  provided 
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AppendiJ 11  Fonns for use In checking dossien 
for completeness 
Active Substance: 
Annex IIA  Infonnation, test or study -
point  circumstances in which required 
8.4.1  Acute toxicity to earthwonns -required 
where preparations containing the active 
substance are to be applied to soil or can 
contaminate soil under practical conditions of 
use 
8.4.2  Sublethal effects on earthwonns- expert 
judgement is necessary to determine if  testing is 
required 
8.5  Impact on soil microbial activity 
*  Nitrogen transformation 
*  Carbon mineralization 
- required where preparations containing the 
active substance are to be applied to soil or 
can contaminate soil under practical 
conditions of  use 
Rates of recovery following 
treatment -required for soil steriJants 
8.6  Summary of  all available data from 
preliminary tests used to assess 
biological activity and dose range 
finding, which may provide 
information on other non-target 
species (flora and fauna) -required 
where available 
A critical assessment as to the 
relevance of  the preliminary test 
data to potential impact on non-
target species - required where 
preliminary test data is available 
8.7  Effects on biological methods for 
sewage treatment -required where 
adverse effects on sewage treatment plants 
can occur 
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AppUcant: 
Information, 
test or study 
provided 
Y/P/N 
Anne1IIA Test and Study Reports 
Date: 
Justification  Undertaking 
provided  provided 
LIN  Date/N 
I 
Official 
use only 
Data Gap 
YIN 
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'  '.I'  ~ •• Appendix 11  Fonns for use in checking dossiers 
for completeness 
Active Substance: 
Annex IIA 
point 
9 
10 
Information. test or study -
circumstances in which required 
Summary and evaluation of points 7 
and 8 - always required 
Justified proposals for the 
classification and labelling of  the 
active substance according to 
Directive 67/548/EEC 
*Hazard symbol(s) 
* Indications of  danger 
*  Risk phrases 
* Safety phrases 
- always required 
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Anne1 IIA Test and Study Reports 
AppUcant:  Date: 
Information,  Justification  Undertaking 
test or study  provided  provided 
provided 
YIP IN  LIN  Date/N 
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I Appendix 11 
Part4 
Annex lilA 
point 
1.1 
1.2 
1.3 
-259- Page 1 of SO 
Fonns for use in checking dossiers  Part 4  Evaluation Fonn 4 
for completeness  · 
Evaluation Form 4 -
for use in checking that all test and study 
reports required in accordance with Annex 
IDA have been provided 
Information, test or study -
circumstances in which required 
Applicant (name, address, contact, 
telephone and telefax numbers)-
always required 
Manufacturer(s) of  the preparation 
(name, address, contact, 
telephone and telefax numbers -
always required 
Manufacturer of  the active 
substance(s) (name, address, 
contact, telephone and telefax 
numbers -always required 
Statement of  purity and detailed 
information on impurities -
required where the active substance in the 
preparation is from a manufacturer other 
the manufacturer for which the Annex II 
dossier was submitted  · 
Trade name or proposed trade 
name and manufacturers code 
number(s), for the preparation 
and similar preparations 
(differences to be specified) -
always required 
Infonna~on, 
test or study 
provided 
YIP  IN# 
Annex lilA Test and Study Reports  · 
Prepantion: 
Adive substaace(s): 
Applicant: 
Date: 
Justification  Undertaking 
provided  provided 
LIN#  Date!N# 
Official 
use only* 
Data Gap 
YIN' 
*  To be completed by the Competent Authority of  the Member State to which application is made 
11 
Y =  yes~ P =  in ~  N =  no~ .  L =  location (vohnne and page) where justification can be found~ Date =  date report to 
be submitted 
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Appendix 1l 
I 
Preparation: 
I  Annex IliA 
point 
I 
I 
1.4.1 
I 
I 
I 
I 
I  1.4.2 
I 
I 
I 
I 
I 
I 
I 
I 
Fonns for use In checking dossiers 
for completeness 
Active Substance(s): 
Information, test or study -
circumstances in which required 
Content expressed: 
- for solids, aerosols, volatile liquids 
(maximum boiling point 50° C) or 
viscous liquids (lower limit 1 Pa at 
20° C) as a percentage by weight; 
- for other liquids as a percentage by 
weight and in grams per litre at 
20° C; 
- for gasses as a percentage by 
volume 
*Technical active substance 
* Pure active substance 
* Formulants 
- always required 
ISO common name proposed or 
accepted for active the substances, 
and synonyms -always required 
Existing CIP AC, EINECS and 
ELINCS numbers for the active 
substance( s) - always required 
Salt, ester, anion or cation present 
for each active substance -required 
where relevant 
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Information, 
test or study 
provided 
YIP IN 
Annes IliA Test and 'Study Reports 
AppUcant: 
Justification 
provided 
LIN 
Undertaking 
provided 
Date/N 
Date: 
Official 
use only 
Data Gap 
YIN Appendix 11 
Pr:eparation: 
Annex IliA 
point 
1.4.3 
1.4.4 
1.5 
1.6 
2.1 
2.2.1 
Fonns for use In checking dossiers 
for completeness 
Active Substance(s): 
Information, test or study -
circumstances in which required 
For each fonnulant, or component in 
fonnulants 
* Chemical name as in Annex I to 
Directive 67/548/EEC, if  not 
included in that Annex, in 
accordance with IUPAC and CA 
nomenclature 
* Structure or structural fonnula 
* Existing CAS, CIP AC, EINECS 
..  and ELINCS numbers 
*Trade name 
- always required 
* Specification of  the fonnulant -
required where the infonnation provided 
does not fully identifY a fonnulant 
Function of each fonnulant -always 
required 
Type of preparation and code -always 
required 
Function (herbicide, insecticide 
etc)- always required 
Description of the physical state of 
the preparation and its colour and 
odour - always required 
Explosive properties of the 
preparation - required except where 
available thermodynamic information 
establishes beyond reasonable doubt  that the 
preparation is incapable of  exothermic 
reaction 
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Part 4  Evaluation Form 4 
lnfonnation. 
test or study 
provided 
Y!PfN 
Annex lilA Test and Study Reports 
Applicant: 
Justification 
provided 
LfN 
Undertaking 
provided 
DatefN 
Date: 
Official 
use only 
Data Gap 
Y/N 
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I 
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Appendix 11 
I 
Preparation: 
I 
Annex IliA 
point 
I 
2.2.2 
I 
I 
2.3 
I 
I 
I 
2.4.1 
I 
2.4.2 
I  2.5.1 
I 
2.5.2 
I 
I 
2.5.3 
2.6.1 
I 
I 
Fonns for use in checking dossiers 
for completeness 
Active Substance(s): 
Infonnation, test or study -
circumstances in which required 
Oxidizing 'properties of the 
preparation -.required except where it 
can be shown without reasonable doubt on 
the basis of  thermodynamic infonnation, 
that the preparation is incapable of  reacting 
exothermically with combustible materials 
The flash point of the preparation -
required for liquids that contain flammable 
solvents 
The flammability of the preparation -
required for solid preparations and gases 
The auto-flammability of the 
preparation -required for preparations 
which are gases, liquids and s.olids and 
which are not explosive 
Acidity Qr alkalinity and pH value -
required for preparations which are acidic 
(pH< 4) or alkaline (pH> 10) 
pH of a 1 % aqueous dilution, 
emulsion or dispersion, as 
appropriate -required for preparations 
applied as an aqueous dilution  · 
Kinematic viscosity of the 
preparation -required for preparations 
for ultra low volume (UL  V) use 
Viscosity of the preparation and 
details of the test conditions -
required for non newtonian liquids 
Surface tension of the preparation -
required for liquids 
Relative density of the preparation -
required for liquids 
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· Infonnation, 
test or study 
provided 
YIP IN 
Annex IliA Test and Study Reports 
AppUcant: 
Justification 
provided 
LIN 
Undertaking 
provided 
Date/N 
Date: 
Official 
use only 
Data Gap 
YIN Appendix ll 
Preparation: 
Annex IliA 
point 
2.6.2 
2.7.1 
2.7.2 
2.7.3 
2.8.1 
2.8.2 
.  Fonns for use In checking dossiers 
for  .completeness 
Active Substance(s): 
Information. test or study -
circumstances in which required 
Bulk or tap density of the 
preparation - required for powders and 
granules 
Stability after storage for 14 days at 
54  ° C - always required 
Stability after storage for other 
periods and/or temperatures (e.g. 
eight weeks at 40° C or 12 weeks 
at 35° C)-required if  the preparation is 
heat sensitive 
Minimum content after heat stability 
testing -required where the active 
substance content decreased by more than S 
% in heat stability testing 
Effect of low temperature on 
stability -required for liquid preparations 
Shelf life following storage at 
ambient temperature -always required 
Shelf life in months - required where 
storage life is less than 2 years 
Wettability -required for solid 
preparations which are diluted with water 
for use 
Persistent foaming - required for 
preparations which are diluted with water 
for use 
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Information, 
test or study 
provided 
YIP IN 
Annex IliA Test and Study Reports 
AppUcant: 
Justification 
provided 
LIN 
Undertaking 
provided 
Date/N 
Date: 
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. Data Gap 
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Appendb: 11 
I 
Preparation: 
I 
Annex IliA 
point 
I 
2.8.3 
I 
I 
I 
2.8.4 
I 
2.8.5 
I 
2.8.6.1 
I 
I 
2.8.6.2 
I 
I 
2.8.6.3 
I 
I 
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I 
Fonns for use in checking dossiers 
for c:ompleteness 
Active Substance(s): 
lnfonnation, test or study -
circumstances in which required 
Suspensibility -required for water 
dispersible products (e.g. wettable powders, 
water dispersible granules, suspension 
concentrates) 
Spontaneity of dispersion -required for 
water dispersible products (e.g. suspension 
concentrates) 
Dilution stability -required for water 
soluble products 
Dty sieve test -required for dustable 
powders 
Wet sieve test -required for water 
dispersible products 
Size distribution of  particles -required 
for powders 
Noririnal size range of granules -
required for granules for direct application 
and water dispersible granules 
Dust content -required for granular 
preparations 
Particle size of dust -required for 
granular preparations where relevant to 
operator exposure (point 7.2.1) 
Friability and attrition characteristics 
of granules 
- required when internationally agreed 
methods are available 
- available data, and details ofthe method 
used. always required 
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Infonnation, 
test or study 
provided 
YIP  IN 
Annex IliA Test and Study Reports 
AppUcant: 
Justification 
provided 
LIN 
Undertaking 
provided 
Date/N 
Date: 
Official 
use only 
Data Gap 
Y/N Appendix 11 
Preparation : 
Forms for use in checking dossiers 
for completeness 
Active Substance: 
Annex IliA lnfonnation, test or study -
point  circumstances in which required 
2.8.7.1 
2.8.7.2 
2.8.8.1 
2.8.8.2 
2.8.8.3 
2.9.1 
2.9.2 
2.10 
Emulsifiability - required for preparations 
which fonn emulsions · 
Emulsion stability - required for 
preparations which fonn emulsions 
Re-emulsifiability - required for 
preparations which fonn emulsions 
Stability of  dilute emulsions - required 
for preparations which fonn emulsions 
Stability of  emulsions - required for 
preparations whic~  are emulsions 
Flowability - required for granular 
preparations 
Pourability (including rinsed residue) 
- required for preparations which are 
suspensions (e.g. suspension concentrates, 
suspo-emulsions) 
Dustability following accelerated 
storage - required for dustable powders 
Physical compatibility of  tank 
mixes - required for mixtures to be 
mentioned on product labels 
Chemical compatibility of  tank mixes 
- required for mixtures to be mentioned on 
product labels, except where examination of 
the individual properties of  the preparations 
establishes beyond reasonable doubt that 
there is no possibility of  reaction taking 
place 
Distribution - required for preparations for 
seed treatment 
Adhesion - required for preparations for 
. seed treatment 
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2.11 
3.1 
3.2 
3.3 
3.4 
3.5 
3.6 
Fonns for use in checking dossiers 
for completeness 
Active Substance(s}: 
Information, test or study.-
.circumstances in which required 
Summary and evaluation of  points 
2.1 to 2.10 -always required 
Fields of  use e.g. forestry -always 
required 
Nature of the effects on harmful 
organisms e.g.  contact action -
always required 
Details of  existing and intended uses 
(crops, groups of  crops, plants or 
plant products treated or protected) . 
- always required 
Details of  harmful organisms against 
which protection is afforded -
required where relevant 
Effects achieved e.g. sprout 
suppression -required where relevant 
:Rate of  application per unit (ha, m
2
, 
m
3
,  tonne) treated, in terms of g or 
kg of  preparation and active 
substance -required for each use and 
method of  application 
Concentration of active substance in 
material used (e.g.  diluted spray, 
baits, treated seed) in gil, g/kg, 
mg/kg or gltonne -always required 
Description of  the method of 
application, type of  equipment used 
and type and volume of diluent 
per unit of area or volume - always 
required 
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3.9 
4.1.1 
Fonns for use in checking dossiers 
for completeness 
Active Substance(s): 
Information. test or study -
circumstances in which required 
Maximum number of applications 
and their timing - always required 
For each application, growth stages 
of  the crop or plants to be 
protected - required where timing of 
applications is important 
For each application, development 
stages of  the harmful organism 
concerned - required where timing of 
applications is important 
Duration of protection afforded by 
each application -required where more 
than one application is reconunended 
Duration of  protection afforded by 
the maximum number of 
applications - required where more than 
one application is recommended 
Minimum waiting periods or other 
precautions between last application 
and sowing or planting succeeding 
crops - required where phytotoxic effects 
on succeeding crops may arise 
Limitations on chpice of  succeeding 
crops, if  any - always required 
Proposed instructions for use as 
printed, or to be printed, on 
labels - always required 
Description and specification of  the 
packaging and materials used in 
packaging, size, capacity, size of 
'openings, types of closure and 
seals -always required · 
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4.1.2 
4.1.3 
4.2 
Fonns for use In checking dossiers 
for completeness 
Active Substance(s): 
Information, test or study -
circumstances in which required 
Suitability of the packaging and 
closures 
*Strength 
* Leakproofness 
* Resistance to nonnal transport and 
handling 
- always required 
Resistance of the packaging material 
to its contents -always required 
Procedures for cleaning application 
equipment and protective clothing -
always required 
Effectiveness of the cleaning 
procedures -always required 
-268- Page 10 of  SO 
Part 4  Evaluation Form 4 
Information. 
test or study 
provided 
YIP  IN 
Annex IliA Test and Study Reports 
·AppUcant: 
Justification 
provided 
LIN 
Undertaking 
provided 
Date/N 
Date: 
Official 
use only 
Data Gap 
YIN Appendix 11 
Preparation: 
Annex IliA 
point 
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4.3.2 
·.  Fonns for use In checking dossiers 
for completeness 
Active Substance(s): 
Information, test or study -
circumstances in which required 
Pre-tuurvestintervals, re-en~ 
intervals or withholding periods to 
minimize residues in crops, plants, 
plant products, treated areas or 
spaces 
* Pre-harvestinterval (in days) for 
each relevant crop 
* Re-en~  period (in days) for 
livestock, to areas to be grazed 
* Re-en~  period (in hours or days) 
for man to crops, buildings or 
spaces treated 
* Withholding period (in days) for 
animal feedingstuffs 
* Waiting period (in days) between 
application and handling treated 
products 
*Waiting period (in days) between 
last application and sowing or 
planting succeeding crops 
- required where risks to man or livestock 
may arise 
Information on any specific 
agricultural, plant health or 
environmental conditions under 
which the preparation may or may 
not be used - required where necessary 
in the light of  test results 
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Fonns for use in checking dossiers 
for completeness 
Active Substance(s): 
Information, test or study -
circumstances in which required 
Statement of  the risks arising and the 
recommended methods, precautions 
and handling procedures to 
minimize those risks, relating to 
*  Warehouse storage 
*User level storage 
*Transport 
*Fire 
- always required 
Protective clothing and equipment 
proposed 
*Nature 
~ Characteristics 
- always required 
Sufficient data to evaluate the 
suitability and effectiveness of  the 
protective clothing and equipment 
under realistic conditions of  use -
required where their use is proposed 
Procedures to minimize the 
generation of  waste - always required 
Information on combustion products 
likely to be generated in the event 
of  fire ~required  where the information is 
available 
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4.5 
4.6.1 
Fonns for use In ehec:ldng dossiers 
for completeness 
Aetive Substanee(s): 
Information, test or study -
circumstances in which required 
Detailed procedures for use in the 
event of an accident during 
transport, storage or use 
* Containment of spillages 
*  Decontamination of areas, vehicles 
and buildings 
*  Disposal of damaged packaging, 
adsorbents and other materials 
* Protection of emergency workers 
and bystanders 
*  First aid measures 
- always required 
Neutralization procedures (e.g. 
reaction with alkali to form less 
toxic compounds) for use in the 
event of accidental spillages 
*  Details of proposed procedures for 
small quantities 
*  Evaluation of products of . 
neutralization (small quantities) 
*  Procedures for disposal of 
neutralized waste (small 
quantities) 
* Details of proposed procedures for 
large quantities 
*  Evaluation of products of 
neutralization (large quantities) 
*  Procedures for disposal of 
neutralized waste (large 
quantities) 
- required where such procedures are feasible 
-271- Page 13 of SO 
Part 4  Evaluation Fonn 4 
Information, 
test or study 
provided 
YIP IN 
Annex IliA Test and Study Reports 
AppUeant: 
Justification 
provided 
LIN 
Undertaking 
provided 
Date/N 
Date: 
Official 
use only 
Data Gap 
YIN 
I 
I 
I 
I 
I 
I· 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
Appendix 11 
Preparation: 
Annex IliA 
point 
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4.6.3 
Fonns for use in checking dossiers 
for completeness 
Active Substance(s): 
Infonnation, test or study -
circumstances in which required 
Pyrolytic behaviour of the active 
substance under controlled 
conditions at 800° C and the 
content of poly halogenated 
dibenzo-p-dioxins in the products 
of pyrolysis -required for preparations 
with a halogen content greater than 60 % 
Detailed instructions for safe 
disposal of the plant protection 
product and its packaging -always· 
required 
Methods other than controlled 
incineration for disposal of  the 
plant protection product, 
contaminated packaging and 
contaminated materials -
*  Detailed description of such 
methods 
* Data to establish their effectiveness 
and safety 
- where available 
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for completeness 
Active Substance(s): 
Annex IliA Infonnation, test or study -
point 
5 
5.1.1 
5.1.2 
circumstances in which required 
* Samples of the preparation -required 
where requested 
*  Analytical standards for pure active 
substance - required where requested 
* Samples of  the active substance as 
manufactured -required where requested 
* Analytical standards for relevant 
metabolites and all other 
components included in the residue 
definition - required where requested 
* Samples of reference substances for 
relevant impurities -if  available, 
required where requested 
Description of  analytical methods for 
the determination of  the active 
substance in plant protection 
products -always required 
For preparations containing more than 
one active substance, a description 
of  a method capable of  determining 
each in the presence of  the other 
- required where relevant 
- if  a combined method is not submitted, the 
technical reasons for same must be stated 
Applicability of existing CIP AC 
methods - always required 
Description of  analytical methods for 
the determination of impurities (non-
active components arising from the 
manufacturing process or from 
degradation during storage) which 
are of toxicological, ecotoxicological 
or environmental concern, in the 
preparation - expert judgement required to 
determine if  required 
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5.1.3.2 
5.1.3.3 
Fonns for use In checking dossiers 
for completeness 
Active Substance(s): 
Infonnation,  ~test or study -
circumstances in which required 
Description of analytical methods for 
the determination of  fonnulants or 
constituents of  fonnulants in the 
plant protection product -always 
required where such compounds are of 
toxicological, ecotoxicological or 
environmental significance 
For each method submitted -
*  Specificity 
*  Extent of  interference by other 
substances present in the 
preparation 
*  Explanation of interferences which 
contribute more than ± 3 % of 
the total quantity determined 
•  always required 
For each method submitted, linearity 
over an appropriate range -
*  Equation of  the calibration line 
* Correlation co-efficient 
*  Representative labelled 
documentation e.g. 
chromatograms 
- always required 
For each method submitted, 
accuracy-
*  Pure active substance -always 
required 
*  Impurities - required for toxicologically, 
ecotoxicologically or environmentally 
significant impurities in the preparation 
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for completeness 
Active Substanc:e(s): 
Annex IliA Infonnation, test or study ~ 
point 
5.1.3.4 
5.2 
circumstances in which required 
For each method submitted, 
repeatability (at least 5 
determinations)-
* % relative standard deviation 
(RSD) - always required 
* Indication as to whether outliers 
identified have been discarded -
always required 
* reasons for the occurrence of 
outliers - must be attempted where 
outliers are discarded 
Description of  analytical methods for 
the determination of  residues (all 
components included in the residue 
definition proposed (see point 8) to 
enable compliance with MRLs to 
be determined or to determine 
dislodgeable residues - always requirCd 
For each method and representative 
matrix-
*Specificity (using a confinnatory 
method, if  appropriate) 
* Repeatability 
*Validation- independent laboratory 
* Limit of  determination 
*  Individual and mean recovery, 
overall standard deviation and 
relative standard deviation at 
each fortification level 
- required for each method reported 
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Fonns for use In checldrig dossiers 
·  for completeness . 
Active Substance(s): 
Infonnation, test or study -
circumstances in which required 
Description of methods for analysis of 
soil for parent compound and 
metabolites of toxicological, 
ecotoxicological or environmental 
concern -always required 
For each method -
* Specificity (using a confirmatory 
method, if  appropriate) 
* Repeatability 
* Limit of determination 
* Individual and mean recovery, 
overall standard d~ation  and 
relative standard deviation at each 
fortification level 
- required for each method reported 
Description of methods for analysis of 
water (drinking water, ground water 
and surface water) for parent 
compound and metabolites of 
toxicological, ecotoxicological or 
environmental concern -always required 
For each method -
*Specificity (using a confirmatory 
method, if  appropriate) 
* Repeatability 
* Limit of determination 
*Individual and mean recovery, 
overall standard deviation and 
relative standard deviation at each 
fortification level 
- required for each method reported 
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Active Substance(s): 
Annex IliA Information, test or study -
point 
6 
circumstances in which required 
Description of methods for analysis of 
air for active substance and 
metabolites, formed during or shortly 
after application, of toxicological 
concern - required unless operator exposure, 
worker exposure or bystander exposure are 
unlikely to occur 
For each method -
*  Specificity (using a confirmatory 
method, if  appropriate) 
* Repeatability 
* Limit of  determination 
* Individual and mean recovery, 
overall standard deviation and 
relative standard deviation at each 
fortification level 
- required for each method reported 
Analytical methods for parent 
compound and toxicologically, 
ecotoxicologically or 
environmentally significant 
metabolites in body fluids and tissues 
- required for active substances classified as 
·  Toxzc or Very Toxzc 
For each method-
*Specificity (using a confirmatory 
·method, if  necessary) 
*Repeatability 
* Limit of determination 
* Individual and mean recovery, 
overall standard deviation and 
relative standard deviation at each 
fortification level 
- required for each method reported 
Efficacy data -see subparagraph 3.1.2 (ii) and 
3.2.2 (ii) 
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Forms for use in checkin1 dossiers 
·  for completeness 
Active Substance(s): 
Information, test or study -
circumstances in which required 
Acute oral toxicity - required unless for 
preparations containing a single active 
substance, it may be classified as being Very 
Toxzc,  Toxic or Hannfol, in accordance with 
Article 3 (2) of  Directive 78/631/EEC 
Acute percutaneous toxicity - required 
unless for preparations containing a single 
active substance, it may be classified as 
being Very Toxic, Toxic or Harmfol, in 
accordance with Article 3 (2) of  Directive 
78/631/EEC 
Acute inhalation toxicity to rats -
required where the preparation, or the 
smoke it generates, is 
. a gas or liquefied gas, 
.  is a smoke generating fonnulation or 
fumigant, 
.  is used with fogging equipment, 
.  is a vapour releasing preparation, 
.  is an aerosol, 
.  is a powder containing a significant 
proportion of  particles or diameter < SO 
nun(> 1 %on a weight basis), 
.  is to be applied from aircraft in cases 
where inhalation exposure is relevant, 
.  contains an active substance with a vapour 
pressure > 1 X 1  0"
2 Pa and is to be 
included in enclosed spaces such as 
warehouses or glasshouses, or 
.  is to be applied in a manner which 
generates a significant proportion of 
particles or droplets of  diameter < SO nun 
(> 1%  on a weight basis) 
Skin irritation - required except where 
severe skin effects may be produced or 
effects can be excluded (see EEC Method 
B4) 
Eye Irritation -required except where 
severe effects may be produced (see EEC 
MethodBS) 
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7.1.6 
7.1.7 
7.2.1.1 
7.2.1.2 
Fonns for use In cheddng dossiers 
for completeness 
Active Substance(s): 
Infonnation, test or study -
circumstances in which required 
Skin sensitization -required except where 
the active substance(s) or fonnulants are 
known to have sensitizing properties 
Supplementary studies for 
combinations of plant protection 
products (tests as at points 7  .1.1 to 
7  .1.6) -required in partieular Cases, 
where label reconunendations require use 
with other plant protection products or 
adjuvants as a tank mix to achieve the 
desired effect, 
. depending on the results of  the acute 
toxicity studies for the individual 
products, 
. the likelihood of  exposure to the 
combination, and 
. available infonnation or practical 
experience with the products concerned or 
similar products  , 
Estimation of  operator exposure 
assuming personal protective 
equipment is not used -always 
required 
Estimation of operator exposure 
assuming personal protective 
equipment is used -required where on 
the basis of  the fust estimate, it  is clear that 
the AOEL or TL  V may be exceeded 
Measurement of operator exposure -
required where on the basis of  estimated 
exposure, either the AOEL or TL  V may be 
exceeded, unless. where dermal exposure is 
the most important exposure route, a 
dermal absorption test (point 7.3) permits 
the estimate of  operator exposure to be 
refmed and when refmed it is clear that the 
AOEL will not be exceeded 
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Fonns for use In eheddng dosslen 
for eompleteness 
Active Substanee(s): 
Information, test or study -
.circumstances in which required 
Estimation of bystander exposure 
asswning personal protective 
equipment is not used  -always 
required 
Measurement of  bystander 
exposure -required where on 1he basis of 
estimates, there is cause for concern 
Estimation of worker exposure 
asswning personal protective 
equipment is not used -always 
required 
Estimation of worker exposure 
asswning personal protective 
equipment is used -required where on 
the basis of  the first estimate, it is clear that 
the AOEL may be exceeded 
Estimation of  worker exposure 
assuming personal protective 
equipment is used and using data 
generated on dislodgeable residues 
under the proposed conditions of 
use -required where on the basis of  the 
second estimate, it is clear that the AOEL 
may be exceeded 
Measurement of worker exposure -
required where on 1he basis of  estimated 
exposure, either the AOEL or TL  V may be 
exceeded, unless, where dermal exposure is 
the most important exposure route, a 
dermal absorption test (point 7.3) permits 
the estimate of  worker exposure to be 
refmed and when refmed it is clear that the 
AOEL will not be exceeded 
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7.3 
7.4 
Fonns for use In checking doulen 
for completeness 
Active Substance(s): 
Information, test or study -
circumstances in which required 
Dermal absorption, in vivo in the rat 
- required where on the basis of  estimated 
operator or worker exposure, it  appears that 
either the AOEL or TL  V may be exceeded 
Comparative dermal absorption, in 
vitro using rat and human skin -
required where on the basis of  estimated 
operator or worker exposure, refmed with 
the benefit of  data from the m vivo dennal 
absorption study, it appears that either the 
AOEL or TLV may be exceeded 
Notification and safety data sheet 
submitted in the context of 
Directive 67/549/EEC and 
Commission Directive 91/155/EEC 
for each fonnulant -required where 
available 
Available toxicological data for each 
fonnulant - always required 
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Fonns for use in checking dossiers 
for completeness 
Active Substance(s): 
Information, test or study -
circumstances in which required 
Stability of  residues during storage of 
samples - required for 
. compounds known to be volatile or labile 
.  samples not :frozen within 24 hours of 
sampling or not analyzed within 30 days of 
sampling or in the case of  radiolabelled 
material, not analyzed within 6 months of 
sampling 
Stability of  residues in sample 
extracts - required where samples are not 
analyzed within 24 hours of  extraction 
Supplementary studies on 
metabolism, distribution and 
expression of  residues in plants or 
livestock - required if  it  is not possible to 
extrapolate :from the data provided in the 
context of  points 6.1 and 6.2 of  Annex IIA, 
e.g. for crops or for livestock for which data 
were not submitted for inclusion of  the active 
substance in Annex I, or to amend .the 
conditions of  inclusion, or where it  can be 
expected that a different metabolism will occur 
Supplementary residue trials 
(supervised field trials) for crops 
or plant products used as food or 
feed on which use is proposed -if 
it is not possible to extrapolate 
from the data provided in the 
context of  point 6.3 of  Annex IIA, 
e.g.  special formulations, different 
application methods, additional 
crops-
*  Pre-harvest use on major crops -
trials over two seasons are required; if  use 
is proposed in both regions, at least 8 trials 
representative of  the northern European 
region and a further 8 trials representative 
of  the Mediterranean region, are required, 
unless it can be justified that there are no 
residues in the edible part of  the plant, or 
unless extrapolation from adequate data on 
another crop is possible; the number of 
trials can be reduced where it can be 
justified that the residue levels in plants 
and plant products are lower than the 
LOQ; where a significant part of  the 
consumable  crop is present at time of 
application, residue disappearance curves 
for half of  the trials are required 
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Active Substance(s): 
Annex IliA Information, test or study -
point  circumstances in which required 
8.3 
*  Pre-harvest use on minor crops -
trials over two seasons are required; if  use 
is proposed in both regions, at least 4 trials 
representative of  the northern European 
region and a further 4 trials representative 
of  the Mediterranean region, are required, 
unless it can be justified that there are no 
residues in the edible part of  the plant, or 
unless extrapolation from adequate data on 
another crop is possible; the number of 
trials can be reduced where it can be 
justified that the residue levels in plants 
and plant products are lower than the 
WQ; where a significant part of  the 
consumable crop is present at time of 
application, residue disappearance curves 
for half of  the trials are required 
*  Post  -harvest uses -at least 4 trials 
carried out at different locations in one 
growing season and with different cuhivars 
are required for each application method 
and store type, unless extrapolation from 
adequate data on another stored crop is 
possible 
Supplementary livestock feeding 
studies -if  it is not possible to 
extrapolate from the data provided 
in the context of point 6:4 of 
Annex IIA. e.g. use on additional 
fodder crops is to be authorized, 
leading to an increased intake of 
residues by livestock -
*  Poultry and/or lactating ruminants 
(goat or cow)- required if 
.  where significant residues occur in crops or 
part of  the crop fed to animals (2: 0.1 mglkg 
of  the total diet as received) except in special 
cases (e.g. accumulation of  active 
substance}, and 
on the basis of  the metabolism studies it 
is evident that significant residues (2: 0.01 
mglkg or greater than the WQ if  that is 
> 0.01 mglkg) occur in any edible 
animal tissue, taking into account the 
residue levels in potential feedingstuffs 
performed at the 1  x dose rate 
I 
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for completeness 
Active Substance(s): 
Information, test or study -
circumstances in which required 
*  Pigs -required where metabolic patterns 
in ruminants differ significantly from those in 
the rat, unless the expected intake by pigs is 
not significant 
Supplementary studies on the effects 
of industrial processing and/or 
household preparation on residue 
levels -if  it is not possible to 
extrapolate from the data provided 
in the context of point 6.5 of 
Annex IIA, e.g. crops for which 
data were not submitted for 
inclusion of  the active substance in 
Annex I, or to amend the 
conditions of inclusion -
* Effects of industrial processing 
and/or household preparation 
(representative processing 
situations) on the nature of  the 
residue -required unless 
. the plant or plant product is mostly eaten 
raw (except products with inedible portions 
such as citrus. banana or kiwi fiuit). 
. the total TMDI is less than 10% ofthe ADI  • 
. no significant residues (> 0.1 mglkg) occur in 
the plant or plant product to be processed, 
or 
. no analytically determinable residues occur 
in the plant or plant product processed 
- required for determinable residues below 0.1 
mglkg where the active substance has high 
acute toxicity or a low ADI 
* Distribution of the residue in 
peel/pulp - may be required for plant 
products with inedible portions such as citrus. 
banana or kiwi fruit 
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Aetive Substanee(s): 
lnfonnation. test or study -
circumstances in which required 
* Balance studies on· a core set of 
representative processes -required 
unless 
. the plant or plant product is mostly eaten 
raw (except products with inedible portions 
such as citrus, banana or kiwi ftuit), 
. the total TMDI is less than 10% of  the ADI, 
. ·no significant residues (> 0.1 mglkg) occur in 
the plant or plant product to be processed, 
or 
. no analytically detenninable residues occur 
in the plant or plant product processed 
- required for detenninable residues below 
0.1 mglkg where the active substance has 
high. acute toxicity or a low ADI 
*Follow-up studies to determine 
concentration or dilution factors -
required where the processed product is 
an important part of  the diet and if  a 
significant transfer of  residue into the 
processed products could occur 
Supplementary studies for residues in 
representative succeeding crops -
required if  it is not possible to extrapolate 
from the data provided in the context of 
point 6.6 of  Annex IIA. e.g. special 
formulations, different application methods, 
additional crops 
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for completeness 
Preparation:  Active Substanee(s): 
Annex IliA Information, test or study -
point  circumstances in which required 
8.6  Proposed residue definition -always 
8.7 
required 
Proposed maximum residue levels 
(MRLs) and justification of  the 
acceptability of  the levels 
proposed, including details of 
statistical analyses used - always 
required 
Proposed pre-harvest intervals, re-
entry intervals or withholding 
periods to minimize ·residues in 
crops, plants, plant products, 
treated areas or spaces and a 
justification for each proposal 
*Pre-harvest interval (in days) for 
each relevant crop 
*Re-entry period (in days) for 
livestock, to areas to be grazed 
*Re-entry period (in hours or days) 
for man to crops, buildings or 
spaces treated 
*Withholding period (in days) for 
animal feedingstuffs. 
*Waiting period (in days) between 
last application and sowing or 
planting the crop to be protected 
* Waiting period (in days) between 
application and handling treated 
products 
* Waiting period (in days) between 
last application and sowing or 
planting succeeding crops 
- required where risks to man or livestock 
may arise 
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8.9 
. Forms for use In checking dossiers 
for completeness 
Active Substance(s): 
Information, test or study -
circumstances in which required 
Estimation of  the potential and actual 
exposure through diet and other 
means-
*  TMDI calculations -always required 
*  NED I calculations - required unless 
the TMDI calculations demonstrate that the 
ADI will not be exceeded 
Summary and evaluation of  residue 
behaviour -always required 
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Forms for use in checking dossiers 
for completeness 
Active Substance(s): 
Information, test or study -
circumstances in which required 
Rate of degradation in soil -if  it is 
not possible to extrapolate from the 
data provided for the active 
substance and relevant metabolites, 
degradation and reaction products 
in the context of point 7.1.1.2.1 of 
Annex IIA. (e.g.  slow release 
formulations) -
Aerobic degradation of the 
preparation in soil -required except 
where the manner of  use ofthe preparation 
precludes soil contamination 
Anaerobic degradation of the 
preparation in soil -required if 
exposure to anaerobic conditions is likely 
following use of  the preparation 
Field studies -
Soil dissipation testing on a range of 
representative soils - normally 4 
soils -required if  it is not possible to 
extrapolate from the data provided in the 
context of  point 7.1.1.2.2 of  Annex IIAfor 
the active substance and relevant 
metabolites, degradation and reaction 
products (e.g. slow release formulations), 
where DTsoLib determined at 20 °C and a 
soil moisture content equivalent to a pF 
value of  2 - 2  .  .5 > 60 days 
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Fonns for use In checking dossiers 
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Active Substance(s): 
Infonnation. test or study -
circumstances in which required 
Soil residue testing - required if  it is not 
possible to extrapolate from the data 
provided in the context of  point 7.1.1.2.2 
of  Annex IIA for the active substance and 
relevant metabolites, degradation and 
reaction products (e.g. slow release 
formulations), where DT5oLib is greater 
than i the period between application ud 
harvest and where absorption by the 
succeeding crop is possible, unless -
soil residues at sowing or planting of  a 
succeeding crop can be reliably estimated 
from the data on soil dissipation, or 
it can be shown that the residues 
concerned will not be phytotoxic to or 
leave unacceptable residues in rotational 
crops 
Soil accumulation testing on 2 
relevant soils - required if  it is not 
possible to extrapolate from the data 
provided in the context of  point 7.1.1.2.2 
of  Annex IIA for the active substance and 
relevant metabolites, degradation and 
reaction products (e.g. slow release 
formulations),~  on the basis of  soil 
dissipation studies DT  90f > I _year and 
repeated application in the same or 
succeeding years is intended, unless reliable 
information can be provided using 
calculations (model) or another appropriate 
assessment 
Mobility of  the plant protection 
product in soil - Column leaching 
studies 
- required if  it is not possible to extrapolate 
from the data provided in the context of 
point 7.1.2 and 7.1.3.1 of  Annex IIAfor 
the active substance and relevant 
metabolites, degradation and reaction 
products (e.g. slow release formulations) 
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. Forms for use in checking dosslen 
for completeness 
Active Substance(s): 
Information, test or study -
circumstances in which required 
Lysimeter studies-expert judgement 
required to decide whether lysimeter or 
field leaching siudies are required 
Field leaching studies - expert 
judgement required to decide whether field 
leaching or lysimeter studies are required 
- a study is required where it is not possible 
to extrapolate from the dat& provided in the 
context of  Annex IIA point 7  .1.3 (e.g. slow 
release formulations) 
Predicted environmental 
concentrations in soil (PECs) for 
the active substance at the highest 
rate of  application proposed and 
relating to the maximum number 
and highest rates of  application 
proposed, for each relevant soil 
tested-
*  Initial PECs value 
* Short-term PECs values - 24 
hours, 2 days and 4 days after last 
application 
*  Long-term PECs values - 7, 28, 
50 and 100 days after last 
application 
- required where contamination of  soil may 
occur 
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Fonns for use In checking dossiers 
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Active Substance(s): 
Information, test or study -
circumstances in which required 
Predicted environmental 
concentrations in soil (PECs) for 
relevant metabolites, degradation 
and reaction products, at the 
highest rate of  application proposed 
and relating to the maximum 
number and highest rates of 
application proposed, for each 
relevant soil tested-
*  Initial PECs value 
*  Short-term PECs values - 24 
hours, 2 days and 4 days after last 
application 
*  Long-term PECs values - 7, 28, 
50 and 100 days after last 
application 
- required where contamination of  soil may 
occur 
Predicted environmental 
concentrations in ground water 
(PECaw) at the highest rate of 
application proposed and relating to 
the maximum number and highest 
rates of application proposed -
* Active substance 
*  Relevant metabolites, degradation 
and reaction products 
- required where contamination of  soil can 
occur 
Additional field testing -expert 
judgement required to decide whether 
testing is required 
Information on impact on water 
treatment procedures -required in the 
context of  conditional authorizations to be 
granted in accordance with Annex VI. Part 
c. point 2.5.1.2 (b) 
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9.2.3 
Fonns for use in eheddng dossien 
for completeness 
Active Substance(s): 
Infonnation, test or study -
circumstances in which required 
Predicted environmental 
concentrations in surface water 
{PECsw) for the active substance 
at the highest rate of application 
proposed and relating to the 
maximum number and highest rates 
of application proposed, relevant to 
lakes, ponds, rivers, canals, 
streams, irrigation/drainage canals 
and drains-
* Initial PECsw value for static 
·  water bodies 
*  Initial PECsw value for slow 
moving water bodies 
*  Short-tenn PECsw values for 
static water bodies - 24 hours, 2 
days and 4 days after last 
application 
*  Short-tenn PECsw'values for slow 
moving water bodies - 24 hours, 2 
days and 4 days arter last 
application 
*  Long-tenn PECsw values for static 
water bodies- 7, 14, 21, 28, 42 
days after last application 
*  Long-term PECsw values for slow 
moving water bodies- 7,  14, 21, 
28, 42 days after last application 
- required where contamination of  surface 
water may occur 
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for completeness 
Active Substance(s): 
Information, test or study -
circumstances in which required 
Predicted environmental 
concentrations in surface water 
(PECsw) for relevant metabolites, 
degradation and reaction products 
at the highest rate of  application 
proposed and relating to the 
maximum number and highest rates 
of application proposed, relevant to 
lakes, ponds, rivers, canals, 
streams, irrigation/drainage canals 
and drains-
· *  Initial PECsw value for static 
water bodies 
*  Initial -PECsw value for slow 
moving water bodies 
*  Short-term PECsw values for 
static water bodies - 24 homs, 2 
days and 4 days after last 
application 
* Short-term PECsw values for slow 
moving water bodies - 24 hours, 2 
days and 4 days after last 
application 
*  Long-term PECsw values for static 
water bodies- 7,  14, 21, 28, 42 
days after last application 
*  Long:.term PECsW values for slow 
moving water bodies - 7,  14, 21, 
28, 42 days after last application 
- required where contamination of  surface 
water can occur 
Additional field testing -expert 
judgement required to decide whether 
testing is required 
Fate and behaviour in air-
requirements being developed 
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Fonns for use in cheddng dossiers 
for completeness 
Active Substance(s): 
Infonnation, test or study -
circumstances in which required 
Acute toxicity exposure ratio (TE~) 
for birds - required unless exposure of 
birds can be precluded (e.g. use in enclosed 
spaces, wound healing treatments) 
Short-tenn toxicity exposure ratio 
(TERs-r) for birds - required unless 
exposure of  birds can be precluded (e.g. 
use in enclosed spaces, wound healing 
treatments) 
In the case of  baits, the 
concentration of  active substance in 
the bait in mglkg - always required 
In the case of  pellets, granules, priUs 
or treated seed -
* Amount of  the active substance in 
or on each pellet, granule, prill or 
treated seed 
*  Proportion of  the LDso for the 
active substance in 100 particles 
and per gram of  particles 
- always required 
In the case of  pellets, granules, and 
priUs, their size and shape -always 
required 
Acute oral toxicity of  the preparation 
to the more sensitive of  the species 
identified in tests with the active 
substance (Annex IIA points 8.1.1 
and 8.1.2) -required where TE~  or 
TER.s-r for the active substance are 
between 10 and 100 or where results from 
testing in rnanunals provided evidence of 
significantly greater toxicity of  the 
preparation compared to the active 
substance, unless it is justified that birds are 
unlikely to be exposed to the plant 
protection product 
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Fonns for u5e In checking dossien 
for completeness 
Active Substance(s): 
Information, test or study -
circumstances in which required 
Supervised cage or field trials 
- required where the TE~  or TERs-r ~  10 
or the TERt.T ~  5 for the active substance 
· - expert judgement required where TE~  or 
TERs-r for the active substance is between 
10 and 100 
- not required where TERA or TERs-r for the 
active substance is > 100 and there is no 
evidence of  risk from any further study on 
the active substance (e.g. reproduction 
study- Annex IIA point 8.1.3) 
Acceptance of  bait, granules or 
treated seeds by birds (palatability 
test) -required for seed dressings, baits 
and granules, where the TE~  for the 
active substance ~  10 
Effects of secondary poisoning -
expert judgement required to decide when 
required 
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.  Fonns for use in checking dossiers 
for completeness 
Active Substance(s): 
Information, test or study -
circumstances in which required 
Toxicity exposure ratios for aquatic 
species 
*  TE~  for fish 
*  TER.t.T for fish 
*  TE~  for Daphnia 
*  TER.t.T for Daphnia 
*  TE~  for an aquatic insect species 
*  TER.t.T for an aquatic insect 
species 
*  TE~  for an aquatic crustacean 
species 
*  TER.t.T for an aquatic crustacean 
species 
*  TE~  for an aquatic gastropod 
mollusc species 
*  TER.t.T for an aquatic gastropod 
mollusc species 
*  TER.t.T for algae 
- required where contamination of  water can 
occur, for both static and slow moving 
water bodies 
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Fonns for use In cheddng dossiers 
for completeness 
Active Substance(s): 
Information, test or study -
circumstances in which required 
Acute toxicity (aquatic) of the 
preparation - unless testing in 
accordance with point 10.2.4 is reported, 
required for one species from each group 
(fish, aquatic invertebrate and algae), ifthe 
plant protection product itSelf can 
contaminate water, where • 
. the acute toxicity of  the preparation 
cannot be predicted on the basis of  data 
on the active substance • especially the 
case if  the formulation contains more than 
one active substance, or fonnulants such 
as solvents, emulgators, surfactants 
dispersants or fertilizers which may 
enhance toxicity, or 
. the intended use includes direct 
application to water 
•  except where information found during 
testing with the active substance (Annex IIA 
point 8.2.1, 8.2.4, 8.2.6) is indicative of  one 
group being significantly more sensitive, when 
testing on a species from that group suffices 
Microcosm or mesocosm study -
required where TERA ~  100 or where 
TERLT ~  10.  Expert judgement is 
required to decide whether a microcosm or 
mesocosm study is appropriate 
Residue data in fish (long term 
microcosm or mesocosm study) -
expert judgement is necessary to decide 
when required 
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Preparation: 
Annex IliA 
point 
10.2.4 
·Forms for use in cheddng dossiers 
for completeness 
Active Substance(s): 
lnfonnation, test or study • 
circumstances in which required 
Clrronic toxicity (28 day exposure) 
to juvenile fish - expert judgement 
necessary to determine if  required in 
circumstances where testing with 
I 
the active substance was required and if  it 
is not possible to extrapolate from data 
relevant to the active substance (Annex IIA 
point 8.2.2.1) 
Analytical data on concentrations in 
the test media -required for all tests 
reported 
Fish early life stage toxicity test • 
expert judgement necessary to determine if 
required in circumstances where testing with 
the active substance was required and if  it is 
not possible to extrapolate from data relevant 
to the active substance (Annex IIA point 
8.2.2.2) 
Analytic31 data on concentrations in 
the test media -required for all tests 
reported 
Fish life cycle test·  expert judgement 
necessary to determine if  required in 
circumstances where testing with the active 
substance was required and if  it  is not possible 
to extrapolate from data relevant to the active 
substance (Annex IIA point 8.2.2.3) 
Clrronic toxicity to aquatic 
invertebrates - · 
* Clrronic toxicity in Daphnia magna 
(21-day) 
* Clrronic toxicity for a 
representative species of  aquatic 
insects 
* Clrronic toxicity for a 
representative species of aquatic 
gastropod molluscs 
•  expert judgement necessary to determine if 
required in circumstances where testing with 
the active substance was required and if  it is 
not possible to extrapolate from data relevant 
to the active substance (Annex IIA point 8.2.5) 
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Fonns for use in eheeldnr: dossien 
for completeness 
Adive Substanee(s): 
Information, test or study -
circumstances in which required 
Effects on terrestrial vertebrates 
other than birds 
*  Acute toxicity exposure ratio 
{1ER,..) -required unless it  is justified 
that direct or indirect exposure is unlikely 
(e.g. use in enclosed spaces) 
*  Short-tenn toxicity exposure ratio 
{lERs,.) -required unless it  is 
justified that direct or indirect exposure is 
unlikely (e.g. use in enclosed spaces) 
*  Long-tenn toxicity exposure ratio 
(1ER.z_T) - required unless it  is 
justified that direct or indirect exposure is 
unlikely (e.g. use in enclosed spaces) 
Toxicity to terrestrial vertebrates 
other than birds, where the 
required information is not 
provided by testing in accordance 
with Annex II, section 5, and 
Annex III, section 7 and where 
exposure is likely -
*  Acute oral toxicity of  the 
preparation 
* Acceptance of  bait, granules or 
treated seeds by terrestrial 
vertebrates (palatability test) 
* Effects of secondary poisoning 
. - not required where TE~  or TERsT > 
I  00 for the active substance and there is no 
evidence of  risk from any other study 
- expert judgement required in other cases 
* Supervised cage or field trials or 
other appropriate studies - required 
where the TE~  or TERsT ~  10 or 
TERLT ~  S for the active substance 
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Preparation: 
Annex IliA 
point 
10.4 
10.4.1 
10.4.2 
Fomu~  for use in checking dossiers 
for completeness 
Adive Substance(s): 
Information, test or study -
circumstances in which required 
Hazard Quotients for bees 
*  Oral exposure ~o 
* Contact exposure ~c 
- required unless the preparation is for 
exclusive use in situations where bees are 
unlikely to be exposed 
. food storage in enclosed spaces 
. non-systemic seed dressings 
. non-systemic preparations for application to 
soil 
. non-systemic dipping trei.tments for 
· transplanted crops and bulbs 
. wound sealing and healing treatments 
. rodenticidal baits 
.  use in glasshouses without pollinators. 
Acute toxicity of  the preparation to 
bees-
* Acute oral toxicity 
*  Acute contact toxicity 
- required the preparation contains more than 
1 active substance, or 
- required if  the toxicity of  the preparation 
cannot be reliably predicted to be the same 
or lower than a preparation tested in 
accordance with Annex IIA point 8.3.1.1 or 
this point 
Effects on bees of residues on 
crops - where OHc  ~  SO, expert 
judgement required to determine if  testing 
is required, unless there are no significant 
residues on crops which could effect 
foraging bees or sufficient information is 
available from testing in accordance with 
points 10.4.3, 10.4.4 and 10.4.5 
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Fonns for use in eheeking dossiers 
for eompleteness 
Aetive Substanee(s): 
Information, test or study-
circumstances in which required 
Cage tests 
- where conducted they must be reported 
- required where the Olio and ONe are > 
50 
- not required where field tests are conducted 
(point 10.4.4) 
- not required where the Olio and ONe are 
< 50, unJess significant effects are 
observed in the bee brood feeding test 
(Annex IIA point 8.3.1.2), or if  there are 
indications of  indirect effects such as 
intoxication through nectar, poUen or 
other residues. delayed action or 
modification ofbee behaviour 
Field tests -taking account of  the proposed 
manner of  use and fate and behaviour of  the 
active substance, required where on the 
basis of  expert judgement, significant 
effects are seen in cage testing 
Investigation of special effects -
*  Larval toxicity 
*  Long residual effects 
*  Disorienting effects on bees 
- required where on the basis of  expert 
judgement, effects identified in field testing 
require further investigation 
Tunnel testing to investigate effects 
of  feeding on contaminated honey 
dew or flowers - required where it is 
not possible to investigate certain effects in 
cage or field trials e.g. preparations for 
control of  aphids and other sucking insects 
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Preparation: 
Annex IliA 
point 
10.5.1 
Fonns for use In checking dossier! 
for completeness 
Active Su~stance(s): 
Information, test or study -
circumstances in which required 
Effects on arthropods other than bees 
- not required where > 99 o/o effect can be 
predicted from relevant available data 
· - not required where preparations containing 
the active substance are for exclusive use in 
situations where exposure does not occur 
. food storage in enclosed spaces 
. wound sealing and healing treatments 
. ·  rodenticidal baits 
- required when significant effects were 
observed (~  30 o/o) in the Annex IIA point 
8.3.2 tests 
- required if 
. the preparation contains more than 1 
active substance 
. the toxicity of  a new preparation cannot 
be reliably predicted to be the same or 
. lower than the fonnulation tested in 
accordance with Annex IIA point 8.3.2 or 
this point 
.  continued or repeated exposure can be 
anticipated 
. there is a significant change in the 
proposed use (e.g. from arable crops to 
orchards) and species relevant to the new 
use have not been tested 
. an increase in the recommended 
application rate. compared to that tested 
under Annex IIA point 8.3 .2; is proposed 
Effects on the 2 most sensitive 
species already tested, using 
artificial substrates -required for new 
mixtures or fonnulations. where effects 
seen in testing in accordance with Annex 
IIA point 8.3.2 were> 30 o/o but< 99 o/o 
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Forms for use ln checking dossiers 
for completeness 
Actin Substance(s): 
Information, test or study -
circumstances in which required 
Effects on the 2 additional species 
relevant to the proposed uses of the 
preparation, using artificial 
substrates 
- required where effects seen in testing in 
accordance with Annex IIA point 8.3.2 
were > 30 %but < 99 %, or 
- required in the case of  a change of  use (e.g. 
from arable crops to orchards) 
- also required for new mixtures or 
formulations, where the new mixture or 
formulation is significantly more toxic than 
that tested in accordance with Annex IIA 
point 8.3.2 
Effects on non-target terrestrial 
arthropods in extended laboratory 
tests -expert judgement required to 
determine when required 
Effects on non-target terrestrial 
arthropods in semi-field tests -
expert judgement required to determine 
when required 
Field tests on arthropod sj>ecies -
expert judgement required to determine if 
testing is necessary 
Toxicity exposure ratios for 
earthworms, TER.,.. and TE:Rt.T -
required, unless it is justified that direct or 
indirect exposure is unlikely 
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Preparation: 
Annex IliA 
point 
10.6.1.1 
10.6.1.2 
10.6.1.3 
· . Fonns for use In checking dossiers 
for completeness 
Active Substance(s): 
Infonnation, test or study -
circumstances in which required 
Acute toxicity to earthwonns -
required, unless it is justified that direct or 
indirect exposure is unlikely, where 
. the preparation contains more than 1 
active substance 
. the toxicity of  a new preparation cannot 
be reliably predicted from the formulation 
tested in accordance with Annex IIA point 
8.4 or this point 
Sublethal effects on earthworms -
required, unless it is justified that direct or 
indirect exposure is unlikely, where 
. the preparation contains more than one 
active substance 
. the toxicity of  a new formulation cannot 
be reliably predicted form tests carried out 
in accordance with Annex IIA point 8.4 
or this point 
. the application rate is to be increased 
relevant to that previously tested 
Field tests (effects on  earthworms)-
required, unless it is justified that direct or 
indirect exposure is unlikely, where the 
long-term toxicity/exposure ratio for the 
active substance (TERLT) < S 
Residue content of earthwormS -
expert judgement necessary to determine if 
requ~red 
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10.7.1 
10.7.2 
Fonns for use in c:hec:ldng dossiers 
for completeness 
Active Substanc:e(s): 
Infonnation. test or study -
circumstances in which required 
Effects on other soil non-target 
macro-organisms -required unless 
. DT  90 values detennined in accordance 
with point Annex IllA. point 9.1 are less 
than 100 days, 
. the nature of  the preparation or its manner 
of  use are such that exposure does not 
occur, or 
. relevant Annex IIA data (points 8.3.2, 8.4 
and 8.S) indicates that a risk does not 
arise for earthworms, soil macroflora or 
soil microflora 
Effect on organic matter 
breakdown -required where DT  9or 
values determined in accordance with Annex 
IllA point 9.1 are> 36S days 
Laboratory test to investigate impact 
on soil microbial activity - required 
where DT  90f values detennined in 
accordance with Annex IliA point 9.1 > 100 
days, unless deviations from the control values . 
in testing in accordance with Annex IIA point 
&.S after 100 days< 2S% and the data 
generated is relevant to the preparation, its 
uses and manner of  use 
Further laboratory, glasshouse of 
field testing to investigate impact 
on soil microbial activity -may be 
required where at the end of  100 days, 
measured activity deviates by more than 25 
% iri laboratory testing 
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Preparation: 
Annex IliA 
point 
10.8 
: Fonns for use in checking dossiers 
for completeness 
Adive Substance(s): 
Information, test or study -
circumstances in which required 
Summary of  availa~le data from 
preliminary tests used to assess 
biological activity and dose range 
finding, which may provide 
information on other non-target 
species (flora and fauna) -required 
where availabl~ 
A critical assessment as to the 
relevance of  the preliminary test 
data to potential impact on non-
target species - required where 
preliminary test data is available 
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YIN Appendix ll 
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Annex IliA 
point 
11 
· Fonns for use In checking dossiers 
for completeness 
Active Substance(s): 
Information, test or study -
circumstances in which required 
Summary and evaluation of points 9 
and 10, together with a detailed 
and critical assessment of the data 
to include-
*  Predicted distri~ution and fate in 
the environment and the time 
courses involved 
*  Non-target species at risk and 
extent of potential exposure 
*  Short and long term risks for non-
target species, populations, 
communities and processes 
*  Risk of  fish kills and fatalities in 
large vertebrates or terrestrial 
predators 
*  Precautions necessary to avoid or 
minimize contamination of  the 
environment and for the 
protection of non-target species 
- always required 
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Annex IliA 
point 
12.1 
12.2 
12.3 
12.4 
12.5 
Fonns for use in checking dosslen 
for completeness 
Active Substance(s): 
Information, test or study -
circumstances in which required 
Information on authorizations in 
other countries (see Initial 
Evaluation Form 1 - document D-2) 
- always required 
Information on established :MR.Ls in 
other countries (see Initial 
Evaluation Form 1 - documents 
E-1 and E-2) -always required 
Justified proposals for the 
classification and labelling of  the 
preparation according to Directive 
67/548/EEC and Directive 
78/631/EEC 
*  Hazard symbol(s) 
*  Indications of  danger 
*  Risk phrases 
*  Safety phrases 
- always required 
Proposals for risk and safety phrases 
in accordance with Article 15 (1), 
(g) and (h) -always required 
Proposed label (see Initial Evaluation 
Form 1 - document C) - always 
required 
Specimens of  proposed packaging -
required where application is being made for 
the auhorization of  plant protection product 
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for eomple~ess 
Part 5  Evaluation Fonn 5 Tier I Quality Checks 
PartS 
Test or 
Study Point 
1.1 
Evaluation Form 5 -
for use in checking that the Tier I 
quality checks for individual tests and 
studies are of acceptable quality 
18 
Description of  the requirement 
The Annex II or Annex III point addressed 
·Active Substance 
AppUeant: 
Date: 
1.2  A descriptive title of  the type of  test or study 
2 
3.1 
3.2 
3.3 
3.4 
3.5 
3.6 
4.1 
4.2 
5.1 
5.2 
6.1 
Reference point (location) of  the report in the dossier (e.g. volume, section and 
Annex point) 
The names of  the authors 
The title of  the report 
The owner of  the test or study report 
An indication as to whether it is a published or unpublished report 
The report number 
The date of  the report 
The name and address of  the testing facility 
The laboratory report/project number 
The dates of  commencement and completion of  experimental work 
A statement of  the objectives of  the test or study 
The identity of  the test substance or material (ISO common name, batch number and 
degree of  purity) 
6.2  An explicit reference to the relevant specification of  composition of  the test substance 
or material 
6.3  Where available, data relevant to the storage stability of  the test substance or material 
# Y =  yes~  N =  no 
18  Relevant for tests and studies for which the test methods used were not those currently specified (e.g. certain older studies) 
Provided 
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for completeness 
PartS  .Evaluation FormS Tter I Quality Checks 
Active Substance:  Applicant:  Date: 
Test or Study Tide:  Anaex Point: 
Test or 
Study Point  · 
6.4 
6.5 
6.6 
6.7 
Description of the requirement 
Where relevant and available, data as to the stability of the test substance or material 
in the dosing vehicle 
Where relevant and available, data as to the homogeneity of the test substance or 
material in the dosing or. testing vehicle 
·Where data relating to the stability or homogeneity of the test substance is not 
available (e.g. certain older studies), a justification of  the scientific validity of  the 
study 
Where relevant, information as to the physical form of  the test substance or material 
6. 8  Full details of the composition of any dosing vehicles or solvents used 
7.1 
7.2 
7.3 
7.4 
7.5 
8.1 
8.2 
8.3 
The identity of the test method used 
Where not a method specified in Annex II, or Annex m, a reasoned justification for 
the choice of method used in terms of its scientific validity and comparability with 
the method specified in Annex II or Annex III 
On request, a copy of the method -full details of methods used which are unlikely to 
be accessible to competent authority of the Member State to which the dossier is 
submitted, should be attached to the study or test report 
Where test guidelines provide choice as to the method to be used, a reasoned 
justification for the choice made 
Where deviations from the test guidelines specified, or from other methods used, are 
employed,  ~  description of and reasoned justification for the deviations 
Where relevant, an indication as to whether, or not, the test or study has been 
conducted by a laboratory certified as to its competence to conduct the test or study in 
compliance with the principles of GLP 
Where relevant, the certifying authority 
Where applicable, an indication as to whether, or not, the principles of GLP have 
been complied with 
8.4  Where relevant, a justification for non compliance with the principles of GLP 
Provided 
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Appendix ll  .  Fonns for use in cheddne dossiers 
for completeness 
Part 5  Evaluation Fonn 5 Trer I Quality Checks 
Active Substance:  Applicant:  Date: 
"rest or Study Title:  Annex Point: 
Test or  Description of the requirement 
Study Point 
9.1 
9.2 
9.3 
10 
11 
12.1 
12.2 
13 
Where relevant, a clear statement that the ~uirements  of points 2.2 and 2.3 of the 
introduction to Annex ill  have been complied with - Good Experimental Practice 
(GEP)  · 
Where the requirements of points 2.2 and 2.3 of the introduction to Annex III apply, 
whether conducted by an official or an officially recognized testing facility or 
organization 
Where relevant, a justification for non compliance with the requirements of points 
2.2 and 2.3 of  the introduction to Annex III 
A description of  the test system 
The identity of  any statistical and other teclmiques applied to the data to aid 
interpretation, together with adequate documentation thereof and a justification for 
the use of  the teclmique selected where non standard teclmiques are used 
Where reference to published papers is made in Tier I checks as to the quality of 
individual test and study reports, the bibliographic references concerned 
On request, copies of  the papers concerned 
Where reference to unpublished data is made in Tier I checks as to the quality of 
individual test and study reports (e.g. historical control data on strains of  test 
animals) a summary of such data 
Assessment of  the Acceptability of  the Quality of the Report 
Report of acceptable quality 
Comments: 
Signature: 
0  Yes  :  No 
Provided 
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Appendix 11  . Part6  Listing of the test guideUnes specified and the requirements relating to compliance with GLP and 
GEP for individual Anne:.: I lA tests and studies 
Part 6  Listing of tbe test guidelines specified and tbe requirements relating to compliance witb 'GLP 
and GEP for individual Annex IIA tests and studies 
19 
Choice of  GLPor 
Annex IIA  Description of  the test or study  Guideline  method  GEP 
point  specified 
20  provided by  applicable 
guideline 
1.11  Analytical profile of  batches  GLP 
2.1.1  Melting/Freezing temperature  EEC A.1  Yes  GLP 
2.1.2  Boiling temperature  EECA.2  Yes  GLP 
2.1.3  Decomposition of  sublimation temperature  EECA.2.  Yes  GLP 
2.2  Relative density  EECA.3  Yes  GLP 
2.3.1  Vapour Pressure  EECA.4  Yes  GLP 
2.3.2  Volatility (Henry's law constant)  GLP 
2.5  Spectra (UVMS, IR., NMR, MS), molecular  GLP 
extinction at relevant wavelengths -
2.6  Water solubility  EECA.6 
I  Yes  GLP 
2.7  Solubility in organic solvents 
2.8  Partition coefficient  EECA.~  Yes  GLP 
2.9.1  Abiotic degradation hydrolysis as a function of  pH  EEC C.7  No  GLP 
19 For reference purposes in completing Evaluation Fonn S 
20  OJ L 133, means Commission Directive 88/302/EEC. OJ No L 133 of30 May 1988 
I 
• 
I  • 
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Annex IIA 
point 
2.9.2 
2.9.3 
2.9.4 
2.10 
2.11.1 
2.11.2 
2.12 
2.13 
2.14 
2.15 
3.8.1 
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Part6  Listing of the test pldeUnes specified and the requirements relatin& to compliance with · GLP and 
GEP for Individual Annes. IIA tests and studies 
Choice of  GLPor 
Description of  the test or study  Guideline  method  GEP 
specified  provided by  applicable 
guideline 
Direct phototransformation in water  SETAC 
21  NO  GLP 
Quantum yield of  direct phototransformation in  SETAC
21  NO  GLP 
water 
Dissociation constants in water  OECD 112  Yes  GLP 
Photochemical oxidative degradation  GLP 
Flammability (solids}  EECA.10  No  GLP 
Flammability (gases)  EECA.ll  No  GLP 
Flammability (contact with water)  EECA.12  No  GLP 
Auto-ignition temperature (liquids and gases)  EECA.15  No  GLP 
Relative self-ignition temperature for solids  EECA.16  No  GLP 
UN-Bowes-Cameron-Cage-Test (UN- No 14.3.4  No  GLP 
Recommendations on the Transport of 
Dangerous Goods, Chapter 14) 
Flash point - closed cup methods only  EECA.9  Yes  GLP 
Explosive properties  EEC A.l4  No  . GLP 
Surface tension  EEC A.5  Yes  GLP 
Oxidizing properties (solids)  EEC A.l7  No  GLP 
Pyrolytic behaviour of  the active substance under  GLP 
controlled conditions at 800° C and the content 
of  polyhalogenated dibenzo-p-dioxins in the 
· products of  pyrolysis 
21 
Procedures for assessing the envirorunental fate and ecotoxicity of  pesticides.  SETAC-Europe, 1995.  ISBN number 90-5607-002-9 Appendix 11 
AnnexiiA 
point 
3.8.2 
5.1 
5.2.1 
5.2.2 
5.2.3 
5.2.4 
5.2.5 
5.2.6 
5.3.1 
5.3.2 
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. Par16  Listing of the test guideUnes specified and the requirements relating to compUance with  GLP and 
GEP for individual Annex I lA tests and studies 
Choice of  GLPor 
Description of the test· or study  Guideline  method  GEP 
specified  provided by  applicable 
guideline 
Effectiveness of methods other than controlled 
incineration for disp()sal of  the active substance, 
contaminated packaging and contaminated 
materials 
Toxicokinetic studies-
* Single dose, oral route, in rats  OIL 133  No  GLP 
(p 51) 
*  Second single dose, oral route, in rats  OIL 133  No  GLP 
(p 51) 
*  Repeated dose, oral route, in rats  OIL 133  No  GLP 
(p 51) 
Acute toxicity (oral)  EECB.l  Yes  GLP 
or B.1 bis 
Acute toxicity (dermal)  EECB.3  No  GLP 
Acute toxicity (inhalation)  EECB.2  No  GLP 
Acute toxicity (skin irritation)  EECB.4  No  GLP 
Acute toxicity (eye irritation)  EECB.5  No  GLP 
Skin sensitization  EECB.6  Yes  GLP 
Repeated dose (28 days) toxicity (oral)  EECB.7  No  GLP 
Sub-chronic oral toxicity test: 90-day repeated oral  OIL 133  No  GLP 
dose using rodent species  (p 8) 
Sub-chronic oral toxicity test: 90-day repeated oral  OIL 133  No  GLP 
dose using non-rodent species  (p 12) 
Sub-chronic oral toxicity test: 12 month repeated  GLP 
oral dose using non-rodent species 
I 
I 
I 
I 
I 
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I 
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point 
5.3.3 
5.4.1 
5.4.2 
5.4.3 
5.5 
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. Part 6  Listin~ of the test guldeUnes specified and the requirements relating to compUance with  GLP and 
GEP for Individual Anne:~ IIA tests and studies 
Choice of  GLPor 
Description of  the test or study  Guideline  method  GEP 
specified  provided by  applicable 
guideline 
Repeated dose (28-days) toxicity (inhalation)  EECB.8  No  GLP 
Sub-chronic inhalation toxicity test: 90-day  OJ L 133  No  GLP 
repeated inhalation dose study using rodent  (p 20) 
species 
Repeated dose (28-days) toxicity (dennal)  EECB.9  No  GLP 
Sub-chronic dennal toxicity test: 90-day repeated  OJL 133  No  GLP 
dennal dose study using rodent species  (p 16) 
Mutagenicity (Salmonella Typhimurium - reverse  EECB.l4  No  GLP 
mutation assay) 
Mutagenicity (in vitro- mammalian cytogenetic  EECB.IO  No  GLP 
test) 
In vitro mammalian cell gene mutation test  OJL 133  No  GLP 
(p 61) 
Mutagenicity (micronucleus test)  EECB.l2  No  GLP 
Mouse spot test  OJL 133  No  GLP 
(p 82) 
Mutagenicity (in vivo mammalian bone-marrow  EECB.ll  No  GLP 
cytogenetic test. chromosomal analysis) 
Rodent dominant lethal test  OJL 133  No  GLP 
(p 76) 
In vivo mammalian genn cell cytogenetics  OJ L 133  No  GLP 
(p 79)  ' 
Mouse heritable translocation  OJL 133  No  GLP 
(p 85) 
Chronic toxicity test  OJ L 133  No  GLP 
(p 27) 
Carcinogenicity test  OJL 133  No  GLP 
(p 32) 
Combined chronic toxicity/carcinogenicity test  OJ L 133  No  GLP 
(p 37) 
Mechanistic studies  GLP Appendix 11 
Annex IIA 
point 
5.6.1 
5.6.2 
5.7 
5.8.1 
5.8.2 
6.1 
6.2 
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Par16  Listing of the test guldeUnes specified and the requirements relating to compUance with  GLP and 
GEP for individual Annex IIA tests and studies 
Choice of  GLPor 
Description of the test or study  Guideline  method  GEP 
specified  provided by  applicable 
guideline 
Two-generation reproductive toxicity test  OJL 133  No.  GLP 
(p 47) 
Separate male and female reproductive toxicity  GLP 
tests 
Three segment design studies  GLP 
Dominant lethal assay for male fertility  GLP 
Cross-matings of  treated males with untreated  GLP 
females and vice versa 
Effect on spermatogenesis  GLP 
Effects on oogenesis  GLP 
Sperm motility, mobility and morphology  GLP 
Investigation of hormonal activity  GLP 
Teratogenicity test - rodent and non-rodent  OJL 133  No  GLP 
(p24) 
Acute delayed neurotoxicity of organophosphorous  OECD418  No  GLP 
substances 
Toxicity studies on metabolites  GLP 
Supplementary studies on the active substance  GLP 
Metabolism. distribution and expression of  Commission  GLP 
residues in plants  Guidelines 
22 
Metabolism, distribution and expression of  Commission  GLP 
residues in livestock  Guidelines 
22 
22 Commission document 1607  Nl/97 - rev I of  22 July 1997, Guidelines for the generation of  data concerning residues as provided in Annex II 
part A. section 6 and Annex III, part A, section 8 of  Directive 9Ij414/EEC concerning the placing of  plant protection products on the market 
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point 
6.3 
6.4 
6.5.1 
6.5.2 
6.6 
6.9 
7.1.1.1.1 
7.1.1.1.2 
\7.1.1.2.1 
7.1.1.2.2 
- JlS- Page 6 of9 
Part6  Listing of the test guidelines specified and the requirements relating to compUance with  GLP and 
GEP for individual Annex IIA tests and studies 
Choice of  GLPor 
Description of the test or study  Guideline  method  GEP 
specified  provided by  applicable 
guideline 
Residue trials (supervised field trials)  Commission  GLP 
Guidelines 
22 
Livestock feeding studies  Commission  GLP 
Guidelines 
22 
Effects of industrial processing and/or household  Commission  GLP 
preparation (representative processing situations)  Guidelines 
22 
on the nature of the residue 
Effects of industrial processing and/or household  Commission  GLP 
.  preparation on residue levels  Guidelines 
22 
Estimates of residues in succeeding crops  Commission 
Guidelines 
22 
Residue trials in succeeding crops  Commission  GLP 
Guidelines 
22 
Estimation of potential and actual exposure  WHO 
through the diet and other means  Guidelines 
23 
Aerobic degradation (route) in soil  SETAC
21  No  GLP 
Anaerobic degradation (route) in soil  SETAC
21  No  GLP 
Soil photolysis  SETAC
21 
Aerobic degradation (rate) in soil  SETAC
21  No  GLP 
Anaerobic degradation (rate) in soil  SETAC 
21  GLP 
Soil (field) dissipation studies  SETAC 
21  No  GLP 
Soil (field) residue studies  SETAC 
21  No  GLP 
Soil (field) accumulation studies  No  GLP 
23 Guidelines for predicting dietary intake of  pesticide residues. WHO. 1989~ 
Application of  risk analysis to food standards issues. Report of  the Joint F  AO/WHO Expert Consultation. Geneva. Switzerland. 13-17 March 
1995 (WHOIFNU/FOS/95.3)~ 
Reconunendations for the revision of  the guidelines for predicting dietary intake of  pesticide residues. Report of  a F  AO/WHO Consultation. 
1995 (WHO/FNU/FOS/95.11) Appendh ll 
Annex IIA 
point 
7.1.2 
I  7.1.3.1 
I  , 
7.1.3.2 
7.1.3.3 
7.2.1.1 
7.2.1.2 
7.2.1.3.1 
7.2.1.3.2 
7.2.1.4 
8.1.1 
8.1.2 
8.1.3 
8.2.1 
8.2.2.1 
8.2.2.2 
8.2.2.3 
8.2.3 
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Part6  Listing of the test l'lideUnes specified and the requirements relating to compliance with  GLP and 
GEP for individual Annex IIA tests and studies 
Choice of  GLPor 
Description of  the test or study  Guideline  method  GEP 
specified  provided by  applicable 
guideline 
Adsorption/desorption  OECD 106  No  GLP 
Column leaching studies  SETAC 
21  Yes  GLP 
Aged residue column leaching studies  SETAC
21  No  GLP 
Lysimeter studies  SETAC
21  Yes  GLP 
Field leaching studies  SETAC 
21  Yes  GLP 
Abiotic degradation hydrolysis as a function of  pH  EEC C.7  No  GLP 
Direct phototransformation in water  SETAC
21
.  No  GLP. 
Quantum yield of  direct phototransformation in  SETAC
21  No  GLP 
water 
Biodegradation: determination of "ready"  EEC C.4  Yes  GLP 
biodegradability 
Water/sediment study  SETAC 
21  No  GLP 
Degradation in the saturated zone  GLP 
Avian acute oral toxicity test  SETAC 
21  No  GLP 
Avian dietary toxicity (5-day) test  OECD 205  No  GLP 
Avian subchronic and reproductive toxicity test  OECD 206  No  GLP 
Acute toxicity for fish  EEC C. I  No  GLP 
Chronic (28-day) toxicity to juvenile fish  GLP 
Fish early life stage toxicity test  OECD 210  No  GLP 
Fish life cycle test  GLP 
Bioaccumulation: flow through fish test  OECD 305E  No  'GLP 
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I 
I 
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point 
8.2.4 
8.2.5 
8.2.6 
8.2.7 
8.2.8 
8.3.1.1 
8.3.1.2 
8.3.2 
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·  Part 6  Listing of the test pldeUnes specified and the requirements relating to compUance with GLP and 
GEP for individual Annex IIA tests and studies 
Choice of  .GLP or 
Deseription of the test or study  ·  Guideline  method  GEP 
specified  provided by  applicable 
guideline 
Acute toxicity for Daphnia  EEC C.2  No  GLP 
Acute toxicity for aquatic insects  GLP 
Acute toxicity for aquatic crustaceans  GLP 
Acute toxicity for aquatic gastropod molluscs  GLP 
Daphnia sp. reproduction test- 21 day  OECD202  No  GLP 
Part II 
Aquatic insect chronic toxicity/reproduction test  GLP 
Aquatic gastropod mollusc chronic toxicity/  GLP 
reproduction test 
Algal inhibition test  EECC.3  No  GLP 
Acute toxicity to sediment dwelling organisms  GLP 
Chronic toxicity to sediment dwelling organisms  GLP 
Effects on aquatic plants  GLP 
Honeybee acute oral toxicity test  EPPO 170  No  GEP~GLP 
24 
Honeybee acute contact toxicity test  EPPO 170  No  GEP-GLP 
24 
Hon~ee  brood feeding test  ICPBR  No  GEP-GLP 
24 
Effects on non-target terrestrial arthropods using  SETAC- GEP-GLP 
24 
artificial substrates  ESCORT 
Effects' on non-target terrestrial arthropods in  SETAC- GEP-GLP 
24 
extended laboratory tests  ESCORT 
Effects on non-target terrestrial arthropods in  SETAC- GEP-GLP 
24 
semi field tests  ESCORT 
24 
At the discretion of the Member State in which they are conducted, tests started on or before 31  December 1999, to be conducted in 
accordance with the principles ofGEP. thereafter to be conducted in accordance with the principles ofGLP Appendix 11 
Annex IIA 
point 
8.4.1 
8.4.2 
8.5 
8.6 
8.7 
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Part6  Listing of the test &WdeUnes specified and the requirements .relating to compUance with  GLP and 
GEP for individual Annex IIA tests and studies 
Choice of  GLPor 
Description of the test or study  Guideline  method  GEP 
specifi.ed  provided by 
guideline 
applicable 
Earthwonn, acute toxicity test  OJ L 133  No  GLP 
(p 95) 
Sublethal effects on earthwonns  GLP 
Impact on soil microbial activity  SETAC
21  GLP 
Rates of recovery following treatment  SETAC
21  GLP 
Effects on other non-target organisms believed to 
be at risk 
Effects on biological methods for sewage treatment  GLP 
I 
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Llstln1 of the test pideUnes specified and the requirements relating to compUance with GLP and 
GEP for individual Annex IliA tests and studies 
Part 7  Listing of the test guidelines specified and the requirements relating to compliance with  GLP 
and GEP for individual Annex lliA tests and studies 
25 
Choice of  GLPor 
Annex IliA  Description of  the test or study  Guideline  method  GEP 
point  specified  provided by  applicable 
guideline 
2.2.1  Explosive properties  EEC A.l4  No  GLP 
2.2.2  Oxidizing prol>erties .(solids)  EEC A.l7  No  GLP 
2.3  Flash point - closed cup methods only  EECA.9  Yes  GLP 
Flammability (solids)  EEC A.IO  No  GLP 
Flammability (gases)  EEC A.ll  No  GLP 
Flammability (contact with water)  EECA.l2  No  GLP 
Auto-ignition temperature (liquids and gases)  EEC A.l5  No  GLP 
Relative self-ignition temperature for solids  EECA.16  No  GLP 
UN-Bowes-Cameron-Cage-Test (UN- No 14.3.4  No  GLP 
Recommendations on the Transport of 
Dangerous Goods, Chapter 14) 
2.4.1  Free acidity or alkalinity  CIPACMT  Yes  GLP 
31 
Determination of  pH values  CIPACMT  Yes  GLP 
75 
2.4.2  Determination of  pH values  CIPACMT  Yes  GLP 
75 
2.5.1  Viscosity of liquids  OECD 114  Yes  GLP 
2.5.2  Viscosity of non ·newtonian liquids  GLP 
2.5.3  Surface tension  EEC A.5  Yes  GLP 
2.6.1  Relative density  EECA.3  Yes  GLP 
25  For reference purposes in completing Evaluation Fonn S 
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point 
2.6.2 
2.7.1 
2.7.2 
2.7.3 
2.8.1 
2.8.2 
2.8.3 
2.8.4 
2.8.5 
2.8.6.1 
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Par17  -Listing of the test guldeUnes specified and the requirements relating to eompUance with  GLP and 
GEP for Individual Annex lilA tests and studies 
Choice of  GLPor 
Description of  the test or study  Guideline  method  'GEP 
specified  provided by  applicable 
guideline 
Bulk (tap) density  CIPACMT  Yes 
33, 159 or 
169 
Accelerated storage tests by heating  CIPACMT  Yes  GLP
26 
46 
Minimum content after heat stability testing  GLP
26 
Low temperature stability  CIPACMT  Yes 
3'9, 48, 51 or 
54 
Shelf  life following storage at ambient temperature  GIFAP 
Method 
27 
Wettability of  dispersible powders  CIPACMT  Yes 
53.3 
Persistent foaming  CIPACMT  Yes 
47 
Suspensibility  ..._CIPACMT  Yes 
15, 161 or 
168 
Spontaneity of  dispersion  CIPACMT  Yes 
160 or 174 
Dilution stability  CIPACMT  No 
41 
Dry sieve test  CIPACMT  No 
59.1 
Wet sieve test  CIPACMT  Yes 
59.3 or 167 
Particle size distribution  OECD 110  Yes  GLP 
Nominal size range of  granules  CIPAC MT  Yes  GLP 
58 3 or 170 
26  GLP required only if  on the basis of  theoretical considerations, hazardous compounds may be fonned during storage 
27  GIFAP Monograph No. 17 Appendix 11 
Annex IliA 
point 
2.8.6.2 
2:8.6.3 
2.8.7.1 
2.8.7.2 
2.8.8.1 
2.8.8.2 
2.8.8.3 
2.9.1 
2.9.2 
2.10 
4.1.2 
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Part7  Listing or the test guldeUnes spedfted and the ~ulrements relating to eompUanee with  GLP and 
GEP for inilJvidual AnneJ. IliA tests and studies 
Choice of  GLPor 
Description of  the test or study  Guideline  method  GEP 
specified  provided by  applicable 
guideline 
Dust content  CIPACMT  Yes  GLP 
171 
Particle size distribution  OECD HO  Yes  GLP 
Friability and attrition characteristics of  granules 
Emulsion characteristics of  emulsifiable  CIPACMT  Yes 
concentrates  36 
Stability of  ~luted emulsions  CIPACMT  No 
173 
Stability of  dilute emulsions  CIPACMT  Yes 
20 or 173 
Flowability of  granules  CIPACMT  No 
172 
Pourability (including rinsed residue) of  CIPACMT  No 
suspensions  148 
Dustability after accelerated storage  CIPACMT  No 
34 
Physical compatibility of  tank mixes 
Chemical compatibility of  tank mixes 
Distribution on seeds  CIPACMT 
175 
Adherence to seeds 
Drop test for packaging  ADR3552  Yes 
Leakproofness test  ADR 3553 or  Yes 
3560 
Internal pressure (hydraulic) test  ADR3554  No 
Stacking tesi  ADR3555  No 
Supplementary permeability test for drums and  ADR3556  No 
jerricans 
'Approval of  combination packagings  ADR3558  Yes 
Child resistant packaging - testing procedures for  ISO 8317  Yes 
re-closable packages 
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4.1.3 
4.2 
4.4 
4.6.1 
4.6.2 
4.6.3 
7.1.1 
7.1.2 
7.1.3 
7.1.4 
7.1.5 
7.1.6 
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.  Part 7  Listing of the test guidelines speclfled and the requirements relating to compUance with  GLP and 
GEP for Individual Annex IliA tests and studies 
Choice of  GLPor 
Description of  the test or study  Guideline  method  GEP 
specified  provided by  applicable 
guideline 
Resistance of  the packaging material to its  GIFAP  No 
contents  Method 
27 
Effectiveness of  cleaning procedures for 
application equipment and protective clothing 
Effectiveness of  protective clothing and equipment 
under realistic conditions of  use  · 
Toxicity of  fire effiuents  ISOTR 9122  Yes 
Evaluation of  products of  neutralization (small 
quantities) 
Evaluation of  products of  neutralization (large 
quantities) 
Pytolytic behaviour of  the active substance under  GLP 
controlled conditions at 800° C and the content 
of  polyhalogenated dibenzo-p-dioxins in the 
products of  pyrolysis 
. Effectiveness of  methods other than controlled 
incineration for disposal of  plant protection 
products~ contaminated packaging and 
contaminated materials 
Acute toxicity (oral)  EEC B. I  Yes  GLP 
or B. I bis 
Acute toxicity (dermal)  . EEC B.3  No  GLP 
Acute toxicity (inhalation)  EEC B.2  No  GLP 
Acute toxicity (skin irritation)  EEC B  .  .J  No  GLP 
Acute toxicity (eye irritation)  EEC B.5  No  GLP 
Skin sensitization  EECB.6  Yes  GLP Appenclb: 11 
Annex IliA 
point 
7.1.7 
7.2.1.1 
7.2.1.2 
7.2.2 
7.2.3.1 
7.2.3.2 
7.3 
7.4 
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·  Part 7  Listing of the test pideUnes specified and thl' requirements relating to compliance with  GLP and 
GEP for individual Anne:~ IliA tests and studies 
Choice of  GLPor 
Description of  the test or study  Guideline  method  GEP 
specified  provided by  applicable 
guideline 
Acute toxicity (oral)  EECB.l  Yes  GLP 
orB.l bis 
Acute toxicity (  dennal)  EECB.3  No  GLP 
Acute toxicity (inhalation)  EECB.2  No  GLP 
Acute toxicity (skin irritation)  EECB.4  No  GLP 
Acute toxicity (eye irritation)  EECB.5  No  GLP 
Skin sensitization  EECB.6  Yes  GLP 
Estimates of  operator exposure 
Measurement of  operator exposure  Directive 
88/642/EEC
28 
.  GLP 
E~mateofbystanderexposure 
Measurement of  bystander exposure  GLP 
Estimates of  worker exposure 
Measurement of  worker exposure  GLP 
Dennal absorption, in vivo in the rat  GLP 
Comparative dermal absorption, in vitro using rat  GLP 
and human skin 
Toxicological data for each formulant 
28  In so far as inhalation exposure is concerned. measuring procedures used must either comply with the reference method in the Armex to 
Council Directive 88/642/EEC of 16 December 1988, amending Directive 80/11 07/EEC on the protection of  workers from the risks related to 
exposure to chemical, physical and biological agents at work.  OJ No L 336,  24 December 1988, p 74, or be a method yielding equivalent 
results 
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Appendix 11  Part7  Listing or the test luideUnes speclfted and the requirements relating to compUance with  GLP and 
GEP for individual Anne1 IliA tests and studies 
Annex IliA  Description of the test or study 
point 
8.1 
8.2 
8.3 
8.4 
8.5 
8.8 
Supplementary studies on metabolism, distribution, 
and expression of residues in plants and livestock 
Supplementary residue trials (supervised field 
trials) 
Supplementary livestock feeding studies 
Supplementary studies on th~ effects of industrial 
processing and/or household preparation (balance 
studies) 
Supplementary residue trials in succeeding crops 
Estimation of  the potential and actual exposure 
through diet and other means 
Guideline 
specified 
Commission 
Guidelines- 29 
Commission 
Guidelines 
29 
Commission 
Guidelines 
29 
Commission 
Gui~elines 
29 
Commission 
Guidelines 
29 
WHO 
Guidelines 
30 
Choice of 
method 
provided by 
guideline 
GLPor 
GEP 
applicable 
GLP 
GLP 
GLP 
GLP 
GLP 
29  Commission document 1607Nl/97-rev 1 of22 July 1997, Guidelines for the generation of  data concerning residues as provided in 
Annex II part A. section 6 and Annex III, part A. section 8 of  Directive 91/414/EEC concerning the placing of  plant protection products on the 
market 
30 Guidelines for predicting dietary intake of  pesticide residues, WHO, 1989; 
Application of  risk analysis to food standards issues, Report of  the Joint FAO/WHO Expert Consultation. Geneva, Switzerland, 13-17 March 
1995 (WHOIFNU/FOS/95.3); 
Recommendations for the revision of  the guidelines for predicting dietary intake of pesticide residues, Report of  a F  AO/WHO Consultation. 
1995 (WHOIFNU/FOS/9 5.11) Appendh-ll 
Annex IliA 
point 
9;1.1.1 
9.1.1.2 
9.1.2.1 
9.1.2.2 
9.1.3 
9.2.1 
9.2.2 
9.2.3 
9.3 
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Part7  Listing of the test pld~Unes speclfted and the requirements relating to compUance with  GLP and 
GEP for individual AQnex IliA tests and studies 
Choice of  GLPor 
Description of the test or study  Guideline  method  GEP 
specified  provided by  applicable 
guideline 
Aerobic degradation (rate) in soil  SETAC
31  No  GLP 
Anaerobic degradation (rate) in soil  SETAC
31  No  GLP 
Soil (field) dissipation studies  SETAC
31  No  GLP 
Soil (field) residue studies  SETAC.31  No  GLP 
Soil (field) accumulation studies  SETAC
32  No  GLP 
Column leaching·studies  SETAC
31  Yes  GLP 
Lysimeter studies  SETAC
31  Yes  GLP  · 
Field leaching studies  SETAC
31  Yes  GLP 
Predicted environmental concentrations in soil 
(PECs) 
Predicted environmental concentrations in. ground 
water (PECaw) 
Additional field testing  GLP 
Impact on water treatment procedures  GLP 
Predicted environmental concentrations in surface 
water (PECsw) 
Additional field testing  GLP 
Fate and behaviour in air  GLP 
31  Procedures for assessing the environmental fate and ecotoxicity of  pesticides.  SETAC-Europe. 1995.  ISBN number 90-5607-002-9 
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Appendix 11 
Annex IliA 
point 
10.1 
10.1.1 
10.1.2 
10.1.3 
10.1.4 
10.2 
10.2.1 
10.2.2 
10.2.3 
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Part7  Listing or the test guideUnes specified and the requirements relating to compliance with  GLP and 
GEP for Individual Anne1 IliA tests and studies 
Choice of  GLPor 
Description of the test or study  Guideline  method  GEP 
specified  provided by  applicable 
guideline 
Acute toxicity exposure ratio (TER,..) for birds 
Short-term toxicity exposure ratio (TERs,.) for 
birds 
Avian acute oral toxicity  SETAC
31  No  GLP 
Supervised cage trials  GLP 
Supervised field trials  GLP 
Avian palatability test  GLP 
Effects of secondary poisoning  GLP 
Acute toxicity exposure ratio (TER,..) for fish, 
Daphnia, aquatic insect species, aquatic 
crustacean species and gastropod mollusc species 
Long-term toxicity exposure ratio (TE~T)  for 
fish, Daphnia, aquatic insect species, aquatic 
crustacean ~ies,  gastropod mollusc ~es  and 
algae 
Acute toxicity for fish  EECC.1  No  GLP 
Acute toxicity for Daphnia  EECC.2  No  GLP 
Algal inhibition test  EEC C.3  No  GLP 
Microcosm or mesocosm study  SETAC- Yes  GLP 
Huntingdon 
&EWOFT 
Residue data in fish  SETAC- Yes  GLP 
Huntingdon 
&EWOFT Appendix 11 
Annex IliA 
point 
10.2.4 
10.3 
10.4 
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. Part 7  Listing of the test pldeUnes speclfled and the requirements relating to compliance with  GLP and 
GEP for Individual Annes IliA tests and studies 
Choice of  GLPor 
Description of  the test or study  Guideline  method  GEP 
specified  provided by  applicable 
.  guideline 
Chronic (28-day) toxicity to juvenile fish  GLP 
Fish early life stage toxicity test  OECD 210  No  GLP 
Fish life cycle test  GLP 
_  Daphnia sp. reproduction test - 21 day  OECD202  No  GLP 
Part II 
Aquatic insect chronic toxicity/reproduction test  GLP 
Aquatic gastropod mollusc chronic toxicity/  GLP 
reproduction test 
Acute toxicity exposure ratio (TE~)  for 
terrestrial vertebrates other than birds 
Short-term toxicity exposure ratio (TERs-r) for 
terrestrial vertebrates other than birds 
Long-term toxicity exposure ratio (TE~T)  for 
terrestrial vertebrates other than birds 
Acute oral toxicity 
GLP 
Supervised cage trials 
GLP 
Supervised field trials 
GLP 
Palatability test for terrestrial vertebrates other 
than birds  GLP 
Effects of  secondary poisoning 
GLP 
Hazard Quotient for bees - oral exposure (~o) 
Hazard Quotient for bees - contact exposure 
(~c) 
I 
'  I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
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I I 
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I 
I 
I 
I 
I 
I 
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Appendis 1l 
Annex IliA 
point 
10.4.1 
10.4.2 
10.4.3 
10.4.4 
10.4.5 
10.5.1 
10.5.2 
10.6.1 
10.6.1.1 
10.6.1.2 
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.  Part 7  Listing of the test guideUnes spedfted 1111d  the requirements relating to eompUanee with  GLP 1111d 
GEP for Individual Anne1 IliA tests 1111d studies 
Choice of  GLPor 
Description of the test or study  Guideline  method  GEP 
specified  provided by  applicable 
guideline 
Bee acute oral toxicity test  EPPO 170  No  GEP-GLP 
32 
Bee acute contact toxicity test  EPPO 170  No  GEP-GLP
32 
Bee residue test  GEP-GLP
32 
Bee cage tests  EPPO 170  No  GEP-GLP 
32 
. Bee field tests  EPPO 170  No  GEP-GLP
32 
Investigation of special effects  GEP-GLP 
32 
Bee tunnel tests  EPPO 170  No  GEP-GLP
32 
Effects on non-target terrestrial arthropods using  SETAC- GEP-GLP-
32 
artificial substrates  ESCORT 
GEP-GLP 
32 
Effects on non-target terrestrial arthropods in  SETAC-
extended laboratory tests  ESCORT  GEP-GLP
33 
Effects on non-target terrestrial arthropods in  SETAC-
semi field tests  ESCORT 
Effects on non-target beneficial arthropods in field  SETAC- GEP-GLP
32 
tests  ESCORT 
Acute toxicity expo~e  ratio (TERA) for 
earthworms 
Long term toxicity exposure ratio (TERr.T) for 
earthworms 
Earthworm acute toxicity test  OECD207  No  GLP 
Sublethal effects on earthworms  GLP 
32 
At the discretion of  the Member State in which they are conducted, tests  started on or before  31  December  1999. to be conducted in 
accordance with the principles ofGEP. thereafter to be conducted in accordance with the principles ofGLP Appendix 11 
Annex IliA 
point 
10.6.1.3 
10.6.2 
'  10.7.1 
10.7.2 
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Part7  Listing of the test pideUnes specified and the requirements relating to eompUance with  GLP and 
GEP for individual Annex IliA tests and studies 
Choice of  GLPot 
Description of the test or study  ·  Guideline  method  GEP 
specified  provided by  applicable 
guideline 
Effects on earthworms in field tests  GLP 
Residue content of earthworms  GLP 
Effects on other soil non-target macro-organisms  GLP 
Effect on organic matter breakdown  GLP 
Laboratory test to investigate impact on soil  SETAC
31  No  GLP 
micro~ial activity 
Further laboratory testing to investigate impact on  GLP 
soil microbial activity 
Glasshouse testing to investigate impact on soil  GLP 
microbial activity 
Field testing to investigate impact on soil microbial  GLP, 
activity 
I 
I 
I 
I 
I 
I 
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